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DIRECTOR'S REPORT
When I was a boy in Chicago, the scientist was a poorly
paid, absent-minded dreamer, very bright, if not a
genius, and culturally destined never to lead the masses,
much less have anything to say to any public official
more important than a high school principal. Then
came Oppenheimer and the atomic bomb, and physi-
cists became men of affairs whom we and the Generals
could not live without. Biologists were another matter.
No one thought they posed a threat to anyone; they
would grow better hybrid corn or even someday cure
cancer, if they stayed by themselves and did not take on
roles where they would only get in someone else's way.
I became one of them, and for twenty years it seemed I
had entered the best of all possible worlds. Lots of
money was dug up by Mary Lasker and her crowd, with
scarcely any accountability save for the quality of our
science. Even better, no one got mad at us when we
didn't soon hit lots of practical medical jackpots. And so
it went until Vietnam. Then came the teach-ins at which
our students were told that the White House collectively
had the brains of a goose, a belief soon reinforced by
Lyndon Johnson when he went out to NIH to give the
word that we troublemakers had better start being useful
or the gravy train would end.
Being a brand-new Salk, however, is not that easy. It is
not that we do not want to be do-gooders, but if it was a
cinch to come up with a new vitamin that would make
everyone live to 100 years of age without Social Security
it would have happened long ago. Invariably, great
challenges mean we don't know what to do next. Con-
sequently, most of our research efforts are holding oper-
ations which, given time, hopefully will generate unex-
pected observations. With further luck we may gain a
fresh outlook on some pressing human problem such as
too many mosquitos or god-awful arthritis. So while
generally we don't go to work thinking about what we
can do next for our fellowman, we never lost any sleep
worrying about whether we were in cahoots with the
idle rich who preach the virtues of hard work to others
and then live off more pollution. Far better to be thought
unworldly and of conscience clean.
Now, however, we are in a strange mess. The word is
about that we are closet big businessmen who need to
be kept in check by massive regulations, if not the threat
of jail. And all because the word has been spread that
DNA, the stuff that makes up our genes, might do us all
in. I find this total nonsense and cannot think of any
potential environmental pollutant that worries me less.
Everyone I know who now works with DNA feels the
same, and mere mention of "NIH Guidelines" or
"Memorandums of Understanding" makes our mouths
froth. Under ordinary circumstances our response
would be obvious-head down to Washington and tell
Congress that these scaremongers are an odd coalition
of environmentalists wanting to block anything new and
middle-class leftists who view the new genetics as a
plausible tool for further "enslaving the masses."
The heart of our trouble, however, does not lie with
the far-out doomsday scenarios these pathetic souls
peddle. It was we presumably responsible molecular
biologists who first gave the DNA scare its legitimacy.
To be sure we never said we were deeply worried, for
none of us were. I don't remember experiencing even
five seconds of mild anxiety prior to signing the call for a
moratorium. This document, a semiofficial response to
fears of genetic engineering at the service of CIA types,
urged restraints on the making of certain recombinant
genomes until we convened a gathering of international
bigwigs at Asilomar on the Monterey Peninsula. There
we were to discuss whether the 1973 breakthrough that
gave us recombinant DNA was likely to generate
dangerous new bugs. I didn't know how we could solve
this dilemma but saw no harm in calling for a little
scientific restraint in the then post-Watergate mood of
self-confession. Most of us were liberal-left types from
birth, and our fellow McGovernites would now see that
we were not always out for quick fame and could place
the general good ahead of our immediate scientific
goals.
Here we were terribly naive-the real world never
stops anything it wants unless it has already smelled
smoke. Though everyone at Asilomar kept saying "po-
tential risk," experienced newspaper addicts thought
differently. No one would invent phrases like P3 or EK2
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cannot be dishonest. This is a point about which Con- 
gress needs no education, and once the issue was raised 
on Capitol Hill it became very likely that some form of 
punitive legislation would be enacted to ensure strict 
compliance with the guidelines.
If, instead, the recombinant DN A community had 
been divided as to whether we needed any guidelines, 
the final outcome would have been less clear and might 
have been decided by whether the Senate and the 
House had the gumption for still another regulatory 
commission. But with virtually every first-class molecu- 
lar geneticist then arguing that we needed protection 
from ourselves. Congress would have been accused of 
shirking its duty if it did not seize the initiative. It then 
became a question of how to get a law where we, not the 
professional demonstrators, would control the action.
Up through today the final outcome is still unclear, 
and that three years have passed since Asilomar without 
legislation reflects more the inherent chaos of Congress 
than the skill with which we lobby. Though there have 
been moments of panic, the situation is now less out of 
control. The most chilling early proposal from Senator 
Kennedy's bailiwick was that final power should reside 
in a committee so constituted by law that scientists who 
know what DN A is must be in the minority. The vision of 
a "Friend of the Earth" bearing a large wig righteously 
telling us what not to do could be a scene from MASH. 
And Representative Rogers' Health Subcommittee dal- 
lied briefly with the thought that the way to keep us 
B e a n  was the taint of a felony and $50,000־a־day fines, 
penalties which most certainly would make docile pup- 
pets even of our nation's bankers, much less our scieti- 
tists.
Through these ups and downs we occasionally h^ve 
had the hope that recombinant DN A would finally so 
bore Congress that no one would do the work necessary 
to see a bill through to enactment. I don't think, how- 
ever, that we shall ever win this way. As long as most 
responsible scientists are thought to favor perpetuation 
of the guidelines, every incident of suspected cheating 
will rekindle some new hysterical outburst. O n ly if the 
scientific community en masse asserts strongly that the 
guidelines can go, do we have a fighting chance to 
weather such incidents without the possible creation of 
a truly imbecilic law.
I fear, however, that we academics do not have the 
skilled politician's knack of suddenly reversing his 
course Without the slightest suggestion that he is soft in 
the brain. So the prevailing approach today is to urge the 
enactment of a much watered-down bill that will both 
keep all control over recombinant D N A research within 
NIH and preempt the power of local bodies to make 
their own decisions as to which experiments should be 
done. There are dreams that we might even get a sunset 
clause that would limit the legislation to a several- 
year period, after which everyone, could bury the
unless they could measure the monster's size. The very 
act of setting up committees to pinpoint the "most risky" 
experiments could only magnify the public fear that we 
biologists now had our own diabolical form of the 
bomb.
By this stage I knew we were in way over our heads 
and felt that this senseless hysteria should somehow be 
nipped in the bud. So I argued, to the surprise of most at 
Asilomar, against the forming of any official guidelines 
that spelled out how we should work with recombinant 
DNA. I thought any regulations by necessity had to be 
capricious, and in the absence of even the slightest 
reason for being afraid, we were very silly to be making 
all this fuss. O nly Joshua Lederberg and Stanley Cohen  
were publicly on my side, and those who privately 
agreed with me thought I was risking my hide by appear- 
ing so indifferent to the general good. Almost everyone 
reasoned that the publ ic would not dump the matter and 
so went along with Sidney Brenn^s.eloquent plea thal 
we must make a show of seff: restraint or the lawyers and 
ethicists would take over and give us stupid laws that 
could really shut us down.
Unfortunately, the high hopes of many that A|ijbmar 
might defuse the public concern, were soon dashed. 
Within weeks Congress got into the act, and the guys 
who gave us the guidelines soon found Themselves in 
front of Senator Kennedy. Given the importance as- 
cribed to the topic, ,he saw no reason to accept the 
argument that a matter which, might affect the life or 
death of our society should be left jp. the scientists' 
hands. Just the opposite— it seemed the perfect occa- 
sion for the public to be Risked whether they were to be 
the next guinea pigs for our experiments. Here the 
molecular biologists quickly found they had little room 
to maneuver. Since they were not that afraid, they could 
only say that there was no reason to be so concerned, 
and certainly no reason for specific laws to control us. 
On the other hand, they were tied to the Asilomar, 
message— we need guidelines. So they were left to 
argue the point of how safe would it be everyone 
followed the guidelines and did the "potentially most 
risky" Experiments using specially disabled bacteria 
and elaborate containment facilities designed to pre- 
vent the escape of organisms bearing recombinant 
DNA. Not surprisingly, this message failed to reassure 
Kennedy, who could not believe that the Asilomar lead- 
ers would propose diverting significant amounts of 
scarce research funds for protective measures or risk 
creating a brand new bureaucracy unless they were 
much moresscared than they publicly let out.
, This and every subsequent defense of the guidelines 
led automatically to how we would deal with sloppy lab 
practices, if not downright cheating. No one would be 
so foolish as to suggest that mistakes will never occur or 
that molecular biologists are so unworldly that they
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guidelines without acute embarrassment. If all this were
to come about, we could breathe easier and stop de-
spairing that we may have closed the door in this coun-
try to many of the better experiments that we can do on
the origins of cancer. For the moment, however, we
must remain on guard. The final form of any legislation
is often imprinted at the last moment in conference, and
I see no reason for expecting that Senator Kennedy will
give way on preemption. So we had best face up to the
prospect that local governments will be able to justify
their own bans by citing Federal law as proof that re-
combinant DNA poses a realistic threat.
We can only hope that those scientists whose first
foray into the public arena gave us Asilomar will ask
themselves whether, if Asilomar had never occurred,
they would now see any compelling public health rea-
son to propose formal restrictions on recombinant DNA
research. If their answer is no, they should ask Congress
for another chance to be heard. They should not delude
themselves that Congress's main advice has come from
the likes of George Wald. Their role has been much
more of noise than of substance. At present, any legisla-
tion that we may finally get will reflect Congress's belief
that they have sensed the mood of our most down-to-
earth experts, and that the guidelines are what they
want. I do not believe this, but I effectively speak only
for myself. Now is the time for my fellow DNA workers
to come forward and speak their minds.
Highlights of the Year
A remarkable research result
Nine years ago when we commenced work on the DNA
tumor viruses we had two main objectives. Obviously,
one was to learn how these viruses transform normal
cells into their cancerous equivalents. The other was to
probe more deeply the molecular genetics of eukaryotic
cells. Recombinant DNA was then hardly a gleam in
anyone's eye, and direct assaults on the immense
genomes of higher eukaryotes were limited necessarily
to highly redundant sequences such as those coding for
the ribosomal RNAs. The only totally clean eukaryotic
DNA available came from viruses, and we chose to
work on two of the most simple examples, the very small
monkey virus, SV40, and the moderately sized human
adenoviruses.
At first our work went slowly compared to that of our
colleagues who remained focused upon bacteria.
Growing up sizable amounts of any animal virus is
seldom a routine, cheap matter, and the methodologies
for working with very small amounts of viral DNA were
not in hand. Fortunately, the situation improved
quickly. First came Cot analysis and the restriction en-
zymes, then gel electrophoresis, the Southern blot, even
better EM methods, and finally the incredibly fast DNA
sequencing tricks. As a result, work on the molecular
biology of tumor viruses now proceeds as fast as com-
parable work on bacterial and phage DNA.
Thus, early in 1977 the stage was set for the carrying
out of experiments (independently here and at MIT) that
were to revolutionize our ideas of genes and the pro-
teins for which they code. The details of our experi-
ments are described in the Year-round Research Section,
and here I want only to relate our total amazement when
we realized that the adenoviral primary transcripts were
modified by a splicing process that removes one to
several internal sequences. Although we had expected
processing, we thought that it would occur by simple
removal of sequences at the 5' and/or 3' ends. The
counter proposal that processing occurs by removal of
multiple internal sections would have been thought
irresponsible speculation had not our experiments been
so foolproof. Soon hints of a similar situation in SV40
emerged from NIH, and at the RNA Tumor Virus Meet-
ing the possibility was raised that splicing generates the
several classes of Rous sarcoma virus messengers. Now
there is a growing belief that splicing may occur in all
eukaryotes, and we expect that a multiplicity of proteins
will be generated from many "single genes."
Spl icing is likely to be the most important observation
in molecular genetics since the 1960 discovery of mes-
senger RNA. Immediately it has led to an explosion of
experiments aimed at understanding its enzymological
basis. And for many genes that previously we instinc-
tively thought would code for a single protein, we now
look to see if there are multiple products. Already it is
clear that the early SV40 "A gene" codes for both "big
T" and "small T/' and we suspect that only through
splicing will we be able to analyze correctly the
transforming region at the left-hand end of the adenovi-
ral genome.
That we have played a major role in such a fundamen-
tal discovery owes much to our Center Grant from the
National Cancer Institute. It let us have an unusually
large number of staff members all focusing on the
molecular biology of tumor viruses. Their collaborative
efforts let us quickly marshall all the key facts.
An historic Symposium on Chromatin
In June our 42nd annual Symposium had chromatin for
its topic. It attracted a record three-hundred and
seventy-five scientists, the large audience properly re-
flecting the intense efforts that now exist in so many
leading laboratories to correlate eukaryotic chromo-
some structure and function. Happily we persuaded
Francis Crick to give the opening talk, in which he
cautioned all to stick to facts and avoid speculation.
Most everyone followed his advice, and when the time
came for Pierre Chambon to summarize, his task to
range from nucleosomes through splicing was indeed
formidable. He did a magnificent job and the meeting
ended in a mood of exhausted euphoria.
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Francis Crick at 1977 Symposium
Because our lecture hall seats only some two-
hundred and thirty, we used closed-circuit TV to bring
the proceedings to several other rooms. And we put up a
large tent behind Blackford so that we could run two
separate food lines even if it were to rain. Despite the
necessary hecticness, no one complained and almost
everyone stayed with the proceedings all throughout the
very long morning and evening sessions.
A very pleasant break for the speakers were the dinner
parties given by many of our neighbors. This tradition
goes back almost two decades, and this year we wish to
thank in particular Mr. and Mrs. T.S. Browne, Mr. and
Mrs. Roderick Cushman, Mr. and Mrs. Norris Darrell,
Jr., Mrs. William Flanigan, Mr. and Mrs. Charles Gay,
Mr. and Mrs. George Hossfeld, Jr., Mr. and Mrs. Gordon
Lamb, Mr. and Mrs. Samuel Parkinson, Mr. and Mrs.
James Pirtle, Jr., Mr. and Mrs. Edward Everett Post, Mr.
and Mrs. Edward Pulling, Mr. and Mrs. Franz Schneider,
Mr. and Mrs. Richard J. Weghorn, and Mrs. Alex White.
A very full program of summer meetings and courses
Our summer session lasted almost four months, com-
mencing in early May with a small meeting on "Par-
voviruses," the tiny, single-stranded, linear DNA
viruses whose replication cycle should provide key in-
sights into how DNA duplicates. The next meeting, on
"The Transformed Cell," was necessarily more hetero-
geneous because we wanted an overview of recent
work on the phenotypes of the cancer cell. The "RNA
Tumor Viruses" gathering was again mammoth, but two
poster sessions kept it in bounds, and the final result was
generally thought first-rate.
As soon as the Symposium ended, our courses began.
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Most had been given before, but two had changes of
emphasis. Instead of a course covering all of Animal
Cell Culture, we settled on "The Transformed Cell" to
give prominence to newer techniques that look at the
biochemistry of the cancer cell. Likewise, the Animal
Virus offering became more restricted, with the entire
emphasis on "Oncogenic Viruses." Our Neurobiology
offering included one brand new course, "The
Synapse." It was essentially an intense lecture-
discussion course and was followed by a month-long
opportunity for almost half the students to do experi-
ments in a "Synapse Workshop" held during July in
McClintock laboratory.
Meetings took over again in mid-August with a suc-
cessfully large gathering on the "Molecular Biology of
Yeast." The annual "Phage Meeting" was in two parts;
the first, which was devoted specifically to single-
stranded DNA phages, will yield in 1978 a volume in
our Monograph series. Next came our "SV40, Polyoma,
and Adenoviruses" meeting, again very large but well
worth the intensity. Concluding the summer was our
fifth Conference on Cell Proliferation, this year devoted
to the "Differentiation of Normal and Neoplastic
Hematopoietic Cells."
Dedication of the Banbury Conference Center
The formal opening of the Banbury Conference Center
was marked by an Open House held in the late after-
noon of Sunday, June 14, for members of the Long Island
Biological Association. Francis Crick was the inaugural
speaker and gave a short, elegant address on "How
Scientists Work." He talked about the need for scientists
to meet frequently with their peers who have the same
objectives. Going to each others' labs is generally much
too time-consuming and expensive, and the best way to
sort out the meanings of new ideas and experiments is to
come together at small conferences like those which we
plan for the Banbury grounds. Our main guest of honor
was Mr. Charles S. Robertson, whose most generous gift
of the Banbury main house, outbuildings, and grounds
allowed the creation of the Center. Many of his family
were also able to join us, and the occasion was a most
happy one. Everyone appeared to like, if not be thrilled
by, the most imaginative renovation scheme which has
provided what we believe to be the most striking con-
ference center now available to biologists.
Later in the summer the lecture components of our
courses on the Synapse and on Tumor Immunology
were held in the Conference Center, with the students
living in Robertson House. Subsequently, we had
numerous discussions as to what should be the first
emphasis for the Banbury Conferences, which will be
held during the spring and fall. The general consensus
was that we should focus on Biological Risk Assess-
ments, particularly of agents thought to act at the genetic
Banbury Conference Center
level. Toward this end a program was developed for
possible consideration by foundation and government
funding sources. Hopefully, this effort will be in full
operation starting in late September of 1978.
Proposed expansion of our Neurobiology teaching
We now have in McClintock and Jones laboratories
first-class facilities for teaching and research in
neurobiology. Thanks to much assistance from the
Sloan Foundation, the Robertson Research Fund, and
the Marie H. Robertson Memorial Neurobiology Fund,
they are splendidly equipped and in the summer let us
offer the world's most advanced program of neurobiol-
ogy teaching. These facilities, however, remain essen-
tially vacant during the remainder of the year, and the
question has been raised whether we could also use
them for programs of year-round research.
To discuss this problem, we assembled late in August
an Ad Hoc Neurobiology Advisory Committee. It was
chaired by Charles Stevens of Yale and had as its other
members David Hubel of Harvard Medical School, Eric
Kandell of the College of Physicians and Surgeons of
Columbia University, Jac Sue Kehoe and Phil I ipe Ascher
of the Eco le Norma le Superieure, Paris, and Rami
Rahamimoff of Hebrew University Medical School,
Jerusalem. They pointed out that the appointment of
neurobiologists to our staff would automatically pre-
empt space that now is used for teaching. If we were to
have, say, three to four full-time neurobiologists, we
would seriously have to restrict teaching in either Jones
or McClintock lab, and this
the number of our courses. The courses we would drop,
however, could not be picked up easily by another
institution and would most likely vanish. So instead of
trying to put together a permanent neurobiology staff,
our advisors urged that uncommitted funds for
neurobiology should go toward the initiation of addi-
tional courses.
We have taken their advice ana arranged two new
courses for this coming summer. One will be a lecture
course on Developmental Neurobiology, to be given on
the Banbury grounds. The other will be a laboratory
course in Jones on the newer neuroanatomical methods
being developed for use in probing the organization of
the central nervous system. The starting of these new
courses will be made possible by the Marie H.
Robertson Memorial Fund for Neurobiology.
As for potential winter use, our committee urged that
we try to attract groups of neurobiologists for joint sab-
batical activities. The eventual success of that plan is
likely to depend on the availability of more governmen-
tal support for our teaching efforts, thereby freeing up
our own funds to support sabbatical activities. Because
of the payback and other restrictions in the current
legislation affecting training grants, federal monies to
support our neurobiology teaching have proved most
9
difficult to arrange. Now our federal contract covers
only one-third of the cost of these programs.
A monumental publication on the
Origins of Human Cancer
Just before the New Year our 1900-page, three-book set
"The Origins of Human Cancer" was published. The
bringing out of these proceedings of our fourth Confer-
ence on Cell Proliferation required a prodigious effort
to ensure that they would successfully record the high
quality of our September 1977 meeting. These volumes
represent the most complete overview yet attempted on
the origins of cancer and should have a major intellec-
tual impact on the cancer research of the next decade.
Toward that end we have kept the price of the books
much below commercial practices and hope that their
distribution will widen correspondingly. We wish to
thank both the Rita Allen Foundation and the Charles E.
Merrill Trust for grants that covered part of the necessar-
ily large production costs.
Our newest Symposium volume was also a major
accomplishment. Two books were required to record
"The Origins of Lymphocyte Diversity." As our Sym-
posia grow more and more crowded with speakers, the
resulting proceedings must grow accordingly. Seeing
that they appear well in advance of the following year's
meeting is not a routine matter, and the help of many
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neighbors is required to minimize the time required for
proofreading.
A much bigger task than anyone predicted was the
publication of the proceedings of our May 1976 "DNA
Insertions" meeting. This was to be a small book, priced
cheaply, and quickly in print. In the end it became a
horrendously complex 800-page book, filled with mas-
ses of tables and maps, and written by authors who
made major changes in proof. When it emerged late in
November, we could not quite believe it had made it.
The final ending, however, is a happy one. All the delays
have helped create a most important book which may
turn out to be a minor best seller.
We thus remain most fortunate that we have a publi-
cations group that responds cheerfully to almost any
setback and which never settles for less than first-class
products. Great credit must go to Ms. Nancy Ford, who
this year has been most ably assisted by Annette
Zaninovic, Roberta Salant, Paul Bethge, Virginia Cleary,
and Thelma Sambrook.
Occupancy of the new Williams House
By frantic efforts all through the spring, the new Wil-
liams House became available late in June for use by
summer course instructors and participants in our
Neurobiology Workshops. The five highly imaginative
apartments that it provides should radically change life
along Bungtown Road and may bring back hints of the
Williams House
isasmioss"
Edward Pulling at LIBA meeting
small village atmosphere that existed during the 1840-
1860 whaling days.
The availability of the Williams apartments has let us
move on to the almost complete rebuilding of Cole
Cottage. Though superficially one of our older dwel-
lings, this cottage first materialized in the early 1930s as
a small, uninsulated building suitable for only summer
occupancy. Subsequently, it was enlarged, given a
bulky hot-air heater, and later became known for its
exorbitant heating costs, Renovation efforts will be
complete by early April, and already we can see that
Jack Richards and his staff will pull off another project
they can be proud of.
Another year of strong support from LIBA
This past year the Long Island Biological Association
(LIBA) came very close to completing its fund drive to
cover construction and furnishing of the new Williams
House. Only $15,000 remains to be raised out of the
total goal of $225,000. The raising of a sum this large,
entirely from neighbors, is a most remarkable achieve-
ment, and we shall long remain indebted for this support
which has been most effectively marshalled by LIBA
Chairman Mr. Edward Pulling. Here I should note that
Ed has now passed his 10th year as Chairman. It is
impossible that anyone could have handled LIBA's af-
fairs more effectively than he, and we are indeed fortu-
nate to have such a remarkable friend to help direct our
future.
The Annual Meeting of LIBA occurred on Sunday,
December 11, the speaker being Dr. George D. Rug-
gieri, Director of the New York Aquarium and Osborn
Laboratories of Marine Sciences. His talk on "Drugs
from the Sea" gave us a most lively look at marine
animals and the remarkable way they may be used for
man's benefit. Departing from the LIBA Board at the
conclusion of the maximum term were Mr. Duncan
Cox, Mr. Arthur M. Crocker, Mr. Nevil Ford, and Mr.
Angus P. McIntyre. All have been active, long-time sup-
porters of the Lab, and we trust we can still count on
their active interest in our future projects. Newly elected
to the LIBA Board were Mr. S.R. Calloway, Mr. Richard
Olney III, Mr. Stanley Trotman, and Mrs. Alex White.
LIBA has for over fifty years been a major factor in our
past successes, and as the Laboratory Director I cannot
stress too strongly how wonderful it is to know that they
are on our side.
Changes in our scientific staff
In the fall we keenly felt the departure of two invaluable
members of our staff. George Fey returned to Lausanne
to a research position at the Swiss Institute for Experi-
mental Cancer Research. George's presence gave us the
talents of a first-class protein chemist, and we sorely
miss his good-natured excellence.And Lan Bo Chen
moved to the Sidney Farber Cancer Center in Boston.
Lan Bo's energy is almost unlimited, and while with us
he carried out many important experiments on the LETS
protein and how its absence from cells is correlated with
of cancer.
We have lost two talented postdocs, John Hassell,
who now has a position at the University of Sherbrooke,
and Elizabeth Ljungquist, who joined the staff at the
Karolinska Institute in Stockholm. We also miss Jim
Manley, who goes to postdoc at MIT after doing most of
his Stony Brook Ph.D. thesis in Ray Gesteland's lab, and
Norman Maitland, who finished his University of Bur-
mingham Ph.D. thesis here with Jim McDougall and
now is in Ken Jones's lab in Edinburgh.
Promoted from Staff Investigator to Senior Staff Inves-
tigator was Louise Chow. Keith Burridge, Dietmar
Kamp, and Regina Kahmann have moved up from the
postdoc ranks to Staff Investigator positions.
The National Cancer Institute award for
construction of a new cancer research facility
In late August the National Cancer Institute formally
awarded us a construction grant of $1.5 million to help
erect a new building for our cancer research efforts. The
major research focus of this new facility will be the
mouse. The building will provide us with extensive
quarters for small laboratory animals as well as a new
complex of laboratories where we shall use molecular
biology to study the early developmental stages of the
mouse and how failures in differentiation may lead to
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the generation of cancer cells. Architectural planning is
being done by the noted firm of Moore, Grover and
Harper of Essex, Connecticut, and we hope to initiate
construction early in 1979. Toward this end we are
actively pursuing the necessary matching funds to cover
the now anticipated final cost of 3.2 million dollars.
Already we have received a most welcome grant of
$150,000 from the Kresge Foundation.
We become more complex to administrate
Although I often fantasize that with each successive year
the Lab will be easier to run, the opposite is happening.
We cannot have more courses and meetings, a sparkling
new conference center, a real endowment, and steadily
more powerful research programs without paying the
price of more administrative complexity. That we re-
main on top owes much to our Administrative Director,
William Udry. Bill has that indispensable knack of re-
maining intelligently optimistic no matter how great the
upheaval and never responds to complexities with
money instead of sense. He has been greatly aided by
our invariably helpful Comptroller, William Keen, and
by the good-natured astuteness of John Maroney our
Purchasing Agent. An unambiguous tribute to their op-
eration came with our recent HEW audit. We were not
seriously faulted on our grant management, and unlike
many leading universities not asked to return improp-
erly spent monies.
An indispensable Board of Trustees
The matters that we bring each year to our Board of
Trustees are frequently not simple, and we continue to
depend much upon their seasoned responses to a
necessarily heterogeneous mix of trivia and the impor-
tant. Most fortunately we have in Harry Eagle a Chair-
man who is near perfect in knowing the tenor of our
various funding sources and so advising us when it
would pay to think big. We moreover can only marvel at
the speed with which Harry runs through tricky agen-
das. Unfortunately, this year we lost the services of Drs.
Sherman Beychok, Robert Webster, Lewis Thomas,
Messrs. Angus P. McIntyre, Charles S. Robertson, and
Colton Wagner. All have served us well, and we shall
much miss their counsel. In particular, I wish to point
out the extraordinary help given by Angus McIntyre. As
our Treasurer for the past four years, Angus was a bas-
tion of sensible advice and performed many, many in-
valuable functions. Fortunately, we have persuaded
Clarence Galston to succeed Angus as Treasurer, and
we shall continue to have experienced integrity at our
side.
At the conclusion of our Annual Meeting on October
12, 1977, a special dinner was held in Robertson House
to honor our retiring Trustees and express our firm hope
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that we shall still be able to count on their able counsel.
Newly elected to the Board this year as Institutional
Trustees were Dr. Charles R. Cantor to represent Co-
lumbia University and Dr. Walter Guild to represent
Duke University. Our new individual Trustees are Mr.
Robert L. Cummings of Laurel Hollow, Mr. Walter
Frank, Jr. of Locust Valley, Mrs. Robert H.P. Olney of
Lloyd Harbor, and Mr. William S. Robertson of Lloyd
Harbor.
The transfer of Wawepex Society assets to the Lab
Science first came to Cold Spring Harbor under the
patronage of Mr. John D. Jones, a member of the illustri-
ous Long Island Jones family who gave the name to the
great beach on the south shore and which dominated
commercial life at Cold Spring Harbor during the 19th
century. Mr. Jones, as President of the Atlantic Mutual
Insurance Company, presided over the largest marine
insurers in the United States and as such was one of New
York City's leading citizens. He was a man of much
strength, and in early life came out for the rights of
slaves, an opinion that angered certain neighbors and
may have led to the burning of his house on the west
shore of Cold Spring Harbor. Later he rebuilt on that site
the grand Victorian house that we now call the Carnegie
Dorm.
In the early 1880s he and his friend, Eugene
Blackford, a leading Fulton Street fish merchant, started
a fish hatchery on his land next to St. John's Church.
Several years later in 1890 he gave the funds and land
for the starting up of the Biological Laboratories adja-
cent to the hatchery. When its first permanent building,
now known as Jones lab, was completed early in
1892, Mr. Jones set up the Wawepex Society to ensure
long-term financial support for his fledgling scientific
community. For over eighty years the Wawepex Society
has flourished as an independent body which long has
been one of our steadiest benefactors. The recent pas-
sage of the Foundation Reform Act, however, made
unnecessarily complicated the long-term existence of
such a family foundation. So over the past several years
the Wawepex Society has transferred to us its assets,
including the land near 25A which we had leased from
them since our creation. The Wawepex Society will
continue to exist, and one of its members, by bylaw a
Jones family descendant, will always continue to be a
member of our Board of Trustees. Since I have been the
Director, Mr. Dudley Stoddard, Mr. Townsend Knight,
and Mr. Bache Bleeker have been our Wawepex Trust-
ees and all have been among our most devoted cham-
pions.
Our long period of emergency is over
For the past fifteen years we have had to work very
hard-first to survive when the Carnegie Institute of
Washington began the close down of its Department of
Genetics and then to grow again into a serious body for
the advancement of fundamental biology. In the begin-
ning the outcome was in doubt, and only through the
efforts of many loyal friends did the Participating Institu-
tions come into existence and join forces with our
friends in this community to see that we kept going as an
independent body. The first years after the reorganiza-
tion were agonizing, but under John Cairns's intelligent
direction the worst was passed, and we were on an
upward course when I took over as Director. Initially, I
focused upon the restoration of a vigorous scientific
program, believing that if we could get rolling, funds
would somehow materialize for our badly worn out
physical plant. Naturally, we were so absorbed in catch-
ing up that our outlook was inward, with little time to
think about the prohlemc of others.
Now we are completely different. The science we do,
the demanding excellence of our courses and meetings,
and the high quality of our publishing program convey
to the world outside the aura of a quality post-graduate
university. We worry not about becoming good, but
instead on how to ensure that we continue to carry out
science at the highest possible level. This is a very new
problem for us, and we are still somewhat uncertain
how we should proceed.
To start with, I suspect that we shall have to provide
more long-term stability for our staff than seemed ideal
when we were just getting going. Our future is too
important to rest on only a few heads, and the expecta-
tion of spending a major fraction of one's research life
here is probably a necessary ingredient in developing
the necessary loyalties. I suspect that tenure in the con-
ventional academic sense is not the answer because
there is no place here for anyone to go asleep intellectu-
ally on full pay. Instead, I believe we should move
toward positions where our more senior staff have con-
tracts that always have at least five more years to run.
This security should allow our scientists to undertake
projects which may require many exploratory years
before results of deep significance materialize.
It is important here to realize that our own resources
can never guarantee the funds that our scientists will
need for their research. For the main part these must
come from federal sources, and the long-term ability of
our senior staff to continue high-powered science will
be largely a function of their past track records. This
situation, of course, is not unique to us and holds for
virtually every important research institution in this
country. We thus can hope that means will be found to
reverse the current discouraging trend for most funding
sources to award monies for shorter and shorter inter-
vals. The insecurity this creates cannot be overem-
phasized and increasingly leads to overattention to
problems whose answers we already partially know.
We must also accept the fact that we cannot go on
expecting our friends to always front for our causes. We
are again strong enough to help fight the battles in
Washington over how the federal monies for science
should be distributed. Only by joining in can we be sure
that our positions are heard, and, conceivably, help lead
to wiser decisions on Capitol Hill and within NSF and
NIH. The time so spent will divert us from our experi-
ments, but we should not have strong opinions unless
we are willing to fight for them.
We should also be increasingly concerned with the
future of Long Island. Our Cold Spring Harbor commu-
nity is still one of the more attractive sites where science
is now practiced in the United States. This may no
longer be the case if virtually all our green fields become
lost first to suburban sprawl and then to suburban blight.
Unlike individual families, we do not have the choice of
moving, and we would be most short-sighted if we did
not fight to keep Long Island livable. We have many
friends who feel as strongly, and we must work hard and
effectively together.
I conclude by noting that this is my tenth report as the
Director. That I still look forward so much to what we
can do in the future owes immeasurably to my wife Liz.
We married just as I took over, and her steadfast desire
never to do a job half-well has been a major factor in
keeping our sights so high.




MOLECULAR BIOLOGY OF TUMOR VIRUS
J. SAMBROOK, M. Botchan, A. Dunn, G. Fey, D. Galloway, L. Garbarini, Y. Gluzman, R. Greene, T. Grodzicker, J.
Hassell, R. Kelch, M. Lazarus, M. Mathews, R. McGuirk, R. Pashley, W. Schaffner, J. Schneider, M. Sleigh, R. Tjian,
W. Topp, S. Weirich, I. Wendel, S. Young
Our major areas of interest are (1) how the various
products of the early region of the SV40 genome cause
cells to enter and settle in the transformed state; (2)
adeno-SV40 hybrid viruses; (3) SV40 as a vector for the
insertion of genes into mammalian cells; and (4) the
structure and synthesis of specific RNAs coded by
adenoviruses.
Integration and expression of SV40 products in
relation to transformation
There is a wealth of evidence indicating that two condi-
tions must be fulfilled for stable transformation to occur.
First, the cells must acquire the sequences of the early
region of the SV40 genome. Usually these viral DNA
sequences recombine with those of the host and are
then passed on to the cell's descendants like any other
part of the cellular genome. In the past, part of the work
of this section has been to decipher the structure and
arrangement of the integrated viral genes in sets of
isogenic transformed cell lines. Comparative analyses at
the molecular level have shown that integration of viral
DNA does not occur at a special location in either the
host or viral genome (Botchan et al., Cell 9:269 [1976]).
Thus, there was no reason to expect that SV40 should be
integrated exclusively into a specific chromosome.
Nevertheless, C. Croce and coworkers, on the basis of
segregation studies with somatic cell hybrids, have
claimed that human chromosome 7 carries a site that is
preferentially used for integration of SV40 DNA. In the
past year, in collaboration with R. Kucherlapati, and J.
K. McDougall (of the Mammalian Cell Genetics Sec-
tion), we have analyzed the arrangement of SV40 DNA
sequences in a series of somatic cell hybrids formed
between SV40-transformed human cells (GM637) and
mouse line B82. We find that, as in other human cells
transformed by SV40, a fraction of the cells in this
population are spontaneously induced and are replicat-
ing free viral DNA. By a two-cycle purification proce-
dure involving a sucrose gradient fractionation and an
agarose gel electrophoresis separation, the replicating
free viral DNA can be removed from the chromosomal
DNA. Our hybridization analysis shows that there is one
stable insertion of SV40 DNA in cell line GM637. The
same SV40 viral insertion was detected in somatic cell
hybrids derived by cell fusion between GM637 and
mouse line B82. Furthermore, in ten hybrid clones ex-
amined, free SV40 DNA could not be observed. This
result is not surprising as the hybrid clones had lost
many human chromosomes, and therefore the genes
needed for viral replication had probably been lost. By
coordinating a careful karyotic analysis of these hybrid
clones with an SV40 T-antigen analysis, we concluded
that the single insertion of viral DNA resides in chromo-
some 8 in the parent line GM637. Although additional
independent transformed cell lines will have to be ex-
amined, it now seems quite clear that SV40 insertion
into human DNA is not chromosome-specific, as sites
have been mapped to chromosomes 7, 8, and 17.
The second prerequisite for transformation is that the
integrated set of viral early genes must be expressed. So
far, two polypeptides have been identified as products
of the SV40 early region - the well-known T antigen
(m.w. 94,000) and a recently discovered 17,000-dalton
moiety (small t). It is securely established, by several
lines of evidence, that transformation of nonpermissive
cells by SV40 requires the presence of functional T
antigen. First, data obtained both here and in A. van der
Eb's laboratory have shown that transformation can be
achieved by infecting cells with subgenomic fragments
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of viral DNA (obtained by the use of restriction endonu-
cleases) which span the entire A gene; no fragment of
DNA that contains only a segment of the gene carries
transforming activity (Graham et al., Cold Spring Harbor
Symp. Quant. Biol. 39:637 [1975]; W. Topp, unpubl.).
Second, cells infected at the nonpermissive temperature
with viruses carrying temperature-sensitive mutations in
the A gene (tsA mutants) do not become transformed;
furthermore, temperature-shift experiments indicate
that the A-gene product begins to be required soon after
infection. Third, cells transformed at the permissive
temperature by tsA mutants of SV40 exhibit a partially
temperature-sensitive phenotype (Tegtmeyer, J. Virol.
15:613 [1975]; Brugge and Butel, J. Virol. 15:619
[1975]; Martin and Chou, J. Virol. 15:599 [1975]; Os-
born and Weber, J. Virol. 15:636 [1975]; Kimura and
Hagaki, Proc. Natl. Acad. Sci. 72:673 [1975]). Fourth,
the product of theA gene IT antigen) is always present in
transformed nonpermissive cells (Risser and Pollack,
Virology 59:477 [1974]). Fifth, revertants of cells trans-
formed by SV40 have either lost the SV40 DNA or
contain a nonfunctional viral set (Steinberg et al., Cell
13:19 [1978].
During the past year we have shown that small t also
plays a role in transformation. A series of SV40 mutants
was isolated which had suffered deletions of varying
lengths between map positions 0.54 and 0.59. Mutants
with deletions mapping within this region showed little
or no change in their ability to grow in a range of
permissive and semipermissive cells. Thus, it is clear
that the deleted sequences are not necessary for viral
replication; neither do they encode structural informa-
tion for T antigen - even the largest deletion caused no
detectable change in the size of T antigen measured by
SDS-acrylamide electrophoresis. Similar results have
been reported for the mutant d1884 by Shenk et al. (I.
Virol. 18:664 [19761) and Tegtmeyer (cited in Cole et
al., I. Virol. 24:277 [1977]). In addition, we found no
difference in the T-antigen levels measured by comple-
ment fixation in CV1 cells 48 hours after infection with
mutant or wild-type virus.
Although T antigen appeared to be unaffected by
deletions in the 0.54 - 0.59 region, the small t protein,
first described by Prives et al. (Proc. Natl. Acad. Sci.
74:457 [19771), was either reduced in size in extracts
from cells infected with the mutants or absent entirely.
This constitutes strong evidence that part of the coding
sequence for small t protein lies between positions 0.54
and 0.59 on the genome. More importantly, the deletion
mutants are defective in their capacity to transform cer-
tain lines of cultured cells. Thus, when compared by the
same assay, rabbit fibroblasts and the revertants of rat-1
SV40 transformants were more readily transformed by
the deletion mutants than the original rat-1 line or NIH
Swiss 3T3 cells. In addition, a striking effect was found
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when the ability of the mutants to transform was mea-
sured by different assays. Thus, the efficiency of trans-
formation of rat embryo fibroblasts by the deletion mut-
ants was indistinguishable from that by wild-type virus
when the assay was carried out at low cell density, i.e.,
by plating cells out at low dilution after infection and
scoring for the formation of densely staining colonies.
However, when the cells were not subcultured after
infection, so that transformation required formation of a
dense focus of cells in a monolayer, transformation by
the deletion mutants was not above background levels.
A possible explanation for this assay-dependence be-
came clear during a closer examination of the properties
of the rat embryo fibroblast lines transformed by mutant
and wild-type virus. All lines displayed a transformed
morphology, and there was little difference in the
abilities of wild-type and mutant transformants to grow
in low and high serum. However, all 13 lines of mutant
transformants reached a saturation density of 2-3 x 105
cells/cm2, only about twice that of the nontransformed
parent; whereas in similar experiments cells trans-
formed by wild-type virus reached significantly higher
saturation densities (4-6 x 10' cells /cm'; Risser and
Pollack, Virology 59:477 [1974]). In our experiments all
but one of the wild-type transformants sloughed off the
plate before a saturation density was reached.
Moreover, only one out of thirteen mutant transformants
grew in semisolid medium, whereas five out of seven
wi Id -type transformants gave measurable colony forma-
tion. It is not surprising, therefore, that the mutants
appear not to transform when assayed by dense-focus
formation on a monolayer of nontransformed cells or by
growth on semisolid medium. From these results it
seems that transformants derived from the deletion mu-
tants are generally less transformed than those derived
from wild-type virus and generally resemble in their
properties the minimal transformants described by Ris-
ser and Pollack (Virology 59:477 [1974]). Studies are
now underway to determine whether cells transformed
by the mutants are tumorigenic.
The major problem that we now face is to define
precisely how small t and T antigen interact with the
cellular machinery to produce the transformed
phenotype. No data are yet available for small t, al-
though it is interesting to speculate that the protein may
be a protein kinase or a protease. In the past twelve
months, however, we have gained significant insight
into the nature of the interaction between T antigen and
specific sequences of nucleic acid. Progress actually
began with the discovery that cells infected with the
Ad2-SV40 hybrid Ad2+1)2 produce large quantities of a
107,000-dalton phosphorylated protein which is specif-
ically immunoprecipitated by anti-T sera and shares
extensive peptide homology with authentic SV40 T
antigen (j. Hassell et al., J. Mol. Biol. [in press ]; R. Tjian,
unpubl.). This hybrid virus greatly facilitated the difficult
task of purifying large quantities of biologically active T
antigen because large quantities of He La cells infected
with Ad2+1)2 could be grown in suspension cultures. In
addition, late after infection host protein synthesis is
inhibited by Ad2, but the infected cells continue to
produce and accumulate protein related to SV40 anti-
gen protein. Thus, 1 mg of highly purified 107,000-
dalton protein can be isolated from 16 liters of infected
He La cells in 3 days by a simple procedure involving
nuclear elution followed by three standard chromato-
graphic columns. Because the 107,000-dalton polypep-
tide encoded by Ad2+D2 is a fusion protein containing
some adenovirus-coded amino acids at its amino ter-
minus and most of the SV40 A-gene sequences at its
carboxy terminus, it is called the D2 hybrid protein.
To check that the purified protein retained at least
some of the biological activity generally attributed to
authentic SV40 T antigen, microinjection experiments
were carried out. After injection into individual cells in
culture by means of a glass capillary, the D2 hybrid
protein was shown to induce the synthesis of cellular
DNA and to provide helper function for the growth of
Ad2 in monkey cells (R. Tjian et al., Proc. Natl. Acad.
Sci. [in press]). With the reassurance that the purified
protein was biologically active, we then asked whether
it could bind to specific regions of the SV40 genome.
Purified protein was allowed to bind radio-labeled
SV40 DNA, and the DNA-protein complex was then
digested with an excess of pancreatic DNase Ito remove
107,000-dalton protein was found to bind to SV40 DNA
and to protect three fragments from nuclease digestion.
These protected fragments consist of double-stranded
DNA approximately 30, 75, and 120 nucleotides in
length. Hybridization, endonuclease cleavage, and
pyrimidine tract analysis of these DNA fragments indi-
cate that all three protected sequences arise from a
region near the origin of SV40 DNA replication and
consist of tandem binding sites extending approxi-
mately 60 nucleotides on either side of position 67. At
low concentrations of D2 hybrid protein, the preferred
binding site is a stretch of 30 nucleotides located at
about position 66; at high concentrations of protein,
binding occurs at adjacent sites extending the protected
sequence toward position 68 (Fig. 1). Thus, the D2
hybrid protein binds in a sequential manner to tandem
recognition sites located within a sequence of 120 nu-
cleotides which is likely to encompass the origin of
DNA replication and may contain the start of early and
late transcription.
More recently, specific bases (A and G), which lie
within the protected sequences and are in close contact
with the protein, have been identified by using dimethyl
sulfate in a modified DNA sequencing reaction as de-
scribed by W. Gilbert and A. Mirzabekov (pers. comm.).
These studies should yield a better picture of the actual
binding and recognition sequences within the protected
fragments. Finally, experiments have been initiated to
determine the functional role of the multiple binding
sites. These experiments involve detailed binding and
sequencing studies of DNA replication mutants con-
structed from viable viruses containing two origins of
replication (T. Shenk, Cell [in press]). We intend to
extend this approach to catalog, identify, and clone the
cellular DNA sequences with which T antigen acts.
With some luck, such studies may lead to a clearer
understanding of the role of T antigen in transformation.
We have also begun to examine the role of T antigen
in transformation of permissive cells. By analogy with
results obtained by others with nonpermissive cells
(cited above) one might have predicted that simian cells
infected at the nonpermissive temperature with tsA
mutants of SV40 would be neither killed nor trans-
formed. Surprisingly, when an early SV40 mutant, tsA
209, was used to infect CV1 cells (a permissive estab-
lished simian line) at 40.5°C, no viral DNA synthesis
was detectable; after several weeks, however, transfor-
mation was observed, as assayed by formation of dense
foci on cell monolayers. The efficiency of transforma-
tion was about 0.1%.
The properties of one established line isolated from a
dense focus are:
1. All cells are T-antigen-positive.
2. The T antigen has an electrophoretic mobility similar
to that of T antigen extracted from lytically infected
cells.
3. Cells are permissive to superinfection with either
5V40 virions or DNA.
4. The cells do not contain free SV40 DNA after incuba-
tion at the permissive temperature (33.5°C).
More lines have been isolated and their properties are
under investigation. We hope that these cell lines may
be useful in investigating, at the molecular level, an
interesting biological phenomenon - the rescue of
SV40 from transformed cells. Although a single active
copy of the viral early region is sufficient to sustain
transformation, cells usually contain additional se-
quences of viral DNA. In many cases the complete viral
genome is present: when lines of cells transformed by
SV40 and free of infectious virus are fused with simian
cells, infectious SV40 becomes detectable a day or so
later (Watkins and Dulbecco, Proc. Natl. Acad. Sci.
58:1396 [1968]; Koprowski et al., Proc. Natl. Acad. Sci.
58:127 [1968]). Our current model for the mechanism
by which rescue of viral DNA from the integrated state
might occur is shown in Figure 2.
Our recent data show unequivocally that the genetic
source for this rescued virus is the integrated copy. On
17
Hind III Hae III
A4.ACCTTTTTGCAAAAGCCTACGCCTCCAAAAAAGCCTCCTCACTACTTC
1 10 20 3n 40TTCGAAAAACGTTTTCCCATCCGGAGGTTTTTTCOCACGAGTGATCAAG
Alu I Rae III Rae III Bgl T Rae III
TCGAATAeCTCAGAGG4:CCCACGCCG+CCT+COCCTCTOCATAAATAAAAA
50 60 70 80 90ACCTTATCGACTCTCCGCCtTCCGCCCGAGCCGGAGACOTATTTATTTTT
Bgl I
AAATTACTCAGCCATGGGGEGOACA ATGGCCOGAAC.Tr:GGCCCAGTTAC








Sequence of nucleotides at the binding site of D2 hybrid protein. The sequence of 140 nucleotides in the region of the SV40 origin
of DNA replication was reproduced from the published data of Dhar et al. (Proc. Natl. Acad. Sci. 74:827 [1977]). Endonuclease
cleavage sites of the indicated restriction enzymes are represented by arrows (U). The 30-, 75-, and 120-nucleotide protected
fragments are represented by ( ), and ( ), respectively. The boxed areas in the lower diagram represent a
possible arrangement of binding sites deduced from the pattern of protected fragments. The large numbers on the bottom
represent coordinates on the conventional SV40 DNA map, and the leftward and rightward arrows represent the directions of
early and late transcription, respectively. (Reprinted, with permission, from Tjian, Cell 13:165 [1978].)
the one hand, by using sensitive blotting hybridization
techniques, we can show that no detectable free viral
DNA is carried in the transformed cell lines (less than
one copy in 1 out of 50 cells); on the other hand, after
cell fusion, between 30% and 60% of the heterokaryons
form infectious centers. This quantitation effectively
rules out the suggestion that rescue of virus reflects a
low-level, persistent infection (or plasmid state) of SV40
in a small proportion of these transformed rodent cells.
A curious problem is raised by this phenomenon in
light of the finding that the attachment of SV40 to the
host chromosome is not site-specific. How then is the
viral DNA specifically recognized for excision if there is
apparently nothing particular about its attachment se-
quences? How does the viral DNA recyclize to form
infectious SV40 DNA? Some recent observations have
given some insight into this problem. When tsA-
transformed rat cells are fused with simian cells, no free
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viral DNA is detected in the Hirt supernatants when the
heterokaryons are incubated at 41°C. However, after
shift to 32°C, free viral DNA is found to be present.
Moreover, there is a five- to tenfold increase in viral
DNA still associated with chromosomal DNA which
precedes the detection of free viral DNA. We believe,
therefore, that the first steps of viral excision involve a
T-antigen-dependent activation of the viral DNA repli-
cation in situ (steps a -e in Fig. 2). The simian cells
would then provide replicative functions not present in
nonpermissive rat cells. This polytenized structure
would be unstable, especially if replication elongation
were not a continuous process. Eventually, a newly
initiated replication fork would meet an old one, and a
free linear molecular containing SV40 DNA would be
generated (step f). Sterically free to recombine with
itself, the SV40 DNA may then re-form a circle. In this






A model for SV40 viral excision from chromosomal DNA.
duplications of integrated SV40 DNA yield infectious
virus with an efficiency 100 to 1000 times greater than
lines that show no detectable duplications. In one cell
line (14B) where the integrated viral DNA has been
carefully analyzed and shows no evidence of terminal
duplication, no infectious virus could be rescued. How-
ever, free, noninfectious viral DNA, heterogeneous in
size, could be detected in the Hirt supernatants of
heterokaryons made between 14B and CV1 cells. This
heterogeneous viral DNA has been used in a DNA
infection as a helper for tsA DNA replication in monkey
cells. Plaques were picked and it was found that the
virus stocks retained insertions of rat DNA. In view of
these findings we can then speculate (step G) that, in the
absence of tandem duplication, SV40 DNA recyclizes
by illegitimate recombination to form deletion or inser-
tion variants. An exciting extension of this reasoning,
which may be very useful for experiments involving
SV40 as a cloning vehicle, is that the SV40 origin se-








tached  to them. In support of this notion we have ob-
served excision and replication of fragments of SV40
DNA in heterokaryons formed between CV1 cells and
rat cell lines transformed with the Bam-Hpall fragment
of SV40 DNA. In short, then, all of our circumstantial
evidence supports the ideas suggested by our
replication-excision model. We intend to obtain more
direct data on the mechanisms of excision by studying
SV40 viral DNA excision from adeno-SV40 hybrid vi-
ruses and by a biochemical investigation of the factors
present in CV1 cells that allow for this replication.
Adeno-SV40 hybrid viruses
We reported last year that Ad2+ND1 host-range mu-
tants that have lost the ability to grow on monkey cells
are chain-terminator mutants. The mutants 140, 162,
and 71 fail to synthesize the 30K proteins specified in
part by the SV40 sequences they contain and instead
produce fragments of 19K (140, 162) and 10K (71). In
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collaboration with Ray Geste land and Jim Lewis of the
Protein Synthesis Section, we found that the synthesis of
the polypeptide fragments directed by mRNA isolated
from mutant-infected cells and translated in mamma-
lian cell-free systems was altered when the in vitro
system was supplemented with yeast suppressor tRNA.
The mRNA of mutant 71 is translated in the presence of
yeast ochre tRNA into wild-type-size 30K protein as
well as the 10K fragment. mRNA from mutants 162 and
140 yield large amounts of 30K protein in the presence
of amber tRNAs. We are now trying to assay in vivo the
activity of suppressor tRNAs by microinjecting them
into mutant-infected monkey cells and determining
whether the yield of virus is thereby increased.
We also reported last year that revertants of the
chain-terminator mutants could be isolated which had
regained the ability to grow efficiently on monkey cells.
Whereas revertants of 162 produced 30K protein and
had genomes identical to Ad2+N D1, some revertants of
ochre mutant 71 had suffered a deletion (revertant 07a)
or contained a partial duplication (revertants dp2a and
dp1a) of the region of the SV40 insertion. It was sug-
gested that the deletion of 07a (which eliminates the
SV40 sequences that map between positions 0.28 and
0.21) removes the ochre triplet, leaving only the C'-
terminal end of the 30K protein which is required for
helper function (see Fig. 3). This deletion now turns out
to be only one of a family of deletion revertants that have
been isolated from mutant 71. So far, five viable and
one defective mutant 71 deletion revertants have been
obtained, as well as one viable deletion revertant from
amber mutant 140 (see Fig. 4). The genomes of the
revertants have been analyzed by analysis with restric-
tion enzymes and heteroduplex mapping and the pro-
teins they produce have been studied in vivo and in










in size from 50 to 300-400 bp. None of these viruses
synthesize either the 30K protein or the mutant frag-
ment. Rather, they all synthesize new proteins, all of
which are smaller than 30K. The larger the deletion, the
smaller the protein that it produces. The defective dele-
tion revertant produces a new protein of 112-115K,
presumably because the C-terminal end of the 30K pro-
tein has become fused to a large adenoviral protein such
as hexon or 100K.
We have also isolated an additional mutant 71 rever-
tant, dp3a, which, like dpl a and dp2a, carries a partial
duplication consisting of a fusion between the begin-
ning of the adenoviral fiber gene and the distal part of
the SV40 insertion. All of the revertants with rearranged
genomes were isolated by growing the mutants at mod-
erately high multiplicities (10-50 pfu/cell) in monkey
cells, and the structures of their genomes suggest that
they have arisen as a result of unequal crossing-over (see
Fig. 3). This further suggests that the SV40 sequences in
Ad2+ND1 can recombine at low frequency with any
region of the Ad2 genome. The recombinant may be
recovered provided that the new virus has a large
enough genome to be packaged and that the distal part
of the SV40 sequences is expressed. We have examined
this possibility further by isolating from another Ad2 -
SV40 hybrid virus, Ad2+ND5, revertants that grow on
monkey cells. Although Ad2±ND5 contains SV40 se-
quences that extend from map position 0.39 to 0.11 and
produces a 42K protein (Kelly et al., J. Virol. 12:643
[1973]; Mann et al., J. Virol. 24:151 [1977]), it fails to
grow on monkey cells. By nitrous acid mutagenesis and
by passage at 10-50 pfu/cell in monkey cells, we have
obtained variants of ND5 that grow on monkey cells.
The viruses grown at moderately high multiplicities are
all defective and have suffered deletions. This suggests
that the region in Ad2+N D5 needed for helper function













Model for the generation of revertants that carry deletions and duplications.
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Revertants of Ad2+ND1 host-range mutants 71 and 140.
is intact. The nitrous acid-induced revertants have
genomes identical to Ad2+ND5, as determined by anal-
ysis with restriction enzymes, and produce the 42K
protein when SV40-specific revertant mRNA is trans-
lated in vitro.
We are presently engaged in studies to determine the
factors responsible for the growth (or lack of it) of vari-
ous mutants and revertants in monkey cells. We are
concentrating our efforts on analyzing the synthesis of a
unique class of viral mRNAs whose 5' ends consist of
adenoviral sequences and whose 3' ends consist of
SV40 sequences (hybrid mRNA). This approach has
been made possible by the development of a technique
(sandwich hybridization) in which RNA is hybridized to
defined fragments of viral DNA bound to nitrocellulose
filters in such a way that the 3' end of the RNA protrudes
as a single-stranded tail. The DNA sequences com-
plementary to the tail sequences can then be detected
by a second round of hybridization using 32P-labeled
SV40 DNA. The high sensitivity of the technique has led
to the observation that the single hybrid mRNA synthe-
sized at late times following infection of monkey cells
with Ad2+N D1 hybridizes not only to sequences adja-
cent to the SV40 insertion in Ad2+ND1, but also to other
discrete regions of the Ad2 genome. This observation,
along with similar discoveries in other laboratories, has
led to the conclusion that RNA sequences (leaders)
derived from multiple, noncontiguous areas of the viral
genome become linked during or after transcription.
Similar studies carried out with a hybrid mRNA syn-
thesized during the course of lytic infection with
Ad2+ND1 dp2 have revealed the presence of four dis-
crete leader sequences associated with sequences at the
5' end of the mRNA. We have been able to demonstrate
that, in the cytoplasm of infected cells, two classes of
hybrid mRNA exist which differ from one another in the
presence or absence of the leader sequence im-
mediately adjacent to the coding sequences of the
mRNA. We have isolated both forms of the hybrid
mRNA and have shown that each is able to function in
an in vitro protein synthesis system.
Our current hypothesis is that the leader sequences
are rather stable processing intermediates which lie at
the end of the chain of events that occurs when precur-
sors are fashioned into mRNAs. We are currently en-
gaged in experiments to test this idea.
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SV40 as a vector for the insertion of genes into
mammalian cells
A eukaryotic vector system is being developed for the
study of gene expression. Our aim is to link eukaryotic
cloned genes to defective SV40 and to propagate the
recombinants in the presence of a complementing tem-
perature-sensitive SV40 helper virus, with the following
question to be answered: Can the genes introduced into
the defective virus be expressed during the lytic infec-
tion cycle, or in cells stably transformed with such a
recombinant? For a start, we have chosen to link histone
genes of the sea urchin Psammechinus miliaris to SV40
because these genes are very well characterized. They
were first isolated by density gradient centrifugation
(Birnstiel et al., Proc. Natl. Acad. Sci. 71: 2900 [1974])
and then by cloning (Clarkson et al., Nucleic Acids Res.
3:2617 [1976]). The DNA sequence of a large, continu-
ous segment of the H2B histone gene has been pub-
lished (Birnstiel et al., Nature 266: 603 [1977]). More
than 3300 nucleotides of the 6000-bp repeat are known
to date, including the whole coding sequence, or large
sections of it, for all five histone genes, as well as pre-
lude and trailing sequences and segments of the AT-rich
spacer DNA (W. Schaffner et al., Cell [submitted]).
For the construction of an appropriate SV40 vector
(Goff and Berg, Cell 9: 695 [1976]), a DNA fragment has
been purified consisting of the origin of replication and
the whole early region, but lacking the late functions.
This fragment was elongated by terminal transferase
with about 100 dAMP residues at each end (Roy-
choudhury et al., Nucleic Acids Res. 3:863 [1976]).
Cloned 6000-bp histone DNA was fragmented to an
average size of 2000 by and was elongated by the same
enzyme with about 100 dTMP residues. Poly(A)-
elongated SV40 "early" fragment was annealed to poly
(T)-elongated histone DNA.
The resulting SV40-histone DNA recombinants were
then used in the presence of DEAE-dextran to infect CV1
monkey cells which had been infected previously with a
high multiplicity of SV40 temperature-sensitive in the
early function (tsA 209). The cells were overlayed with
agar medium and kept at high temperature. Cells that
had received both a tsA and A+-histone DNA recom-
binant could support viral growth, resulting in the for-
mation of a plaque. To date, 54 plaques which showed
hybridization to "P-labeled histone DNA have been
identified by the blotting technique of Villareal and Berg
(Science 196:183 [1977]). The virus of the correspond-
ing agar overlay has been recovered. Eight such recom-
binant clones have been purified by replaquing. Exper-
iments are in progress to find out whether sea urchin
histone genes are expressed during the lytic cycle in
monkey cells.
Another approach is the study of histone gene expres-
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sion in (nonpermissive) rodent cells transformed by re-
combinant SV40. Starting from two recombinant virus
clones, nine transformed cell lines have been obtained
and subcloned. All of them are positive in an im-
munoassay for T antigen. They are currently being
tested for the presence of sea urchin-specific DNA and
for expression of the histone genes.
Structure and synthesis of specific RNAs coded by
adenoviruses
Work has continued on both the virus-associated (VA)
RNAs and the 9S messenger RNA which codes for
polypeptide IX of adenoviral particles. Despite the
heterogeneity of VA RNAs isolated from adenovirus-
infected cell cytoplasm, there are just two genes in the
viral DNA which give rise to those small, abundant
transcripts. The genes are close neighbors, separated by
only 80 by and-unique in the viral genome-are
transcribed by the host cells' RNA polymerase Ill.
Studies of the RNAs themselves and of the correspond-
ing region of the viral DNA in this laboratory and in that
of S. Weissman have elucidated most of the sequence of
each of these two genes. As anticipated from earlier
hybridization and fingerprint data, the sequences of VA
RNA, and VA RNA', show little homology. By contrast,
the regions preceding the 5' terminus of the RNAs con-
tain a number of similar clusters of nucleotides, al-
though the sequences as a whole differ greatly. The
similarities presumably reflect the function of these re-
gions, which both groups thought to be involved in the
initiation of transcription. Other genes, from sources as
disparate as yeast and Xenopus, which are also recog-
nized by polymerase III share the same clusters of nu-
cleotides, an observation that strengthens the idea that
these sequences may play a general role in the
DNA:protein recognition process.
Unlike the genes for other structural constituents of
the adenoviral particle, the gene for polypeptide IX is
located in a portion of the genome that is transcribed
into RNA in the early phase of the infectious cycle,
before the beginning of viral DNA synthesis. The gene
also shares with one other virion component, polypep-
tide IVa2, the distinction of lying outside the region
encoding the long nuclear transcript that gives rise to
most of the "late" mRNA species. As a further corollary,
the 9S RNA product of this gene lacks the tripartite
leader sequence common to the other "late" messen-
gers. These properties suggest that the synthesis of
polypeptide IX might be controlled by a mechanism
distinct from that which operates over the other "late"
mRNAs. Experiments carried out with H. Persson and U.
Pettersson uphold this hypothesis. Polypeptide IX is first
detectable in adenovirally infected cells before the
other "late" proteins, but after the appearance of au-
thentic "early" proteins. Furthermore, unlike the other
"late" proteins, its production is not prevented by inter-
ference with viral DNA replication. On the basis of
these findings, another class of adenoviral products has
to be added to the well-established "early" and "late"
categories. By analogy with phage T4, we propose to
include polypeptide IX in a class of "quasi-late" pro-
teins, which are defined as products whose syntheses do
not require viral DNA replication absolutely but accel-
erate markedly in the postreplicative phase of the lytic
cycle.
The revelation of unexpectedly complex patterns of
overlapping and partially overlapping viral transcripts,
the result of work from several laboratories employing
varied techniques, has underlined the need for a more
detailed analysis of translationally active messenger
RNAs. Using cell-free translation systems to identify
their coding ability, we have begun to characterize
mRNAs with respect to size and sequence content.
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Suppressors
We have further characterized yeast suppressor tRNAs
using the cell-free synthesis of bacteriophage Qi3 synth-
etase as an assay system. The serine-inserting suppres-
sor tRNAs from the allelic ochre and amber resessive
lethal suppressor mutants have been purified to
50-90% homogeneity. The combination of BD cel-
lulose chromatography and Sepharose 4B chromatog-
raphy results in material that has two components, as
seen on acrylamide gel electrophoresis, one of which is
the serine-inserting suppressing species. The identity of
the second component is not yet known and has so far
proven difficult to purify from the suppressor species.
We have also been investigating a yeast UGA sup-
pressor (from Gerry Fink of Cornell University) and have
been using the readthrough of the normal UGA ter-
minator at the end of the beta chain of rabbit globin as
an assay. This UGA suppressor tRNA is strongly re-
tarded on BD cellulose. A second assay-production of
the Q/3 coat protein readthrough-does not give a posi-
tive response to this tRNA. We are currently looking at
the protein chemistry of the products from the globin
readthrough to identify which tRNA is involved.
Cloning
Using serine tRNA as a probe, we have identified three
clones among the recombinant DNA collection pro-
duced by Peter Wensink of Brandeis University and
David Botstein of the Massachusetts Institute of
Technology that have serine tRNA sequences. In addi-
tion, using the Southern procedure, the serine tRNA
probe reveals 12-14 restriction fragments from DNA of
the suppressor-carrying cells, and we are cloning these
fragments in E. coll. The known sequences for the serine
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tRNAs make strong predictions about the presence of
sites for various restriction enzymes in the DNA of these
clones and should provide valuable information for
identification of the various species. Once these
suppressor-containing clones are in hand, they will be
tested for activity by reintroduction into yeast cells and
will be used to try to construct vectors that may express
these genes in mammalian cells with the hope of pro-
ducing suppressor cell lines.
Nonsense mutants of Ad2-SV40
We have identified two amber and one ochre mutant
among the host-range mutants of Ad2-SV40 hybrid virus
isolated by Terri Grodzicker of the Tumor Virus Section.
These mutants were selected to be defective in the
SV40-encoded function that permits the hybrids to grow
in monkey cells. Thus, mRNA from the infected cells
purified by hybridization to SV40 DNA was translated
in a cell-free system to which various suppressing tRNAs
could be added. The SV40-specific message from the
wild-type infected cells encodes a 30,000 m.w. protein.
Two of the mutants produce a 19,000 m.w. protein,
which when translated in the presence of amber sup-
pressor tRNA produces some of the wild-type 30K pro-
tein. Another mutant makes a 10,000 m.w. fragment,
which when suppressed with ochre tRNA gives wild-
type product. Hence, we are convinced that ochre and
amber nonsense mutations of adeno-SV40 hybrid virus
are in hand and will provide a biological assay for
potential suppressor cell lines. We are now trying to
microinject suppressing tRNAs into mutant-infected
monkey cells to see whether these tRNAs can function
in vivo and whether serine inserted at these positions
can give a product with biological activity.
Prokaryotic translation
With the arrival of John Atkins as a visitor in the labora-
tory, we have reinvestigated the old problem of transla-
tion in vitro of RNA phage RNAs that results in the
synthesis of some small fraction of protein longer than
any of the known genes. In particular, the synthetase of
either R17 or MS2, which has a molecular weight of
63,000, is translated in vitro in predominantly this form
but also gives rise to a 5% component that has a molecu-
lar weight of 66,000. Examination of this reveals that
additional, longer components are present, and by trans-
lation under various conditions with various tRNAs, we
have tentatively concluded that the only viable explana-
tion for the existence of these longer polypeptides is that
at some low frequency ribosomes can frame-shift, thus
avoiding the normal termination site and giving rise to
proteins longer than normal. It is necessary to invoke
both +1 and 1 frame-shifting to explain the results.
The level of frame-shifting is greatly enhanced by addi-
tion of purified wild-type threonine tRNA (obtained
from Brian Reed, University of California at Riverhead)
to the cell-free system, and this enhancement is di-
minished by inclusion of increasing amounts of a spe-
cific proline tRNA. Hence, the tentative model is that
threonine tRNA is causing frame-shifting of both the +
and types of proline condons, and that if sufficient
proline tRNA is present to compete, the frame-shifting is
not observed. Experiments done to date are all cir-
cumstantial with respect to supporting these ideas, and
we are currently setting out to do appropriate protein
chemistry experiments to test the frame-shift model. In
addition, we are setting up a genetic system that we
hope will be able to answer whether such phenomena
occur in vivo and are utilized.
Host-range mutant 1 Ad2 that multiplies
on monkey cells
A variant (hr400) of Ad2 that overcomes the block to
multiplication of the wild-type Ad2 on monkey cells has
been selected, after nitrous acid mutagenesis, by se-
quential passage on monkey cells. Its growth properties
are similar on human and monkey cells and comparable
to those found for wild-type Ad2 on human cells (Kles-
sig, J. Virol. 21:1243 [1977]. An extensive comparison
of the genome of hr400 with that of its parent by restric-
tion endonucleases, electron microscopy, and hybridi-
zation analysis failed to detect any differences, which
suggests that a point mutation may be responsible for its
increased host range. SV40 sequences, which in certain
Ad2-SV40 hybrid virus (e.g., Ad2+ND1) allow adeno-
virus to multiply efficiently in monkey cells, were
not detected in hr400. Whereas the synthesis of many of
the late Ad2 proteins is markedly inhibited in monkey
cells, hr400 can fully express all of its late genes in both
monkey and human cells. Thus, the mutation affects
directly and/or indirectly the expression of most or all of
the late viral genes. The mutation has been mapped by a
modified marker-rescue technique to within 16% of the
viral genome (coordinates 59-75). Its position suggests
that it may alter a protein (100K) whose function may be
involved in the metabolism of the late viral mRNAs,
since the 100K protein has been reported to bend to
ribosomes (Russell and Blair, I. Gen. Virol. 34:19
[19771) and/or associate with RNA in the form of RNP
particles (Lindberg and Sundquist, J. Mol. Biol. 86:451
[1974]).
Common leader on late Ad2 mRNAs-RNA splicing
The analysis of the 5' termini of two late Ad2 mRNAs
which encode the fiber and 100K proteins has been
continued. After obtaining highly purified mRNA by
hybridization to restriction endonuclease fragments of
Ad2 DNA followed by electrophoresis on polya-
crylamide gels containing 98% formamide, the 5' termi-
nal oligonucleotides generated by RNase T., digestion of
the messengers were selected by dihydroxyboryl-
cellulose chromatography. Both mRNAs gave an iden-
tical 5' undecanucleotide with the general structure
7mG5'ppp5'Ar"C")U(C4U3)G. This undecanucleotide
could be removed from the mRNA by mild RNase
treatment after hybridization to DNA fragments contain-
ing the main coding sequence of the messenger. In
contrast, a small region defined by Ball E (14.7-21)
protected this undecanucleotide from RNase. A second
region contained within both HindlIl B (17-31.5) and
Hpal F (25.5-27.9), although unable to protect the
undecanucleotide, hybridized to both fiber and 100K
mRNAs and protected a similar sequence of 100 to 150
nucleotides. These observations indicate that both
mRNAs contain a long common sequence complemen-
tary to at least two different sites on the Ad2 genome
remote from the start of these two genes. This suggests
that these mRNAs are chimeric molecules, parts of
which are encoded at, at least, three noncontiguous
sites on the Ad2 genome. Electron microscopic analyses
by Chow et al. (Cell 12:1 [19771) indicate that the
common leader sequence is found on eight different late
mRNAs, including fiber and 100K, and that parts of it are
encoded at three noncontiguous segments on the viral
genome (at coordinates 17, 20, and 27). A general
mechanism for the biosynthesis of such chimeric
mRNAs from larger precursor molecules is shown in
Figure 1. Its basic feature is that two or more noncon-
tiguous segments of RNA within the large precursor
molecule, which will become adjacent, are brought
together by looping out the intervening sequences and
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Figure 1
The model diagrammed above presents a mechanism by which different segments of an RNA molecule encoded at
widely spaced sites on the DNA are brought together to form a contiguous leader sequence, which is then attached to
various structural RNAs encoded downstream. The numerical coordinates indicate the region on the Ad2 genome
encoding the three segments (XYZ) of the leader. These three segments are brought into close proximity by
looping-out of the intervening sequences (S, and S3) and are then covalently joined by intramolecular ligation. This
leader is coupled to various structural RNAs (G, -G4) encoded downstream by another looping-out of any intervening








Ribosome-binding sites on Ad2 messenger RNA
Jim Manley has investigated whether the leader se-
quences found on late Ad2 messenger RNAs are in-
volved in ribosome binding. "P-labeled mRNA was
bound to ribosomes in a reticulocyte lysate in the pres-
ence of diphtheria toxin and sparsomycin to inhibit
ribosome movement. After loading with RNase, the pro-
tected fragments were sized, fingerprinted, and hybrid-
ized to restriction fragments of Ad2 DNA. Sequences
corresponding to the 5' ends of genes could be iden-
tified, but neither the capped oligonucleotide nor the
leader sequences that map from position 17 through 27
were found. Hence, these structures that are found on
the 5' end of messenger sequences are not an intimate
part of the initiation site.
Purification and cell-free translation of Ad2 mRNA
Our efforts have continued toward producing a more
complete map of the Ad2 genome by using hybridiza-
tion to a specific fragment of Ad2 DNA to purify one or a
few mRNAs, which are then identified according to the
protein produced upon cell-free translation of the
mRNA. A few changes in our experimental procedures,
such as using higher multiplicities of infection when
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preparing early Ad2 mRNA and substituting KOAc for
KCI in cell-free translation, resulted in the recognition of
the additional early proteins 13K, 14K, 17K, and 21K.
Increasingly these experiments have benefited through
collaboration with others here at Cold Spring Harbor.
For example, Ad2 mRNA that had been characterized
by cell-free translation, and in some cases greatly en-
riched by hybridization purification, has been, in col-
laboration with Louise Chow and Tom Broker of the
Electron Microscopy Section, mapped precisely by
R-loop analysis in the electron microscope. A summary
of our current knowledge of mRNA map positions and
of the proteins encoded by each mRNA is given in Table
1.
Our previous experiments mapping late Ad2 mRNA
by hybridization to specific DNA fragments were par-
tially hampered by the fact that many late mRNAs
seemed to hybridize to two sections of the genome. The
majority of the mRNA for a given protein was selected
by hybridization to a DNA fragment specific for that
protein. However, smaller amounts of many mRNAs
were also selected by fragments from near the left end of
Ad2 DNA. In particular, each of the late Ad2 mRNAs
encoded to the right of 29 map units exhibited some
hybridization to fragments within the internal 17-19
Table 1
Coordinates of AD2 mRNAs
Map units of Ad2 DNA
Protein







Early 40-50K 0-4.4 1.3-4.0 R
Early 15K 4.4-17.0 \ R(5.0-6.4
5.0-11.1/ R
Late IX 7.5 -17.0 9.8-11.1 R
Late IVa2 7.5 -17.0 11.2-14.9(5
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rLate III 29.1-59.0
LLate V 29.1-59.0
Late P-VII 40.9 -59.0
Late P-VI 40.9 -70.7 49.5 -51.9(5 R
Late II 40.9 -70.7 51.9-62.2
Early 72K 58.5 -70.7 62.4-67.9
[Late 100K









Late IV 83.4-98.5 86.2-91.5 R
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Brackets indicate proteins whose mRNAs have not been ordered with respect to each other, or which may be translated from the
same mRNA.
Parentheses indicate mRNAs that hybridize to overlapping regions so that one or both may be the mRNA for the protein(s)
whose gene(s) map to that region.
map units. This complementarity was not shown by
early RNAs or by those late mRNAs mapping to the left
of 17-19 map units. Ashley Dunn (Mammalian Cell
Genetics Section) and John Hassell (Tumor Virus Sec-
tion) have used a different technique to show that sev-
eral mRNAs of Ad2-SV40 hybrid viruses are each
homologous to two or more widely separated regions of
the genome. These observations appear much more
sensible in light of the demonstration by Dan Klessig,
Louise Chow, and Tom Broker (Electron Microscopy
Section) and Richard Gel inas and Rich Roberts (Nucle-
ic Acid Chemistry Section) that several, if not all, Ad2
late mRNAs mapping to the right of 29 contain at their 5'
ends a sequence of 100 to 200 nucleotides coded for by
three different regions of the genome, mapping at 16.6,
19.6, and 26.6 map units. The implications of these
findings are not yet clear, but the organization and
expression of Ad2 genetic information are apparently
considerably more involved than previously thought.
Characterization of revertants of Ad2+ND1
host-range mutants
Amber and ochre translation-termination mutants of
Ad2+ND1 have been isolated by Terri Grodzicker.
These mutants synthesize, respectively, only 19K and
10K fragmgnts of the Ad2+ND1-specific 30K protein
and grow only on human (not monkey) cells. In collab-
oration with Eugene Lukanidin, George Fey, Denise
Galloway, Terri Grodzicker, and Joe Sambrook (Tumor
Virus Section) and Sayeeda Zain (Nucleic Acid
Chemistry Section) we have been characterizing rever-
tants of these mutants. Cell-free translation of purified
"30K" mRNA from cells infected with revertants deter-
mined for each revertant whether the revertant protein
was the Ad2+ND1 30K, the mutant 19K or 10K, or
something different from either. This information was
correlated with studies of the revertant DNA, and in
some cases the peptide composition of the revertant
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protein was studied. In brief, these experiments show
that only a small part of the C-terminal region of 30K,
which is missing in the amber and ochre mutants, is
necessary for growth on monkey cells. This result arises
from comparison of the many ways in which the ability
to grow on monkey cells is regained in different rever-
tants. In some cases no gross changes in DNA structure
are evident, and the revertant synthesizes the wild-type
30K. In other cases a region of the DNA, presumably
including the mutation, is deleted so that a protein
smaller than 30K is synthesized by the revertant. The
revertant protein (18K-29K in various revertants) pre-
sumably contains both the N- and the C-terminal re-
gions of the wild-type 30K but lacks a region in the
middle. In still other cases the region of the DNA coding
for the C-terminal of 30K is duplicated and inserted into
another region in the genome. The resulting protein has
the C-terminal of 30K but an entirely different
N-terminal sequence. In this model genetic system the
virus clearly utilizes a variety of different strategies to
regain expression of the portion of the 30K gene re-
quired for growth on monkey cells.
Studies of Ad2 early proteins
Many Ad2 early proteins can be identified in extracts of
cells that have been treated with cycloheximide to en-
hance synthesis of early Ad2 mRNA and then labeled
with [35S]methionine. Using SDS-polyacrylamide gel
electrophoresis to analyze cell extracts, proteins of 11 K,
14K, 15K, 19K, 21K, and 72K were found in extracts of
infected, but not mock-infected, cells, and these corre-
spond in electrophoretic mobility to proteins synthe-
sized in vitro using purified early Ad2 mRNA. Two-
dimensional gel electrophoresis reveals, in addition, six
polypeptides of 38-50K and acidic (pH 5.9-6.0)
isoelectric point not present in mock-infected cells and
similar in apparent molecular weight and isoelectric
point to the 40-50K synthesized in vitro. Furthermore,
a comparison of peptides produced by partial enzyma-
tic proteolysis shows that the six 38-50K polypeptides
synthesized in infected cells are much related in peptide
composition to each other and to the 40-50K synthe-
sized in vitro using mRNA complementary to the left-
most Ad2 early gene, which is associated with the trans-
forming ability of Ad2. The chemical basis for the elec-
trophoretic heterogeneity of this protein is unknown
(why are there six polypeptides of 38-50K for the prod-
uct of one gene with a maximum coding capacity of
36K?). However, the identification of 40-50K in in-
fected cells enables us to use two-dimensional gel anal-
ysis as an assay to guide the purification of this protein.
These experiments are in progress.
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MAMMALIAN CELL GENETICS
J. McDOUGALL, C. Casserly, C. Copp le, A. Fabrizi, K. Jones, S. Levings, N. Maitland, C. Mutt, E. Paul, M.
Shevchuk, C. Stewart, M. Szadkowski, R. Tepper, D. Whitfield
During this year we have concentrated on emphasizing
that part of our program which deals with mechanisms
of tumor induction and the investigation of more sensi-
tive methods for detecting viral nucleic acid sequences
in human tumors. With regard to the in vivo experimen-
tal aspects of tumor induction, we continued to be
limited by the lack of suitable animal facilities at Cold
Spring Harbor but were lucky to have the collaboration
of Phil Gallimore at Birmingham and Raju Kucherlapati
at Princeton, in whose laboratories studies could be
carried out in the athymic nude mouse.
In attempts to develop the in situ hybridization tech-
nique further, the contribution of Ken Jones from Edin-
burgh was of great value and it was a pleasure to have
him in this laboratory for part of the year. The coopera-
tion of Dr. Cecilia Fenoglio at the College of Physicians
and Surgeons of Columbia University was invaluable.
Transformation by adenoviruses
We have continued the studies on the tumorigenicity of
adenovirus-2 (Ad2)-transformed cell lines, in collabora-
tion with Phil Gallimore and Lan Bo Chen (Harvard).
A number of in vitro characteristics were examined in
an attempt to define one or more correlating with the
ability to produce tumors in adult athymic nude mice.
The results indicate that high saturation density, in-
creased protease activity, decreased doubling time, and
anchorage-independent growth are frequently features
of Ad2-transformed cell lines but are not essential for a
cell line to be tumorigenic. Three of the seven
adenovirus-transformed lines failed to uphold the hy-
pothesis that anchorage-independent growth correlates
with tumor formation in adult athymic nude mice.
Ad2/F17 (efficiency of plating [EOP] 5.25%) and Ad5/
HEK FG (EOP 30.3%) both show anchorage-indepen-
dent growth in methyl-cellulose but were non-
tumorigenic in the adult nude mouse, and Ad2/F19
(EOP 0.02%) shows anchorage dependency in this sys-
tem but produced two slow-growing tumors which,
although benign in nature, did not regress, being ex-
cised when 2.5 cm in diameter.
If anchorage-independent growth reflects a potential
for growth in vivo, then there should be a correlation
between both plating efficiency and/or colony size in
methyl-cellulose and the latent period and/or tumor
incidence in the nude mouse. This was not observed in
our study even for Ad2 lines that show anchorage-
independent growth.
From their study of SV40-transformed rat embryo cell
lines, Pollack et al. (Proc. Natl. Acad. Sci. 71:4792
[1974]) provided evidence that elevated levels of plas-
minogen activator accompanied loss of anchorage de-
pendency, and they suggested that this proteolytic activ-
ity may have a significant role in tumor invasion and
metastatic spread. The significance of fibrinolytic activ-
ity for malignancy has recently been questioned by the
observation of Pearlstein et al. (Cancer Res. 36:1475
[1976]) that some normal cells-e.g., cells from calf
bladder-produce high levels of protease as measured
by fibrinolysis. In the same report Pearlstein et al. ob-
served that loss of LETS protein from transformed cells
was not due to their increased synthesis of protease. We
have confirmed this finding in that the nontumorigenic
line Ad2/F17 has high fibrinolytic activity and yet pro-
duces a massive three-dimensional network of LETS
protein. It is possible that proteolytic enzymes different
from plasminogen activator may be associated with a
cell line's malignant behavior, and, with this in mind,
we have recently investigated Ad2/50A further. This cell
line is the most malignant and the highest producer of
fibrinolytic activity of the Ad2-transformed rat lines;
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however, exponentially growing cultures of Ad2/50A
do not hydrolyze overlays of purified rat tail collagen
even after prolonged incubation (10 days at 37°C). This
preliminary finding implies that collagenase activity is
not associated with this cell line's aggressive infiltration
of normal tissues.
Ad2-transformed cells expressing normal levels of
LETS protein either grow poorly in vivo or respond to the
control processes that inhibit the growth of normal cells
in vivo. This could explain a previous observation that
tumorigenicity in syngenic rats did not always appear to
be a reflection of the antigenic status of a cell line. Cell
line Ad2/F4 is heterogeneous for the expression of LETS
protein, and it can be postulated that the requirement for
additional anti-thymocyte serum-induced immuno-
suppression before this line produces tumors in
syngenic rats is a reflection of the time it takes for
LETS-protein-negative cells to establish themselves in
vivo, the latent period of this line in nude mice being 19
days. The finding that all three Ad2/F4 nude mouse
tumor lines show a dramatic reduction in LETS-
protein-positive cells and are highly tumorigenic when
inoculated into newborn syngenic rats lends some sup-
port to this theory.
LETS protein therefore appears to have a major role in
determining the in vivo behavior of Ad2-transformed
cell lines. We are continuing to study the role of LETS
protein in other transformation systems and in human
tumor sections.
Adenovirus-12 replication
A series of hybrid cell lines derived from fusions of
mouse and human cells has been established in culture
in order to examine the factor(s) that permit replication
of this serotype in human cells, but presumably are
absent or repressed in the cells of other mammals in
which this virus cannot replicate but can transform. The
hybrid cell lines carry subsets of the human genome in
various combinations. Initial results suggest that the
block to virus replication in mouse cells is dominant in
the hybrids examined so far.
Transformation of human cells by SV40
In collaboration with Raju Kucherlapati and Mike
Botchan (Tumor Virus Section), we are analyzing a
number of human cell lines transformed by SV40 to
determine the integration sites in the human genome. In
one such cell line we have shown that the presence of
integrated SV40 DNA and the expression of virus-coded
T antigen are associated with the retention of human
chromosome 8 in mouse/human hybrids. This increases
the number of human chromosomes (from different
SV40-transformed cell lines) with integration sites for
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SV40 DNA to four (nos. 2, 7, 8, and 17). This finding is
consistent with the concept of random integration sites
for viral DNA.
Transformation by herpesvirus type 2
We have previously reported transformation of TK-
cells to a TK+ phenotype by the transfection of specific
restriction endonuclease-derived HSV2 DNA frag-
ments. We have continued to study these biochemically
transformed cells to obtain information about the con-
trol of viral gene expression in such cells. The initial
experiments indicated that growth of the transformed
cells on medium where TK gene expression was not
required for cell survival did not affect gene expression,
but more careful study revealed that a small fraction of
the transformed cells had ceased to produce viral TK
under these nonselective conditions. Revertant TK-
cells were subsequently produced by growth in back-
selective medium containing 5-bromodeoxyuridine
and were investigated for reversibility of the loss of TK
expression. The results raise the possibility that viral TK
expression is under some form of cellular control in
these cells.
Detection of virus mRNA in tumor sections
The application of molecular hybridization techniques
to the detection of viral DNA integrated into host-cell
genomes has provided identification of specific trans-
forming regions of the chromosomes of smaller DNA
viruses. Such methods are based upon hybridization in
solution or hybridization in situ to DNA transferred from
gels to nitrocellulose. Although it is true that these ap-
proaches have advanced our knowledge of experimen-
tal systems and provide a sound biochemical basis for
developing an understanding of the mechanisms of
transformation, there have been no unequivocal studies
implicating these smaller DNA viruses (e.g., SV40,
adenovirus) in the etiology of human tumors, and, in-
deed, the results of some recent studies argue that the
evidence is strongly against such an involvement.
In the case of the larger DNA viruses, e.g., herpes-
viruses (particularly Epstein-Barr virus and herpes
hominis type 2), the epidemiologic and serologic data
present stronger arguments for an etiologic association
with human tumors. However, the fact that the size and
complexity of herpesvirus genomes are of a higher order
than those of SV40 and adenovirus genomes does raise
greater problems in terms of detection of putative inte-
grated viral sequences. If the minimum quantity of DNA
required for transformation is of a size similar to that
established for the smaller viruses, then the target for
hybridization represents only 1-2% of the herpesvirus
genome. Probes presently in use do not provide an
efficiency of detection at this level and are therefore of
limited value, even when used to examine a cell popula-
tion wholly composed of cells retaining, say, 1 2% of
the virus DNA molecule. Furthermore, there is as yet no
herpesvirus fragment identified as containing "trans-
forming genes," a prerequisite for obtaining increased
hybridization efficiencies in searching for integrated
viral DNA.
Examination of tumor tissue, as opposed to trans-
formed cell lines, is complicated by a number of factors
not encountered in experimental tissue-culture systems.
Tumor, or putative tumor, samples may be small in
mass, especially in the case of biopsies, and will cer-
tainly consist of both neoplastic and normal tissues,
with the normal frequently present as the dominant
type. Extraction of DNA or RNA from such samples will
certainly result in a dilution of the nucleic acid se-
quences from any particular cell type and could provide
false negatives. Outgrowth of cells in culture may also
be inefficient in terms of a preferential selection of cells
able to grow in vitro; the resulting cell line may not be
representative of the original tumor cells.
To overcome these factors. we propose to approach
the problem of detecting viral sequences by further
developing the technique of in situ cytological hybridi-
zation of viral DNA to virus-specified messenger RNA.
The primary advantages of the method are that (1) direct
examination of individual cells in smears or sections
can be achieved, and (2) the target sequences should be
amplified as mRNA, provided that any integrated viral
DNA is transcribed. Experience with experimental
transformations using DNA viruses argues strongly that,
if viral sequences are present, then there is transcription
of at least part of the DNA. Thus, a transformed cell line
of Ad2 (rat) origin containing 14% of the Ad2 genome in
six copies (each amounting to 1.6 x 10 6 daltons [5.3 kb])
of transcribed DNA has been used to provide a model
system of viral insertion sequence detection. Viral
mRNA was detected after a 4-6 week exposure using
an in-vivo-synthesized DNA probe (3H-labeled whole
virus genomal DNA). The level of autoradiographic sig-
nal was at saturation at the time of examination, indicat-
ing a very much shorter practical time for detection.
Similar cells recently have been shown by direct analy-
sis to have a number average of about 300 400 mRNA
molecules of viral origin per cell (Flint and Sharp, J. Mol.
Biol. 106:749 [1976]). Assuming a total transcript, this
is about 1.8 x 104 kb mRNA (or approximately 0.5 times
as much as in the case of globin mRNA in the fully
expressing cell). Experiments (C. Godard and K.W.
Jones, ms. in prep.) using AKR-MuLV cDNA to detect
70S RNA tumor virus genomes in leukemia cells have
confirmed the value of the technique in this area as well
and have led to a number of technical improvements to
the method.
Herpesvirus-transformed cells have been examined
in our laboratory using the in situ cytological hybridiza-
tion method to detect virus mRNA, and we are continu-
ing these studies in experimental HSV2-induced
tumors.
With the foregoing as a basis, we have commenced a
program in which we intend to examine biopsies from
cases of cervical carcinoma and premalignant cases of
dysplasia and carcinoma in situ. Our preliminary re-
sults from experiments in which an HSV2 [3H]DNA
probe has been hybridized to frozen sections and im-
pression smears indicate specific hybridization to only
some areas of the sections. Pathology results on serial
sections from the positive biopsies show that HSV2
hybridization is found only to cells in the neoplastic
tissue or in macrophages and lymphoid cells associated
with areas of abnormality. Results from similar attempts
at hybridization to other human tissue and other neo-
plasms have so far been negative. We must stress that
the numbers tested so far are small. We cannot at pre-
sent rule out the possibility that these preliminary find-
ings indicate replicating virus DNA in the neoplastic
cells. Should this prove to be the case, it would be
surprising to find that HSV2 grows preferentially in these
cells when the expectation is that all cells in the biopsy
would be permissive. Hybridization of other nick-
translated viral DNA probes, i.e., Ad2, SV40, and bac-
teriophage lambda, to the same tissues gave negative
resu Its.
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MOLECULAR GENETICS
D. ZIPSER, E. Cheng, R. Kahmann, D. Kamp, D. Kwoh
Bacteria recognize a wide variety of mutant and altered
proteins as abberant and degrade them. This degrada-
tion occurs in actively growing bacteria and apparently
is not related to the degradation of proteins induced by
starvation. Over the years, our laboratory has used non-
sense mutations in the Z gene of the lac operon as a
model system to study this degradation. The degrada-
tion of long nonsense fragments is totally dependent on
an energy supplied to the cell. It is instantly blocked by
the addition of cyanide or other respiratory poisons but
is unaffected by protein-synthesis inhibitors such as
chloramphenicol. The degradation of shorter nonsense
fragments is greatly slowed by the addition of energy
poisons but is not completely stopped. In the past year
we have continued our study of a class of mutations
that affects the degradation of proteins in E. coli.
These mutants were originally isolated in our laboratory
several years ago by Ahmad Bukhari, and in the past
year their genetics and physiology have been actively
studied and analyzed in cooperation with Susan Got-
tesman at the National Institutes of Health. We have
shown unambiguously that all of the mutations isolated
by us so far that affect degradation are synonymous
with a class of mutations identified previously by the
characteristic that they make the cells mucoid. These
mucous-producing mutations are called Ion, and so we
have changed the name of all protein-degradation-
inhibiting mutations to Ion. This is a significant finding
because Ion has long been known to have an extremely
polytropic phenotype affecting many features of the
cell, including cell-wall properties, DNA replication,
the ability to repair UV damage, and the inducibility of a
variety of enzymes. The action of Ion on f3- galactosidase
nonsense fragments is virtually the same as the action of
energy poisons such as cyanide. These Ion mutations
block the degradation of long nonsense fragments, such
as X90, completely but only slow the degradation of the
shorter fragments, such as 545. This year we have been
able to demonstrate that, in the Ion background, what-
ever degradation of nonsense fragments occurs is com-
pletely insensitive to the addition of cyanide. Thus, we
have come to the conclusion that the Ion mutation
blocks all energy-dependent degradation in E. coli but
does not affect energy-independent degradation. We
have known since the visit of Charles Miller two years
ago that the /on mutation does not affect any of the
known proteases of E. coli, and this statement is still
true. If Ion affects a protease, this protease is still un-
known.
Clearly, a study of protein degradation requires that
the reaction should be studied in cell-free conditions.
We have been trying for a long time to carry this out and
the studies continued this year. So far, they have been a
complete failure. Since the result is negative, we do not
know the cause, but we do know that it is not the result
of an obvious error. For example, energy-dependent
degradation does not take place in an in vitro system
capable of synthesizing p-galactosidase starting with
DNA. In addition, we have shown this year that ener-
gy-dependent degradation is blocked instantly by the
addition of toluene to growing bacteria under condi-
tions in which sufficient ATP and other metabolities are
present in the external media to allow cells to continue
DNA synthesis. These conditions of toluene plus added
ATP are sufficient to allow the degradation of lambda
repressor by the X protein, as demonstrated by Jeffrey
Roberts at the University of Wisconsin. We feel quite
confident that the X protein, or the recA function, is not
involved in the degradation of nonsense fragments, as
this degradation occurs in rec- cells and, in addition,
probably does not occur under in vitro conditions in
which lambda repressor is degraded by the product of
the recA gene. Thus, although we have failed com-
pletely in our attempts to run energy-dependent degra-
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dation of nonsense fragments in vitro, our experiments
this year have convinced us of the importance of con-
tinuing this effort to find out what mysterious ingredient
or structure is missing from our in vitro work.
We have had considerably greater success in study-
ing energy-independent degradation of nonsense frag-
ments. Small nonsense fragments are degraded in the
absence of energy, and this degradation continues in in
vitro systems. For example, extracts of E. coil rapidly
degrade the smaller N-terminal peptides of /3-
galactosidase which are detectable by complementa-
tion and are called "auto-a." These peptides are pro-
duced by autoclaving /3- galactosidase and can be sensi-
tively assayed in a complementation system. In our
work this year we have shown that when 13-
galactosidase is autoclaved, a series of peptides ranging
in size from about 3000-4000 m.w. up to about 20,000
m.w. are produced which are active in complementa-
tion. When these peptides are mixed with crude extracts
of E. con, the smaller size class is degraded rapidly,
whereas the larger size classes are virtually untouched,
the cutoff being at about 7000 m.w. We have confirmed
that this is in fact due to protein degradation by partially
purifying the fragments involved and following their
disappearance from acrylamide gels. Using the degra-
dation of small autoa as an assay, we have been able to
purify the enzyme that carries out the reaction and have
called it "protease III." Protease III is present in actively
growing E. coil as well as in extracts of Ion mutations. Its
purification was very difficult because it binds strongly
to other proteins but only weakly to various ion-
exchange columns. It required a rather elaborate purifi-
cation procedure that took considerable time to work
out. The other factor complicating its purification was
that it is present in very low amounts in cells. While it is
still too early to make an accurate estimate of its concen-
tration, it could be as low as 10 molecules per cell. The
enzyme has a large molecular weight, about 110,000, is
active as a monomer, and, when purified, is quite stable
under proper conditions and is very active. The purified
enzyme has a size selectivity. It degrades practically no
proteins larger than 7000 m.w., although there may be
specific exceptions to this, and degrades many peptides
smaller than 7000 m.w. Degradation appears to be to
fragments too small to retain on acrylamide gels. We
have not yet determined the mechanism of degradation.
During the year we have also developed a variety of
strategies for isolating mutations in protease III but so far
we have not obtained a mutant in this enzyme. A mutant
in protease III is extremely important because, in addi-
tion to being able to remove this background from our in
vitro systems to allow us to have a higher sensitivity for
finding the energy-dependent system in vitro, mutants
should also throw light on any relationship between the
energy-dependent and energy-independent systems.
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Cloning the left end of phage Mu
and the repressor and operator
The genetic maps of the lytic and lysogenic forms of
phage Mu are the same. The left end of the virion DNA
has a short segment of random bacterial DNA attached
to it. Extensive mapping of phage Mu has indicated that
the repressor gene, called the "C gene," is the first
identifiable Mu function on the left end. When phage Mu
is cut with the restriction enzyme Hindlll, the extreme
left-end piece is about 1000 base pairs long and con-
tains the short, random, bacterial DNA segment. During
the past year we have cloned this fragment on the ampl i-
fiable plasmid pMB9 using the method of adding
poly(A) and poly(T) tails with the enzyme terminal trans-
ferase. We believed these clones would be useful for
two purposes: first, to try to isolate the previously unde-
tected Mu-repressor protein, which mapping indicated
probably resided in this fragment; and second, to have
material for use in sequencing the ends of phage Mu.
These plasmids would also serve as a source of se-
quence material for sequencing the left end. Clones
were obtained which rendered their host immune to
Mu. Examination of the biological properties of these
strains indicated that many of them overproduced re-
pressor. The level of repressor was so high that even
though the cloned repressor was from a temperature-
sensitive gene, high temperatures did not remove all
traces of repression. This pattern is virtually identical to
that found when clones that overproduce lambda tem-
perature-sensitive repressors are studied. By transferring
the plasmids carrying the cloned repressor gene to
minicell-producing strains, we were able to identify on
acrylamide gels a band of 25,000 m.w. which was
clearly correlated with the presence of Mu immunity.
Minicells are ideal for this because the only proteins
produced in them are directed by the small plasmids
present in the strain, as the chromosomal DNA does not
enter the minicell itself. Having identified the repressor
protein as a band on a gel, and being able to obtain it
virtually radioactively pure by lysing minicells, we pro-
ceeded to see if it would bind specifically to Mu-
operator-containing DNA. For this we used sucrose
gradients to separate DNA-bound repressor from solu-
ble labeled proteins. Each fraction of the gradient was
then analyzed on an acrylamide gel; in this way we
could follow the binding of repressor to DNA in a very
straightforward and unambiguous fashion. These exper-
iments showed that at low salt concentration repressor
would bind to any DNA but that at appropriate higher
salt concentration it bound only to DNA carrying Mu
operators. For example, at the appropriate salt concen-
tration repressor did not bind to lambda DNA or to DNA
from phage D108 (which is homologous to Mu
everywhere except in the immunity regions), but it did
bind to wild-type Mu DNA. We also found that Mu
repressor at the appropriate salt concentration did not
bind to the original plasmid pMB9, but it did bind to the
plasmid which was used to synthesize it, i.e, the plasmid
on which the repressor gene had been cloned. This
indicates that the operator maps very close to the repres-
sor gene, not an unexpected result in view of our knowl-
edge from other phages.
We have also cloned segments from the right-hand
end of Mu which contain the boundary between the
right-hand end of Mu and the large section of bacterial
DNA present at that end. These segments will enable us
to sequence the Mu bacterial boundary at the right end,
and, together with the previously described left-end
clone, we should be able to sequence both ends of Mu.
Sequencing has already begun on a left-end clone, but
we do not yet have sufficient data to be able to define the
unique sequences of Mu.
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INSERTION ELEMENTS AND PLASMIDS
A.I. BUKHARI, L. Ambrosio, F. de Bruijn, M. Du Bow, H. Khatoon, E. Ljungquist
Transposition of DNA sequences is one of the most
exciting topics in molecular genetics today. Many
laboratories around the world are examining the struc-
ture and functioning of transposable elements in pro-
karyotic organisms. Intriguing cases of inserts in
eukaryotic genes are also beginning to raise some in-
teresting questions concerning the organization and
evolution of eukaryotic genomes. It is too early to tell,
however, whether these inserts are a manifestation of
the complex phenomenon of transposable elements.
A fundamental property of the prokaryotic transposa-
ble elements is that they have "active" ends. Various
genetic rearrangements-deletions, inversions, dupli-
cations-can be initiated at the ends. The ends can
also link up with unrelated host genes to form complex
transposable units called transposons. The temperate
bacteriophage Mu, the focus of our work, also has "ac-
tive" ends whose behavior is strikingly similar to the
behavior of the ends of transposable elements. Thus, the
mechanism by which Mu DNA is inserted into the host
DNA is interesting not only because of the random
integration of Mu, but also because it is a model system
for studies on transposition of DNA sequences.
During the last two years, work in our laboratory on
the structure and integration of Mu DNA has led us to
propose that integration of Mu DNA follows its replica-
tion. We have continued to test the replication-
integration hypothesis in detail. In addition, we have
begun an analysis of the Mu proteins involved in the
replication-integration cycle of Mu and are determining
the nucleotide sequences at the ends of prophage Mu
DNA. The sequencing studies should answer the ques-
tions of whether there is any peculiarity at the host sites
at which Mu DNA is inserted and whether or not the two
ends of prophage Mu contain identical sequences in
inverted order, as is the case with the transposable
elements.
Mu integration and replication
The problem of circles
Whether or not Mu DNA is converted to a covalently
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closed, circular form after infection of host cells has
been a major point of discussion. Mature Mu DNA has a
unique structure. It contains random host sequences at
both ends; thus, a special mechanism would be re-
quired for fusion of Mu ends. Last year we reported that
Mu DNA is, in fact, not converted to a circular form. To
examine this question further, we infected Mu-sensitive,
or Mu lysogenic cells in which Mu does not replicate,
with 32P- labeled Mu particles, extracted the DNA at
various times after infection, and subjected the DNA
samples to electrophoresis in 0.3% agarose gels. On
these gels Mu DNA can be separated from host DNA.
No unusual form of Mu DNA could be detected in these
experiments. In parallel experiments with bac-
teriophage P2, whose DNA is about the same size as Mu
DNA, conversion of 32P-labled P2 DNA to a circular
form could be demonstrated readily. These results
strengthen our conclusion that initial events in the infec-
tious cycle of Mu do not include circularization of in-
fecting Mu DNA.
Integration of infecting Mu DNA
The experiments discussed in last year's annual report
indicated that the infecting Mu DNA is not a good
substrate for integration and that it is probably repli-
cated before any integration can take place. We have
tested the ability of 32P- labeled Mu DNA to integrate
into the host chromosome under various conditions.
The main approach was to infect cells with labeled
phage particles and then separate the host DNA and the
phage DNA on 0.3% agarose gels. The phage band and
host band were then cut out and analyzed for radioactiv-
ity in the scintillation counter. These experiments
showed that integration of Mu DNA occurs slowly,
reaching a maximum of 20% to 30% of the input label
(subtracting the background of label associated with
host DNA) about 40-50 minutes after infection. This
result indicated that some integration of infecting phage
DNA does take place. However, this integration is
blocked when host DNA synthesis is inhibited either by
pretreating cells with mitomycin C or by temperature
shift of E. coli mutants temperature sensitive for DNA
synthesis. Furthermore, integration of infecting Mu
DNA does not take place if Mu amber A or B mutants,
which are blocked in DNA replication, are used for
infection. These observations are consistent with our
hypothesis that Mu DNA replication is necessary for its
integration and imply the intriguing possibility that host
DNA replication might also be involved in Mu integra-
tion.
Mutants blocked in DNA packaging
By using the technique of separation of Mu DNA from
host DNA on 0.3% agarose gels, we have been able to
determine which of the Mu mutants available in our
collection are defective in packaging. We have found
that the mutants defective in head morphogenesis fall
into two groups: those that are normal for the DNA
packaging reaction and those that are blocked in the
appearance of mature phage DNA. The packaging-
defective Mu mutants would be very useful for studying
the structure of replicating Mu DNA and maturation
precursors of Mu DNA.
X Mutants
We have shown that, unlike some other well-known
temperate bacteriophages, prophage Mu DNA is not
excised upon induction and must therefore replicate in
situ (Ljungquist and Bukhari, Proc. Natl. Acad. Sci.
74:3143 [1977j). Paradoxically, a mechanism does
exist by which the prophage DNA can be cut out of the
host DNA. This excision occurs at low frequency and
can be detected if the prophage carries mutations that
eliminate the killing functions of Mu. We have termed
the excisable defective prophages the X mutants. The X
mutations have been shown to be caused by insertions
near the left end of Mu DNA.
Nature of insertions
The Mu X mutants isolated by us originally all carried
the 800-base-pair transposable element IS1. We have
now found that the X mutations can also be caused by
the 1200-base-pair transposable element 155. The iden-
tity of IS5 has been established by restriction
endonuclease cleavage analysis and DNA-DNA hy-
bridization. 155 insertions are located in the same region
as the IS1 insertions in the previously described X mu-
tants. The properties of the Mu X IS5 mutants are being
examined further.
Mechanism of excision
Why is the excision of Mu DNA detected in these spe-
cial cases at a low frequency and not after induction of a
prophage? We think excision of Mu DNA as seen with
the X mutants is a by-product of the Mu replication-
integration cycle. If the replication-integration cycle is
initiated but cannot proceed normally, a prophage DNA
is rendered susceptible to excision. It is still not clear
whether the insertions in the X mutants play any role in
the excision process.
Excision of Mu cts X mutants is blocked by a secon-
dary Mu c+ prophage but can occur in the presence of
phage D108, a heteroimmune, Mu-like phage. This ob-
servation implies that Mu gene expression, which can
be blocked by Mu repressor but not by D108 repressor,
is necessary for X excision. This is consistent with the
previous finding that gene A of Mu is required for the
excision process to occur. In a strain diploid for Mu cts
X/Mu cts X mutants, excision of one X prophage does
not lead automatically to the excision of the other. This
result can be interpreted to mean that excision of Mu
DNA is not an efficient, instantaneous process.
Products of excision
Excision of Mu cts X mutants can be precise (10-6 to
10-' per cell) or imprecise (10-5 to 10-6 per cell). When
a Mu cts X prophage is located in the Z gene of the lac
operon, Mel+ revertants arise at a frequency 10- to
100-fold higher than the frequency of Lac" revertants.
Reversion of cells to Lac' requires precise excision (res-
toration of activities of both the /acZ and /acY genes),
whereas reversion to Mel+ requires restoration of only
Y-gene activity and thus indicates imprecise excision.
We have confirmed by extensive deletion mapping that
most Mel+ revertants have deletions in the Z gene.
Surprisingly, about 20% of the Mel+ revertants were
found to have retained Mu DNA at its original site in the
Z gene. Perhaps the Y gene is now linked to a Mu
promoter because of rearrangement of Mu sequences
proximal to the Y gene. In some cases we have been able
to show a rearrangement in prophage sequences by
DNA-DNA hybridization. In other cases, where no re-
arrangements of prophage sequences can be seen,
perhaps rearrangements involving transposable ele-
ments have occurred independently of Mu DNA and
have generated a new promoter in the vicinity of the Y
gene. These observations open up the possibility of
using Mu to promote expression of the nearby genes.
Mu-induced modification of DNA
During the course of our routine cleavage of Mu DNA
with restriction endonucleases, we found that Mu DNA
is not cut to completion with the enzyme Ball. Fur-
thermore, from the Mu X and Mu X cam mutants, Ball
generated fragments whose presence could not be ex-
plained on the basis of known sites for Ball cleavage in
Mu DNA. These fragments turned out to be partial frag-
ments that were present in approximately equimolar
amounts. We have concluded that, after induction, Mu
DNA is modified in such a manner that a given Ball
recognition site is affected in about 50% of the
molecules. This modification requires the mom func-
tion of Mu, as well as the dam (deoxyadenosine
methylase modification) function of E. col i , as suggested
by Ariane Toussaint (University of Brussels). In the case
of Mu X cam mutants, a Ball recognition site within the
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gene for chloramphenicol resistance can be unmasked
only if the Mu X cam mutants are grown in dam- cells.
Since thedam and mom functions act in concert, it must
mean either that the specificity of the dam function is
changed by mom or that mom requires dam as an
activator.
The G segment of Mu DNA
Experiments by June Scott's group at Emory University
and by Ariane Toussaint and her associates at the Uni-
versity of Brussels have shown that Mu and bac-
teriophage P1 can exchange their host-range properties.
Since the homology between Mu and P1 is apparently
restricted to the invertible segments (termed the G seg-
ment in Mu and the C segment in P1), it can be inferred
that these segments encode at least some components of
the host-range system. Our colleagues at Cold Spring
Harbor have shown that only one G orientation, called
the "flip" or plus orientation, gives rise to viable phage
particles (Kamp et al., Nature 271:575 [1978]). If the
prophage carries the "flop" or minus orientation, no
plaque-forming phage particles are produced upon in-
duction. We have extended these observations further
by examining the adsorption properties of the Mu parti-
cles made by induction of a lysogen. In these lysates,
only the phage particles with the "flip" orientation of G
can adsorb to the cells properly. Therefore, upon infec-
tion, only Mu particles with the "flip" G orientation are
obtained. The simplest explanation for this observation
is that the Mu component needed for adsorption to E.
coli cells is made only when Mu is in the "flip" orienta-
tion. This case provides an interesting example of the
"flip-flop" control of gene expression. We are examin-
ing the nature of this regulation of gene expression
further.
Transposable elements
Several simple transposable elements, called the IS ele-
ments, have been identified in the genome of E. coli,
and in the F factor, and in various R plasmids. We have
systematically examined the presence of some of the
elements in several different bacterial species. The re-
sults so far show that 151 is present in multiple copies in
all species belonging to the family Enterobacteriaciae.
However, we have so far not detected 151 or IS2 in
several other bacterial species.
Last year we determined that IS1 is present in the
genome of bacteriophage P1. All P1 strains apparently
have one copy of IS/ at the same site. We detected an
additional copy of IS1 in at least one strain. Analysis of
the chloramphenicol resistance transposon Tn9, which
contains 151 at each end, in a P1 cam strain (originally
isolated by Mitsuhashi's group in Japan) has shown that
Tn9 is located at exactly the same site as the1.51 found in
Pl. This structure of Tn9 in this P1 cam strain appears to
be interesting (Fig 1). Tn9 is present in this strain in
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Figure 1
Proposed structure of Tn9 in P1 cam. At least two Tn9
copies in tandem are present in the P1 cam strain in use in
our laboratory. The figure shows the P1 segment (defined
by the EcoR/ cleavage sites at coordinates 15 and 22.5)
containing Tn9. The arrows pointing upward indicate
EcoRl cleavage sites; the arrows pointing downward indi-
cate Ball sites. The Ball cuts, outside of Tn9, are indicated
by dotted arrows. Recently, L. MacHattie (pers. comm.)
has shown that many tandem copies of Tn9 can be gener-
ated in bacteriophage A, beginning from one Tn9 copy.
Visiting colleagues
Dr. Ariane Toussaint, from the University of Brussels,
spent some time with us examining the properties of her
Mu mutants that carry insertions in the 0 segment, near
the right end of Mu DNA. These studies led to the
identification of an insertion in Mu as IS2 element.
Dr. Anthony Garro, from Mt. Sinai School of Medi-
cine, New York, initiated experiments on the excision
process of 0105 prophage from Bacillus subtilis cells in
order to compare the process of 0105 induction with
that of prophage Mu induction.
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Adenovirus-2 RNA transcripts
We have used electron microscopic RNA-loop map-
ping to determine the chromosome coordinates of the
Ad2 RNA transcripts isolated at early and late times from
the cytoplasm of productively infected human KB cells,
some details of which were described in last year's
report. R loops are formed by hybridizing RNA to the
complementary DNA sequences in partially heat-
denatured double-stranded DNA. In the presence of
70-80% formamide, the RNA:DNA hybrids are more
stable than DNA:DNA duplexes. After the annealing
mixture is cooled, loops of displaced DNA remain op-
posite DNA:RNA hybrids and, when observed by elec-
tron microscopy, constitute distinctive landmarks by
which the map positions of the transcripts are deter-
mined. Many of the individual transcripts have discrete
lengths and well-defined termini and have been corre-
lated with the Ad2 proteins mapped previously by cell-
free translation of enriched messages (Lewis et al. Cell 7:
141 [1976]; Cell 12:37 [1977], Harter and Lewis, J.
Virol. [1978, in press] (Fig. 1).
Alternation of DNA template strands in different re-
gions can be observed directly in R loops in which the 3'
ends of RNAs complementary to opposite strands con-
verge, as seen at map positions 11.0, 62.3, and 91.5 (cf.
Fig. 2d). Interestingly, these strand switches separate
blocks of early and late genes, and there is no detectable
nontranscribed region between the blocks at the switch
points.
Families of RNAs from the four map intervals
4.9-11.0, 38.8-49.9, 49.9-62.2, and 67.9-82.8
contain common sequences. The longer transcripts are
complementary to two or more adjacent genes, notably
RNA with coordinates 4.9-11.0 (proteins El 5K and IX),
coordinates 49.9-62.2 (proteins pVI and hexon), coor-
dinates 67.9-78.2 (proteins 100K and pVIII), and coor-
dinates 96.8-91.5 (proteins El 1 K, El 7K, El 9K, E21K,
40
and E24K). Shorter RNAs from these same regions gen-
erally have the same 3' end but different 5' ends. This
heterogeneity suggests that the signals governing RNA
length determination during transcription or processing
are not absolute. In at least two cases the 5' end of an
mRNA appears to be located within the adjacent gene.
The 5' terminus at coordinate 74.1 for pVIII mRNA
seems well within the gene for nonvirion protein 100K
(67.9-76.1); despite ambiguity in the relative map
order of the genes for penton (III) and minor core (V),
either the predominant 5' terminus at coordinate 38.8
or the minor species near coordinate 42 is within the
penton gene. These observations imply that protein-
encoding sequences might also serve as mRNA process-
ing sites.
Ad2 leader sequences and spliced transcripts
Biochemical studies by Richard Gelinas, Dan Klessig,
Sayeeda Zain, Richard Roberts, John Hassell, Ashley
Dunn, and Jim Lewis at Cold Spring Harbor Laboratory
have accumulated evidence that the 5' ends of late Ad2
transcripts are not encoded next to their respective
genes. These 5' ends seem to be complementary to a
remote portion of the genome, within the HindlIl B
restriction endonuclease fragment (coordinates
17.0-31.5). When we prepared R loops from late
cytoplasmic RNA, about 200 nucleotides at the 5' ter-
minus of one-third of the transcripts observed were not
hybridized to the DNA and formed visible branches.
In a collaborative effort with Richard Gelinas and
Richard Roberts, we established that the 5' terminal
sequences of all late mRNAs were encoded at several
remote sites. The approach we took was to anneal sepa-
rated strands of the Hindlll B restriction fragment to late
polysomal mRNA loops preformed in Ad2 DNA. The
rightward-transcribed DNA strand (R strand) of the
Nina! B fragment paired with the 5' branches present
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Transcription and translation maps of Ad2 (Broker et al. 1977; see below for additional references). Assignments are based
upon EM RNA-loop mapping (Chow et al. 1977a,b)and upon cell-free translation of purified mRNAs (Lewis et al. 1975, 1976,
1977). A tripartite leader sequence derived from coordinates 16.6, 19.6, and 26.6 is coupled to the 5' end of each species of
late, polysomal R-strand transcript from the interval 29-92 at the positions indicated by vertical bars on the arrows. At least
some fiber mRNA has a fourth leader component derived from coordinates 78.6 -79. /. The L-strand transcript from
15.1 -11.0 has a 5' leader from coordinate 15.6. Another composite late transcript has sequences from 4.9-6.0 linked
directly to those from 9.6-11.0, while a simple species of the same family consists of just those sequences from 9.6-11.0.
Dashed lines designate sequenCes absent in the mature polysomal mRNA. Arrowheads represent 3' termini. In the intervals
36.6-49.9, 49.9-62.2, 67.9-78.2, and 78.2-86.2, families of transcripts of different lengths share common 5' and/or 3'
termini. The asterisk ( *) designates that additional 5' ends are seen near coordinate 42.7. Each of the two viral-associated (VA)
RNAs extends rightward for 0.45 map units from the 5' ends indicated (Seiderlund et al. 1976). Spliced early RNA transcripts
that map from 78.2 to 86.2 and from 96.8 to 91.5 were first reported by Kitchingman et al. (1977), as were recombinant
transcripts of E72K mRNA (not shown). The lengths of the protein blocks indicate the necessary coding capacity of the DNA.
Some protein-mRNA assigments are provisional, and gene products within parentheses have not been ordered unequivocally.
Hatched blocks represent proteins made both early and late.
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at each of nine different R loops located in the interval
30.5-91.5. Quite unexpectedly, the restriction frag-
ment was constrained into a looped configuration, sug-
gesting that two short segments of the DNA located
2400 nucleotides apart were complementary to the con-
tiguous sequences at the 5' end of each of the mRNAs.
When the R strand of the longer BamHl B restriction
fragment was similarly hybridized to the 5' termini of
the mRNAs in R loops, a third short DNA segment
complementary to the RNA was revealed by the forma-
tion of two loops (1000 bases and 2400 bases long) in
the DNA fragment (Fig. 2a). Separated strands of other
restriction fragments derived from all portions of the
Ad2 genome were also tested. The results were com-
pletely consistent with the conclusion that sequences
on the rightward-transcribed DNA strand at coordinates
16.6, 19.6, and 26.6 encode a total of about 150-200
nucleotides found at the 5' terminus of at least 12 late
transcripts, all of which are synthesized from the R
strand downstream from the leader.
Further EM experiments showed that mRNA from the
distal gene in the series (for the fiber protein) had a
fourth leader component. This was noted because fiber
mRNA hybridized occasionally to the same DNA du-
plex in two distinct intervals: from coordinates 86.2 to
91.5, where the coding portion of the gene is located,
and also from 78.6 to 79.1, immediately to the left of the
nonessential early region of the chromosome. The RNA
formed a bridge and constrained the duplex DNA be-
tween 79.1 and 86.2 into a loop (Fig. 2b). In such
structures the 5' terminal portion of the fiber mRNA was
still capable of hybridizing to DNA sequences at coor-
dinates 16.6, 19.6, and 26.6. Studies in collaboration
with Ashley Dunn indicate that not all fiber mRNA has
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Figure 2
R loops exhibiting the four classes of recombinant Ad2 late mRNAs.
(a) The R strand of the BamHl B DNA restriction fragment annealed to the 5' end of mRNA for the hexon protein is
constrained into two loops (FL) because sequences at coordinates 16.6, 19.6, and 26.6 are all complementary to the RNA
leader. At least 12 other late mRNAs transcribed from the R strand form the same complex, three-component hybrid.
(b) The primary R loop corresponding to the fiber-encoding sequences extends from coordinates 86.2 to 89.9, with a
characteristic branch (3' Br) of RNA displaced at the 3' end (89.9 -91.5), presumably due to stable RNA secondary structure at
89.9. Near its 5' end, a bridge (5' Bg) of RNA formed a secondary R loop at coordinates 78.9 -79.1, and in addition paired with
the BamHl B fragment at three positions (FL), as in panel a.
(c) A mosaic late transcript consists of sequences from genome coordinates 4.9 -6.0 (E15K gene) linked directly to RNA
transcribed from 9.6-10.9 (peptide IX; a late hexon-associated virion component). It formed a double R loop, with the
intervening DNA (6.0-9.6) constrained into a duplex DNA loop (DL) by an RNA bridge (Bg) as in panel b.
(d) The convergent R loop revealing the switch in transcribed strands consists of mRNA for peptide IX (9.7 -11.0) annealed
to the Ad2 R strand and the neighboring mRNA for virion component IVa2 (15.1 -11.0) annealed to the L strand. The
double-strand/single-strand (d/s) junctions are indicated. The 5' leader for IVa2 mRNA has formed a bridge (5' Bg) from
coordinate 14.7 to its complement at 15.6 and has constrained the DNA into a loop (DL) similar to those illustrated in panels b
and c.
the fourth leader component, but all do have the tripar-
tite leader. The cause of this variability is not yet under-
stood.
RNA-bridge structures were also observed elsewhere.
We found a late RNA transcript complementary to a
region considered previously to encode only early pro-
teins. It consists of sequences from coordinates 4.9 to
6.0 linked directly to those from coordinates 9.6 to 11
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(Fig. 2c). Another late transcript is a subset of that
mosaic RNA and is complementary to a shorter segment
of DNA from 9.6 to 11.0 (Fig. 2d). The short species, but
not the mosaic RNA, encodes late protein IX, a virion
component (Pettersson and Mathews, Cell 12: 741
[1977]). The relations among the variously sized early
and late transcripts of interval 4.9-11.0 are not yet fully
established.
The left late transcript complementary to the L strand
has been assigned provisionally to virion protein IVa2. It
also has a recombinant structure, with a short leader
component from coordinatesl 5.6-16.0 attached to the
coding sequences from 15.1 to 11.0 (Fig. 2d). Interest-
ingly, the first segment of the major R-strand leader and
the late L-strand leader for IVa2 message are in close
proximity in the interval 16.0-16.5, which suggests a
late promoter region from which transcription diverges.
In conclusion, all late mRNAs encoded by Ad2 are
recombinant with respect to the genome from which
they are transcribed. This startling fact has abruptly
changed our conception of what a eukaryotic gene is
and how its expression is controlled. It provokes many
intriguing questions about the generality of RNA splic-
ing, the nature of the nucleotide sequences and en-
zymes involved, and the purposes and consequences of
the processing. Is late RNA splicing catalyzed by a viral
enzyme? Does it serve to differentiate late mRNAs from
host and early viral mRNAs to allow selective loading
onto ribosomes for translation? Does it serve to bypass
protein termination codons that may be present in pre-
cursor RNA? Does RNA splicing occur uniquely and
reproducibly or, for instance, in the cases of the fourth
leader of fiber and the early mRNAs, are there alterna-
tive patterns that allow the eventual synthesis of families
of related proteins? On the presumption that only one
late message can be derived from each long nuclear
precursor RNA (since the leader sequences are rep-
resented only once per transcript), what recombination
mechanism assures that each of the nine late mRNAs is
produced in relatively equal abundance? The simple
concept of intrastrand deletion events would incorrectly
predict that the joining of leader to message would be
inversely proportional to the distance separating the
nine possible combinations. A new type of recombina-
tion may have to be sought which is relatively insensi-
tive to distance. What process-transcription termina-
tion, simple cleavage of precursor RNA, or splicing of
polyadenylate to one of the nine messages in nuclear
precursor RNA-determines the 3' end of late mRNAs?
Have leader sequences diverged among the various
adenovirus serotypes, and, if so, might not this be a
reason why genetic recombinants between different
classes of adenoviruses cannot be obtained? Presuma-
bly, nucleotide sequences near the leaders, as well as
near the 5' end of each gene, must be matched to allow
splicing. Many of these challenging problems will be
addressed in the forthcoming year.
Bacteriophage Mu DNA G segment and /3 region:
Structure and function
The DNA from temperate bacteriophage Mu is a linear
duplex about 38 kilobase pairs (kb) in length. A 3-kb
segment of its DNA, designated G, can be present in
either orientation relative to its neighboring segments to
the left (a, 30.7 kb) and to the right (p, 1.7 kb). The Mu G
segment is flanked by short (less than 0.05 kb) inverted
duplications at which a hypothetical Mu function (gin)
promotes G-segment inversion by intramolecular re-
combination. When phage are grown by induction, the
G segment can be found in either orientation (the [+]
and the [-] orientations) with roughly equal frequency.
In contrast, when phage are grown by lytic infection,
more than 98% of the progeny have G in the (+) orienta-
tion.
We have carried out a variety of experiments on the
structure, functions, and phylogenetic distributions of
the invertible G segment, as detailed below.
Comparison of the G inversion in phages
Mu, Pl, and P7
Phages P1 and P7 are related to each other but are
unrelated to Mu. Nonetheless, both contain an inverti-
ble segment which is homologous to the Mu G segment.
P1 has inverted duplications of 0.6 kb in length flanking
the G segment. In contrast, we found that P7 has only
one flanking segment of 0.6 kb, and the other segment
has a small (0.3 kb) internal deletion, so it is only 0.3 kb
long. The P7 G segment, like Mu-G DNA, is present in
only one orientation when phage are grown by infec-
tion. In contrast, the P1 G segment is found in either
orientation when phage are produced by lytic infection
or by induction of lysogens. We have postulated that the
long inverted duplications flanking the P1 and P7 G
segments are functionally homologous to the Mu /3
segment and are part of the gin system, which promotes
the G inversion (see below).
Isolation and characterization of viable deletion/
substitution Mu mutants
An E. coli strain DK445 lysogenic for Mu was found by
electron microscopy to contain an insertion of 2.6 kb in
the middle of the prophage Mu /3 region. Seven inde-
pendent viable mutant phages have been isolated from
it. Each of them has been characterized by EM
heteroduplex studies and was found to have a deletion
and/or substitution in the G /3 region (Fig. 3a). The
lengths of the bacterial DNA normally linked to the /3
end were found to decrease or increase in response to
the increase or decrease of the Mu genome caused by
the deletion/substitution in these mutants. These find-
ings strongly support the concept of a headfu I packaging
mechanism for Mu phage.
The G segment of the parental Mu prophage in
DK445 inverts normally. However, five of the mutants
have their G segment locked in the (+), or the lytic,
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orientation because one of the inverted duplications
flanking G is deleted. Since these phage are viable, we
conclude that the inversion of G from the (+) to the (-)
orientation is not essential for the Mu life cycle. A sixth
mutant, designated 445-5, has an intact G segment but
no longer inverts its G segment. This mutant has a small
deletion/substitution in the f3 region; presumably, this
deletion has damaged the gin function. G inversion in
this mutant can be achieved in trans by a wild-type
helper phage. Therefore, we have located at least part of
the Mu G inversion (gin) gene in the left half of j3 and
believe that it encodes a diffusable enzyme.
The infectivity of phage Mu depends on the
orientation of the G segment
Although mature Mu 445-5 gin- with the G segment in
the (+) orientation is viable, mature Mu 445-5 gin-
G( -) produced by induction of the lysogen is not infec-
tious. Using the gin- G(+) and gin- G(-) mutants as
controls, the G-segment inversion of wild-type Mu was
examined thoroughly. We have found that the effi-
ciency of an induced lysogen culture to yield infectious
centers is directly proportional to the percentage of
phage in the lysate with the G segment in the (+) orien-
tation. We take this to mean that the inversion of G
occurs predominantly or exclusively in the prophage
and does not occur to any appreciable extent after heat
induction of the prophage. Thus, each cell produces
either G(+) or G(-) phage, but not both. The amount of
phage in the lysate reflects the proportion of
G(+) and G(-) prophages in the population at the mo-
ment of heat induction. We can conclude also that
wild-type Mu phage with G in the (-) orientation is not
infectious. This explains why the G segment can be
observed in either orientation when Mu is grown by
induction but only in the (+) orientation when it is
grown lytically.
Although Mu G(-) phage do absorb to bacterial cells,
their defect cannot be restored by providing the gin
function from inside the cell. This indicates that the
DNA of the phage does not penetrate the cell wall, a
conclusion which is strengthened further by the failure
of marker rescue from a G(-) phage after infection.
We have evidence that an essential gene, designated
S, which has previously been mapped to the left of G is,
in fact, at least partially located within the G segment.
Inversion of G from the (+) to the (-) orientation would
then split the gene and inactivate it; alternatively, inver-
sion might separate the gene from its promoter.
5- phage particles are similar to G(-) phage particles
in that they too show no killing of the host. Both G(-)
phage and 5- phage inhibit growth of the G(+) gin-
phage during coinfection. Furthermore, a G(-)
prophage does not seem to complement S when intro-
duced into a Mu 5- lysogen. We are presently trying to
construct an S- gin- double mutant to verify this obser-
vation. We have tried unsuccessfully to restore infectiv-
ity to G(-) phage by growing them in the presence of the
viable Mu 445-5G(+) phage. Therefore, the effects of G
inversion are more complicated and cannot be ex-
plained solely by S inactivation; a cis-acting function
might also be involved.
Mu gin
We have studied the potential of other recombination
systems to substitute for Mu gin in catalyzing the inver-
sion of the Mu G segment. E. coli rec, X red, X int, and
080 int systems all fail to complement; P1, P7, and
D108, a phage largely related to Mu, complement Mu
gin- phage. We have shown that G inversion is not
affected by an E. coli himA mutation, which blocks the
integration of certain phages. We have cloned the
right-end Eco RI B fragment of Mu wild type with a phage
lambda vector. This hybrid phage expresses gin upon
infection as well as in the lysogenic state. We have used
this phage to study the kinetics of G inversion: a strain
lysogenic for the defective Mu 445 -5G( -) phage was
superinfected with Xgt-Mu Eco RI B and tested at various
times after infection for production of viable Mu phage.
The rate of G inversion was found to be 0.1% to 1% per
phage generation.
A 6000-base-pair Sall-EcoRI fragment overlapping
the G segment and gin, derived from Mu 445-8, was
cloned into pBR322. This plasmid expresses gin and we
intend to use it to study the gin protein and other pro-
teins made from this region of Mu DNA in an E. coil
minicell system.
P1 gin
The P1 EcoRI A fragment has been cloned with a lambda
vector. This fragment contains the P1 G segment and gin
function. A series of deletion mutants of this hybrid
phage was isolated after EDTA treatment of the phage
Figure 3
(a) A graphic representation of the Mu prophage in E. coli strain DK445 and some of the substitution/deletion phage derived
from it. The segments of Mu DNA are designated as a (30.7 kb), G (3.0 kb), g (1.7 kb), and SE (heterogeneous bacterial DNA
that forms split ends in heteroduplexes). The prophage has an insertion of 2.6 kb in the middle of the g region, which consists of
adjoining bacterial insertion elements 155 and 152. The mutant phages retain all or part of the insertion. Gaps represent
deletions in the mutant DNAs.(b)A three-component heteroduplex demonstrating the presence of155 in Mu 445-1. The heteroduplex of Mu 445-1 and Mu
vir DNA contains a substitution loop. The 155 in lambda charon 1 has hybridized to the substitution loop at the 155 resident in
Mu 445-1.
45
and is presently being analyzed with restriction en-
zymes. The goals of this work are to determine the
precise location of the P1 gin function and to isolate P1
gin- mutants. We hope that these experiments will pro-
vide clues as to the relatedness of G segments and gin
functions as well as to their origins.
Studies on the Mu mom System
(modification of Mu DNA)
We have studied the effect of G on the system of Mu
mom, a DNA modification function. Both Mu 445 -
5G(+) and Mu 445-5G(-) phage are mom-, as deter-
mined by restriction enzyme cleavage patterns of the
Mu DNA. Because the original prophage in DK445 and
all deletion phages derived from it are mom-, the mom
gene must map to the right of gin, or largely or entirely to
the right of the insertion. The mom- phenotype is due
either to the destruction of mom gene by the insertion or
to the block of transcription caused by the insertion in
the 445 series of Mu phages.
We have also determined the specificity of mom by
comparing restriction endonuclease digests of mom+
and mom- DNAs. A 5-base-pair sequence ( )A( E )XY
is recognized. The sequence is highly degenerate in
positions 4 and 5. In the absence of host E. coli dam
(methylase) function, no mom activity can be detected.
However, the dam recognition sequence (GATC) does
not seem to overlap those for mom. Therefore, mom
does not act as positive regulatory protein to turn on the
dam methylase.
Identification of bacterial insertion sequences
/S5 and IS2 in viable Mu mutants and IS5 in a
Adarg transducing phage
Evidence from restriction endonuclease analyses and
EM heteroduplex mapping shows that the 2.6-kb inser-
tion in the Mu prophage which generated our viable Mu
mutants consists of bacterial insertion element 155
linked directly to 152. Some of the deletion/substitution
mutants contain this tandem IS5: IS2, others have either
155 or part of IS2 (Fig. 3b).
Using EM heteroduplex methods, we have also found
that an insertion in the argB gene of a lambda transduc-
ing phage (,1argB2) is IS5. Demonstration of two addi-
tional, independent examples of 155 helps establish it as
a bona fide insertion element. Our physical results,
taken together with genetic information obtained by
others (W. Szybalski and N. Glansdorff, pers. comm.),
suggest that IS5, like ISI, exerts a polar effect on trans-
cription in either orientation.
Bacteriophage lambda attachment site (aft)
We have developed an in vivo assay for active attach-
ment sites that is based on our observation that a plas-
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mid containing a 450-base-pair long Hindi!! Bam HI
fragment spanning the A att site can be integrated into
phage lambda DNA, packaged, and excised after infec-
tion of a recipient cell. This process has an absolute
requirement for an on the plasmid and int on the
superinfecting lambda phage. By in vitro manipula-
tions, a special lambda vector has been constructed that
has deleted an Sstl and an Hindi!l fragment to the left of
the attachment site but is int+ and xis+. This vector can
accommodate an insertion of 12,000 base pairs. The
test has been used for two purposes: (1) the detection of
plasmids carrying small attachment-site fragments and
(2) the detection of attachment sites from other origins.
Using the assay described above we have identified
two chimeric plasmids that are active in the attach-
ment-site assay: one was obtained from a shotgun clon-
ing of Proteus vulgaris DNA using pMB9 as a vector; the
other contains the right-end EcoRI fragment of Mu
445-1 in pMB9.
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appears to be the only capped T, oligonucleotide found
at the 5' end of late Ad2 mRNAs. When hybrids be-
tween Ad2 mRNAs and Ad2 DNA are treated with
ribonuclease T,, this capped T, oligonucleotide is re-
leased, which suggests that it is not complementary to
sequences lying immediately adjacent to the main cod-
ing region of the mRNA. Experiments carried out in
collaboration with Louise Chow and Tom Broker of the
Electron Microscopy Section have provided direct evi-
dence for this interpretation by showing that many late
Ad2 mRNAs are mosaic molecules composed of se-
quences encoded at several positions on the Ad2
genome. When RNA displacement loops (R loops) are
formed between Ad2 mRNAs and Ad2 DNA, sequences
at the 5' terminus of each mRNA are available for hy-
bridization. If single strands of restriction endonuclease
fragments of the Ad2 genome are added to these R
loops, complex tertiary hybrids are formed between the
R strands of fragments containing short sequences from
map positions 16.6, 19.6, and 26.6 and the 5' ends of all
late mRNAs mapping to the right of map position 30.
The resulting structures show that a typical mRNA con-
tains a leader sequence whose 5' end is encoded at map
position 16.6, which is covalently joined to sequences
encoded at map positions 19.7 and 26.7 and has a total
length of 150 to 200 nucleotides. This leader is in turn
covalently joined to a main coding segment which is
transcribed from a region of the Ad2 genome previously
characterized as a structural gene. These unexpected
findings require that a novel mechanism must exist for
the biosynthesis of these late viral mRNAs. A wealth of
data from the laboratory of James Darnell at Rockefeller
University suggests that the primary transcription prod-
uct is a large RNA molecule which is initiated between
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map positions 15 and 20 (perhaps at 16.6) on the Ad2
genome and may extend as far as the right-hand ter-
minus of the genome (map position 100). If such a
transcript is the precursor of these late viral mRNAs, as
seems likely, then the production of these mRNAs will
require a series of cleavage and joining events to pro-
duce the observed structures. Experiments are in prog-
ress to determine the nature of the sequences present at
these junctions and to isolate the enzyme(s) involved in
their formation.
One particular mRNA, that encoding the major struc-
tural protein fiber, is being studied in detail. The 5' end
of the main coding region of this mRNA lies within Ad2
sequences immediately adjacent to one of the junctions
between Ad2 and SV40 sequences in the nondefective
hybrid virus Ad2+ND1. DNA sequences from this re-
gion of the genome have been obtained previously.
Experiments carried out in collaboration with Dan Kles-
sig and Jim Manley of the Protein Synthesis Section have
shown that within 200 nucleotides of this junction se-
quences occur which are present on fiber mRNA and
which are also present in ribosome-protected fragments
of fiber mRNA. Direct DNA sequence analysis of this
region reveals that two of the three possible reading
frames contain termination signals for protein synthesis.
The third frame contains a long stretch of in-frame co-
dons preceded by an initiation codon. Immediately fol-
lowing this initiation codon within the DNA sequence is
a sequence which, if transcribed, would lead to the
presence of a long T, oligonucleotide in fiber mRNA. A
long oligonucleotide of the predicted composition has
been found when fiber mRNA is hybridized to a restric-
tion fragment containing this region of the genome and
has also been found in the fragment of fiber mRNA
protected by ribosomes. Furthermore, experiments to
assess the extent of hybridization between this region of
the DNA and fiber mRNA suggest that the mRNA is
complementary to sequences lying no more than 30
nucleotides to the left of this initiation codon. Presuma-
bly, this represents the point at which the leader se-
quence is joined to the main coding region of fiber
mRNA. Experiments are in progress to define exactly the
point of divergence between sequences present on the
DNA and sequences present on fiber mRNA.
Terminal structure of the adenovirus-2 genome
The complete sequence of the inverted terminal repeti-
tion of Ad2 is now available. This repetition is 102
nucleotides long and contains a number of repeated
sequences whose significance is unknown. It is perhaps
noteworthy that the terminal 40 nucleotides are ex-
tremely AT-rich, whereas the internal section is highly
GC-rich. If, as seems likely, replication begins at the
very end of the molecule, the AT-rich nature of the
termini would thus allow for relatively easy strand sep-
aration. Several stable secondary structures can be
drawn from the primary sequence, including one that
would allow a self-priming mechanism for DNA repli-
cation. Since the sequence of the inverted terminal repe-
tition is both unique and nonpalindromic, any self-
priming mechanism would cause scrambling of the se-
quences at the termini of the DNA. Such scrambled
sequences are not present either in viral DNA or in free
nuclear DNA, and thus it is unlikely that DNA replica-
tion proceeds by a self-primed mechanism.
Restriction endonucleases
The collection of restriction endonucleases continues to
expand. Nearly 130 such enzymes are now known,
with almost 60 different specificities. New endonu-
cleases include enzymes from several strains of Ag-
robacterium tumefaciens (which may be of great biolog-
ical interest), Bpa I and Bpa II from Bordetella paraper-
tussis, Cpel from Corynebacterium petrophilum, Pvul
and Pvull from Proteus vulgaris, SfaNl from Strep-
tococcus faecalis, TgII from Thermopolyspora glauca,
Xnil from Xanthomonas nigromaculans, and Xpal from
Xanthomonas papavericola. In addition, second en-
zymes have been found in two strains of Moraxella
nonliquefaciens (Mnoll and Mnnll) and in Thermus
aquaticus (Tagil).
Recognition sequences have been deduced for a
number of restriction endonucleases, including BO
(TaGATCA) from Bacillus caldolyticus and its
isoschizomer Cpe I; Bpal GT AC); Blul from
Brevibacterium luteum, Xhol from Xanthomonas hol-
cicola, and Xpa I from Xanthomonas parahaemolyticus
(C4 TCGAG) Pvul I (CAG CTG); Sall from Streptomyces
albus G (G4TCTAC); Sac II from Streptomyces
achromogenes, Sstll from Streptomyces stanford, and
Tgll (CCGC1GG); and Xba I from Xanthomonas badrii
(T +CTAGA). In addition, the recognition sequence for
Mn)! from Moraxella nonliquefaciens has been deduced
as CCTC; however, the site of cleavage is known only to
lie within 5 to 10 nucleotides 3' of this sequence. This
enzyme is of considerable interest for DNA sequence
analysis as it is expected to cleave DNA at twice the
frequency of enzymes such as Haelll which recognize a
tetranucleotide palindrome. It is becoming LIcreasingly
apparent that many different kinds of recognition and
cleavage processes are possible for the type-II restriction
endonucleases and studies of their mechanisms of ac-
tion should provide much valuable information about
protein-nucleic acid interactions.
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CELL BIOLOGY
G. ALBRECHT-BUEHLER, K. Burridge, A. Bushnell, L.B. Chen, W. Gordon, R.C. Gudor, L. Jordon, R. Lancaster,
T. Lukralle
Most types of cancer could be eliminated surgically if it
were not for the metastasizing cells. Therefore, the un-
derstanding of migration of mammalian cells seems of
great importance for the understanding of many types of
cancer, as well as, of course, for the understanding of
normal cell behavior, e.g., during embryogenesis.
Recently, we have developed a new technique which
allows migrating animal cells to record their own
movements on a glass substrate which is densely and
evenly covered with colloidal gold particles, ranging in
size between 0.2 gm and 0.4 gm. The migrating cells
remove these particles from the substrate during their
displacement and in this way leave a particle-free track
behind. We suggested that these tracks be called
"phagokinetic tracks." The convenience of studying
such tracks and their large numbers have helped us to
make several observations which point to the possibility
that animal cells are in command of their migration
-their pathways follow preset programs which can be
revised however, in a predictable way upon collision
with another cell.
The first, and still strongest, evidence for predetermi-
nation in cellular migration comes from the observation
that the track of one daughter 3T3 cell appears predom-
inantly as the mirror image or identical copy of the track
of the other daughter cell. We described this observa-
tion in last year's annual report. This year's work con-
centrated on other aspects of predetermination of migra-
tion and on attempts to localize in 3T3 cells a putative
"control center of movement" responsible for such pro-
gramming. As will be pointed out below, we believe at
present that the centrioles are part of this postulated
"control center." If substantiated, this "control center"
might offer a new approach to cancer cells, because one
can imagine that transforming events may affect this
"control center" and unleash less controlled motile
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activities, thus, perhaps, leading to the metastasis of
such cells.
Cell-line characteristic track patterns
Different cell lines or single-cell clones of established
cell lines produce characteristically different tract pat-
terns. In this context, we use the term "cell-line charac-
teristics" in the same sense as it is commonly used to
describe culture morphologies of different cell lines.
Upon changes in culture conditions, the appearance of
the track patterns may change, but so do culture mor-
phologies. We found that the track patterns of a cell line
are in this sense representative. In a given cell line the
morphologies of single cells can differ considerably
from one another; so did track patterns of single cells.
As a preliminary observation, we should like to note
that transformed 3T3 cells, even in the presence of 20%
calf serum, seem to produce much shorter phagokinetic
tracks than the parental cells.
Track patterns formed by cells from
the second or third generation
From the finding of symmetry between the tracks of two
daughter 3T3 cells, the question arose whether such
predetermination can go beyond one generation.
Therefore, we searched for track patterns produced
by second- or third-generation descendants of a single
cell. Unfortunately, such track patterns are rarely read-
able because the descendant cells or other cells may
cross the "ancestor" tracks too often. Screening about
20 preparations, we found several track systems that
suggested that descendant cells up to the third genera-
tion can reproduce the track patterns of their ancestors.
This finding strengthens the notion that migration is
predetermined and controlled by 3T3 cells.
Collision behavior of 3T3 cells
The movements during a collision between two migrat-
ing homologous cells have been known for quite some
time (Abercrombie and Heaysman, Exp. Cell Res. 6:293
[1954]; Trinkaus et al., Exp. Cell Res. 64:291 [1971];
Weiss, lnt. Rev. Cytol. 7:391 [1958]). Invariably, a cessa-
tion of ruffling at the impact area is followed by the
formation of retraction fibers and the expression of a
new ruffling lamellipodium somewhere else at the cell's
circumference. The study of phagokinetic tracks of col-
liding cells seems to offer an additional aspect to this
complex cellular behavior. The new lamellipodia do
not seem to form just "somewhere else" on the cell
circumference, but in such places and in such succes-
sions that the cell eventually moves away from the
impact area as if it were reflected.
Within 100-200 gm from the collision area the
angles between ingoing tracks and a central line appear
equal to the angles of the outgoing tracks. Unfortu-
nately, based on the tracks alone, one cannot be com-
pletely certain that two migrating cells actually collided
at the point of closest approach of either track, although
one can argue that if it were otherwise the tracks should
have crossed.
To make more certain that two cells were at the point
of closest approach of their respective tracks at the same
time, one can use nonmigrating cells, such as BSC-1
cells, as one collision partner. We plated 3T3 cells
together with BSC-1 cells on a particle-coated cover slip
and screened for collision patterns 1 or 2 days later.
Again we observed that the 3T3 cells formed ingoing
tracks within 100-200 Am from the impact area which
appeared as if reflected. The target BSC-1 cell, however,
did not seem to change its position after the impact and
in most cases remained centrally located inside its
particle-cleared area.
In view of the many hours duration of a cell-cell
collision, the above finding suggests that the colliding
cells reorient their path in a predictable, and therefore
nonrandom, way.
Actin patterns and phagokinetic tracks
The front and rear ends of a cell can be determined by
the track direction (they are indicated as "f" and "r" in
Fig. 1). According to this definition, the major actin-
containing bundles stretched between the rear end of
the cell and the nucleus (Fig. 1). The front end showed
bundles only rarely.
We examined the actin patterns and corresponding
tracks of 113 individual 3T3 cells. In 61% of the cases
the symmetry axis of the main bundle stretched parallel
to the current (Fig. 1 a) or previous segment of the corre-
sponding track. In 39% of the cases no relationship
between bundles and track segments could be deter-
mined because the segments were either too short or
irregular. Sometimes the cells had too many different
bundle directions or were rounding up.
Tubulin patterns and phagokinetic tracks
Most of the cytoplasmic microtubular patterns appeared
in the front half of the cells. The density of fluorescent
fibers in the rear end seemed to be reduced unless
diffuse fluorescence around the accumulated gold par-
ticles made it impossible to detect single fibers. Due to
the complexity of the cytoplasmic microtubular pat-
terns, a relationship between them and the track direc-
tions was not obvious.
Most helpful for the search for structures that are
conspicuously oriented to track segments, however,
was the fluorescent-labeled rodlike structure which was
described by Osborn and Weber (Proc. Natl. Acad. Sci.
73:867 [1976]). In electron microscopy studies, Wheat-
ley (1. Anat. 110:367 [1971], I. Anat. 113:83 [1972])
had shown earlier that 50-75% of 3T6 cells contained
one, single, mostly intracellular cilium growing out of a
centriole ("primary cilium") whose shaft was embed-
ded in a vacuole.
Screening 101 3T3 cells on plain glass, we found a
single, primary cilium in 87% of them. Invariably, it was
located close to the nucleus. As far as one can tell from
light microscopy, using an objective lens (N.A. 1.4) with
a small depth of focus (approx. -± 0.7 gm), in 61% of the
cells the cilium was straight and ran approximately
parallel to the substrate. In 14% of the cells it was bent,
and in 12% it was oriented vertically to the substrate.
The cilia frequency in 3T3 cells plated on gold-
particle-coated glass substrates was lower than on plain
glass (53%). This reduced frequency may be explained
by a reduced visibility of cilia on such substrates due to
internalized gold-particle clusters or a high background
level of diffuse fluorescence around the nucleus. There
may be other, as yet unknown, factors influencing the
expression of cilia.
Comparing the orientation of the primary cilium with
the direction of the phagokinetic track in 258 cells, we
found that where the structure could be detected it ran
approximately parallel to the substrate and the current
segment in 73% of the cells (Fig. 1 b). In the remaining
27% it was vertical, or bent, or pointed in a direction
that did not seem related to the track direction. The
cilium could be detected near the cell bottom or close to
the dorsal surface (Fig. 1b). In cells that extended side-
ways, the primary cilium remained oriented parallel to
the segment just completed.
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The interpretation of the above results is complicated
by the difficulty in distinguishing between cause and
effect in the relationships described between the direc-
tions of the primary cilia, the main actin bundles, and
the track segments. Nevertheless, we should like to
submit the following possibilities.
The main actin-containing bundles stretched pre-
dominantly from the rear end of the cells to beneath the
nucleus and ran parallel to the current segments of the
tracks. It seems possible, therefore, that the fibers of the
main bundles became organized close to the substrate
in parallel lines, and that the nucleus and the bulk
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cytoplasm moved along them as if on "rails." Conceiv-
ably, the bundles could lengthen farther during this
process. According to this model, the used parts of the
rails were left behind, converged in the rear, and even-
tually were dissembled during the tail retraction.
This notion of cellular displacements on "rails" offers
a reason why the main bundles in 3T3 cells, which are,
in fact, microfilament bundles (Goldman et al., Exp. Cell
Res. 90:333 [1975]), are located near the substrate and
are often tied to the substrate by adhesion plaques
(Goldman et al., Cell Motility, p. 217. Cold Spring Harbor
Laboratory, New York [1976]). Such features are implied
by the term "rail" in the first place. Movement along rails
would also allow the nucleus and bulk cytoplasm to
move parallel to themselves, thus possibly reducing the
chance of entangling the complex cytoplasmic architec-
ture during displacement. Furthermore, it would explain
the observation that 3T3 cells, if considered random
walkers, move persistently during short time intervals of
2.5 hr (Gail and Boone, Biophys. ). 10:980 [1970]).
Most striking is the observed relationship between the
orientation of primary cilia and current track segments.
There are various possible interpretations of this rela-
tionship, ranging from the assumption that the cilium
shaft is passively oriented by certain cytoplasmic forces
that act during cellular displacement, to the assump-
tion that the direction of the cilium determines the direc-
tion of a migrating 3T3 cell by an as yet unknown
mechanism. One could also think of the primary cilium
as a "sensor" or mechanotransducer which is aligned
with the "intended" direction of movement so as to
yield to, and thus detect, cytoplasmic movements de-
viating from this direction. There is also the possibility
that the cilium itself is of little relevance for the move-
Figure 1
Parallels between the directions of the main actin-
containing bundle (a) or the primary cilium (b) and the
current direction of displacement in 3T3 cells.
The inserts show dark-field light micrographs of the
same cells (white clusters) in their phagokinetic tracks as
those seen in fluorescent light microscopy. Inserts and
fluorescence micrographs are shown in identical orienta-
tions relative to the observer. Bars in b represent 20 irm and
100 Arn. The connected arrows indicate the observed paral-
lels between the actin bundles or the primary cilium and
the respective track directions. The letters "f" and "r"
designate the front and rear ends of the cells as derived
from the track directions. The black clusters in the fluores-
cence micrographs are internalized clusters of gold parti-
cles.
(a) Pair of daughter cells with the main bundles parallel
to the current track segment. The bundles of cell 2 con-
verge due to the tail formation.
(b) Primary cilium (arrow) oriented parallel to the current
direction of a 3T3 cell. The focus in the fluorescence mi-
crograph is raised to the level of the cilium, thus producing
only a blurred image of the whole cell.
ment of cells. One may consider it simply a convenient
light microscopic marker for the direction of the axis of
the centriole out of which it grew. In other words, the
parallels between the direction of primary cilia and
current track segments described here may have to be
interpreted as a geometric relationship between the
direction of migration and the orientation of one cen-
triole in migrating interphase cells. On-going experi-
ments, which will be described in next year's annual
report, support the interpretation that it is not the cilium,
but rather its basal centriole, that is involved in the
control of directional changes in migrating 3T3 cells.
Local inhibition of centripetal particle
transport where LETS protein patterns
appear on 3T3 cells
The assay of phagokinetic tracks described above is
based on the phenomenon that a cell encountering a
particle removes it from the substrate and transports it
centripetally to the perinuclear area of the cell where it
is phagocytosed. Therefore, we are very interested in
this general phenomenon of centripetal particle trans-
port which has been described by Marcus (Cold Spring
Harbor Symp. Quant. Biol. 27:351 [1963(1, Abercrom-
bie et al. (Exp. Cell Res. 62:389 [19701), and Harris (Exp.
Cell Res. 73:519 [19721). We found that the so-called
LETS protein, which recently has attracted much atten-
tion, seems to be related to the expression of centripetal
particle transport along the surface of 3T3 cells.
Originally discovered as a major surface glycoprotein
of molecular weight 220,000-250,000, which disap-
peared upon cell transformation, LETS protein on the
dorsal surface of fibroblastic cells shows several intrigu-
ing aspects. The protein distribution patterns, or at least
their antigenic availability, seem to originate from cell -
cell contact areas. Later on, the protein can cover large
cell-surface areas in the form of intertwined streaks,
indicating a major nonhomogeneity in the cell-surface
composition.
Assuming a constant centripetal flow, one might ex-
pect that fibrillar surface components like LETS protein
would eventually have to orient themselves parallel to
the radial flow lines. The complex distribution patterns
of LETS protein in all cell lines investigated so far, how-
ever, seemed hard to reconcile with a radial centripetal
flow. One may suspect, therefore, that the flow has
ceased in areas covered with LETS protein.
Therefore, we allowed 3T3 cells to pick gold particles
from the substrate and transport them centripetally.
Subsequently, we fixed and stained them for LETS pro-
tein using indirect immunofluorescence. We found that
cells that were able to accumulate the gold particles
all around the nucleus in the form of a ring showed only
a few patches of LETS protein or none at all, whereas
cells with extended patterns of LETS protein still had the
particles scattered randomly all over their surfaces. We
also observed quite a few cells with incomplete rings of
centripetally accumulated gold particles. In many such
cases, the ring segment marked a cell-surface sector
without LETS protein, whereas the complementary sec-
tor contained extended LETS-protein patterns.
These observations suggest that the particles cannot
move radially into or inside areas where LETS protein
covers the cell surface in the form of extended patterns.
One would expect, therefore, that removal of LETS pro-
tein from the cell surface would increase the centripetal
transport of particles.
During a mild treatment of a 3T3 cell culture with
trypsin, the predominant component removed from
dorsal cell surfaces is LETS protein; yet the cells show no
detectable shape alteration in response to this treat-
ment. In contrast, similarly treating the cells with
thrombin does not affect the LETS protein (Teng and
Chen, Nature 259:578 [1976]). Treating 3T3 cells in this
way with trypsin or thrombin prior to exposing them to
particles resulted in a considerable increase of cen-
tripetal particle transport in the trypsin-treated cells as
compared with the thrombin-treated cells.
It seems, therefore, that the centripetal transport of
surface-attached particles and, perhaps, the surface
flow itself are locally inhibited by those surface net-
works that are built predominantly of LETS protein.
LETS protein and the extracellular matrix
In last year's annual report we described our studies on
the large, external, transformation-sensitive (LETS) pro-
tein. This is a prominent extracellular glycoprotein as-
sociated with the surfaces of many cell types, including
fibroblasts, myoblasts, and epithelial cells. Our main
approach to studying this cell-surface component in-
volved the use of specific antisera and immunofluores-
cent microscopy. In some transformed cells LETS pro-
tein is expressed only in regions of cell-cell contact,
whereas in normal cells at confluence it is distributed
over the whole cell surface and appears to be a major
component of the extracellular matrix. We have ex-
tended the study of LETS protein and the extracellular
matrix by means of both scanning and transmission
electron microscopy. Figure 2 shows a scanning elec-
tron micrograph of a chick embryo fibroblast after 4
days in culture. The cell is surrounded and overlaid with
an extensive matrix of fibers of varying dimensions. If a
comparable cell is reacted first with antibody against
LETS protein, next with a fluorescent antibody, and then
viewed by fluorescent microscopy, an equivalent ma-
trix extending both over and beyond the cell is found to
be brightly fluorescent, indicating the presence of LETS
protein. Further evidence that this extracellular matrix
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Figure 2
A scanning electron micrograph of a chick embryo fibroblast
extending over the cell. This network is rich in LETS protein.
contains LETS protein as a major constituent has come
from transmission electron microscopy. Cells were
again treated with antibody against LETS protein but
then with a ferritin-conjugated second antibody di-
rected against the first. The electron-dense ferritin
molecules could be located in the electron microscope
and confirmed the abundance of LETS protein in the
fibrils of the extracellular matrix surrounding normal
cells in culture.
To study LETS protein and the extracellular matrix
further it would be desirable to isolate the matrix free
from the cell and cellular debris. To this end we have
followed and modified procedures of cell extraction
with nonionic detergents which have been found by
others to leave LETS protein and much of the cytoskele-
ton behind while extracting most other cellular compo-
nents (Hynes et al., J. Supramol. Struct. 1:189 [1976];
Brown et al., ). Supramol. Struct. 5:119 [1976]). Previ-
ously, such extractions were performed at or near neu-
tral pH, but we have found that extraction in 1% NP-40
at pH 9.6 followed by 0.3 nit KCI extracts most of the
cellular components, including microfilaments, inter-
mediate filaments, and the nucleus, leaving behind
what appears to be only the extracellular matrix. Analy-
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after 4 days in culture. Note the extracellular fibrillar network
sis of this matrix has confirmed that the major compo-
nent is LETS protein. Some actin and myosin were also
detected in the gels, but immunofluorescent micros-
copy showed that these were not part of the matrix but
were present as a random, speckled pattern in between
the fibers of the matrix.
Experiments have been performed to examine the
response of cells to the extracellular matrix prepared as
described above. It was found to have a marked influ-
ence on the morphology of certain cells when these
were plated on it. A line of Chinese hamster ovary cells,
for example, that normally possess a rounded-up mor-
phology, when plated on these matrix preparations
spread and became spindle-shaped. Currently, we are
uncertain as to the role of LETS protein in effecting this
morphological transition, but various other substrates,
such as collagen, fibrinogen, and polylysine, did not
induce it.
Hormones and LETS protein
In most experiments where the expression of LETS pro-
tein has been studied, serum is routinely present in the
culture medium at concentrations between 5% and
10%. While studying the effect of thrombin on the LETS
protein of mammalian cells we noticed that serum-free
control cultures frequently lost the fibrillar LETS net-
work as compared with cultures in 10% serum. This
prompted us to investigate whether hormones normally
present in serum might affect the expression of LETS
protein. Many hormones and growth factors have been
tested, and one, epidermal growth factor (EGF), has
been found to have a marked effect on the expression of
LETS protein. Confluent cultures of 3T3 cells in medium
supplemented with 10% calf serum have massive fibril-
lar networks of LETS protein, as detected by immuno-
fluorescence. If the medium of such cells is replaced by
medium containing 0.7% serum, after 2 days most of the
LETS network disappears or deteriorates significantly.
When such cultures are supplemented with EGF at 1
ng/ml, the extensive network of LETS protein is restored
within 30 hours. This effect has been found with many
cell types, including secondary fibroblasts from mouse,
rat, and hamster, and with the established cell lines
NIL-8 and BHK. An exception, however, was found in
the case of chick embryo fibroblasts, where the fibrillar
LETS network remains unaffected even when the cells
are cultured in serum-free medium for 2 days.
EGF can stimulate the growth of many fibroblasts,
such as 3T3 cells. We have investigated whether this
stimulation of growth can be dissociated from the stimu-
lation of LETS-protein production. At high doses of EGF,
significant growth stimulation does not occur; however,
LETS-protein production is enhanced considerably.
Evidence such as this, which indicates different dose-
response ranges, suggests that the two effects can be
dissociated. Little is known about the way hormones
like EGF function, and we hope that this identification of
a biochemical response to EGF will open up new direc-
tions for research into how such hormones affect their
cellular targets.
The cytoskeleton
Our work on the distribution and behavior of contractile
and cytoskeletal proteins in nonmuscle cells has con-
tinued. Recently, we have been concentrating on a line
of gerbil fibroma cells that have a very flat morphology
on glass and that reveal arrays of comparatively narrow
stress fibers. These properties make them ideal for im-
munofluorescent microscopy. In previous studies the
distributions of myosin and a-actinin along the stress
fibers have been shown to be periodic. We have ex-
tended this observation and have shown that the distri-
butions of these two proteins alternate and are com-
plementary. This is reminiscent of the distributions of
these proteins in skeletal muscle myofibrils and sup-
ports the theory that the arrangement of actomyosin in
these nonmuscle stress fibers is sarcomeric. A most
intriguing observation with these cells has been that we
have also seen, by immunofluorescence, an intermittent
distribution of actin in some fibers. This may suggest that
even the actin is distributed periodically in nonmuscle
"sarcomeres." This actin periodicity, however, has
been observed only with a low frequency, but this may
be because in most stress fibers there is an overlap of the
actin filaments obscuring the periodicity. Such an over-
lap might depend on the state of contraction of the stress
fiber during fixation, the average state being a con-
tracted one. Alternatively, this occasional periodic dis-
tribution of actin may indicate that only some fibers
have a sarcomeric arrangement of actin and that this
occurs as a result of a particular physiological state in
localized regions of certain cells.
The ultrastructure of these gerbil fibroma cells has
been studied by electron microscopy. Such studies have
shown that these stress fibers, like those in many other
fibroblasts, are bundles of tightly packed microfilaments
with an intermittent distribution of electron-dense struc-
tures (dense bodies). A comparison between the elec-
tron micrographs and the immunofluorescent images
reveals that the fluorescent units of the a-actinin pattern
have the same size, shape, and spacing along the stress
fibers as the dense bodies, whereas the fluorescent units
of the myosin pattern have the same dimensions as the
spaces between the dense bodies. From this we have
concluded that the dense bodies are the sites of
a-actinin localization and that the spaces between them
are the sites of myosin localization. No indication of a
periodic actin distribution has as yet been found at the
EM level, but here we are limited by the small number of
cells that can be examined by this technique.
Intermediate filaments
During our work with antisera against various structural
proteins we have routinely screened the sera of rabbits
before immunization to test for any preexisting im-
munological activity. In one nonimmunized rabbit an
antiserum was found that reacted strongly with a system
of filaments in various cell types, such as fibroblasts,
epithelial cells, macrophages, and neuroblastoma. A
gerbil fibroma cell reacted with this antiserum is illus-
trated in Figure 3. These filaments are distinct from the
actin microfilament bundles made visible by an anti-
body against actin and they are not affected by brief
treatment with cytochalasin B. Although resembling
microtubules somewhat, these filaments can be distin-
guished both by a comparison of their respective loca-
tions during cell division and by their responses to the
drugs colchicine and vinblastine. During cell division
the mitotic spindles bind antibodies against micro-
tubules, whereas the system of filaments reactive with
this unknown antiserum is found generally dispersed
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Figure 3
Indirect immunofluorescent micrograph of a gerbil fibroma cell stained with an autoimmune rabbit antiserum. The fibers reacting
with this antiserum are the intermediate (10 nm) filaments.
through the cytoplasm everywhere except at the spin-
dles. In response to treatment of the cells with col-
chicine or vinblastine, the filaments reacting with this
antiserum condense to form a compact perinuclear coil
of fibers, a distribution and behavior in agreement with
that described previously for intermediate (10-nm) fila-
ments studied by electron microscopy. A comparison of
electron micrographs and immunofluorescent patterns
from parallel cell cultures has provided further evidence
that this antiserum reacts with intermediate filaments.
To identify the antigens reacting with this antiserum
we have used the technique of immunoautoradiog-
raphy on SDS gels, the development of which was de-
scribed last year. Two reactive polypeptides have been
identified in both 3T3 cells and the gerbil fibroma cells,
having apparent molecular weights of about 56,000 and
30,000 daltons, respectively. As far as we know, this is
the first time an autoimmune antiserum has been ana-
lyzed in this way.
Antigen and glycoprotein detection in SDS gels
Last year we described the methods we had developed
for analyzing both antigens and glycoproteins directly
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in SDS gels by their binding of labeled antibodies or
lectins, respectively. We have continued to improve the
techniques and they have been put to a variety of appli-
cations. As described above, the technique of detecting
antigens in SDS gels has been used to analyze an au-
toimmune serum reactive with the intermediate fila-
ments of nonmuscle cells. A different application has
been found in collaboration with R. Bigelis (Protein
Synthesis Section) who has been working on the yeast
his4 gene complex, which codes for a multifunctional
protein that catalyzes three steps in the pathway of
histidine biosynthesis. An antibody raised by R. Bigelis
against this protein will detect the 95,000-dalton
polypeptide in SDS gels. We have varied the antibody
technique by replacing the second antibody with
radioiodinated staphylococcal protein A. This protein A
has the property of binding to the Fc portion of the
immunoglobulins of many species. In the experiments
with the antibody against the his4 protein we could
detect in gels not only the 95,000-dalton protein, but
also the fragment polypeptides from those mutant
strains bearing nonsense, frameshift, and deletion muta-
tions in this region. Many of these polypeptide frag-
ments are unstable, and because they are degraded
rapidly they have not been detected by conventional
immunoprecipitation techniques. However, with im-
munoautoradiograpy on SDS gels the immunological
reaction occurs after the proteins are resolved in the gel
rather than before (as in conventional immunoprecipita-
tion), and since proteolytic degradation can be kept to a
minimum, this has allowed us to identify mutant pro-
teins that were previously undetectable.
Cell-surface glycoproteins and development
The cell surface must play a critical role in develop-
ment, and yet surprisingly little is known about most of
the proteins and glycoproteins that are present on cell
surfaces. The general ignorance concerning cell-surface
molecules results largely from inadequate analytical
techniques. One technique that may contribute infor-
mation in this area is the identification of specific
glycoproteins in SDS gels by their direct binding of
labeled lectins, which has been mentioned above and
which has been developed independently in several
laboratories. During the last year we have applied this
technique to the analysis of glycoproteins in two differ-
entiating systems in which cell-surface events must take
place. Glycoproteins have been analyzed from the cel-
lular slime mold Dictyostelium discoideum. This in-
teresting creature spends most of its life cycle as a free-
living amoeba feeding on bacteria. When the food sup-
ply is exhausted, however, the amoebae respond by
aggregating and forming a fruiting body, with sporula-
tion being the end result. During aggregation the cells
become more adhesive and bind selectively to each
other. Clearly, changes at the cell surface must occur.
After aggregation, the mass of cells will differentiate,
giving rise to spore cells that are raised up above the
substrate on a pedestal of stalk cells. When the glyco-
proteins from successive stages in the developmental
cycle are analyzed, some pronounced changes are re-
vealed with some lectins. With Concanavalin A many
reactive glycoproteins are found over the complete
molecular weight range. During development some of
these glycoproteins remain constant, whereas others
appear or are lost at particular stages in the sequence.
The free-living amoebae have very few glycoproteins
that react with the wheat germ agglutinin, but during
their differentiation several prominent reactive glyco-
protein gel bands appear. Similarly, lectins with a speci-
ficity for fucose do not reveal any reactive glycopro-
teins either in the free-living amoebae or during the
early stages of development. Late in development,
however, and possibly corresponding to the stage of
spore-cell differentiation, several reactive bands ap-
pear. Little, if any reaction was found with lectins spe-
cific for terminal galactose residues or terminal
N-acetyl-galactosamine. This was somewhat surprising
as a lectin isolated from Dictyostelium by several
laboratories has a specificity for galactose. The expres-
sion of this lectin is developmentally regulated and it
appears as the amoebae become more adhesive. It has
therefore been implicated in the aggregation process.
Since it would be of considerable interest to identify the
receptor for this protein, we have purified and radio-
labeled it and have then applied it back to fixed SDS
gels. To our surprise we have not yet detected any
reactive material in these gels. We suspect that the
receptor for this Dictyostelium lectin may be a
glycolipid. This might escape detection even if it mi-
grated in the gel, as it would very likely be lost during the
fixation procedure. More work is needed in this area.
Another system we have been exploring is muscle
development. This is of interest because much is known
about the biochemistry of the internal muscle structural
proteins and it is a system that can be studied conve-
niently in tissue culture. Single-celled myoblasts mature
in culture, aligning with fellow myoblasts and fusing to
form multinucleate myotubes. Clearly, the cell surface
must be important both during myoblast recognition
and in the subsequent fusion process. After fusion, the
myotubes acquire new surface properties, such as the
appearance of acetylcholine receptors. We have been
analyzing this sequence of myogenic development
using a rat myoblast cell line and have been analyzing
the glycoproteins of these cells before and after fusion.
Some interesting changes have been revealed. In an
attempt to determine the functions of some of these
alterations we are currently trying to raise antibodies
against those components that change with develop-
ment. Specific antibodies will permit localization
studies and will also enable us to probe the possible
functions of some of these components. It would be
interesting, for example, to raise an antibody that would
block fusion or that would disrupt other events in this
sequence of myogenic development.
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Since its inception, the postgraduate program at Cold Spring Harbor
Laboratory has been aimed at meeting the rather special need for
training in interdisciplinary subjects that are either so new or so
specialized that they are not adequately treated by universities. Our
intention is to provide intensive training in the most recent develop-
ments and techniques in each of the subjects so that, upon completion,
the students will be able to enter directly into research in the particular
area. To ensure this up-to-date coverage of current research work, we
bring together a workshop staff from many laboratories around the
world and supplement this staff with a series of seminar speakers.
THE TRANSFORMED CELL, June 12-July 1
INSTRUCTORS
Pollack, Robert, Ph.D., State University of New York, Stony Brook
Hynes, Richard, Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANTS
Feldman, Jonathan, B.A., State University of New York, Stony Brook
Lanza, Robert, B.A., University of Pennsylvania, Philadelphia
In vitro transformation of mammalian cells by oncogenic viruses or by
environmental agents has served in the last decade as a central model
for the earliest steps in the process of oncogenesis. This new course
presented an integrated series of laboratory exercises, informal discus-
sions, and guest lectures designed to provide each student with a
chance to carry out and to review critically the many different assays
that detect differences between normal and transformed cells. Wher-
ever possible, these assays were also made to serve as starting points
for examinations of the molecular events underlying them and of their
relationship to in vivo processes such as initiation, promotion, an-
giogenesis, invasion, and metastasis. Exercises included SV40 virion
and DNA transformation of murine precrisis fibroblasts and cell lines,
selection of phenotypic revertants, karyotype analysis, immunofluo-
rescent localization of viral antigens, preparation of chick embryo
myoblasts and fibroblasts, transformation by is and wt RSV, fibrinoly-
sis, HAT selection, gel electrophoresis and localization of LETS by
antibody- and lectin-staining on gels, immunofluorescent localization
of cytoskeletal proteins and of LETS, sugar transport, and explantation
of tumors from the nude mouse.
Special thanks for their contributions of time and material to these
exercises go to Bill Topp, Keith Burridge, Bettie Steinberg, Kate Ny-
man, Andrew Lo, Seung-II Shin, Dan Rifkin, Bill Brinkley, Bob
Goldman, Guenter Albrecht-Buehler, and Peter Morrell.
PARTICIPANTS
Alexander, Stephen, Ph.D., Sidney Farber Cancer Institute, Boston, Massachusetts
Anholt, Robert H., M.S., University of California, La Jolla
Birchmeier, Walter, Ph.D., University of California, La Jolla
Brad law, June A., Ph.D., Food and Drug Administration, Washington, D.C.
Hiscott, John, M.S., New York University, New York
Hsu, Wen-Tah, Ph.D., University of Chicago, Illinois
Huesgen, Adi, Ph.D., Max-Planck-Institut, Tubingen, West Germany
Karess, Roger E., B.S., Rockefeller University, New York, New York
Lockwood, Arthur, Ph.D., New York University, New York
Makan, Nizar R., M.D., Cornell University, Ithaca, New York
Mayo, Kristen A., B.A., University of California, Santa Barbara
Mueller, Christian, Ph.D., University of Berlin, West Germany
Peehl, Donna M., B.S., University of Colorado, Boulder
Scandella, Carl J., Ph.D., State University of New York, Stony Brook
Schollmeyer, Judith E., Ph.D., University of Minnesota, Minneapolis
Smith, Karen K., B.S., Rockefeller University, New York, New York
Villereal, Mitchel L., Oak Ridge National Laboratory, Tennessee
Yefenof, Eitan, B.S., Karolinska Institute, Stockholm, Sweden
SEMINARS
Todaro, G., National Cancer Institute. Transformations.
Goldman, R., Carnegie-Mellon University. Cytoskeleton.
Botchan, M., Cold Spring Harbor Laboratory. Recombination and papovaviruses.
Varmus, H., University of California, San Francisco. Sarc gene and its products(s).
Rifkin, D., Rockefeller University. Proteases.
Tegtmeyer, P., State University of New York, Stony Brook. A gene and its product(s).
Hynes, R., Massachusetts Institute of Technology. Cell surfaces.
MacDougall, J., Cold Spring Harbor Laboratory. Adenovirus.
Brinkley, B., University of Texas, Houston. Cytoplasmic microtubule complex.
Fidler, J., Frederick Cancer Research Center. Metastasis.
Folkman, J., Children's Hospital, Boston. Angiogenesis.
Green, H., Massachusetts Institute of Technology. Normal skin in culture.
Lilly, F., Albert Einstein College of Medicine. Host genetics of murine tumor viruses.
Shin, Albert Einstein College of Medicine. Nude mice.
Smith, H., University of California, Oakland. Human tumors in culture.
Sato, G., University of California, San Diego. Hormones.
MOLECYLAR CYTOGENETICS, June 12-July 2
INSTRUCTORS
Pardue, Mary Lou, Ph.D., Massachusetts Institute of Technology
Gall, Joseph, Ph.D., Yale University, New Haven, Connecticut
ASSISTANTS
Erba, Harry, Yale University, New Haven, Connecticut
The molecular cytogenetics course emphasized the integration of classical and molecular techniques for
analysis of chromosome structure and function. A number of visiting scientists joined with the class for
discussion of current problems in the field and for experiments utilizing chromosome banding, the isolation of
chromatin subunits, in situ hybridization, visualization of transcription by electron microscopy, restriction-
enzyme digestion of DNA, nucleic acid sequencing, heteroduplex mapping, and fluorescent antibody studies of
the cytoskeleton. As always, we benefited from the many contributions of Barbara McClintock.
Students came from Switzerland, Germany, England, Canada, and various parts of the United States. Their
previous research experience ranged from neurobiology to crystallography, adding a wide variety of interests
and expertise to the group.
PARTICIPANTS
Baumgartel, D. Mona, Ph.D., San Diego Zoological Society, California
Hayashi, Shizu, Ph.D., University of British Columbia, Canada
Jones, C. Weldon, B.A., Harvard University, Cambridge, Massachusetts
Kay, Alan C., Ph.D., National Cancer Institute, Bethesda, Maryland
Mauron, Alex, M.S., Swiss Institute for Cancer Research, Lausanne
Rosa, Margaret D., Ph.D., Yale University, New Haven, Connecticut
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Sato, J. Denry, B.S., Oxford University, England
Schafer, Ulrich, Ph.D., University of Dusseldorf, West Germany
Wigley, Caroline, Ph.D., Imperial Cancer Research Fund Laboratories, London, England
SEMINARS
Bakken, A., University of Washington. Chromosome structure during mammalian oogenesis.
Let, S., Harvard Medical School. Fluorescent dyes as probes of chromosome structure.
Noll, M., University of Basel. The structure of the nucleosome.
Fujiwara, K., Harvard Medical School. Probing the cytoskeleton with fluorescent antibodies.
Lindsley, D.L., University of California, San Diego. Genetic studies on Drosophila.
Gall, J.G., Yale University. Gene amplification in Tetrahymena.
Pardue, M.L., Massachusetts Institute of Technology. Structure and function of Drosophila polytene chromosomes.
Davis, R., Stanford Medical School. Expression of eukaryotic genes in bacteria.
NERVOUS SYSTEM OF THE LEECH, June 12-July 2
INSTRUCTORS
Nicholls, John, Ph.D., M.D., Stanford University Medical School, California
Jansen, Jan, Ph.D., M.D., University of Oslo, Norway
Muller, Kenneth J., Ph.D., Carnegie Institution, Washington, D.C.
The aim of this workshop was to provide students with an intensive lab and seminar course that would enable
them to pursue independent work on the leech. To this end, we hoped to provide the students with techniques
for recording from leech cells, now considered straightforward and relatively easy, which took much time and
effort to be refined. With this knowledge, they might avoid many of the trivial technical difficulties that bedevil
anyone starting on the nervous system of the leech or other animals.
The initial work was devoted mainly to recognizing the individual cells, learning how to record from them
with intracellular and extracellular electrodes, getting familiar with the equipment, and performing dissections.
The students then progressed to more difficult experiments, such as recording synaptic potentials while
changing the fluid bathing the preparation or injecting individual cells with marker substances in order to study
their geometry.
The final phase of the course consisted of devising and performing original experiments, some of which
proved to be of sufficient interest to be pursued in greater detail. For example, the nervous systems of various
hitherto unexplored leeches were studied.
PARTICIPANTS
Bearer, Elaine L., M.A., Stanford University, California
Grinvald, Amiram, Ph.D., Yale University, New Haven, Connecticut
Katzel, Les I., B.S., Johns Hopkins University, Baltimore, Maryland
Kramer, Andrew P., B.A., University of California, Los Angeles
Laffer, Cheryl L., B.S., University of Wisconsin, Madison
Nelson, Margaret C., Ph.D., Harvard Medical School, Boston, Massachusetts
Schnapp, Bruce J., Ph.D., University of Connecticut, Storrs
Scott, Sheryl A., Ph.D., McMaster University, Ontario, Canada
Tilney, Lewis G., Ph.D., University of Pennsylvania, Philadelphia
Wu, Chun-Fang, Ph.D., California Institute of Technology, Pasadena
SEMINARS
Sawyer, R., University of California, Berkeley. Biology and development of leeches.
Stewart, A.E., Harvard Medical School. Motoneurons and control of muscle.
Stent, G., University of California, Berkeley. Neurons responsible for swimming and the initiation of rhythmical heartbeat.
Parnas, I., Hebrew University. Methods for killing individual nerve cells in intact animals.
Salzberg, B., University of Pennsylvania. Optical techniques for recording from neurons without electrodes.
TECHNIQUES FOR STUDYING THE VERTEBRATE CENTRAL NERVOUS SYSTEM, June 12-July 4
INSTRUCTORS
Shatz, Carla, Ph.D., Harvard Medical School, Boston, Massachusetts
Stryker, Michael, Ph.D., Harvard Medical School, Boston, Massachusetts
Kirkwood, Peter, Ph.D., Institute of Neurology, London, England
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ASSISTANT
Mates, Sharon, B.A., Harvard Medical School, Boston, Massachusetts
One aim of the course was to provide students with the basic technical competence necessary for conducting
independent experimental work. Another was to provide an introduction to the functional organization of
several different areas in the vertebrate central nervous system. The course consisted of four different laboratory
exercises. In all labs students learned the appropriate surgical techniques, the preparation of microelectrodes,
and simple histological procedures for reconstructing electrode tracks. In one lab the reflex activity of motoneu-
rons in the cat's spinal cord was studied using both intracellular and extracellular recording techniques. Two
other labs focused on the visual system. In one, extracellular recordings were made from the cat's visual cortex,
and the response properties of neurons to visual stimuli were examined. In the other, stereotaxic techniques
were used to place electrodes within deeper structures (lateral geniculate nucleus and superior colliculus) for
recordings. In this laboratory the corticocollicular pathway of the Siamese cat, a neurological mutant, was
studied. The retrograde transport of horseradish peroxidase injected into the superior colliculus was used to
trace afferent connections. In the fourth lab, the regions of the cortex and superior colliculus receiving
somatosensory input from the whiskers of the rat were studied. The relationship between these two structures
was examined using both anatomical and extracellular recording techniques. Additional anatomical methods,
such as silver stains selective for degenerating fibers, were demonstrated.
PARTICIPANTS
Batson, Deidre E., B.A., University of Bristol, England
Hofbauer, Alois, B.S., University of Freiburg, West Germany
Jan, Yuh Nung, Ph.D., California Institute of Technology, Pasadena
Katz, David M., B.A., State University of New York, Stony Brook
Kennedy, Mary B., Ph.D., Harvard Medical School, Boston, Massachusetts
Nakamura, Richard K., Ph.D., National Institutes of Health, Bethesda, Maryland
Schein, Stanley J., Ph.D., M.D., Albert Einstein College of Medicine, Bronx, New York
Wagner, John A., Ph.D., University of California, San Francisco
SEMINARS
Bizzi, E., Massachusetts Institute of Technology. Sensory feedback in the control of head and eye movements.
Moore, G.P., University of Southern California. Mathematical techniques for analyzing neural connectivity.
Kirkwood, P., Institute of Neurology, London. Neural control of respiration.
Shatz, C., Harvard Medical School. Visual system abnormalities in a genetic mutant.
Sherk, H., Massachusetts Institute of Technology. The role of early experience in the development of the visual cortex.
Stryker, M., Harvard Medical School. Metabolic mapping of activity in the visual cortex using the 2-deoxyglucose
autoradiographic technique.
Burke, R., National Institutes of Health. Motor units, motor neurons, and the control of movement.
Schiller, P., Massachusetts Institute of Technology. The role of the superior colliculus in eye movement and vision.
THE STRUCTURE AND FUNCTION OF SYNAPSES, June 19 -July 10
INSTRUCTORS
Rahamimoff, Rami, M.D., Hebrew University Medical School, Jerusalem, Israel
McMahan, Jack U., Ph.D., Harvard Medical School, Boston, Massachusetts
Purves, Dale, M.D., Washington University, St. Louis, Missouri
This course was designed for graduate students and research workers interested in the structure and function of
synapses. It consisted of lectures; reading of papers; group discussions; presentation of selected topics by
participants; seminars by instructors, faculty, and participants; and demonstrations. After the course ended, nine
participants who were uninitiated in electrophysiological techniques stayed on to learn the usage of basic
methods.
The topics covered included microscopic anatomy of the nervous system; ionic bases of membrane and
action potentials; membrane structure and ionic selectivity; morphology, microphysiology, and biochemistry of
the postsynaptic membrane and receptors; excitatory and inhibitory synaptic potentials; physiology and
morphology of release of neurotransmitters; electrical synapses and gap junctions; neurotoxins; principles of
synaptic pharmacology; transmission in autonomic ganglia; transmission at invertebrate synapses; integrative
processes in the nervous system; slow synaptic potentials; immunological studies of acetylcholine receptors,
cyclic nucleotides, and neuronal function; structure of central nervous system synapses; biochemistry and
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physiology of the adrenergic system; development of the nervous system; denervation, reinnervation, and
sprouting in the nervous system; nerve growth factor; the postsynaptic channel and its voltage dependence; and
fluctuation analysis in synaptic physiology.
PARTICIPANTS
Bondi, Ardith Y., Ph.D., New York University, New York
Corey, David P., BA., California Institute of Technology, Pasadena
Curran, Michael J., M.S., University of Toronto, Canada
Gozes, Illana, B.S., The Weizmann Institute, Rehovot, Israel
Greenberg, Allan S., B.A., Purdue University, West Lafayette, Indiana
Hicks, Philip T., B.S., University of British Columbia, Canada
Jan, Lily, Ph.D., California Institute of Technology, Pasadena
Johnson, David A., B.S., University of Connecticut, Storrs
Lansman, Jeffrey B., B.A., Tufts University, Medford, Massachusetts
Lasher, Stuart S., B.S., University of Virginia, Charlottesville
Levine, Richard B., B.S., State University of New York, Albany
Marchand, Claudine, Ph.D., State University of New York, Stony Brook
Miller, Thomas M., B.A., University of California, San Francisco
Orida, Norman K., B.A., University of California, Irvine
Peters, Tim K., M.D., University of Berlin, West Germany
Redmann, Greg A., B.A., Stanford University, California
Salama, Guy, M.S., University of Pennsylvania, Philadelphia
Thomas, William E., M.S., Meharry Medical College, Nashville, Tennessee
Wendon, Linda, B.A., University College London, England
SEMINARS
Hall, Z., University of California, San Francisco. Acetylcholine receptor: Synthesis and control of distribution.
Myasthenia gravis and immunological studies of acetylcholine receptor.
Cyclic nucleotides and neuronal function.
Nicholls, J., Stanford University. After effects of signaling.
Integrative processes in the nervous system.




Martin, AR., University of Colorado, Denver. Statistics of transmitter release. 1.
Statistics of transmitter release. II.
Electrical synapses: Physiology.
The effect of acetylcholine on eel electroplaque.
Principles of transmission in sympathetic ganglion.
Nichols, J., J. Jansen,* and K. Muller,t Stanford University; *University of Oslo; tCarnegie Institution. Leech
demonstration.
Blaustein, M., Washington University, St. Louis. The regulation of intracellular calcium in nerve terminals.
The physiology of synaptosomes.
Sodium calcium exchange.
Goodenough, D., Harvard University. Morphology of gap junctions and electrical synapses.
Erulkar, S., University of Pennsylvania. Neurotoxins.
Principles of synaptic pharmacology.
Squid synapses.
Kuffler, S.W., Harvard University. Microphysiology of the postsynaptic membrane.
Slow synaptic potentials in the parasympathetic ganglion.
Yoshikami, D., Harvard University. Microphysiology of the postsynaptic membrane at the neuromuscular
junction.
Autonomic ganglia.
Raviola, E., Harvard University. Structure of central nervous system synapses.
Workshop on freeze-fracture.
Patterson, P., Harvard University. The adrenergic system.
Autonomic ganglia tissue.
Frank, E., Harvard University. The development of synaptic contacts in tissue culture.
Stevens, C., Yale University. The postsynaptic channel and its voltage dependence.
Selectivity and ion permeation through Mu synaptic channel.
Fluctuation analysis and single-channel conductance.
Applications of fluctuation analysis.
Shimoni, Y., and A. Lev Toy, Hebrew University, Intracellular recording and stimulation.
Extracellular recording and stimulation.
Analysis of synaptic activity.
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ADVANCED BACTERIAL GENETICS, July 5-July 25
INSTRUCTORS
Botstein, David, Ph.D., Massachusetts Institute of Technology, Cambridge
Roth, John, Ph.D., University of Utah, Salt Lake City
Wensink, Peter, Ph.D., Brandeis University, Waltham, Massachusetts
ASSISTANTS
Meyer, Barbara, B.S., Harvard University, Cambridge, Massachusetts
Chum ley, Forrest, B.S., University of Utah, Salt Lake City
Guergen, Peter, B.S., Brandeis University, Waltham, Massachusetts
Students in the course carried out complete in vitro recombination experiments in which fragments of
Salmonella DNA were joined to E. coli plasmid vehicles by the terminal transferase method. The in vitro
recombinants were analyzed by methods which included colony hybridization to radioactive yeast ribosomal
RNA and heteroduplex analysis in the electron microscope and attempted genetic complementation of specific
genetic defects in the bacterial hosts.
Students also carried out a variety of genetic experiments with translocatable drug-resistance elements of S.
typhimurium and E. coll. Some of the E. coil insertion mutants were used to screen the in vitro recombinants for
complementation.
PARTICIPANTS
Berget. Peter B., Ph.D., Massachusetts Institute of Technology, Cambridge
Brefort, Georges A., M.D., Pasteur Institute, Paris, France
Federoff, Howard J., B.A., Albert Einstein College of Medicine, Bronx, New York
Frick, Kevin K., B.A., University of Illinois, Urbana
Guarneros, Gabriel, Ph.D., Institute Politec Nacional, Mexico City
Hennecke, Hauke H., University of Regensburg, West Germany
Hertz, Rachel, M.S., Hebrew University, Jerusalem, Israel
Koch, Arthur L., Ph.D., Indiana University, Bloomington
Kunst, Frank F., M.S., University of Paris, France
Lerner, Terry T., M.A., Rockefeller University, New York, New York
Lillis, Marcella T., B.A., University of Pennsylvania, Philadelphia
Malik, Vedpal S., Ph.D., The Upjohn Company, Kalamazoo, Michigan
Maurelli, Anthony T., B.S., University of Alabama, Birmingham
Neff, Norma F., B.A., University of California, Berkeley
Palva, Tapio E., Ph.D., The Wallenberg Laboratories, Uppsala, Sweden
Schoffl, Friedrich, Ph.D., University of Erlangen, West Germany
Siegel, Eli C., Ph.D., Tufts University, Medford, Massachusetts
Stahl, Franklin, Ph.D., University of Oregon, Eugene
Sullivan, Mark A., B.S., University of Wisconsin, Madison
Vennstrom, Bjorn, Ph.D., Uppsala University, Sweden
SEMINARS
Davis, R., Stanford University. Quantitative electron microscopy of DNA.
Simon, M., University of California, San Diego. Molecular basis of phase variation in Salmonella flagella.
Botstein, D., Massachusetts Institute of Technology. Genetic studies of translocation of the translocatable element Tn 1.
Stahl, F., University of Oregon, Eugene. Recombination in bacteriophage lambda.
Ptashne, M., Harvard University. Mechanism of action of lambda repressor.
Brenner, S., Medical Research Council. Molecular biology of nematodes.
New in vitro recombination methods.
Miller, J., University of Geneva. Genetic studies in lac I.
Kleckner, N., Harvard University. The genetics of transposition.
ONCOGENIC VIRUSES, July 5-July 25
INSTRUCTORS
Sharp, Phillip A., Ph.D., Massachusetts Institute of Technology, Cambridge
Spear, Patricia G., Ph.D., University of Chicago, Illinois
GUEST LECTURER
Baltimore, David, Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANT
Wilcox, Kent, Ph.D., University of Chicago, Illinois
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Four animal virus groups were discussed during the course and used in laboratory experiments: papovaviruses,
adenoviruses, herpesviruses, and retroviruses. Both the biology and molecular biology of the viruses were
covered by various speakers in a format that allowed the lecturers to provide background information so that
their current work could be understood by students without previous training in the field. Several members of the
permanent staff of Cold Spring Harbor Laboratory gave research seminars and demonstrations of specific
techniques. The afternoons and part of the evenings were occupied with laboratory work. Topics covered
included counting and plating of mammalian cells in culture; transformation of 3T3 cells by Harvey sarcoma
virus; SV40 virus and SV40 DNA; transfection of cells with herpes simplex viral DNA; transformation of
thymidine-kinase-negative mouse cells to thymidine-kinase-positive cells with herpes simplex DNA; plaque
titering of SV40; adenovirus 2 and herpes simplex virus; extraction of adenovirus-2 virions and SV40 and
herpesvirus DNAs from infected cells; restriction endonuclease cleavage and gel electrophoresis analysis of
viral genomes; nick translation of viral DNA; Southern blotting of cellular and viral DNA; XC assay of Moloney
leukemia virus and preparation of an in vitro protein-synthesizing system using rabbit reticulocyte lysate
digested with micrococcal nuclease. Brief demonstrations of injection of mammalian cells by microneedles and
electron microscope techniques for visualization of DNA were given. In addition to these activities, some
students worked on the development of other procedures used in molecular virology.
PARTICIPANTS
Abovich, Nadja B., B.S., Universidad Catolica, Valparaiso, Chile
Biswas, B., Ph.D., Rose Institute, Calcutta, India
Chiang, Tom C.H., Ph.D., University of Texas, Richardson
Cioe, Livia, Ph.D., University of Rome, Italy
d'Auriol, Luc, MA., Hopital St. Louis, Paris, France
Flavell, Andrew J., Ph.D., Imperial Cancer Research Fund Laboratories, London, England
Gattoni, Sebastiano, M.D., New York University, New York
Gissmann, Lutz, Ph.D., University of Erlangen, West Germany
Jofre, Juan T., Ph.D., Baylor College, Houston, Texas
Kramer, Barnett S., M.D., National Cancer Institute, Bethesda, Maryland
Miovic, Margaret L., Ph.D., Swarthmore College, Pennsylvania
Murray, Mark J., M.S., University of Oregon, Portland
Ricciardi, Robert P., M.A., University of Illinois, Urbana
Roos, Raymond P., M.D., University of Chicago, Illinois
Sonenberg, Nahum, Ph.D., Roche Institute, Nutley, New Jersey
SEMINARS
Martin, R.G., National Institutes of Health. Transformation by papovaviruses.
Weissman, S.M., Yale University. Structure of the SV40 genome.
Tegtmeyer, P., State University of New York, Stony Brook. Genetics and gene products of papovaviruses.
Philipson, L., University of Uppsala. Structure of adenovirus virion and viral DNA transcription.
Levine, A.J., Princeton University. Early adenovirus gene products.
Sharp, P.A., Massachusetts Institute of Technology. Adenovirus transcription.
Roberts, B., Brandeis University. In vitro translation and coupled transcription and translation.
Roizman, B., University of Chicago. Herpesvirus: Structure, replication, and transcription.
Spear, P., University of Chicago. Herpesvirus gene expression in transformed cells.
Deinhardt, F., Max von Pettenkonter Institute. Biology of Epstein-Barr viruses.
Baltimore, D., Massachusetts Institute of Technology. Molecular biology of RNA tumor viruses.
Todaro, G., National Cancer Institute. Evolution and functions of RNA tumor viruses.
Rowe, W.P., National Institutes of Health. Biology of RNA tumor viruses.
Hanafusa, H., Rockefeller University. Genetics of avian RNA tumors.
Boettiger, D., University of Pennsylvania. Transformation of differentiated cells.
Basilico, Claudio, New York University Medical School. Genetics and biochemical analysis of somatic animal cells.
IMMUNOGENETICS AND TUMOR IMMUNOLOGY, July 28-August 13
INSTRUCTORS
Nowinski, Robert, Ph.D., Fred Hutchinson Cancer Center, Seattle, Washington
Eisenman, Robert, Ph.D., Fred Hutchinson Cancer Center, Seattle, Washington
ASSISTANTS
Shaikh, Rashid, B.S., Fred Hutchinson Cancer Center, Seattle, Washington
Doyle, Terri, B.S., Fred Hutchinson Cancer Center, Seattle, Washington
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The course focused on current research in immunogenetics as it relates to differentiation, tumor biology, and
host-virus interactions, primarily in the mouse. Among the topics covered were cellular immunology, differ-
entiation of lymphoid cellS in vivo and in vitro, the H-2 and TL loci, the Dix system, the T locus, and the
physiology and genetics of type-C viruses. Approaches at the molecular level were stressed, particularly with
respect to genetic specification of normal and malignant cell surfaces.
The course consisted of lectures by instructors and invited speakers, discussions, and laboratory experiments
in tissue-culture systems and in specially constructed genetic crosses between inbred mouse strains.
PARTICIPANTS
Baluch, John D., B.S., University of Pittsburgh, Pennsylvania
Candler, Edrick L., Ph.D., Union Carbide Corporation, Tarrytown, New York
Carry, Paul J., B.S., University of Colorado, Boulder
Celis, Esteban, M.D., Ciudad University, Mexico
Fabian, Ursula, Ph.D., University of Hamburg, West Germany
Lind!, Toni, Ph.D., University of Konstanz, West Germany
Mansion, Sy, M.A., University of Colorado, Denver
Moen, J.E.T., M.D., University of Leiden, The Netherlands
Pfister, Herbert, Ph.D., University of Freiburg, West Germany
Shuman, Stewart, B.A., Albert Einstein College of Medicine, Bronx, New York
Walker, Mary Clare, Ph.D., New York University, New York
Zarling, David A., Ph.D., University of Wisconsin, Madison
SEMINARS
Nowinski, R., Fred Hutchinson Cancer Center. Introduction to immunogenetic studies of neoplasia.
Murphy, D., Stanford University. Major histocompatibility locus.
McDevitt, H., Stanford University. Immune response genes.
Press, J., Brandeis University. Differentiation of B
Hood, L., California Institute of Technology. Immunogenetics and structure of immunoglobulins and histocompatibility
antigens.
Martin, G., University of California, San Francisco. Teratomas as models of differentiation. I.
Levine, A., Princeton University. Teratomas as models of differentiation. II.
Nowinski, R., Fred Hutchinson Cancer Center. Basic principles of tumor immunology.
Krag, S., Johns Hopkins University. Biochemistry and synthesis of glycoproteins.
Nowinski, R., Fred Hutchinson Cancer Center. Expression of viral proteins on the surface of lymphocytes.
Yamada, K., National Institutes of Health. Cell surfaces of transformed cells.
Pollack, R., State University of New York, Stony Brook. Cell biology of transformed cells.
Eisenman, R., Fred Hutchinson Cancer Center. Cell regulation of RNA tumor viruses.
Gershon, R., Yale University. Differentiation of T cells.
Rowe, W., National Institutes of Health. Leukemogenesis in AKR mice.
Lilly, F., Albert Einstein College of Medicine. Genetic influences of H-2 on viral leukemogenesis.
Waelsch, S., Cornell Medical School. T locus.
Linial, M., Fred Hutchinson Cancer Center. Genetics of RNA tumor viruses.
Stollar, D., Tufts University. Antibodies against nucleic acids.
Levine, A., Princeton University. Transformation proteins of DNA tumor viruses.
Livingston, D., Harvard Medical School. Relationship of T antigen to TSTA of papovavirus.
Rohrschneider, L., Fred Hutchinson Cancer Center. Identification of tumor-specific sarcoma antigens on the surface of
RSV-transformed cells.
Lerner, R., Scripps Clinic. Physiology of leukemia virus protein expression in normal mouse tissues.
THE MOLECULAR BIOLOGY AND GENETICS OF YEAST, July 28-August 17
INSTRUCTORS
Sherman, Fred, Ph.D., University of Rochester, New York
Fink, Gerald, Ph.D., Cornell University, Ithaca, New York
Petes, Thomas D., Ph.D., University of Chicago, Illinois
ASSISTANT
Johnson, Tina, B.A., Cornell University, Ithaca, New York
This program emphasized the major laboratory techniques used in the genetic analysis of yeast:tetrad analysis,
mitotic recombination, and fine-structure mapping. The isolation and characterization of both chromosomal
and cytoplasmic mutants were undertaken. Biochemical studies were performed with chromosomal and
mitochondrial mutants. Studies on chromosomal and extrachromosomal DNA were pursued by electron
microscopy and by digestion with restriction endonucleases.
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PARTICIPANTS
Abelson, John N., Ph.D., University of California, San Diego
Beckman, Jacques S., Ph.D., University of California, San Diego
Bedard, Dennis P., Ph.D., Dalhousie University, Nova Scotia, Canada
Foy, James J., M.S., Miami University, Oxford, Ohio
Frezza, Domenico, Ph.D., National Institutes of Health, Research Triangle Park, North Carolina
Hieda, Kotaro, Ph.D., Rikkyo University, Tokyo, Japan
Jazwinski, S. Michal, Rockefeller University, New York, New York
Larimer, Frank W., Ph.D., Oak Ridge National Laboratory, Tennessee
Loriez Calderone, Isabel, M.S., University of Seville, Spain
Maccecchini, Maria L., M.S., University of Basel, Switzerland
Piepersberg, Wolfgang, Ph.D., University of Regensburg, West Germany
Rabinowitz, Jesse C., Ph.D., University of California, Berkeley
Steege, Deborah A., Ph.D., Duke University, Durham, North Carolina
Taylor, Fred R., B.A., Yale University, New Haven, Connecticut
Walenga, Ronald W., Ph.D., University of Connecticut, Farmington
Willsky, Gail R., Ph.D., Harvard University, Cambridge, Massachusetts
SEMINARS
Hartwell, L.H., University of Washington. Cell cycle of yeast.
Control of cell division in yeast.
Petes, T.D., University of Chicago. Structure and replication of yeast DNA.
Genetic and physical analysis of yeast ribosomal DNA.
Byers, B., University of Washington. Cytology of the yeast life cycle.
Tzagoloff, A., Public Health Research Institute, New York City. Saturation of the mitochondrial genome.
Abelsen, J., University of California, San Diego. Cloning of yeast tRNA genes.
Mackay, V.L., Rutgers University. Genetic and hormone control of mating in yeast.
McLaughlin, C.S., University of California, Irvine. Protein synthesis in yeast.
Warner, J., Albert Einstein College of Medicine. Regulation of ribosomal proteins and RNA.
Mortimer, R.K., University of California, Berkeley. Genetic mapping in yeast.
Gene conversion and post meiotic segregation.
Fink, G.R., Cornell University. Regulation of gene clusters in yeast.
The yeast killer factor.
Jones, E.W., Carnegie-Mellon University. Proteinase mutants of yeast.
Lawrence, C., University of Rochester. Radiation mutagenesis and repair in yeast.
Sherman, F., University of Rochester. Nonsense suppression in yeast.
Regulation of the isocytochromes c.
EXPERIMENTAL TECHNIQUES IN NEUROBIOLOGY August 7-August 28
INSTRUCTORS
Kehoe, Jac Sue, Ph.D., Ecole Norma le Superieure, Paris, France
Chiarandini, Dante, M.D., New York University, New York
Stefani, Enrique, M.D., Instituto Politecnico Nacional, Mexico City, Mexico
GUEST LECTURER
Kado, Ray, Ph.D., Centre National de la Recherche Scientifique, Gif-sur-Yvette, France
In this Neurobiology course the neuromuscular junction of the frog and the central ganglia of the mollusc
Aplysia were used as experimental preparations for training students in basic electrophysiological methods for
cellular neurobiology. Examination of certain characteristics of the resting potential, action potential, and
synaptic potentials of these two preparations served as a framework for introducing the following techniques:
microdissection, fabrication of single and mu ltibarrelled capillary microelectrodes, intracellular and extracellu-
lar recording and stimulation procedures, current-clamp and voltage-clamp circuitry, extracellular and intracel-
lular application of ions and drugs (ionophoresis and pressure injection), and intracellular staining for light and
electron microscopy.
The first three days of the course were devoted to lectures and exercises on electronics for cellular
neurobiologists given by Ray Kado. The last few days of the course were devoted to individual experimental
projects chosen by the students projects that permitted them to try techniques not taught in the course and to use
biological preparations that they intended to study upon returning to their own laboratories.
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PARTICIPANTS
Bastiani, Michael J., BA., University of California, Davis
Boyle, Mary B., BA., Yale University, New Haven, Connecticut
Carlson, Steven S., Ph.D., University of California, San Francisco
Deutsch, James W., Ph.D., University of California, San Francisco
Harris-Warrick, Ronald M., Ph.D., Stanford University, Stanford, California
Hildebrand, John G., Ph.D., Harvard Medical School, Boston, Massachusetts
Kingan, Timothy G., B.A., Oregon State University, Corvallis
Sardet, Christian, Ph.D., Station Zoologique, Villefranche, France
So, Yuen T., B.S., Rockefeller University, New York, New York







Chromosome research has long been one of the main investigative
endeavors at Cold Spring Harbor, and numerous past Symposia have
been devoted to delving into chromosomal structure and function. The
decision to choose this topic once again for this year's meeting reflects
the amazing progress made over the last three years on the chromo-
somal DNA-protein complexes called chromatin. Here the key dis-
covery has been that it has a repeating subunit (the nucleosome)
comprised of some two hundred base pairs wrapped around an oc-
tamer of histones. With this fact to work from, the chromatin field has
broken out of the speculative straightjacket which for so long held it
down and has emerged as one of the most exciting areas in biology.
And we felt somewhat secure in our anticipation of a full meeting at
which many new facts would be presented and from which many new
avenues of investigation would lead. The final product, however, was
even more exciting than anyone could have hoped. The existence of
recombinant DNA and the powerful new DNA sequencing methods
have begun to generate results that a few years ago we would have
predicted could not emerge until a decade or two of more sustained
work. Even more surprisingly, a variety of experimental approaches
gave us the bombshell that functional RNA molecules can derive from
physically quite separate sections along a DNA molecule. At the end
we were both overwhelmed and dazzled, and many participants left
feeling they had been part of an historic occasion.
The great breadth of the prospective program meant that substantial
help was needed from outside advisors. Invaluable advice was given
by Drs. Bruce Alberts, Pierre Chambon, Francis Crick, Gerry Felsen-
feld, Joe Gall, Aaron Klug, Roger Kornberg, Mary Lou Pardue, and
Harold Weintraub. A total of one hundred and eight formal presenta-
tions were given at the week-long gathering. Three hundred and
seventy-five participants were in attendance, a Symposium record.
Only with the receipt or substantial outside financial help could we
have invited so many speakers. Again we are most indebted to the
National Institutes of Health, the National Science Foundation, and
the United States Energy Research and Development Administration.
WEDNESDAY EVENING, June 1
Welcoming remarks: J.D. Watson, Cold Spring Harbor Laboratory
Opening comments: F.H.C. Crick, Salk Institute
Session 1: Nucleosome structure I: Crystallographic analysis
Chairperson: G. Felsenfeld, National Institutes of Health, Bethesda, Maryland
J.T. Finch and A. Klug, Medical Research Council Laboratory of Molecular Biology, Cambridge, England: X-ray
study of crystals of nucleosome cores.
J.F. Pardon, R.I. Cotter, D.M.J. Lilley, D.L. Worcester,* A.M. Campbell,t J.C. Woo ley, and B.M. Richards, Searle
Research Laboratories, High Wycombe, Bucks, England; *Atomic Energy ResearchEstablishment, Harwell,
England; 1-Biochemistry Department, University of Glasgow, Scotland: Neutron and X-ray scattering studies
of chromatin subunits.
THURSDAY MORNING, June 2
Session 2: Nucleosome structure II: Conformational studies
Chairperson: E.M. Bradbury, Portsmouth Polytechnic Institute, England
M. Zama, P.N. Bryan, R.E. Harrington, A.L. Olins, and D.E. Olins, Oak Ridge Graduate School of Biomedical
Sciences, University of Tennessee, and Biology Division, Oak Ridge National Laboratory, Tennessee:Conformational states of chromatin.
C.L.F. Woodcock and L.-L.Y. Frado, Department of Zoology, University of Massachusetts, Amherst: Ultrastruc-
ture of chromatin subunits during unfolding, histone depletion, and reconstitution.
R.D. Camerini-Otero, B. Sollner -Webb, R. Simon, P. Williamson, M. Zasloff, and G. Felsenfeld, National
Institutes of Health, Bethesda, Maryland: DNA folding and histone interactions in the nucleosome.
M. Noll, Department of Cell Biology, Biozentrum University of Basel, Switzerland: Internal structure of the
nucleosome-DNA folding in the conserved 140-base-pair core particle.
H.M. Sobel!, S.C. Jain, C.-C. Tsai, T.D. Sakore, and S.G. Gilbert, Department of Chemistry and Department of
Radiation Biology and Biophysics, University of Rochester School of Medicine and Dentistry, New York:
Conformational flexibility in DNA structure as revealed by structural studies of drug intercalation and its
implications in understanding the organization of DNA in chromatin.
A. Prunell, B. Baer, and R.D. Kornberg, Department of Biological Chemistry, Harvard Medical School,Boston,
Massachusetts: Relation of nucleosomes to nucleotide sequences.
H.G. Zachau, Institut fur Physiologische Chemie, Physikalische Biochemie and Zellbiologie der Universitat
Miinchen, West Germany: Nuclease cleavage of chromatin.
THURSDAY EVENING, June 2
Session 3: Transcription I: Primary products
Chairperson: W. Gilbert, Harvard University, Cambridge, Massachusetts
R. Evans, N. Fraser, S. Goldberg, J. Weber, M. Wilson, E. Ziff, and J.E. Darnell, Molecular Cell Biology
Department, Rockefeller University, New York, New York: Localization of transcription units for mRNA by
nascent RNA hybridization and UV mapping.
S.M. Berget, A.J. Berk, T. Harrison, and P.A. Sharp, Center for Cancer Research and Department of Biology,
Massachusetts Institute of Technology, Cambridge: Adenovirus mRNAs.
T.R. Broker, L.T. Chow, A. Dunn, R.E. Gelinas, J. Hassell, D.F. Klessig, J. Lewis, and R.J. Roberts, Cold Spring
Harbor Laboratory, New York: Novel structure at the 5' end of Ad2 mRNA.
R.G. Roeder, C.S. Parker, J.A. Jaehning, and V.E.F. Sklar, Department of Biological Chemistry, Division of
Biology and Biomedical Sciences, Washington University, St. Louis, Missouri: Faithful transcription of
specific genes in chromatin and nuclear templates by purified eukaryotic RNA polymerases.
R.C. Huang, M.M. Smith, and A.E. Reeve, Department of Biology, Johns Hopkins University, Baltimore,
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Maryland: Transcription in vitro of specific genes in isolated mouse myeloma nuclei, chromatin, and DNA.
J.O. Bishop, D.J. Bower, N.D. Hastie, M. Izquierdo, and S. Perlman, Department of Genetics, University of
Edinburgh, Scotland: Measurements of genomic expression.
J. Paul and R.S. Gilmour, Beatson Institute for Cancer Research, Glasgow, Scotland: Reconstitution of functional
chromatin.
FRIDAY MORNING, June 3
Session 4: Simple systems
Chairperson: D. Nathans, Johns Hopkins University, Baltimore, Maryland
W. Gilbert, Department of Molecular Biology, Harvard University, Cambridge, Massachusetts: Contact be-
tween proteins and DNA.
J. Rouviere-Yaniv, Department de Biologie Moleculaire, Institut Pasteur, Paris, France: Characterization and
functional role of a histonelike protein in prokaryotes.
B. Thimmappaya, V.B. Reddy, R. Dhar,* K.N. Subramanian,t B.S. Zain,* and S.M. Weissman, Department of
Human Genetics, Yale University School of Medicine, New Haven, Connecticut; *National Institutes of
Health, Bethesda, Maryland; +University of Illinois Medical School, Chicago; *Cold Spring Harbor Labora-
tory, New York: The structure of the genome of SV40.
A.J. Varshaysky, V.V. Bakayer, and G.P. Georgiev, Institute of Molecular Biology, Academy of Sciences of the
USSR, Moscow: On the structure of eukaryotic, prokaryotic, and viral chromatin.
R.L. Rill, D.A. Nelson, and W.R. Beltz, Florida State University, Tallahassee: Studies on isolated chromatin
subunits from yeast.
R.M. Lawn, G. Herrick, J. Heumann, and D.M. Prescott, Department of Molecular, Cellular, and Developmental
Biology, University of Colorado, Boulder: Structural organization of the gene-sized pieces of DNA in the
ciliate Oxytricha.
M. Gorovsky, D. Mathis, C. Glover, C. Johmann, M. Samuelson, and J. Keevert, Department of Biology,
University of Rochester, New York: Histones, chromatin structure, and gene activity in Tetrahymena.
V.G. Allfrey, E.M. Johnson, I.Y.C. Sun, H.R. Matthews,* and E.M. Bradbury, Rockefeller University, New York,
New York; *Portsmouth Polytechnic Institute, England: Structural organization and control of the ribosomal
genes in Physarum.
FRIDAY EVENING, June 3
Session 5: Nucleosome structure Ill: The core
Chairperson: B. Alberts, University of California, San Francisco
1.0. Thomas, Department of Biochemistry, University of Cambridge, England: The nucleosome "core protein."
R.T. Simpson, J.P. Whitlock, Jr., M. Bina-Stein, and A. Stein, Developmental Biochemistry Section, NIAMDD,
National Institutes of Health, Bethesda, Maryland: Histone-DNA interactions in chromatin core particles.
L.C. Lutter, MRC Laboratory of Molecular Biology, Cambridge, England: Studies on the internal structure of the
nucleosome core.
A. Mirzabekov, Institute of Molecular Biology, Academy of Sciences of the USSR, Moscow: Organization of
histones on DNA in chromatin.
I. Isenberg and S. Spiker, Department of Biochemistry and Biophysics, Oregon State University, Corvallis: The
interactions of histones.
J.E. Hearst, Department of Chemistry, University of California, Berkeley: The photochemistry of psoralen
derivatives with nucleic acids-A probe to structure.
A. Dieterich, R. Axel, and C.R. Cantor, Departments of Chemistry and Biological Sciences, and Institute for
Cancer Research, Columbia University, New York, New York: Fluorescent labeling of nucleosomes.
L. Kievan, M.E. Hogan, N. Dattagupta, and D. Crothers, Departments of Chemistry and Molecular Biophysics
and Biochemistry, Yale University, New Haven, Connecticut: Characterization of nucleosomes and related
complexes by rotational relaxation and electric dichroism.
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SATURDAY MORNING, June 4
Session 6: Nucleosome structure IV: H1 interactions
Chairperson: D. Crothers, Yale University, New Haven, Connecticut
P. Oudet, J.E. Germond, M. Bel lard, and P. Chambon, Institut de Chimie Biologique et Laboratoire de Biologie
Molecu laire des Cellules Eucaryotes de CNRS, Strasbourg, France: Nucleosome structure. I. All four histones
H2A, H2B, H3, and H4 are required to form a nucleosome, but an H3-H4 subnucleosomal particle is formed
with H3-H4 alone.
P. Oudet, C. Spadafora, and P. Chambon, Institut de Chimie Biologique et Laboratoire de Biologie Moleculaire
des Cellules Eucaryotes de CNRS, Strasbourg, France: Nucleosome structure. II. Structure of SV40 mini-
chromosome and electron microscopic evidence that a nucleosome could be constituted of two half
nucleosomes.
J. Griffith and G. Christiansen, Department of Biochemistry, Stanford University Medical School, California:
Salt- and histone-H1-dependent conformations of chromatin probed with the aid of the SV40 minichromo-
some.
W. Keller, I. Wendel, I. Eicken, and H. Zentgraf, Department of Microbiology, University of Heidelberg, and
Institute for Virology, German Cancer Research Center, Heidelberg, West Germany: Studies on SV40
chromatin.
E.M. Bradbury, Biophysics Laboratories, Portsmouth Polytechnic Institute, England: Histone interactions,
histone modifications, and chromatin structure.
M. Renz, P. Nehls, and J. Hozier, Max-Planck-Institut fur Virusforschung, Tubingen, West Germany: Involve-
ment of histone H1 in the maintenance of the structure of the chromosome fiber.
R.D. Cole, G.M. Lawson, and M.W. Hsiang, Department of Biochemistry, University of California, Berkeley: H1
histone and the condensation of chromatin and DNA.
R. Hardison, J. Gaubatz, and R. Chalkley, Department of Biochemistry, University of Iowa, Iowa City: The
organization of H1 on the eukaryotic chromosome.
SATURDAY EVENING, June 4
Session 7: Cloned eukaryotic genes I
Chairperson: J. Sambrook, Cold Spring Harbor Laboratory
B. Mach, S. Longacre, M.-F. Aellen, and F. Rougeon, Department of Pathology, University of Geneva,
Switzerland: The use of recombinant plasmid DNA in the study of immunoglobulin genes.
P. Leder, M.H. Edgell, F.I. Polsky, J.G. Seidman, S.M. Tilghman, and D.C. Tiemeier, Laboratory of Molecular
Genetics, NICHHD, National Institutes of Health, Bethesda, Maryland: Characteristics of cloned genetic
sequences expressed in mouse reticulocytes and plasmacytoma cells.
S. Tonegawa, C. Brack, M. Hirama, N. Hozumi, and G. Matthyssens, Basel Institute for Immunology, Switzer-
land: Arrangement of immunoglobulin genes studied with DNA clones.
T. Maniatis,* A. Efstratiadis,t G.K. Sim,* N. Rosenthal,t C.W. Jones,t M. Koehler,t B.F. Roberts,* H.M.
Kronenberg,t L. Villa Komaroff,t and F.C. Kafatos,tDivision of Biology, California Institute of Technology,
Pasadena; +Cellular and Developmental Biology, The Biological Laboratories, Harvard University, Cam-
bridge, Massachusetts; tBiology Department, Massachusetts Institute of Technology, Cambridge: The
structure and organization of developmentally regulated genes.
E. Ryskov, Y. Ilyian, and G. Georgiev, Institute of Molecular Biology, Academy of Sciences of the USSR,
Moscow: Studies on sequence arrangements in the genetic units of eukaryotes.
E.M. Southern and N.J. Hanscomb, MRC Mammalian Genome Unit, Department of Zoology, University of
Edinburgh, Scotland: Restriction-site mapping of globin genes in rabbit DNA.
P. Curtis, N. Mantel, J. van den Berg, and C. Weissmann, Institute for Molecular Biology I. University of Zurich,
Switzerland: Characterization of putative precursors of a and R globin mRNA from Friend cells.
W. Salser, Molecular Biology Institute, University of California, Los Angeles: Analysis of globin gene copies
cloned in bacteria.
72
SUNDAY MORNING, June 5
Session 8: Transcription II: Regulated systems
Chairperson: M. Birnstiel, University of Zurich, Switzerland
B.W. O'Malley, M.-J. Tsai, H.C. Towle, and S.Y. Tsai, Department of Cell Biology, Baylor College of Medicine,
St. Luke's Episcopal Hospital, Houston, Texas: Regulation of gene expression.
K.R. Yamamoto, M.R. Stallcup, J. Ring, and G.M. Ringold, Department of Biochemistry and Biophysics,
University of California, San Francisco: Integrated mammary tumor virus genes-Transcriptional regulation
by glucocorticoids and specific effects on host gene expression.
R.D. Palmiter and E.R. Mulvihill, Department of Biochemistry, University of Washington, Seattle: Steroid
receptor translocation along chromatin.
F.W. Alt, R.E. Kellems, R.T. Schimke, and R. Kaufman, Department of Biological Sciences, Stanford University,
California: The regulation of folate reductase synthesis in methotrexate-resistant cultured cells.
P. Feigelson and D. Kurtz, Institute of Cancer Research and Department of Biochemistry, Columbia University
College of Physicians and Surgeons, New York, New York: Studies on hormonal induction of specific hepatic
mRNA species.
H. Busch, N.R. Ballal, R.K. Busch, Y.C. Choi, F.M. Davis, I.L. Goldknopf, M. Rao, and L.I. Rothblum,
Department of Pharmacology, Baylor College of Medicine, Houston, Texas: The nucleolus-A model of
hierarchical chromatin controls.
R. Baserga, S. Whelly, and T. Ide, Department of Pathology and Fels Research Institute, Temple University
School of Medicine, Philadelphia, Pennsylvania: Stimulation of ribosomal RNA synthesis in isolated nuclei
by partially purified preparations of SV40 T antigen.
H. Weideli, P. Schedl, S. Artavanis-Tsakonas, R. Steward, R. Yuan, and W.J. Gehring, Department of Cell
Biology, Biozentrum, University of Bawl, Switzerland: Purification of a protein with specific affinity for a
defined DNA sequence from unfertilized eggs of Drosophila and the cloning of this DNA sequence in
bacterial plasmids.
SUNDAY AFTERNOON, June 5
Session 9: Chromosome coiling
Chairperson: H. Swift, University of Chicago, Illinois
A. Worcel, C. Benyajati, and R. Deich, Department of Biochemical Sciences, Princeton University, New Jersey:
Higher-order coiling of DNA in chromatin.
J. Sedat and L. Manuelidis, Yale University School of Medicine, New Haven, Connecticut: A direct approach to
the structure of eukaryotic chromosomes.
S.M. Cheng, K.W. Adolph, J.R. Paulson, and U.K. Laemmli, Department of Biochemical Sciences, Princeton
University, New Jersey: Metaphase chromosome structure-A study of the role of nonhistone proteins.
A. Leth Bak and J. Zeuthen,* Institutes of Medical Microbiology and *Human Genetics, University of Aarhus,
Denmark: Higher-order structure of mitotic chromosomes.
M. Bustin, P.D. Kurth,* E.N. Moudrianakis,* D. Goldblatt,t R. Sperling,t and W. Rizzo, National Institutes of
Health, Bethesda, Maryland; *Johns Hopkins University, Baltimore, Maryland; tWeizmann Institute of
Science, Rehovot, Israel: Immunological probes for chromatin structure.
E.K.F. Bautz, M. Jamrich, and A.L. Greenleaf, Moleculare Genetik der Universitat Heidelberg, West Germany:
Functional organization of Drosophila polytene chromosomes.
H. Weintraub, I.M. Leffak, and R. Grainger,* Department of Biochemistry, Princeton University, New Jersey;
*Department of Biology, University of Virginia, Charlottesville: Nonrandom assembly of newly synthesized
histones into histone octamers.
K.M. Newrock and L.H. Cohen, Institute for Cancer Research, Fox Chase, Philadelphia, Pennsylvania: Chroma-
tin remodeling during sea urchin embryogenesis.
R.L. Seale, Division of Molecular and Cellular Biology, National Jewish Hospital and Research Center, and
Department of Biophysics and Genetics, University of Colorado School of Medicine, Denver: Chromatin
replication in vitro.
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MONDAY MORNING, June 6
Session 10: Transcription III: In vivo pathways
Chairperson: C. Weissmann, University of Zurich, Switzerland
M.E. Mirault, M. Goldschmidt-Clermont, L. Moran, A.P. Arrigo, and A. Tissieres, Department of Molecular
Biology, University of Geneva, Switzerland: The effect of heat shock on gene expression in D. melanogaster.
H. Biessmann, S. Wadsworth, B. Levy W., and B.J. McCarthy, Department of Biochemistry and Biophysics,
University of California, San Francisco: Correlation of structural changes in chromatin with transcription in
the Drosophilia heat-shock response.
S.C.R. Elgin, R. De Lorimier, D.W. Miller, A.A. Ribolini, L.A. Serunian, L.M. Silver, and C.E.C. Wu, The
Biological Laboratories, Harvard University, Cambridge, Massachusetts: Structure and function in
Drosophila chromatin.
J.J. Bonner, M. Berninger, and M.L. Pardue, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Transcription of polytene chromosomes and the mitochondrial genome in D. melanogaster.
B. Daneholt, S.T. Case, J. Derksen, M.M. Lamb, L. Nelson, and L. Wieslander, Department of Histology,
Karolinska Institutet, Stockholm, Sweden: The 75S RNA transcription unit in Balbiani ring 2.
J.-E. Edstrom, E. Ericson, S. Lindgren, U. Lorin, and L. Rydlander, Department of Histology, Karolinska Institutet,
Stockholm, Sweden: Fate of Balbiani ring RNA in vivo.
W.M. Le Stourgeon, A.L. Beyer, M.E. Christensen, B.W. Walker, S.M. Poupore, and L.P. Daniels, Department of
Molecular Biology, Vanderbilt University, Nashville, Tennessee: The packaging proteins of "core" hnRNP
particles and the maintenance of proliferative cell states.
T. Martin, P. Billings, and H. Swift, Department of Biology, University of Chicago, Illinois: Protein core
complexes associated with newly synthesized RNA in the nuclei of higher eukaryotes.
MONDAY EVENING, June 6
Session 11: Transcriptionally active chromatin
Chairperson: O.L. Miller, Jr., University of Virginia, Charlottesville
A. Garel and R. Axel, Institute of Cancer Research, Columbia University, New York, New York: The structure of
transcribing genes in chromatin.
R. Reeves, Department of Zoology, University of British Columbia, Vancouver, Canada: Structure of Xenopus
ribosomal gene chromatin during changes in genomic transcription rates.
V.E. Foe, Department of Biochemistry and Biophysics, University of California, San Francisco: Chromatin
structure and transcriptional activity-An electron microscopic study of RNA synthesis.
S.L. McKnight,* M. Bustin,t and O.L. Miller, Jr.,* *University of Virginia, Charlottesville; tNational Institutes of
Health, Bethesda, Maryland: Ultrastructural and antigenic properties of metabolically active chromatin.
W.W. Franke, U. Scheer, M.F. Trendelenburg, H. Zentgraf, and H. Spring, Division of Membrane Biology and
Biochemistry, Institute of Experimental Pathology, German Cancer Research Center, Heidelberg, West
Germany: Morphology of transcriptionally active chromatin.
M. Bellard, F. Gannon, and P. Chambon, Institut de Chimie Biologique et Laboratoire de Biologie Moleculaire
des Cellules Eucaryotes du CNRS, Strasbourg, France: Nucleosome structure. III. Are actively transcribed
genes compacted in nucleosomes?
G.H. Dixon, B. Levy W., N.C.W. Wong, E.H. Peters, and D.C. Watson, Division of Medical Biochemistry,
Faculty of Medicine, University of Calgary, Canada: The structure and function of low-salt-extractable
chromosomal proteins-Association of trout testis FI6 with active genes.
J. Bonner, Division of Biology, California Institute of Technology, Pasadena: New insight into control of gene
expression.
S.J. Flint, Department of Biochemical Sciences, Princeton University, New Jersey: Sensitivity of viral genes in
adenovirus-transformed cell chromatin to deoxyribonuclease I.
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TUESDAY MORNING, June 7
Session 12: Cloned eukaryotic genes II
Chairperson: D. Brown, Carnegie Institution of Washington, Baltimore, Maryland
A. Chovnick, M. McCarron, W. Gelbart, J. O'Donnell, S. Clark, and A. Hilliker, Genetics and Cell Biology
Section, University of Connecticut, Storrs: Gene organization in Drosophila.
M.M. Green, Department of Genetics, University of California, Davis: Directed induction of putative insertion
mutants in D. melanogaster.
S.S. Potter and C.A. Thomas, Jr., Harvard Medical School, Boston, Massachusetts: Restriction analysis of the
organization of Drosophila DNA.
P.C. Wensink, Department of Biochemistry and the Rosenstiel Center, Brandeis University, Waltham, Mas-
sachusetts: Sequence homology within families of D. melanogaster middle repetitive DNA.
G.M. Rubin, Department of Basic Sciences, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: Structure of telomeric DNA in D. melanogaster.
DJ. Finnegan, G.M. Rubin,* M. Young,t and D.S. Hogness,t MRC Molecular Genetics Unit, University of
Edinburgh, Scotland; *Sidney Farber Cancer Institute, Boston, Massachusetts; tDepartment of Biochemistry,
Stanford University School of Medicine, California: Multigene families in the genome of D. melanogaster.
D.S. Hogness, Department of Biochemistry, Stanford University School of Medicine, California: Dispersed and
tandem topographies of repeated genes.
E.H. Davidson, R.C. Angerer, W.H. Klein, C. Lai, A.S. Lee, W.D. Niles, T.L. Thomas, R.H. Scheller, and R.J.
Britten, Division of Biology, California Institute of Technology, Pasadena: Organization and character of
interspersed repetitive-sequence families studied in cloned sea urchin DNA fragments.
TUESDAY AFTERNOON, June 7
Session 13: Histone genes
Chairperson: C.A. Thomas, Jr., Harvard Medical School, Boston, Massachusetts
M.L. Birnstiel, W. Schaffner, A. Kressmann, and H.O. Smith, Institute for Molecular Biology, University of
Zurich, Switzerland: Sequence organization and transcription in the Xenopus oocyte nucleus of cloned
histone DNA.
L.H. Kedes, R.H. Cohn, I. Sures, and J. Lowry, Department of Medicine, Stanford Medical School, and Veterans
Administration Hospital, Palo Alto, California: Comparative anatomy of histone genes from two sea urchin
species.
M. Grunstein, J.E. Grunstein, and T. Platt,* Molecular Biology Institute and Department of Biology, University of
California, Los Angeles; *Department of Molecular Biophysics and Biochemistry, Yale University, New
Haven, Connecticut: Sequence of the histone H4 gene of the sea urchin S. purpuratus.
G. Stein, J. Stein,* W. Park, J. Thomson, R. Jansing, S. Detke, D. Kota, A. Lichtler, I. Phillips, and A. Phillips,
Department of Biochemistry and Molecular Biology and *Department of Immunology and Medical Micro-
biology, University of Florida, Gainesville: Nonhistone chromosomal protein fractions and transcription of
histone mRNA sequences from chromatin.
R.A. Laskey, B.M. Honda, A.D. Mills, N.R. Morris, A.H. Wyllie, J.E. Mertz, E.M. De Robertis, and J.B. Gurdon,
MRC Laboratory of Molecular Biology, Cambridge, England: Chromatin assembly and transcription in eggs
and oocytes of X. laevis.
WEDNESDAY MORNING, June 8
Session 14: Repeated DNA sequences
Chairperson: J.G. Gall, Yale University, New Haven, Connecticut
W.J. Peacock, A.R. Lohe, W.L. Gerlach, P. Dunsmuir,* E.S. Dennis, and R. Appels, Division of Plant Industry,
Commonwealth Scientific and Industrial Research Organization, Canberra, Australia; *The Biological
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Laboratories, Harvard University, Cambridge, Massachusetts: Fine structure and evolution of DNA in
heterochromatin.
D. Brut lag, M. Carlson, K. Fry, and T.S. Hsieh, Department of Biochemistry, Stanford University, California:
DNA sequence organization in the pericentric heterochromatin of D. melanogaster.
P.R. Musich, F.L. Brown, and J.J. Maio, Department of Cell Biology, Albert Einstein College of Medicine, Bronx,
New York: Mammalian repetitive DNA and the subunit structure of chromatin.
R.H. Reeder, H.L. Wahn, P. Botchan, and B. Sollner-Webb, Department of Embryology, Carnegie Institution of
Washington, Baltimore, Maryland: Ribosomal genes and associated proteins from Xenopus.
I.B. Dawid, Department of Embryology, Carnegie Institution of Washington, Baltimore, Maryland: Drosophila
ribosomal DNA-Relation of the insertion sequence to nonribosomal parts of the genome.
N.V. Fedoroff and D.D. Brown, Department of Embryology, Carnegie Institution of Washington, Baltimore,
Maryland: The nucleotide sequence of the repeating unit in X. laevis oocyte 5S DNA.
Summary: P. Chambon, Institut de Chimie Biologique, Strasbourg, France: The molecular biology of the
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THURSDAY EVENING, May 12
Welcoming remarks: D.C. Ward, Yale University
Session 1: Biology and parvovirus-cell interactions
Chairperson: P. Tattersall, Imperial Cancer Research Fund, Mill Hill,
London, England
G. Margolis and L. Kilham, Departments of Pathology and Microbiol-
ogy, Dartmouth Medical School, Hanover, New Hampshire: The
parvoviruses-Pantropes or selective cytotropes.
H.W. Toolan, Putnam Memorial Hospital Institute for Medical Re-
search, Bennington, Vermont: The maternal role in susceptibility of
the embryo and newborn hamster to H-1 parvovirus.
M.D. Hoggan, J.F. Sears, G.F. Thomas, and A. Roy, National Institutes
of Health, Bethesda, Maryland: Biological properties of rat virus
variants.
P. Tattersall, Imperial Cancer Research Fund, Mill Hill Laboratories,
London: Susceptibility to MVM as a function of host-cell differ-
entiation.
P. Linser and R.W. Armentrout, Department of Biological Chemistry,
University of Cincinnati Medical Center, Ohio: Binding of MVM to
cells in culture.
H.S. Joo, R.H. Johnson, and D.L. Watson, Department of Tropical
Veterinary Science, James Cook University of North Queensland,
Australia: Serological procedures to determine duration of infec-
tion with porcine parvoviruses.
B.A. Federici, Department of Entomology. University of California,
Riverside: A parvovirus in larvae of the blackflySimulium vittatum.
L. Wosu, R.H. Johnson, and S. Locarnini, Department of Tropical
Veterinary Science, James Cook University of North Queensland,
Australia: Attempts to demonstrate parvovirus in fecal specimens
from patients with infectious hepatitis.
FRIDAY MORNING, May 13
Session 2: Structure of parvovirus DNA
Chairperson: K. Berns, Department of Microbiology and Immunology, University of Florida, Gainesville
K.I. Berns, K.H. Fife, and I. Spear, Department of Immunology
and Medical Microbiology, University of Florida,Gainesville: Fine structure of AAV DNA.
L.M. de la Maza, F.T. Jay, and B.J. Carter, National Institutes of Health, Bethesda, Maryland: Structure of theDNA from incomplete AAV particles.
M.B. Chow and D.C. Ward, Department of Molecular Biophysics
and Biochemistry, Yale University, New
Haven, Connecticut: Comparative studies on the DNA genomes of non-defective parvoviruses.
G. Lavelle, S.K. Niyogi, and S. Mitra, Biology Division, Oak Ridge National Laboratory, Tennessee: Double-helical regions in Kilham rat virus DNA.
D.C. Kelly, National Environment Research Council, Unit of Invertebrate Virology, Oxford, England: The fine
structure of densonucleosis virus DNA.
N. Black low, Department of Medicine and Microbiology, University of Massachusetts Medical School, Worces-ter: Interaction of AAV with herpesvirus-transformed cells.
FRIDAY AFTERNOON, May 13
Meeting to discuss Restriction enzyme nomenclature for parvovirus physical maps
FRIDAY EVENING, May 13
Session 3: Replication of adeno-associated viruses (AAV)
Chairperson: W. Hauswirth, Department of Microbiology and Immunology, University of Florida, Gainesville
W.W. Hauswirth and K.I. Berns, Department of Immunology and Medical Microbiology, College of Medicine,
University of Florida, Gainesville: Initiation and termination of AAV DNA replication.
S.E. Straus, E.D. Sebring, and J.A. Rose, Washington University, St. Louis, Missouri: Self-primed replication ofAAV DNA.
S.E. Straus, R.M.L. Buller,* and J.A. Rose,* Washington University, St. Louis, Missouri; *National Institutes of
Health, Bethesda, Maryland: AAV replication in African green monkey kidney cells.
H.D. Mayor, Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas:
Complementation of AAV by temperature-sensitive mutants of human adenoviruses and herpesviruses.
H. Handa, K. Shiroki, and H. Shimojo, Department of Tumor Virus Research, Institute of Medical Science,
University of Tokyo, Japan: Establishment and characterization of KB cell lines latently infected with AAV-1.
J.F. Young and H.D. Mayor, Baylor College of Medicine, Houston, Texas: Theeffect of phosphonoacetic acid on
the replication of adeno-associated satellite virus.
SATURDAY MORNING, May 14
Session 4: DNA replication of nondefective parvoviruses
Chairperson: S. Rhode, Institute of Medical Research, Putnam Memorial Hospital, Bennington, Vermont
S.L. Rhode, Institute for Medical Research, Putnam Memorial Hospital, Bennington, Vermont: H-1 DNA
synthesis.
I.I. Singer and S.L. Rhode III, Institute for Medical Research, Putnam Memorial Hospital, Bennington, Vermont:
Immuno-electron microscopic autoradiography of H-1 parvovirus DNA synthesis and protein accumulation.
A.T. Li, G.C. Lavelle, and R.W. Tennant, University of Tennessee-Oak Ridge Graduate School of Biomedical
Sciences, and Biology Division, Oak Ridge National Laboratory, Tennessee: Guanidine hydrochloride
extraction of intracellular forms of Kilham rat virus DNA.
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L. Salzman, Laboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland: In vitro
DNA synthesis with Kilham rat virus.
M. Gunther and B. Revet, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France: Study of Kilham rat
virus nucleoprotein complexes extracted from infected rat cells.
G.S. Hayward, H. Bujard, and M. Gunther,* Institute for Molecular Genetics, University of Heidelberg,
Germany; *Institut de Recherches Scientifiques sur le Cancer, Villejuif, France: Replicative forms of Kilham
rat virus DNA.
G. Siegl and M. Gautschi, Institute of Hygiene and Medical Microbiology, University of Berne, Switzerland:
Isolation and characterization of RF and RI DNA molecules of parvovirus Lulli.
D. Ward, M. Chow, and J. Idriss, Department of Molecular Biophysics and Biochemistry, Yale University, New
Haven, Connecticut: Studies on the replication of MVM DNA.
R.C. Bates, C.P. Kuchenbuch, J.T. Patton, and E.R. Stout, Department of Biology, Virginia Polytechnic Institute
and State University, Blacksburg: DNA polymerase activity in parvovirus-infected cells.
SATURDAY AFTERNOON, May 14
Session 5: Transcription, translation and properties of viral proteins
Chairperson: B. Carter, Laboratory of Experimental Pathology, NIAMDD, National Institutes of Health,
Bethesda, Maryland
B.J. Carter, F.T. Jay, C.A. Laughlin, W.J. Cook, and L.M. de la Maza, National Institutes of Health, Bethesda,
Maryland: AAV RNA synthesis in vivo and in vitro.
F.B. Johnson, D.A. Vlazny, T.A. Thomson, P.A. Taylor, and M.D. Lubeck, Department of Microbiology, Brigham
Young University, Provo, Utah: AAV polypeptides-Molecular similarities.
J.L. Peterson and D.C. Ward, Department of Molecular Biophysics and Biochemistry, Yale University, New
Haven, Connecticut: Comparison of parvovirus capsid proteins-Evidence for posttranslational modifica-
tion.
D.C. Kelly and N.F. Moore, National Environment Research Council, Unit of Invertebrate Virology, Oxford,
England: The structural proteins of densonucleosis virus.
E. Kurstak and P. Tijssen, Comparative Virology Research Group, Universite de Montreal, Canada: Study of
DNA and proteins of densonucleosis parvovirus.
A. Roy, G.F. Thomas, J.F. Sears, and M.D. Hoggan, National Institutes of Health, Bethesda, Maryland: Use of
immuno-electron microscopy to demonstrate antigenic and structural differences between infectious AAV
particles banding at different densities in cesium chloride.
SUNDAY MORNING, May 15
Session 6: Virus maturation and morphogenesis
Chairperson: R. Armentrout, Department of Biological Chemistry, University of Cincinnati, Ohio
R. Richards, P. Linser, and R.W. Armentrout, Department of Biological Chemistry, University of Cincinnati
Medical Center, Ohio: Assembly of MVM particles in synchronized rat brain cells.
M. Gautschi, P. Reinhard, J.R. Gautschi, and G. Siegl, Institute of Hygiene and Medical Microbiology, University
of Berne, Switzerland: Maturation of parvovirus Lull! in Brij-58-lysed cells.
H.P. Muller, M. Gautschi, and G. Siegl, Institute of Hygiene and Medical Microbiology, University of Berne,
Switzerland: Defective particles of parvovirus Lulli.
S.L. Rhode, Institute for Medical Research, Putnam Memorial Hospital, Bennington, Vermont: A preliminary
report on the defective interfering viruses of H-1.
I.I. Singer and S.L. Rhode III, Institute for Medical Research, Putnam Memorial Hospital, Bennington, Vermont:
Immuno-electron microscopy of H-1 parvovirus temperature-sensitive mutants.
S.L. Rhode, I.I. Singer, and J.R. Kongsvik, Institute for Medical Research, Putnam Memorial Hospital, Ben-
nington, Vermont: The abortive infection of human diploid fibroblasts by the parvovirus H-1.
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J.R. Kongsvik, M.S. Hopkins, and K.A.O. Ellem, Institute for Medical Research, Putnam Memorial Hospital,




ROBERT POLLACK, State, University of New York, Stony Brook
RICHARDS HYNES, Massachusetts Institute of Technology
LAN BO CHEN, Cold Spring Harbor Laboratory
131 participants
WEDNESDAY EVENING, May 18
Welcoming remarks: J.D. Watson, Cold Spring Harbor Laboratory
Session 1: Tumors-Transformation in vivo
Chairperson: G. di Mayorca, University of Illinois Medical Center, Chicago
V.H. Freedman, A.S. Klein, M. Greenberg, P.K. Canary, and S. Shin, Department of Genetics, Albert Einstein
College of Medicine, Bronx, New York: Use of the nude mouse to assay for cell transformation.
J.K. McDougall, L.B. Chen, and P.H. Gallimore, Cold Spring Harbor Laboratory, New York: In vitro traits of
adenovirus-transformed cell lines and their relevance in tumorigenicity in nude mice.
L. Kopelovich,* S. Conlan,t and R. Pollack,t *Memorial Sloan-Kettering Cancer Center, New York, New York;
tMicrobiology Department, State University of New York, Stony Brook: Defective organization of actin in
cultured skin fibroblasts from individuals with an inherited adenocarcinoma.
C.W. Boone and N. Takeichi, NCI, National Institutes of Health, Bethesda, Maryland: Spontaneous neoplastic
transformation in vitro is a modified form of foreign-body tumorigenesis.
M.S. Paranjpe and C.W. Boone, NCI, National Institutes of Health, Bethesda, Maryland: Correlation of growth
aggressiveness of tumors formed by substrate-attached C3H/10T1 /2 cells with degree of loss of density,
anchorage, and serum regulation in vitro.
W.C. Topp, J.D. Hall,* D. Rifkin,t A.J. Levine* B. Lane, § S. Shin,** and R. Pollack,* Cold Spring Harbor
Laboratory, New York; *University of Arizona, Tucson; 1-Rockefeller University, New York, New York;
*Princeton University, New Jersey; §Department of Pathology and *Department of Microbiology, State
University of New York, Stony Brook, **Albert Einstein College of Medicine, Bronx, New York: Properties of
mouse teratocarcinoma cell lines cloned by SV40 establishment.
S. Silagi, E. Newcomb, and S. Silverstein,* Cornell University Medical College, New York, New York;
*Rockefeller University, New York, New York: Loss of tumor-forming ability by malignant melanoma cells
mixed with nonmalignant BrdU-grown derivatives.
THURSDAY MORNING, May 19
Session 2A: Transformed cells-Induction and maintenance
Chairperson: R. Hynes, Massachusetts Institute of Technology, Cambridge
N. Bouck and G. di Mayorca, Department of Microbiology, University of III inois at the Medical Center, Chicago:
The mutagenic nature of in vitro transformation by chemicals.
J. Kamine and J.M. Buchanan, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Cell-free synthesis of two proteins unique to RNA of transforming virions of Rous sarcoma virus.
C. Prives, Y. Gluzman, M. Revel, and E. Winocour, Virology Department, Weizmann Institute of Science,
Rehovot, Israel: The cellular and cell-free synthesis of SV40 T antigen in transformed and lytic state.
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D. Kiehn, Department of Microbiology and Immunology, University of Washington, Seattle: Mechanisms of
transformation in rat embryo cells.
D. Zouzias and C. Basil ico, Department of Pathology, New York University School of Medicine, New York:
T-antigen expression in SV40-transformed cells.
B. Steinberg, R. Pollack, K. Nyman, A. Lo, W. Topp,* and M. Botchan,* Department of Microbiology, State
University of New York, Stony Brook; *Cold Spring Harbor Laboratory, New York: T-antigen-negative
revertants from transformed rat cells carrying one copy of SV40 DNA.
N.J. Maitland and J.K. McDougall, Cold Spring Harbor Laboratory, New York: Biochemical transformation of
mouse cells by fragments of herpes simplex virus DNA.
H.L. Ozer and K.K. Jha, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts: Expres-
sion of transformation in cell hybrids.
R. Sager, N. Howell, and P. Hoover, Sidney Farber Cancer Institute, Boston, Massachusetts: Cellular transforma-
tion in Chinese hamster cell hybrids and cybrids.
THURSDAY AFTERNOON, May 19
Session 2B: Transformed cells-Induction and maintenance
Chairperson: R. Sager, Sidney Farber Cancer Institute, Boston, Massachusetts
P.B. Fisher, D. Eisenberg, and I.B. Weinstein, Institute for Cancer Research, Columbia University College of
Physicians and Surgeons, New York, New York: Interaction between an initiating agent carcinogen, a
promoting agent, and adenovirus in the transformation of rat embryo cells.
P.E. Driedger and P.M. Blumberg, Department of Pharmacology, Harvard Medical School, Boston, Mas-
sachusetts: Effects of phorbol myristate acetate and related derivatives on chick embryo fibroblasts.
J. Mather and G. Sato, Department of Biology, University of California, San Diego: Hormone requirements of a
clonal line of the B-16 mouse melanoma.
R.R. Bark, Friedrich Miescher-Institut, Basel, Switzerland: Is the progression of transformation the progressive
derepression of the production of growth factors?
R. Ross, J. Glomset, E. Raines, B. Kariya, and A. Vogel, Department of Pathology, University of Washington
School of Medicine, Seattle: Platelet mitogens and growth control.
C.D. Scher, C.D. Stiles, and H.N. Antoniades, Harvard Medical School and the Center for Blood Research,
Harvard University School of Public Health, Boston, Massachusetts: Radioimmunoassay of a human serum
growth factor polypeptide which induces cell proliferation.
C.D. Stiles, J.W. Pledger, H. Antoniades, and C.D. Scher, Harvard Medical School and the Center for Blood
Research, Harvard University School of Public Health, Boston, Massachusetts: Growth requirement of
normal and neoplastic cell cultures for platelet factors.
W.J. Pledger, C.D. Stiles, H. Antoniades, and C.D. Scher, Harvard Medical School and the Center for Blood
Research, Harvard University School of Public Health, Boston, Massachusetts: The commitment of BALB/c
3T3 cells to DNA synthesis.
THURSDAY EVENING, May 19
Session 3: Phenotypes of transformed cellsMaintenance
Chairperson: H. Ozer, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts
H. Rubin, D. Moscatelli, and J. Kamine, Department of Molecular Biology, University of California, Berkeley:
The coordinate response of chick embryo fibroblasts to external stimuli and to viral transformation.
R.D. Dubrow, R. Pollack,* and A.B. Pardee, Sidney Farber Cancer Institute, Boston, Massachusetts; *State
University of New York, Stony Brook: Transport rates by 3T3, SV3T3 and revertant lines under various growth
conditions.
W. Heiser and E. Englesberg, Biochemistry and Molecular Biology Section, Department of Biological Sciences,
University of California, Santa Barbara: Amino acid sensitivity and SV40 transformants-Characteristics of
methionine-resistant SV40 3T3 (SVT2).
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M.J. Weber, K. Nakamura, and M. Johnson, Department of Microbiology, University of Illinois, Urbana:
Functional membrane alterations in cells transformed by Rous sarcoma virus.
D. Paul and H.-J. Ristow, Cell Biology Laboratory, The Salk Institute, San Diego, California: Cell-cycle control by
Ca++ ions in 3T3 cells and in transformed 3T3 cells.
J. Fenno and E. Gurney, Department of Biology, University of Utah, Salt Lake City: SV40 transformation and
cAMP-dependent protein kinases.
D.R. Critchley, M. Vicker, S. Dilks, and J. Ingram, Department of Biochemistry, University of Leicester, England:
The effect of cholera toxin on serum-stimulated uridine uptake in mouse fibroblasts.
M. Rieber, Institute Venezolano de Investigaciones Cientificas, Caracas, Venezuela: On the conditions promot-
ing the expression of nonvirion oncornaviruslike glycoproteins in transformed cells.
FRIDAY MORNING, May 20
Session 4A: Cytoskeleton
Chairperson: D. Rifkin, Rockefeller University, New York, New York
R.W. Tucker and F.R. Frankel, NCI, National Institutes of Health, Bethesda, Maryland: Microtubules and actin
cables in neoplastic and non-neoplastic rodent cell lines-Indirect immunofluorescence.
H.S. Smith, A.J. Hiller, E.L. Springer, R.E. Pollack,* and D. Rifkin,-1- University of California, Berkeley; *State
University of New York, Stony Brook; 1-Rockefeller University, New York, New York: In vitro characteriza-
tion of human epithelial cells.
K. Weber and M. Osborne, Max Planck Institut fill. Biologisch Chemie, Goettingen, West Germany: Studies on
microtubu le system by indirect immunofluorescence.
G.M. Fuller and C.S. Anus, University of Texas, Galveston: Involvement of cAMP and a possible role of calcium
in the in vivo control of microtubu le assembly.
G. Albrecht-Buehler, Cold Spring Harbor Laboratory, New York: Predetermination of movement in 3T3 cells.
E. Lazarides, B.D. Hubbard, and J.G. Izant, Division of Biology, California Institute of Technology, Pasadena:
Immunological and biochemical characterization of the major subunit of the 100-A filaments from chick
muscle cells.
R.D. Goldman and 1.M. Starger, Biological Sciences Department, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Rapid isolation and purification of 10-nm filaments from cultured cells.
J.M. Starger and R.D. Goldman, Biological Sciences Department, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Analysis of 10-nm-filament-associated proteins from cultured cells.
R. Hynes and A. Destree, Center for Cancer Research, Department of Biology, Massachusetts Institute of
Technology, Cambridge: 100-A filaments in normal and transformed cells.
P. Cooke, Department of Physiology, University of Connecticut Health Center, Farmington: A filamentous
cytoskeleton in vertebrate smooth muscle fibers.
FRIDAY AFTERNOON, May 20
Session 4B: Cytoskeleton
Chairperson: R.D. Goldman, Carnegie-Mellon University, Pittsburgh, Pennsylvania
V. Mautner and R. Hynes, Center for Cancer Research, Department of Biology, Massachusetts Institute of
Technology, Cambridge: Surface distribution of LETS protein in relation to the cytoskeleton of normal and
transformed NIL8 hamster fibroblasts.
K. Wang, Clayton Foundation Biochemical Institute, Department of Chemistry, University of Texas, Austin:
Filamin, molecular properties, interaction with F-actin, and immunocytological localization.
1.F. Ash, D. Louvard, and S.J. Singer, Department of Biology, University of San Diego, California: Cytoskeletal-
membrane interaction.
R. Pollack, Department of Microbiology, State University of New York, Stony Brook: Actin-containing cables
within normal rat embryo cells require a divalent cation.
W. Gordon and A. Bushnell, Cold Spring Harbor Laboratory, New York: Myosin and 100-A filament local iza-
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Lion in a nonmuscle cell type-A combined immunofluorescent electron microscopic study.
R. Schlegel and T. Benjamin, Department of Pathology, Harvard Medical School, Boston, Massachusetts:
Morphological alteration of rat cells by wild-type and HR-T mutants of polyoma virus.
M.C. Willingham, K.M. Yamada, S.S. Yamada, J. Pouyssegur, and I. Pasten, Laboratory of Molecular Biology,
NCI, National Institutes of Health, Bethesda, Maryland: Microfilament bundles and cell shape are d issoci-
able from growth control in cultured fibroblasts.
T. Graf and H. Beug, Max-Planck-Institut fur Virusforschung, Biologisch-Medizinische Abteilung, Tubingen,
West Germany: Cell transformation induced in enucleated cells infected with a thermosensitive mutant of
Rous sarcoma virus.
J.C. Brown and M.L. Nagpal, Department of Microbiology, University of Virginia School of Medicine, Charlot-
tesville: Identification of myosin associated with purified phagosome membranes from mouse L cells.
FRIDAY EVENING, May 20
Session 5: Proteases and cell proliferation
Chairperson: A. Pardee, Sidney Farber Cancer Institute, Boston, Massachusetts
S.T. Rohrlich and D.B. Rifkin, Department of Chemical Biology, Rockefeller University, New York, New York:
Patterns of plasminogen activator production in cultured normal embryonic cells.
B.A. Wolf and A.R. Goldberg, Rockefeller University, New York, New York: Elevation of plasminogen activator
levels by the src gene of Rous sarcoma virus can be either cellularly or virally determined.
R.H. Goldfarb and J.P. Quigley, Department of Microbiology and Immunology, State University of New York,
Downstate Medical Center, Brooklyn: Studies on the nature of the membrane-associated form of plasmino-
gen activator-Comparison with the soluble, extracellular form.
V. Mandavi and R. Hynes, Center for Cancer Research, Department of Biology, Massachusetts Institute of
Technology, Cambridge: Membrane-bound proteases in normal and transformed cells.
D. Rifkin and R. Pollack,* Rockefeller University, New York, New York; *Department of Microbiology, State
University of New York, Stony Brook: The production of plasminogen activator by established cell lines of
mouse origin.
I.N. Chou, C. Dietrich, and P.H. Black, Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts: Calcium stimulation of plasminogen activator secretion by Swiss 3T3 cells.
M.H. Park, J.G. Burr, and J.M. Buchanan, Department of Biology, Massachusetts Institute of Technology,
Cambridge: Binding and internalization of [12511thrombin to chick embryo fibroblasts.
B.M. Martin and J.P. Quigley, Department of Microbiology and Immunology, Downstate Medical Center, State
University of New York, Brooklyn: Thrombin-induced mitogenesis-Binding and uptake of [1251]thrombin in
chick fibroblasts.
B.R. Zetter and D. Gospodarowicz, Cancer Research Institute, University of California Medical School, San
Francisco: Effects of thrombin, fibroblast growth factor, and epidermal growth factor on endothelial cell
proliferation.
D.D. Cunningham and D.H. Carney, Department of Medical Microbiology, College of Medicine, University of
California, Irvine: Initiation of chick cell division by trypsin action at the cell surface.
V.B. Hatcher and P.G. Burk, Department of Biochemistry and Medicine, Albert Einstein College of Medicine,
and Montefiore Hospital and Medical Center, Bronx, New York: The relationship between surface protease
activity and the rate of cell proliferation in normal and transformed cells.
H.B. Bosmann, I. Evans, and A.C. Spataro, Department of Pharmacology and Toxicology and University of
Rochester Cancer Center, University of Rochester School of Medicine and Dentistry, New York: Proteolytic
activity-Does it have a role in control of cell division?
R. Roblin,* M. Fitzsimmons, T. Rakusanova, and P.H. Black, Infectious Disease Unit, Massachusetts General
Hospital, and Departments of Microbiology and Molecular Genetics, Harvard Medical School, Boston:
SV40-transformed 3Y1 cells: Mycoplasma curing and resultant properties.
SATURDAY MORNING, May 21
Session 6: Major cell-surface glycoproteins Biochemistry
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Chairperson: R. Pollack, State University of New York, Stony Brook
M.W. Mosesson, A.B. Chen, and D.L. Amrani, Department of Medicine, Downstate Medical Center, State
University of New York, Brooklyn: Heterogeneity of the cold-insoluble globulin of human plasma (Clg), a
circulating cell surface protein (LETS).
A. Vaheri, D.F. Mosher, K. Hedman, J. Keski-Oja, M. Kurkinen, 0. Saksela, S. Stenman, and J. Wartiovaara,
University of Helsinki, Finland: Fibronectin in cultures of normal and transformed adherent cells.
R. Hynes, A. Destree, and I.U. Ali, Center for Cancer Research, Department of Biology, Massachusetts Institute
of Technology, Cambridge: Extensive disulfide bonding at the cell surface.
L.B. Chen, K. Burridge, P.H. Gallimore, R. Gudor, J.K. McDougall, and M.W. Mosesson,* Cold Spring Harbor
Laboratory, New York; *Downstate Medical Center, State University of New York, Brooklyn: Studies on the
major cell-surface glycoprotein.
L.B. Chen, A. Murray, A. Bushnell, and J.K. McDougall, Cold Spring Harbor Laboratory, New York: Alteration in
extracellular matrix upon oncogenic transformation.
K.M. Yamada, D.H. Schlessinger, D.W. Kennedy, and I. Pastan, Laboratory of Molecular Biology, NCI, National
Institutes of Health, Bethesda, Maryland: Characterization of the transformation-sensitive cell-surface pro-
tein of chick embryo fibroblasts.
K.M. Yamada and K. Olden, Laboratory of Molecular Biology, NCI, National Institutes of Health, Bethesda,
Maryland: Quantitation of a transformation-sensitive cell-surface glycoprotein-Mechanism of decrease
after transformation.
S.L. Adams, M.E. Sobel, B.H. Howard, K. Olden, K.M. Yamada, B. de Crombrugghe, and I. Pastan, Laboratory of
Molecular Biology, NCI, National Institutes of Health, Bethesda, Maryland: Reduction in functional mRNA
for CSP and for collagen in Rous sarcoma virus-transformed chick embryo fibroblasts.
D. Becker, R. Kurth, D. Critchley, R.R. Friis, and H. Bauer, Institut fur Virologie, Giessen, West Germany, and
Imperial Cancer Research Fund Laboratories, London, England: Significance of transformation-associated
cell-surface changes as investigated with two groups of temperature-sensitive, transformation-defective Rous
sarcoma virus mutants.
E. Wang, and A.R. Goldberg, Rockefeller University, New York, New York: Analysis of concurrent changes of
microfilament organization and LETS protein distribution in mammalian cells infected with a temperature-
sensitive mutant of Rous sarcoma virus.
SATURDAY AFTERNOON, May 21
Session 7: Major cell-surface glycoproteins II: Reconstitution and secretion
Chairperson: J.M. Buchanan, Massachusetts Institute of Technology, Cambridge
J.A. Weston, K.M. Yamada, and K.L. Hendricks, Department of Biology, University of Oregon, Eugene: Factor(s)
in culture supernatants affecting cell social behavior.
I.U. Ali, V. Mautner, and R. Hynes, Center for Cancer Research, Department of Biology, Massachusetts Institute
of Technology, Cambridge: Effects of addition of LETS protein to transformed cells.
L.I. Gold and E. Pearlstein, Irvington House Institute, Department of Pathology, New York University Medical
Center, New York: Studies on the nature and mechanism of cell adhesion factor (CAF)-mediated attachment.
M. Imada, L.M. Fink, and S.M. Clarke, Department of Pathology, University of Colorado Medical School,
Denver: Heterogeneity of the 220,000 m.w. proteins of syrian hamster cells as analyzed by two-dimensional
electrophoresis.
R. Nairn, Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York:
The cell-surface glycoproteins of normal, transformed, and variant fibroblasts.
R.C. Hughes, S. Rosen, A. Meager, R. Nairn, and J. Garrett, National Institute for Medical Research, Mill Hill
Laboratories, London, England: LETS glycoprotein of normal and transformed fibroblasts.
Y.M. Plesser and F. Doljanski, Department of Experimental Medicine and Cancer Research, The Hebrew
University-Hadassah Medical School, Jerusalem, Israel: The shedding of glucosamine-labeled cell-surface
components and the possible role of a large surface glycoprotein in intercellular associations.
E. Ruoslahti and E. Engvall, Division of Immunology, City of Hope National Medical Center, Duarte, California:
Binding of fibroblast surface protein, fibronection, to collagen.
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C.H. Damsky, D.W. Wylie, and C.A. Buck, The Wistar Institute, Philadelphia, Pennsylvania: Cytoskeletal
changes in BHK cells treated with anti-surface-membrane serum.
D.F. Mosher and A. Vaheri, *University of Wisconsin, Madison; *University of Helsinki, Finland: Secretion and
catabolism of alpha-2-macroglobulin ( 004) by cultured fibroblasts.
M.M. Gottesman, Laboratory of Molecular Biology, NCI, National Institutes of Health, Bethesda,Maryland:
Transformation-dependent secretion of a 33,000 m.w. protein by mouse cells.
SUNDAY MORNING, May 22
Session 8A: Membrane alterations
Chairperson: P.W. Robbins, Massachusetts Institute of Technology, Cambridge
B. Whittenberger and L. Glaser, Department of Biological Chemistry, Division of Biology and Biomedical
Sciences, Washington University, St. Louis, Missouri: Control of DNA synthesis by plasma membranes.
R.J. Mannino, K. Ballmer, and M.M. Burger, Department of Biochemistry, Biozentrum, University of Basel,
Switzerland: Cell-surface modulation and growth inhibition of transformed cells.
J.F. Perdue, Lady Davis Institute, Jewish General Hospital, Montreal, Canada: Loss of regulation of insulin
binding but not thrombin binding in virus-transformed cells and cultured avian and mammalian tumor cells.
L.A. Smets, The Netherlands Cancer Institute, Amsterdam: Membrane glycopeptides of transformed and
neoplastic mouse 3T3 cells.
R.M. Evans and L.M. Fink, Department of Pathology, University of Colorado Medical School, Denver: Identifica-
tion of transmembrane bridging proteins in plasma membrane of cultured mouse L cells.
J.R. Sheppard, A.J. Faras, and C.M. Moldow, University of Minnesota, Minneapolis: Decreased catecholamine
hormone receptors in transformed cells.
R.P.C. Shiu, J. Pouyssegur, and I. Pastan, Laboratory of Molecular Biology, NCI, National Institutes of Health,
Bethesda, Maryland: Glucose depletion accounts for the induction of two transformation-sensitive mem-
brane proteins in Rous sarcoma virus-transformed chick embryo fibroblasts.
D.E. Wylie, C.H. Damsky, and C.A. Buck, The Wistar Institute, Philadelphia, Pennsylvania: Effect of anti-
surface-membrane serum on morphology and growth properties of normal and transformed BHK cells.
P.E. Branton and J. Landry-Magnan, Department of Pathology, McMaster University, Hamilton, Ontario,
Canada: Plasma membrane protein phosphorylation and transformation.
H. Bauer, J. Ignajatovie, H. Riiosamen, M. Hayami, and R.R. Fri is, Institut fur Virologie, Geissen, WestGermany:
Immunological and biochemical studies on tumor cell-surface-associated proteins.
SUNDAY AFTERNOON, May 22
Session 88: Membrane alterations
Chairperson: J. Weston, University of Oregon, Eugene
A.B. DeLeo, H. Shiku, T. Takahashi, M. John, and L.J. Old, Sloan-Kettering Institute, New York, New York:
Cell-surface antigens of murine fibroblasts and sarcoma cells.
E.A. Davidson, V.P. Bhavanandan, and J. Banks, Department of Biological Chemistry, The Milton S. Hershey
Medical Center, Pennsylvania State University, Hershey: Complex saccharides of cultured mammalian cells.
G.A. Molinaro, E.O. Major, G. Bernhardt, S. Dray, and G. di Mayorca, Department of Microbiology, University
of Illinois Medical Center, Chicago: Similar cell-surface antigens on hamster cells transformed by different
polyoma viruses.
D. Kyner, P. Zabos, R. Seide-Kehoe, J. Christman, and G. Acs, Departments of Pediatrics and Biochemistry,
Mount Sinai School of Medicine, City University of New York, New York: Effect of ethionine on lymphocyte
activation.
J.K. Christman, P. Price, and L. Pedrinan, Departments of Pediatrics and Biochemistry, Mount Sinai School of
Medicine, City University of New York, New York: Ethionine, hypomethylation of DNA, and expression of
globin genes in Friend erythroleukemia cells.
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P.H. Atkinson, Departments of Pathology and Developmental Biology and Cancer, Albert Einstein College of
Medicine, Bronx, New York: Glycoprotein and protein precursors to plasma membranes in virus-infected
and uninfected He La cells.
P. Kurth, J. Smart, and V. Bosch, Imperial Cancer Research Fund Laboratories, London: Cell-membrane
glycoproteins of endogenous avian oncornaviruses.
M. Kotler, Y. Rosenberg, and B. Fried lender, Laboratory for Molecular Virology, The Hebrew University-
Hadassah Medical School, Jerusalem, Israel: Ribonuclease-sensitive DNA polymerase, a membrane-bound
enzyme specific for transformed cells.
RNA TUMOR VIRUSES
arranged by
DAVID BALTIMORE, Massachusetts Institute of Technology
NAOMI ROSENBERG, Massachusetts Institute of Technology
301 participants
WEDNESDAY EVENING, May 25
Session 1: Reverse transcription
Chairperson: J.M. Bishop, University of California, San Francisco
G.G. Peters, F. Harada, and J.E. Dahlberg, Department of Physiological Chemistry, University of Wisconsin,
Madison: Interaction of primer and template for RNA-directed DNA synthesis in Moloney murine leukemia
virus.
B. Cordell, R. Swanstrom, H.M. Goodman,* and J.M. Bishop, Departments of Microbiology, *Biochemistry and
Biophysics, University of California, San Francisco: Transcription of DNA from the genome of avian sarcoma
virus may initiate on tRNAtrP in the absence of stable binding between primer and enzyme.
M.S. Collett and A.J. Faras, Department of Microbiology, University of Minnesota Medical School, Minneapolis:
The nature of RNA-directed DNA transcription at the 5' end of the Rous sarcoma virus genome.
J. Leis, P. Scheible, and R. Smith, Department of Surgery, Duke University Medical Center, Durham, North
Carolina: In vitro transcription of reconstituted 34S Rous sarcoma virus RNAtRNAtrP template primer
complexes by the avian oncornavirus DNA polymerase-Demonstration of intra- and interstrand transcrip-
tion by hybridization and electron microscopic analysis.
R. Joho, A. Palmenberg, M.A. Billeter, and C. Weissmann, Institut fur Molekularbiologie I, Universitat Zurich,
Switzerland: Concordance of 5' and 3' terminal sequences in recombinant Rous sarcoma virus RNA issuing
from crosses of parents with distinct terminal redundancies.
E. Stoll, M.A. Billeter, A. Palmenberg, and C. Weissmann, Institut fur Molekularbiologie I, Universit5t Zurich,
Switzerland: Nucleotide sequence of the termini of AMV RNA-Terminal redundancy extending for 16-19
nucleotides.
E. Rothenberg, R.A. Weinberg, and D. Baltimore, Center for Cancer Research, Department of Biology, Mas-
sachusetts Institute of Technology, Cambridge: Characterization of infectious DNA synthesized by reverse
transcription in vitro.
W.A. Haseltine, J. Coffin,* and A. Maxam,t Sidney Farber Cancer Institute; *Tufts Medical School; tHarvard
Medical School, Boston, Massachusetts: A jumping polymerase-Replication and structure of RNA tumor
viruses.
D.P. Grandgenett, Institute for Molecular Virology, St. Louis University Medical Center, Missouri: A 32,000-
dalton protein from avian retravirus cores possesses endonuclease activity.
S.G. Lee and P.P. Hung, Molecular Virology Laboratory, Abbott Laboratories, North Chicago, Illinois: Isolation
of nucleic acid-binding protein from Rous sarcoma virus-transformed cells and its interaction with the RSV
genome.
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THURSDAY MORNING, May 26
iession 2: Viral DNA: Integration and expression
:hairperson: J. Dahlberg, University of Wisconsin, Madison
P.R. Shank, G. Ringold, S. Hughes, H.J. Kung, K. Yamamoto,* J.M. Bishop, and H.E. Varmus, Departments of
Microbiology and *Biochemistry, University of California, San Francisco: Restriction endonuclease mapping
of the unintegrated DNA of RNA tumor viruses.
S.H. Hughes, P.R. Shank, H.-J. Kung, J.M. Bishop, and H.E. Varmus, Department of Microbiology, University of
California, San Francisco: Integration of avian sarcoma virus DNA into the host genome.
C.J. Collins and J.T. Parsons, Department of Microbiology, University of Virginia, Charlottesville: Integration of
avian sarcoma virus DNA sequences.
E.F. Fritsch and H.M. Temin, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison:
Absence of complete "+" and "" strand viral DNAs in stationary chicken embryo fibroblasts infected with
avian ribodeoxyviruses.
F. Yoshimura, M. Goldfarb, D. Steffen, J. Hoffmann, and R.A. Weinberg, Center for Cancer Research and
Department of Biology, Massachusetts Institute of Technology, Cambridge: Restriction endonuclease map-
ping of the genomes of Harvey sarcoma and Moloney leukemia viruses.
Y. Chien, I. Verma,* and N. Davidson, Department of Chemistry, California Institute of Technology, Pasade-
na; *Salk Institute, San Diego, California: A heteroduplex study of sequence relations between RNAs of
several murine viruses.
C.A. Roberts and I.M. Verma,* Department of Biology, University of California, San Diego; *Tumor Virology
Laboratory, Salk Institute, San Diego, California: In vitro synthesis of double-stranded DNA complementary
to the genomes of avian and murine RNA tumor viruses.
R. Jaenisch, Heinrich-Pette-Institut, Hamburg, West Germany: Insertion of tumor virus genes into the germ line
of mice.
Rascati and R.W. Tennant, Biology Division, Oak Ridge National Laboratory, Tennessee: Induction of
endogenous murine leukemia virus by hydroxyurea and related compounds-Evidence for involvement of
DNA damage and repair.
R. Risser, J. Hartley,* and W.P. Rowe,* McArdle Laboratory, University of Wisconsin, Madison; *Laboratory of
Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland: Geneticcontrol of the frequency of
endogenous MuLV induction.
THURSDAY AFTERNOON, May 26
Session 3: Evidence for retroviruses in human tissues
Chairperson: H. Kaplan, Stanford University Medical Center, California
R.J. Huebner, D.C. Fish,* R. Toni,* D.B. Djurickovic,* C.E. Whitmire,t J. Rhim,t R.V. Gilden,* P.R. Hill, and
R.W. Hill, NCI, National Institutes of Health, Bethesda, Maryland; *Frederick Cancer Research Center,
Frederick, Maryland; tMicrobiological Associates, Bethesda, Maryland: Immuneprotection against cancer
in experimental animals and a strategy for protection against cancer in man.
H.S. Kaplan, R.S. Goodenow, A.L. Epstein, S. Gartner, A. Decleve, and P.N. Rosenthal, Cancer Biology
Research Laboratory, Department of Radiology, Stanford University Medical Center, California: Isolation
and characterization of C-type virus from an established human histiocytic lymphoma cell line.
K. Nooter, P. Bentvelzen, J.C. Coolen,* and C. Zurcher,* Radiobiological Institute TNO and *Institute for
Experimental Gerontology TNO, Rijswijk, The Netherlands: Isolation of a leukemogenic virus from human
leukemic bone marrow by cocultivation procedures.
G. Koch, K. Nooter, P. Bentvelzen, and 1.1. Haaijman,* Radiobiological Institute TNO and *Institute for
Experimental Gerontology TNO, Rijswijk, The Netherlands: Serological characterization of a putative
human C-type oncornavirus by means of the Sepharose bead immunofluorescence assay.
R.G. Smith, S.A. Lee, and R.C. Gallo, NCI, National Institutes of Health, Bethesda, Maryland: Detection by
competitive molecular hybridization of type-C viral related sequences in RNA derived from normal and
neoplastic human tissues.
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P. Jacquemin, W. Saxinger, and R. Gallo, National Institutes of Health, Bethesda, Maryland: Evidence for a
specific immunological response against viral reverse transcriptase as evidenced by natural Ig found on the
membrane of leukocytes from patients with leukemia.
D. Gillespie, R.C. Gallo, B. Nelkin, W. Prensky,* and D. Strayer, NCI, National Institutes of Health, Bethesda,
Maryland, and *Sloan-Kettering Institute, New York, New York: Organization of type-C viral related
sequences in human DNA.
F. Wong-Staal, N.R. Miller, M.S. Reitz, E.G. Lewis, D.H. Gillespie, and R.C. Gallo, NCI, National Institutes of
Health, Bethesda, Maryland: Distribution of primate type-C viral related sequences in DNA from humans.
THURSDAY EVENING, May 26
Session 4: Genetics and restriction
Chairperson: H. Hanafusa, Rockefeller University, New York, New York
G.M. Cooper, Sidney Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston,
Massachusetts: Marker rescue with subgenomic fragments of avian leukosis virus DNA.
K. Steimer and D. Boettiger, Department of Microbiology, School of Medicine, University of Pennsylvania,
Philadelphia: A complementation system for Rous sarcoma virus replication genes using absolute mutants.
J.M. Coffin, M. Planitz, and F. Chabot, Department of Molecular Biology and Microbiology, Cancer Research
Center, Tufts University School of Medicine, Boston, Massachusetts: Relationship between the genomes of
exogenous and endogenous avian RNA tumor viruses.
A. Rein, R.H. Bassin, and B.I. Gerwin, NCI, National Institutes of Health, Bethesda, Maryland: A replication-
defective variant of Moloney MuLV-Interactions with amphotropic MuLV.
D.V. Faller, J. Rommelaere, and N. Hopkins, Biology Department, Massachusetts Institute of Technology,
Cambridge: RNase T,-resistant oligonucleotides of MuLVs.
W.K. Yang, L.R. Boone,* I.C. Hsu, D.M. Yang, R.W. Tennant, and A. Brown,* Biology Division, Oak Ridge
National Laboratory, Tennessee; *Department of Microbiology, University of Tennessee, Knoxville: DNA
transfection of N- and B-tropic MuLVs in cell cultures of Fv-1 permissive and nonpermissive genotypes.
G. Duran-Troise, R.H. Bassin, B.I. Gerwin, and A. Rein, NCI, National Institutes of Health, Bethesda, Maryland:
Abrogation of Fv -1 b restriction by N-tropic MuLV rendered noninfectious by gamma irradiation or by
heating.
S.J. O'Brien and J.M. Simonson, Laboratory of Viral Carcinogenesis, NCI, National Institutes of Health,
Bethesda, Maryland: Pleiotropic restriction of BALB/c endogenous oncornavirus expression by the Bvr -1
gene in cat-mouse hybrid cells.
R.S. Lemons, S.J. O'Brien, and C.J. Sherr, Laboratory of Viral Carcinogenesis, NCI, National Institutes of Health,
Bethesda, Maryland: A new gene on human chromosome 6 which controls the replication of baboon type-C
virus in human cells.
FRIDAY MORNING, May 27
Session 5: Leukemia viruses and leukemia
Chairperson: S. Aaronson, NCI, National Institutes of Health, Bethesda, Maryland
H. Hiai, P. Morrissey, R. Khiroya, and R.S. Schwartz, Department of Hematology, Tufts-New England Medical
Center, Boston, Massachusetts: Expression of xenotropic virus in hairless mice.
A.J. Mayer, A. Bosch, C. Comas, M.L. Duran-Reynals, and F. Lilly, Department of Genetics, Albert Einstein
College of Medicine, Bronx, New York: Resistance to spontaneous leukemia in the (AKR x RF)F, mouse.
M. Lieberman, A. Dec leve, and H.S. Kaplan, Department of Radiology, Cancer Biology Research Laboratory,
Stanford University School of Medicine, California: Rescure of RadLV from cultured, nonproducer lym-
phoma cells of strain C57131/Ka mice.
N. Rosenberg, D. Baltimore, and C.D. Scher,* Massachusetts Institute of Technology, Cambridge, and *Harvard
Medical School, Boston, Massachusetts: The effect of helper virus on Abelson virus-induced
leukemogenesis.
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U.R. Rapp, Laboratory of Viral Carcinogenesis, NCI, National Institutes of Health, Bethesda, Maryland:
Leukemia in inbred strains of mice-Virulence of endogenous ecotropic virus as a determinant of disease
incidence.
J.H. Elder, F.C. Jensen, R.A. Lerner, J.W. Hartley,* and W.P. Rowe,* Department of Immunopathology, Scripps
Clinic and Research Foundation, La Jolla, California; *Laboratory of Viral Diseases, NIAID, National
Institutes of Health, Bethesda, Maryland: Generation of a new leukemogenic virus via recombination
between the envelope genes of endogenous ecotropic and xenotropic proviruses.
D.H. Troxler, J.K. Boyars, and E.M. Scolnick, Laboratory of Tumor Virus Genetics, NCI, National Institutes of
Health, Bethesda, Maryland: The Friend strain of spleen focus-forming virus-A recombinant between
mouse type-C ecotropic viral sequences and sequences related to xenotropic virus.
Y. Ikawa and M. Yoshida, Laboratory of Viral Oncology, Cancer Institute, Toshima-ku, Tokyo, Japan:
Erythroblastosis-inducing RNA sequences in virions from Friend leukemia virus-induced erythroleukemia
cells of a DDD mouse origin.
FRIDAY AFTERNOON, May 27
Session 6: Poster session on retrovirus biochemistry
Reverse transcription
T.Y. Shih, H.A. Young, W.P. Parks, and E.M. Scolnick, Laboratory of Tumor Virus Genetics, NCI, National
Institutes of Health, Bethesda, Maryland: In vitro transcription of Moloney leukemia virus genes in infected
cell nuclei and chromatin-Elongation of chromatin-associated RNA by E. coli RNA polymerase.
J. Harel, S.A. Leibovitch, and H. Tapiero, Groupe de Recherche do CNRS, Institute Gustave-Roussy, Villejuif,
France: Single-stranded DNA related to transcription of cellular and oncornavirus genes.
S.R. Tronick, W.A. Haseltine,* C.D. Cabradilla, K.C. Robbins, and S.A. Aaronson, Laboratory of RNA Tumor
Viruses, NCI, National Institutes of Health, Bethesda, Maryland: *Sidney Farber Cancer Institute, Harvard
Medical School, Boston, Massachusetts: Demonstration of 5'-terminal nucleotide sequences of the mamma-
lian helper type-C viral genome in replication-defective mammalian transforming viruses.
B.I. Gerwin and J.G. Levin, National Institutes of Health, Bethesda, Maryland: Properties of MuLV reverse
transcriptase assembled into noninfectious virions lacking the 60-70S genome.
A.M. Wu, V.S. Kalyanaraman,* L. Cellei,* and T. Le Bon,* Department of Anatomy (Histology), University of
Toronto, Canada; *Department of Biology, Litton Bionetics, Inc., Bethesda, Maryland: Dilemma of molecu-
lar weight of mammalian type-C viral reverse transcriptase.
R.C. Sawyer, C.M. Metroka, W.S. Mason, and H. Hanafusa, Rockefeller University, New York, New York, and
Institute for Cancer Research, Philadelphia, Pennsylvania: Lack of functional viral reverse transcriptase in
normal chicken cells.
Viral DNA integration and expression
T. Tsuruo and M.A. Baluda, Department of Pathology, University of California School of Medicine, Los Angeles:
DNA repair and provirus integration.
D.P. Nayak and K. Som, University of California School of Medicine, Los Angeles: Purification of the coding
strand of the avian myeloblastosis virus by affinity chromatography and molecular hybridization.
Y. Akiyama, Department of Microbiology, University of Southern California School of Medicine, Los Angeles:
Evidence against tandem integration of two different avian sarcoma viruses in the same cell.
P.C. Kimball, Comprehensive Cancer Center and Department of Microbiology, Ohio State University, Colum-
bus: Comparison of RNA components from feline and murine sarcoma-leukemia virus complexes.
W. Drohan, R. Kettmann, D. Colcher, and J. Schlom, Meloy Laboratories, Springfield, Virginia, and NCI,
National Institutes of Health, Bethesda, Maryland: Isolation of the mouse mammary tumor virus sequences
not transmitted as germinal provirus in the C3H and RIII mouse strains.
Translation and mRNA
E.C. Murphy, Jr. and R.B. Arlinghaus, The University of Texas System Cancer Center, M.D. Anderson Hospital
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and Tumor Institute, Houston: In vitro translation of Rauscher leukemia virus 35S RNA in nuclease-treated
mouse cell extracts.
S.A. Edwards and H. Fan,* Department of Biology, University of California, San Diego; *Salk Institute for
Biological Studies, La Jolla, California: Analysis of nascent polypeptides on polyribosomes precipitated with
antibody to p30.
E.M. Scolnick and W.P. Parks, Laboratory of Tumor Virus Genetics, NCI, National Institutes of Health, Bethesda,
Maryland: Identification of a protein coded for by Harvey sarcoma virus.
U. Olshevsky, I. Kerr,* and D. Baltimore,t Laboratory for Molecular Virology, The Hebrew University-Hadassah
Medical School, Jerusalem, Israel; *The National Institute for Medical Research, London, England; tCenter
for Cancer Research, Massachusetts Institute of Technology, Cambridge: In vitro translation of RNA from
Moloney murine leukemia virus and Harvey murine sarcoma virus.
G.F. Okasinski and L.F. Velicer, Department of Microbiology and Public Health, Michigan State University, East
Lansing: Cell-free translation of feline leukemia virus subunit RNA.
H.-H.M. Dahl, R. McCormick, and B. Ozanne, Imperial Cancer Research Fund Laboratories, London, England:
In vitro translation of murine leukemia virus and Kirsten sarcoma virus RNA.
Proteins and morphogenesis
R. Klemenz and H. Diggelmann, Swiss Institute for Experimental Cancer Research, Epalinges-Lausanne,
Switzerland: Peptide analyses of envelope glycoproteins of Rous sarcoma virus.
W.J.M. van de Ven and H.P.J. Bloemers, Department of Biochemistry, University of Nijmegen, The Netherlands:
Impaired expression of the env gene of Rauscher murine leukemia virus.
M.C. Kemp, K.S. Wise, R.T. Acton, and R.W. Compans, Department of Microbiology, University of Alabama,
Birmingham: Characterization of minor glycoproteins of MuLVs.
J.-S. Tung and E. Fleissner, Memorial Sloan-Kettering Cancer Center, New York, New York: Two species of
type-C viral core polyprotein on AKR mouse leukemia cells.
R. Ascione,* D.K. Haapala,t W.G. Robey,* and G.F. Vande Woude,* *Laboratory of DNA Tumor Viruses and
tLaboratory of Viral Carcinogenesis, NCI, National Institutes of Health, Bethesda, Maryland: The site of
synthesis and the location of Moloney sarcoma virus-specific polyprotein P60 (gag).
B.K. Pal, M.L. Bryant, and P. Roy-Burman, Departments of Pathology and Biochemistry, University of Southern
California School of Medicine, Los Angeles: Phosphoproteins of RNA tumor viruses-Primary structural
analysis and virion location of the multiple-charged species.
A.F. Shields, N. Rosenberg, and D. Baltimore, Center for Cancer Research and Department of Biology,
Massachusetts Institute of Technology, Cambridge: The characterization of defectivevirions produced by
Abelson leukemia virus-transformed lymphoid cells.
J. Forchhammer and G. Turnock,* The Fibiger Cancer Laboratory, Copenhagen, Denmark;
*Department of
Biochemistry, School of Biological Sciences, University of Leicester, England: Isomers of viral proteins from
Moloney-MuLV and M-MSV(MuLV).
J.E. Bubbers, S. Chen, and F. Lilly, Department of Genetics, Albert Einstein College of Medicine, Bronx, New
York: Detection of selectively incorporated H-2 antigens in disrupted, but not intact, Friend virus particles.
P. Dezelee and F. Catala, Foundation Curie-Institut du Radium, Centre Universitaire, Orsay, France: Structural
proteins of Schmidt-Ruppin Rous sarcoma virus and transformation thermosensitive mutants.
S.L. Marcus, S.W. Smith, J. Racevskis, and N.H. Sarkar, Memorial Sloan-Kettering Cancer Center, New York,
New York: Characterization of oncornaviral proteins by hydrophobic chromatography.
D. Robertson and R.E. Thach, Department of Biological Chemistry, Washington University, St. Louis, Missouri:
Characterization of the proteins of intracisternal A-type particles and extracellular oncornavirusl ike particles
produced by MOPC-460 cells.
C. Dickson, M. Atterwill, and H. Dahl, Imperial Cancer Research Fund Laboratories, London, England:
Polyprotein precursors to the envelope and internal proteins of the mouse mammary tumor virus.
J. Racevskis and N.H. Sarkar, Memorial Sloan-Kettering Cancer Center, New York, New York: Synthesis and
processing of precursor polypeptides to mouse mammary tumor virus structural proteins.
J.M. England, B. Dietzschold, and M.S. Halpern, Wistar Institute of Anatomy and Biology, Philadelphia,
Pennsylvania: Antibody-independent detection of virus-specific glycoprotein synthesis in oncornavirus-
i nfected cells.
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FRIDAY AFTERNOON, May 27
Session 7: Poster session on retrovirus biology
Leukemia and leukemia viruses
S.K. Datta, N. Manny, C. Andrzejewski, M. Casey, and R.S. Schwartz, Department of Hematology, Tufts-New
England Medical Center, Boston, Massachusetts: Relation between virus-inducing loci and autoimmune
disease in NZB mice.
K.F. Manly, Department of Medical Viral Oncology, Roswell Park Memorial Institute, Buffalo, New York:
Pathogenesis by sublines of an MuLV.
A. Bosch, C. Comas, A. Mayer, M.L. Duran-Reynals, and F. Lilly, Albert Einstein College of Medicine, Bronx,
New York: Leukemogenesis in mice by X irradiation and by 3-methylcholanthrene-Expression of endogen-
ous MuLV in irradiated leukemic mice.
R.C. Nowinski, Fred Hutchinson Cancer Research Center, Seattle, Washington: Expression of viral antigens on
the cell surface of lymphocytes.
M.S. Halpern and R.R. Friis,* Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania; *Institilit fur
Virologie, Fachbereich Humanmedizin, Justus Leibig Universitat, Giessen, West Germany: Immune reactiv-
ity to endogenous viral glycoprotein is a consequence of the sensitization of chf (+) chickens to the
glycoprotein of exogenous avian tumor virus.
P. O'Donnell, E. Stockert, A. DeLeo, N. Famulari, T. Lee, U. Rapp,* and N. HookinsT Memorial Sloan-Kettering
Cancer Center, New York, New York; *NCI, National Institues of Health, Bethesda, Maryland: TCenter for
Cancer Research, Massachusetts Institute of Technology, Cambridge: Studies on the XC- to XC± conversion
of N-ecotrooic murine type-C viruses.
Virus-cell interaction
P. Moss, N. Sandefur, and G.S. Martin, Department of Zoology, University of California, Berkeley: Transforma-
tion of myogenic cells by Rous sarcoma virus.
H.L. Robinson, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts: Presence of an
endogenous non-subgroup-E type-C virus in line 15 chickens.
N.A. Wivel and H.L. Malech, Laboratory of Cell Biology, NCI, National Institutes of Health, Bethesda,
Maryland: Studies on the transfer and replication of murine intracisternal A particles.
B.J. Weimann, J. Schmidt, and I.B. Pragnell,* Bawl Institute for Immunology, Switzerland; *Beatson Institute for
Cancer Research, Glasgow, Scotland: Biochemical studies on intracisternal A-type particles trom mouse
myelomas.
A. Bernstein and T. Mak, Ontario Cancer Institute, Toronto, Canada: Isolation of Friend spleen focus-forming
virus nonproducer NIH/3T3 clones.
B. Moll, J.W. Hartley, and W.P. Rowe, North Shore University Hospital, Manhasset, New York, and NIAID,
National Institutes of Health, Bethesda, Maryland: Induction of B-tropic and N-tropic MuLV from B10.BR
mouse embryo cell lines.
C. Moroni, P. Monckton, J. Stoye, J. De Lamarter, A. Matter, and G. Schumann, Friedrich Miescher-Institut,
Hoffmann-La Roche & Co., Ltd., and CIBA-GEIGY, Ltd., Bawl, Switzerland: Induction of endogenous C-type
viruses from lymphoid cells.
R.P. Monckton and C. Moroni, Friedrich Miescher -Institut, Bawl, Switzerland: Serum acts as an inducer of
endogenous murine C-tvoe viruses.
G. Vecchio, G. Colletta, F. Fragomele, M. Laurenza, and M.L. Sandomenico, Cattedra di Virologia Oncologica,
Istituto di Patologia Generale, II Facolta di Medicina, University of Naples, Italy: Induction of viral polypep-
tides and viral messenger RNA in Friend erythroleukemic cells.
F.W. George IV, D.W. Krempin, and V. Klement, Departments of Microbiology and Pediatrics, University of
Southern California School of Medicine, Los Angeles: Sendai virus-mediated infection of mink cells with
ecotropic mouse leukemia virus.
C. Kryceve-Martinerie, S. Barlati,* J.M. Biquard, D. Lawrence, and P. Vigier, Faculte des Sciences, Institut du
Radium, Orsay, France; *Laboratorio di Genetica Biochimica ed Evoluzionistica del CNR, Pavia, Italy:
Characteristics of the transformation-enhancing factor(s) produced by Rous sarcoma virus-transformed and
other transformed cells.
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S.P. Staal, J.W. Hartley, and W.P. Rowe, Laboratory of Viral Diseases, NIAID, National Institutes of Health,
Bethesda, Maryland: Isolation of transforming viruses from spontaneously arising tumors of high-lymphoma
strain mice.
Genetics and restriction
M. Linial, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle,
Washington: Characterization of two coordinately defective mutants of Roussarcoma virus.
Y.C. Chen, M.J. Hayman,* and P.K. Vogt,t Department of Micribiology, Texas College of Osteopathic
Medicine, North Texas State University; *Imperial Cancer Research Fund, London, England; tDepartment of
Microbiology, University of Southern California, Los Angeles: Mammalian cells transformed by
temperature-sensitive mutants of avian sarcoma virus.
K. Toyoshima, M. Nasu, and H. Nomaguchi, Research Institute for Microbial Diseases, Osaka University,
Yamada-kami, Suita, Osaka, Japan: Selection and modification by quail cell passage of avian sarcoma virus.
R.W. Tennant, W.K. Yang, R.J. Rascati, and A. Brown,* Biology Division, Oak Ridge National Laboratory,
Tennessee;* University of Tennessee, Knoxville: Factors affecting transfer of Fv-1 locus-specific resistance to
mouse leukemia cells.
M.E. Blackstein and T. Mak, Departments of Anatomy (Histology) and Medical Biophysics, University of
Toronto, Ontario, Canada: Inherited resistance to N- and B-tropic MuLVs in vitro-Expression of N-tropic
viral RNA and integrated sequences of N- and B-tropic viruses in cells of the Fv-1 congenic pair SIM.S and
SIM.R.
F. Westenbrink, W.H. Koornstra, P.C. Creemers, J. Brinkhof, J.J. Haaijman,* and P. Bentvelzen,Radiobiological
Institute TNO and *Institute for Experimental Gerontology, TNO, Rijswijk, The Netherlands: Epigenetic
factors causing differential synthesis of murine mammary tumor virus polypeptides.
Natural history
M. Barbacid, S. Hino, J.M. Krakower, S.R. Tronick, and S.A. Aaronson, Laboratory of RNA Tumor Viruses, NCI,
National Institutes of Health, Bethesda, Maryland: Immunologic approaches to the genetic analysis of
mammalian type-C RNA viruses.
W.A. Haseltine and D. Kleid,* Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts;
Stanford Research Institute, Menlo Park, California: A new method of RNA tumor virus classification.
M.L. Bryant, P. Roy-Burman, M.B. Gardner, and B.K. Pal, Departments of Pathology and Biochemistry,
University of Southern California School of Medicine, Los Angeles: Genetic sequence homology among
ecotropic, xenotropic, and amphotropic murine type-C RNA viruses.
R. Callahan, C.J. Sherr, and G.J. Todaro, Laboratory of Viral Carcinogenesis, NCI, National Institutes of Health,
Bethesda, Maryland: Immunologic and biochemical characterization of isolates from a new class of murine
retroviruses.
P.R. Andersen and D. Boettiger, Department of Microbiology, School of Medicine, University of Pennsylvania,
Philadelphia: Biological and biochemical studies of reptilian C-type viruses.
S. Rasheed and M.B. Gardner, Department of Pathology, University of Southern California School of Medicine,
Los Angeles: Isolation of type-C virus from a wild rat.
J.S. Rhim, D.L. Putman, D.K. Park, P. Hill, and R.J. Huebner, Microbiological Associates, Inc., and NCI, National
Institutes of Health, Bethesda, Maryland: Expression of common rat tumor antigen in rat cells transformed by
guinea pig herpesvirus.
A.R. Davis and D.P. Nayak, Department of Microbiology and Immunology, University of California School of
Medicine, Los Angeles: Expression of endogenous retraviral genes in leukemic guinea pig cells.
T.G. Kawakami and L. Sun, Comparative Oncology Laboratory, University of California, Davis: Type-C virus-
induced leukemia in gibbons.
S.T. Barker, R.L. Heber ling, J.W. Eichberg, and S.S. Kalter, Southwest Foundation for Research and Education,
San Antonio, Texas: Expression of baboon endogenous virus in tissues of animals infected with a murine
sarcoma-baboon endogenous pseudotype virus.
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FRIDAY EVENING, May 27
Session 8: Translation and mRNA
Chairperson: H. Diggelmann, Swiss Institute for Experimental Cancer Research, Epalinges-Lausanne
S.R. Weiss, H.E. Varmus, and J.M. Bishop, Department of Microbiology, University of California, San Francisco:
Size and genetic composition of cytoplasmic avian sarcoma virus-specific RNAs.
D.W. Stacey and H. Hanafusa, Rockefeller University, New York, New York: Determination by microinjection
of the size of RAV-2 envelope-glycoprotein mRNA.
W.S. Hayward and S.Y. Wang, Rockefeller University, New York, New York: Gene-specific viral RNAs in
uninfected and avian sarcoma virus-infected cells.
B. Baker, H. Robinson, H.E. Varmus, and J.M. Bishop, Department of Microbiology, University of California, San
Francisco: Regulation of endogenous viral gene expression in uninfected chicken cells.
A.J. Conley and L.F. Velicer, Department of Microbiology and Public Health, Michigan State University, East
Lansing: Analysis of intracellular feline leukemia virus-specific RNA.
H. Oppermann, A. Ulrich, S. Weiss, H.E. Varmus, J.M. Bishop, and L. Levintow, Department of Microbiology,
University of California, San Francisco: Cells producing avian sarcoma virus contain a polypeptide (pr180)
translated from the genes gag and pol.
J. McGinnis and J. Leis, Department of Surgery, Duke University Medical Center, Durham, North Carolina:
Translation of 34S Rous sarcoma virus RNA in vitro into a polymerase-gs antigen precursor polypeptide and
processing of 34S RNA with purified RNase III.
K. Beemon and T. Hunter, Tumor Virology Laboratory, Salk Institute, San Diego, California: In vitro translation
yields a possible Rous sarcoma virus src gene product
R. Palmiter, S. Ripley, and R. Eisenman, Department of Biochemistry, University of Washington, and Fred
Hutchinson Cancer Research Center, Seattle, Washington: Annealing with tRNA '13 specifically inhibits the
in vitro translation of Rous sarcoma virus 35S RNA.
SATURDAY MORNING, May 28
Session 9: Proteins and morphogenesis
Chairperson: E. Fleissner, Memorial Sloan-Kettering Cancer Center, New York, New York
R. Eisenman, R. Shaikh, and W. Mason, Fred Hutchinson Cancer Research Center, Seattle, Washington; Center
for Cancer Research, Massachusetts Institute of Technology, Cambridge; Institute for Cancer Research, Fox
Chase, Philadelphia, Pennsylvania: Identification of an endogenous virus polyprotein in uninfected chick
fibroblast cells.
K. Bister, M.J. Hayman, P.H. Duesberg,* and P.K. Vogt, Department of Microbiology, University of Southern
California School of Medicine, Los Angeles; *Department of Molecular Biology and Virus Laboratory,
University of California, Berkeley: The defectiveness of strain MC29 avian leukosis virus.
D.L. Buchhagen and H. Hanafusa, Rockefeller University, New York, New York: Identification and characteri-
zation of a precursor to the avian RNA tumor virus glycoprotein.
K. Moelling and M. Hayami* Max-Planck-Institut fur Molekulare Genetik, Berlin-Dahlem, West Germany;
Institut fill. Virologie der Justus-Liebig Universitat, Fachbereich Humanmedizin, Giessen, West Germany:
Analysis of precursors to the envelope glycoproteins of avian RNA tumor viruses in chicken and quail cells.
R.B. Arlinghaus, J.J. Kopchick, G.A. Jarnjoom, and R.B. Naso, The University of Texas System Cancer Center,
M.D. Anderson Hospital and Tumor Institute, Houston: Characterization of intracellular polyprotein precur-
sors of reverse transcriptase in cells infected with Rauscher leukemia virus.
S. Oroszlan and R. V. Gilden, Viral Oncology Program, NCI, National Institutes of Health, Bethesda, and
Frederick Cancer Research Center, Frederick, Maryland: Primary structure and immunologic analysis of env
and gag gene products.
J.W. Gautsch and J.H. Elder, Department of Immunopathology, Scripps Clinic and Research Foundation, La
Jolla, California: Conservation of the primary structure of the gag gene products of ecotropic, xenotropic, and
amphotropic MuLVs-A contrast to the variability of the env gene product gp70.
E. Fleissner, H. Snyder, Jr., and E. Stockert, Memorial Sloan-Kettering Cancer Center, New York, New York: The
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molecular nature of the Gross surface antigen.
R.B. Luftig and Y. Yoshinaka, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts:
Cleavage of MuLV P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand
(immature) to a collapsed (mature) form of the virus core.
Y. Yoshinaka and R.B. Luftig, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts:
Partial characterization of a P70 proteolytic factor that is present in purified virions of Rauscher leukemia
virus.
0. Witte and D. Baltimore, Center for Cancer Research and Department of Biology, Massachusetts Institute of
Technology, Cambridge: Mechanism of formation of pseudotypes between vesicular stomatitis virus and
murine leukemia virus.
SATURDAY AFTERNOON, May 28
Session 10: Virus-cell interaction
Chairperson: R. Benveniste, NCI, National Institutes of Health, Bethesda, Maryland
P.M. Pitha, B.F. Fernie, S.P. Staal, D.P. Bolognesi, and W.P. Rowe, Johns Hopkins Oncology Center, Baltimore,
Maryland; National Institutes of Health, Bethesda, Maryland; Duke University, Durham, North Carolina:
The effect of interferon on MuLV infection.
E. Hunter and G.L. Davis, Department of Microbiology, University of Alabama, Birmingham: Inhibition of Rous
sarcoma virus replication by interferon.
J. Peries, M. Canivet, R. Emanoil-Ravicovitch, M.C. Debons-Guillemin, J. Robert, and C.J. Sherr, Laboratoire
d'Hematologie Experimentale, Hociital Saint Louis, Paris, France, and Laboratory of Viral Carcinogenesis,
NCI, National Institutes of Health, Bethesda, Maryland: Expression and infectivity of murine type-C viruses in
mouse teratocarcinoma cells.
R. Michal ides, R. Nusse, and R. van Nie, Department of Genetrics and Virology, Netherlands Cancer Institute,
Amsterdam: Identification by nucleic acid hybridization of the gene responsible for the occurrence of
pregnancy-dependent mammary tumors in the GR mouse strain.
D.R. Lowy, Dermatology Branch, NCI, National Institutes of Health, Bethesda, Maryland: Glucocorticoid-
induced transformation of a mink cell line which contains a sarcoma viral genome.
J.-M. Biquard and P. Dezelee, Fondation Curie-Institut du Radium, Orsay, France: Changes in cellular glycopro-
teins after treatment of chick embryo fibroblasts with 5-bromodeoxyuridine.
P. Roy-Burman,*t H.L. Niman,t J.R. Stephenson,* and M.B. Gardner,* *Departments of Pathology and
tBiochemistry, University of Southern California School of Medicine, Los Angeles; *Laboratory of RNA
Tumor Viruses, NCI, National Institutes of Health, Bethesda, Maryland: Endogenous RD-114 virus genome
expression in malignant cat tissues.
W.D. Hardy, Jr., E.E. Zuckerman, E.G. Mac Ewen, and M. Essex, Laboratory of Veterinary Oncology, Memorial
Sloan-Kettering Cancer Center, New York, New York, and Department of Microbiology, Harvard School of
Public Health, Boston, Massachusetts: Evidence that the feline oncornavirus-associated cell-membrane
antigen is an FeLV- and FeSV-induced tumor-specific antigen.
R.E. Benveniste and G.J. Todaro, Laboratory of Viral Carcinogenesis, NCI, National Institutes of Health,
Bethesda, Maryland: Primate retroviruses-Different origins and modes of transmission.
SUNDAY MORNING, May 29
Session 11: Src and avian viral genomes
Chairperson: R. Weinberg, Massachusetts Institute of Technology, Cambridge
D. Spector, K. Smith, H.E. Varmus, and J.M. Bishop, Department of Microbiology, University of California, San
Francisco: The DNAs of uninfected vertebrates contain nucleotide sequences related to the transforming
gene of avian sarcoma virus.
A.L. Schincariol, Cancer Research Unit, University of Western Ontario, London, Canada: Analysis of sarcoma-
specific sequences from murine sarcoma virus growing on thymus-bone marrow cells.
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T. Graf, B. Royer-Pokora, and H. Beug, Max-Planck-Institut fur Virusforschung, Biologisch-Medizinische Ab-
teilung, Tubingen, West Germany: Transformation parameters in chicken fibroblasts transformed by avian
leukosis viruses.
D. Stehel in and T. Graf,* Virology Unit, INSERM, Lille, and Institut Pasteur de Lille, France,* Max-Planck-Institut
far Virusforschung, Tubingen, West Germany: Avian erythroblastosis and myelocvtomatosis viruses lack the
avian sarcoma virus-transforming gene.
M.M.C. Lai, S. Hu, and P.K. Vogt, Department of Microbiology, University of Southern California School of
Medicine, Los Angeles: The occurrence of partial deletion and substitution of src gene in the RNA genome of
avian sarcoma virus.
E. Wang and A.R. Goldberg, Rockefeller University, New York, New York: Effect of the src gene product on
microfilament and microtubule organization in mammalian cells infected with a temperature-sensitive
mutant of Rous sarcoma virus.
G. Calothy, F. Poirier, and B. Pessac, Fondation Curie-Institut du Radium, Orsay, France: Transformation-
defective mutants of Rous sarcoma virus inducing chick embryo neuroretinal cell multiplication.
E. Keshet and H.M. Temin, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison:
Pheasant-derived nucleotide sequences in the genome of recombinant avian leukosis viruses with subgroup
F specificity.
P.E. Neiman, University of Washington and The Fred Hutchinson Cancer Research Center, Seattle, Washing-
ton: Mapping by competitive hybridization of genome sequences which differ between endogenous and
exogenous chicken leukosis viruses.
L.B. Crittenden, W. Okazaki, P.E. Neiman, J.M. Sharma, and R.L. Witter, Regional Poultry Research Laboratory,
East Lansing, Michigan, and The Fred Hutchinson Cancer Research Center, Seattle, Washington: Occur-
rence of lymphoid tumors in chickens free of infection with known avian tumor viruses.
THE MOLECULAR BIOLOGY OF YEAST
arranged by
FRED SHERMAN, University of Rochester
JAMES BROACH, Cold Spring Harbor Laboratory
254 participants
THURSDAY EVENING, August 18
Session 1
Chairperson: V. MacKay, Rutgers University, New Brunswick, New Jersey
E. Ciejek, Y. Jones-Brown, and J. Thorner, Department of Bacteriology and Immunology, University of Califor-
nia, Berkeley: The mode or action of a factor-A synthetic approach.
R. K. Chan, Department of Microbiology, University of Cincinnati College of Medicine, Ohio: A yeast mutant
super-sensitive to a factor.
R. Sumrada and T. G. Cooper, University of Pittsburgh, Pennsylvania: Control of protein degradation by a factor,
the cell cycle arrest signal, and inhibition of protein synthesis.
J. McCullough and I. Herskowitz, Institute of Molecular Biology and Department of Biology, University of
Oregon, Eugene: Relationship of S. cerevisiae and S. kluyveri mating factors.
J. E. Haber, B. Garvik, D. D. Wygal, and J. M. Stoler, Department of Biology, Brandeis University, Waltham,
Massachusetts: Mutations affecting the efficiency of homothallic mating-type interconversion.
D. B. Finkelstein and M. Udden, Department of Biochemistry, University of Texas Health Science Center,
Dallas: a Factor-Cell-cycle arrest and a factor metabolism.
L. M. Melnick and J. Blamire, Department of Biology, Brooklyn College, New York: Regulation of sporulation by
functions located on chromosome III.
J. Rine, J. Strathern, J. Hicks, and I. Herskowitz, Institute of Molecular Biology and Department of Biology,
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University of Oregon, Eugene: Control of cell type in heterothallic cells.
L. M. Mel nick and J. Blami re, Department of Biology, Brooklyn College, New York: The effect of the dmt gene on
the mating reaction and chromosome Ill in yeast.
A. K. Hopper and J. Forest, Department of Microbiology, University of Massachusetts Medical Center, Worces-
ter: Mutants of yeast which alter mating-type control of meiosis and spore formation.
A. J. S. Klar, D. N. Radin, and S. Fogel, Department of Genetics, University of California, Berkeley: Switching of a
yeast mating-type mutant allele, a°, in homothallic and heterothallic strains.
L. C. Blair, J. Strathern, J. Rine, J. Hicks, and I. Herskowitz, Institute of Molecular Biology and Department of
Biology, University of Oregon, Eugene: Extensions and tests of the cassette model of homothall ism.
FRIDAY MORNING, August 19
Session 2
Chairperson: G. R. Fink, Cornell University, Ithaca, New York
H. L. Klein and S. K. Welch, Department of Genetics, University of Washington, Seattle: Inverted repeated
sequences in yeast nuclear DNA.
M. Forte and W. Fangman, Department of Genetics, University of Washington, Seattle: Quantitation of
cross-links in yeast chromosomes.
D. Lohr and K. E. Van Holde, Department of Biochemistry and Biophysics, Oregon State University, Corvallis:
Evidence for nucleosomal phasing in S. cerevisiae nuclear chromatin.
D. Lohr, G. Riedel, and K. E. Van Holde, Department of Biochemistry and Biophysics, Oregon State University,
Corvallis: The structure of chromatin in stationary-phase cells of S. cerevisiae and comparison to log-phase
cel Is.
S. G. Elliott and C. S. McLaughlin, Department of Molecular Biology and Biochemistry, University of California,
Irvine: RNA synthesis during the cell cycle of S. cerevisiae.
N. J. Pearson and J. E. Haber, Department of Biology, Brandeis University, Waltham, Massachusetts: Changes in
the regulation of ribosome synthesis in growing and sporulating yeast.
C. Gorenstein and J. R. Warner, Departments of Biochemistry and Cell Biology, Albert Einstein College of
Medicine, Bronx, New York: Aspects of the metabolism of ribosomal proteins.
C. Gorenstein and J. R. Warner, Departments of Biochemistry and Cell Biology, Albert Einstein College of
Medicine, Bronx, New York: The synthesis of mRNA for ribosomal proteins may depend on concurrent
synthesis of ribosomal RNA.
D. Ursic, B. Littlewood, and J. Davies, Department of Biochemistry, University of Wisconsin, Madison: A
cold-sensitive mutant of S. cerevisiae defective in ribosome processing.
J. L. Bennetzen, L. D. Schultz, and B. D. Hall, Departments of Biochemistry and Genetics, University of
Washington. Seattle: Nuclear function of yeast RNA polymerase III.
S. G. Oliver, J. R. Ludwig II, and C. S. McLaughlin, Department of Molecular Biology and Biochemistry,
University of California, Irvine: Separate controls on tRNA and rRNA synthesis in yeast.
A. K. Hopper and F. Banks, Department of Microbiology, University of Massachusetts Medical Center,
Worcester: Mutants of yeast which are conditionally defective in the synthesis of yeast tRNA.
J. W. Gorman, J. D. Young, H. M. Laten, F. H. Webb, and R. M. Bock, Laboratory of Molecular Biology,
University of Wisconsin, Madison: Isolation and characterization of eight recessive antisuppressors in S.
cerevisiae.
M. R. Culbertson and G. R. Fink, Department of Genetics, Development, and Physiology, Cornell University,
Ithaca, New York: Frameshift suppression.
FRIDAY AFTERNOON, August 19
Session 3: Poster session
B. G. Adams and I. M. Gladstone, Department of Microbiology and Immunology, University of Washington,
Seattle: Genetic basis for the sugar-negative phenotype.
96
B. B. Chattoo, F. Sherman, and M. Ogur, Department of Radiation Biology and Biophysics, University of
Rochester Medical School, New York, and Department of Microbiology, Southern Illinois University,
Carbondale: A system for selecting lys2 mutants.
D. Fraenkel, Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Mas-
sachusetts: Glycolysis mutants of S. cerevisiae.
L. R. Friedman and H. M. Sobell, Department of Chemistry, University of Rochester, New York: Evidence for
symmetric and asymmetric hybrid DNA formation during genetic recombination-Unselected tetrad analy-
sis in S. cerevisiae.
F. Karst and F. Lacroute, Laboratoire de Genetique Physiologique, Institut de Biologie Moleculaire et Cellulaire
du CNRS, Strasbourg, France: Yeast mutants in the early part of the sterol pathway.
C. W. Lawrence and R. B. Christensen, Department of Radiation Biology and Biophysics, University of
Rochester Medical Center, New York: Potential pyrimidine dimer sites and UV mutagenesis.
W. J. Colonna and P. T. Magee, Yale University Medical School, New Haven, Connecticut: Glycogen degrading
enzymes: Sporulation-specific gene products in S. cerevisiae.
C. A. Michels and S. Dhar, Department of Biology, Queens College, City University of New York, New York:
Catabolite-repression-resistant mutants in S. carlesbergensis.
A. P. Mitchell and E. W. Jones, Department of Biological Sciences, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Protease-B mutants of S. cerevisiae.
C. Moore, Department of Biology, University of Rochester, New York: Comparisons of growth inhibition by
bleomycin and phleomycin among normal and radiation-sensitive strains of S. cerevisiae.
B. Ono, J. W. Stewart, and F. Sherman, Department of Radiation Biology and Biophysics, University of
Rochester Medical School, New York: Serine-inserting UAA suppressors of yeast.
L. Prakash, Department of Radiation Biology and Biophysics, University of Rochester School of Medicine, New
York: Defective excision of pyrimidine dimers in nuclear DNA in rad7, rad14, and rad17 mutants of S.
cerevisiae.
S. Prakash, Department of Biology, University of Rochester, New York: Characterization of mutants of S.
cerevisae sensitive to the alkylating agent methyl methane sulfonate.
L. Skogerson and U. Somasundarsan, Department of Biochemistry, The Medical College of Wisconsin, Mil-
waukee: Interaction of cycloheximide with yeast cytoplasmic ribosomes.
B. F. Sloat and J. R. Pringle, Division of Biological Sciences, University of Michigan, Ann Arbor: Studies of a yeast
mutant defective in bud formation.
J. S. Swedes and C. S. McLaughlin, Department of Molecular Biology and Biochemistry, University of California,
Irvine: Regulation of protein synthesis during energy limitation in S. cerevisiae.
FRIDAY EVENING, August 19
Session 4
Chairperson: C. S. McLaughlin, University of California, Irvine
H. M. Fried and G. R. Fink, Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca,
New York: Electron microscope heteroduplex analysis of yeast killer double-stranded RNA plasmids.
J. Bruenn and W. Kane, Division of Cell and Molecular Biology, State University of New York, Buffalo: Repeated
sequences and sequence diversity in yeast double-stranded RNAs.
S. R. de Kloet, G. I. Chang, and J. L. Lilquist, Institute of Molecular Biophysics, Florida State University,
Tallahassee: Some properties of double-stranded RNA of yeast.
K. A. Bostian,* J. E. Hopper, L. B. Rowe, and D. J. Tipper, *University of Massachusetts Medical Center,
Worcester; Brandeis University, Waltham, Massachusetts: Translational analysis of the double-stranded
RNA genome of the killer-associated-viruslike particles of S. cerevisiae.
R. B. Wickner, M. J. Leibowitz, and A. Toh-E, Laboratory of Biochemical Pharmacology, NIAMDD, National
Institutes of Health, Bethesda, Maryland: Bypass of chromosomal genes normally needed for killer-virus
replication.
C. Denis, J. Hopper, R. Menard, and T. Young, Department of Biochemistry, University of Washington, Seattle:
Preparative polyacrylamide gel electrophoresis of yeast mRNA.
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R. D. Water, J. R. Pringle, and L. J. Kleinsmith, Division of Biological Sciences, University of Michigan, Ann
Arbor: Identification of yeast messenger RNAs coding for the synthesis of tubulin and actinlike proteins.
J. E. Hopper and L. B. Rowe, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: Molecular
expression and regulation of the galactose gene cluster-mRNA sizes and gaI4 control of inducible mRNAs.
C. E. Sripati and J. R. Warner*, Institut de Biologie Physicochimique, Paris, France;* Department of Biochemistry
and Cell Biology, Albert Einstein College of Medicine, Bronx, New York: Kinetics of formation and decay of
yeast messenger RNA.
P. Neiderberger, G. Miozzari, and R. Hater, Institute of Microbiology, Federal Institute of Technology, Zurich,
Switzerland: Growth behavior and RNA synthesis in mutants of S. cerevisiae defective in the general control
of amino acid biosynthesis.
H. C. Kelker and A. 0. Pogo, Laboratory of Cell Biology, The New York Blood Center, New York: Effect of amino
acid starvation and addition of cycloheximide on the rate of [3H]uridine incorporation into yeast RNA
species.
C. A. Saunders, S. J. Sogin, and H. 0. Halvorson, Rosenstiel Center, Brandeis University, Waltham, Mas-
sachusetts: Cytoplasmic poly(A) in S. cerevisiae.
J. F. Harper and P. T. Magee, Yale University Medical School, New Haven, Connecticut: Characteristics of
poly(A)-associated RNA in ascospores of S. cerevisiae.
SATURDAY MORNING, August 20
Session 5
Chairperson: D. Botstein, Massachusetts Institute of Technology, Cambridge
J. R. Cameron and R. W. Davis, Department of Biochemistry, Stanford University School of Medicine,
California: Cloning and characterization of S. cerevisiae tyrosine tRNA genes.
M. V. Olson, H. M. Goodman, and B. D. Hall, Department of Genetics, University of Washington, Seattle:
Identification, cloning, and DNA sequencing of the sup4 gene from S. cerevisiae.
G. Page, M. Olson, and B. D. Hall, Department of Genetics, University of Washington, Seattle: Isolation and
characterization of tRNA"r genes from S. cerevisiae.
K. Nath, P. Holmans, and A. P. Bolton, Department of Biochemistry, University of Texas Health Science Center,
Dallas: Organization of ribosomal genes on chromosomal DNA.
J. H. Cramer, J. T. Barnitz, F. W. Farrelly, D. D. Womble, and R. H. Rownd, Laboratory of Molecular Biology and
Department of Biochemistry, University of Wisconsin, Madison: Organization of ribosomal DNA in yeast.
P. Philippsen, R. A. Kramer, J. Ferguson, M. Thomas, J. R. Cameron, and R. W. Davis, Department of
Biochemistry, Stanford University School of Medicine, California: The gene cluster for ribosomal RNA in S.
cerevisiae.
P. Valenzuela, A. Venegas, G. I. Bell, and W. J. Rutter, Department of Biochemistry and Biophysics, University of
California, San Francisco: DNA sequence studies of the yeast ribosomal RNA genes.
T. Petes,* I. Broach,t P. Wensink,t L. M. Hereford,* G. R. Fink,§ and D. Botstein,* Department of Biology,
Massachusetts Institute of Technology, Cambridge, tCold Spring Harbor Laboratory, New York; *Depart-
ment of Biology and Rosenstiel Center, Brandeis University, Waltham, Massachusetts; §Department of
Genetics, Cornell University, Ithaca, New York: Isolation and analysis of recombinant DNA molecules
containing yeast DNA.
D. Petes and D. Botstein, Department of Biology, Massachusetts Institute of Technology, Cambridge: Simple
Mendelian inheritance of the reiterated ribosomal DNA genes of yeast.
P. E. Berg, A. Lewin, T. Christianson, A. Lustig, and M. Rabinowitz, Departments of Medicine, Biology, and
Biochemistry, University of Chicago, and the Franklin McLean Research Institute, Chicago, Illinois: Cloning
of yeast mitochondrial DNA in E. coli.
C. P. Hollenberg and H. D. Royer, Max-Planck-Institut fOr Biologie, Tubingen, West Germany: Expression of
cloned S. cerevisiae 2-gm DNA in E. coli minicells."
G. D. Lauer and L. M. Hereford, Department of Biology and Rosenstiel Center, Brandeis University, Waltham,
Massachusetts: Isolation of S. cerevisiae histone genes cloned in pMB9.
T. St. John and R. W. Davis, Department of Biochemistry, Stanford University School of Medicine, California:
Isolation of yeast DNA fragments showing regulated gene expression.
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SATURDAY AFTERNOON, August 20
Session 6: Poster session
J. Adams and E. D. Rothman, Division of Biological Sciences and Department of Statistics, University of
Michigan, Ann Arbor: The demography of yeast populations.
H. N. Anathaswamy and R. K. Mortimer, Division of Medical Phys'ics, University of California, Berkeley:
Isolation and analysis of X-ray-sensitive mutants.
K. D. Atkinson, T. F. Donahue, A. I. Kolat, and S. A. Henry, Department of Genetics, Albert Einstein College of
Medicine, Bronx, New York: Physiology of inositol-less death in yeast inositol synthetase mutants.
A. P. Bolton, Department of Biochemistry, University of Texas Health Science Center, Dallas: Characterization
of ilvl constitutive mutants.
C. Greer and R. Schekman, Department of Biochemistry, University of California, Berke ly: Yeast actin.
R. A. Hackel and N. A. Khan,* Graduate Department of Biochemistry, Brandeis University, Waltham, Mas-
sachusetts; *Department of Biology, Brooklyn College, New York: Isolation and characterization of mutants
conferring invertase hyperproduction in strain EK-6B of S. cerevisiae carrying the suc3 gene.
D. P. Morrison, P. J. Hastings, and S.-K. Quah, Department of Genetics, University of Alberta, Edmonton,
Canada: The effect of mating type on the expression of mutator mutations in diploids.
R. H. Haynes, F. Eckardt, and S.-J. Teh, Department of Biology, York University, Downsview, Ontario, Canada:
Mathematical analysis of mutation induction kinetics in Rad wild-type yeast.
M. Bieri, J. Kolodynski, and T. M. Lachowicz, Institute of Microbiology, Wroclaw University, Poland: Respira-
tory mutation and galactose metabolism in yeast S. cerevisiae.
N. E. Trimble and J. G. Little, Department of Biology, York University, Downsview, Ontario, Canada: Thymidy-
late starvation sensitizes yeast cells to ultraviolet light.
V. L. MacKay and G. P. Livi, Waksman Institute of Microbiology, Rutgers University, Piscataway, New Jersey:
Influence of the mating-type locus on MMS survival in diploid yeast cells.
J. H. McCusker and J. E. Haber, Rosenstiel Center, Brandeis University, Waltham, Massachusetts: Characteriza-
tion of mutant causing nonrandom mitotic chromosome loss.
D. Mowshowitz, Department of Biology Sciences, Columbia University, New York: Control of a glucosidase
levels in yeast strains carrying different mal genes.
R. J. Planta, R. C. Brand, and J. Klootwijk, Biochemisch Laboratorium, Vrije Universiteit, Amsterdam, The
Netherlands: Processing of ribosomal precursor RNA in yeast.
S.-K. Quah, R. C. Von Borstel, and P. J. Hastings, Department of Genetics, University of Alberta, Edmonton,
Canada: Antimutators in yeast.
G. H. Rank and R. P. Van Hoeven,* Department of Biology, University of Saskatchewan, Canada; *Division of
Cell Biology, The Netherlands Cancer Institute, Amsterdam: Separation of high- and low-viscosity vesicles
by aggregation at pH 4.
R. Snow, Department of Genetics, University of California, Davis: Genetic evidence for complementation
between nonhomologous proteins in S. cerevisiae.
E. F. Walton, B. L. A. Carter, and J. R. Pringle,* Department of Genetics, University of Dublin, Ireland; *Division
of Biological Sciences, University of Michigan, Ann Arbor: An enrichment method for temperature-sensitive
mutants of yeast.
SATURDAY EVENING, August 20
Session 7
Chairperson: L. Hartwell, University of Washington, Seattle, Washington
D. Stinchcomb and R. W. Davis, Department of Biochemistry, Stanford University School of Medicine,
California: Yeast gene expression during lytic infection of E. coli by X-yeast hybrids.
K. Struhl and R. W. Davis, Department of Biochemistry, Stanford University School of Medicine, California:
Genetic expression of yeast DNA in E. coli-isolation and mapping of the structural gene for IGP dehydratase
(his 3).
M.-L. Bach,*-1- T. D. Petes,f F. Lacroute,* and D. Botstein,t *Institut de Biologie Moleculaire et Cellulaire du
CNRS, Strasbourg, France;t Department of Biology, Massachusetts Institute of Technology, Cambridge:
Cloning of the yeast ura3 gene in E. coli.
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J. I. Stiles, J. W. Szostak,* R. Wu,* and F. Sherman, Department of Radiation Biology and Biophysics, University
of Rochester School of Medicine, New York;* Department of Biochemistry, Molecular and Cell Biology,
Cornell University, Ithaca, New York: Detection and restriction analysis of the iso-1-cytochrome c gene.
J. W. Szostak, J. I. Stiles, F. Sherman, and R. Wu, Department of Biochemistry, Molecular and Cell Biology,
Cornell University, Ithaca, New York, and Department of Radiation Biology and Biophysics, University of
Rochester, New York: Sequence analysis of the 5' noncoding region of yeast iso-l-cytochrome c mRNA.
D. M. Livingston, Department of Genetrics, University of Washington, Seattle: Control of S. cerevisae 2-gm
DNA replication by cell-division-cycle genes that control nuclear DNA replication.
U. Wintersberger, Institute for Cancer Research, University of Vienna, Austria: DNA synthesis in isolated yeast
nuclei.
K. Nasmyth, Department of Zoology, University of Edinburgh, Scotland: DNA ligase mutants in fission yeast.
G. Viehauser, R. Grtin, and E. Wintersberger, Physiologische Chemisches Institut, University of Wilirzburg, West
Germany: Yeast histones-Properties and synthesis in the cell cycle.
B. Shilo and G. Simchen, Department of Genetics, The Hebrew University, Jerusalem, Israel: Environmental
regulation of cell-cycle initiation in S. cerevisiae.
S. I. Reed and T. Naujack, Department of Genetics, University of Washington, Seattle: Isolation and characteri-
zation of cell-cycle "start" mutants of S. cerevisiae.
T. J. Zamb and R. Roth, Biology Department, Illinois Institute of Technology, Chicago: The timing of early
meiotic events in yeast.
M. A. Resnick, D. H. Williamson, and G. Brunborg,* National Institute for Medical Research, Mill Hill, London,
England; *Institute of General Genetics, University of Oslo, Blindern, Norway: Cell-cycle-dependent
variations in the repair of DNA double-strand breaks.
SUNDAY MORNING, August 21
Session 8
Chairperson: R. Needleman, Albert Einstein College of Medicine, Bronx, New York
R. Morimoto, A. Lewin, S. Merten, and M. Rabinowitz, Departments of Medicine, Biochemistry, and Biology,
University of Chicago, and the Franklin McLean Research Institute, Chicago, Illinois: Mapping of yeast
mitochondrial genes and the organization of petite mitochondria! DNA.
D. Hanson, D. H. Miller, and H. R. Mahler, Department of Chemistry, Indiana University, Bloomington: Peptide
mapping of mitochondria! translation products of S. cerevisiae.
G. Faye and F. Sor, Section Biologie, Fondation Curie-Institut du Radium, Orsay, France: Analysis of mitochond-
ria! ribosomal proteins of S. cerevisiae.
F. Cabral, M. Solioz, and G. Schatz, Department of Biochemistry, Biozentrum, University of Basel, Switzerland:
Identification of the structural gene for yeast cytochrome oxidase subunit II on mitochondrial DNA.
D. Levens, R. Morimoto, and M. Rabinowitz, Departments of Medicine, Biochemistry, and Biology, University
of Chicago, and the Franklin McLean Research Institute, Chicago, Illinois: Transcription complex and
partially purified RNA polymerase from yeast mitochondria.
I. Z. Ades and R. A. Butow, Department of Biochemistry, University of Texas Health Science Center, Dallas:
Studies on the mechanism of transport of cytoplasmically synthesized proteins into mitochondria of yeast.
R. D. Vincent, D. M. Ellis, and P. S. Perlman, Developmental Biology Program and Department of Genetics,
Ohio State University, Columbus: Physical mapping of the structural gene for a mitochondrial protein, varl .
R. L. Strausberg and R. A. Butow, Department of Biochemistry, University of Texas Health Science Center,
Dallas: Expression of petite mitochondrial DNA in vivo-Zygotic gene rescue.
E. D. Zanders and R. A. Butow, Department of Biochemistry, University of Texas Health Science Center, Dallas:
Molecular basis for the polymorphism of the mitochondrial gene var 1 .
D. H. Miller, T. Bilinski, D. Hanson, H. R. Mahler, P. S. Perlman,* and D. M. Ellis,* Department of Chemistry,
Indiana University, Bloomington; *Department of Genetics, Ohio State University, Columbus: The charac-
terization of mitochondria! function in mit- mutants of S. cerevisiae.
A. Singh, T. L. Mason, and R. A. Zimmermann, Department of Biochemistry, University of Massachusetts,
Amherst: A cold-sensitive cytoplasmic mutant of S. cerevisiae with defective synthesis of the 50S subunit of
mitochondrial ribosomes.
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B. J. Stevens, Laboratoire de Biologie Cellulaire, University de Paris-Sud, Orsay, France, and Department of
Biology, University of Chicago, Illinois: Mitochondrial form and numbers during sporulation.
SUNDAY AFTERNOON, August 21
Session 9
Chairperson: P. S. Perlman, Ohio State University, Columbus
R. Needleman, J. Cohen, and J. Marmur, Albert Einstein College of Medicine, Bronx, New York: Rhodamine 6G
resistance-A new yeast mitochondria! gene in the omega region.
B. Dujon, Centre de Genetique Moleculaire, Centre National de la Recherche Scientifique, Gif-sur-Yvette,
France: Approaches to the mechanisms of genetic recombination between mitochondria! genes in S.
cerevisiae.
W. Band low, Genetics Institute, University of Munich, West Germany: Control of gene expression by a
mitochondria! gene product of mitochondrial and extramitochondrial enzymes.
E. P. Sena, Department of Biology, Case Western Reserve University, Cleveland, Ohio: Molecular and genetic
studies on mitochondrial DNA inheritance during mating in S. cerevisiae.
M. F. Waxman, J. A. Knight, and P. S. Perlman, Department of Genetics, Ohio State University, Columbus:
Nuclear suppressors of mitochondrial drug resistance in bakers' yeast.
B. J. Barclay and J. G. Little, Department of Biology, York University, Downsview, Ontario, Canada: Induction of
mutations in the mitochondria] genome of yeast by thymidylate starvation.
S. C. Nixon and E. Moustacchi,* Department of Biochemistry, University of Alabama, Birmingham; *Fondation
Curie-Institut du Radium, Orsay, France: Degradation of yeast mitochondrial DNA during post-UV dark
liquid holding recovery of the petite mutation.
J. Leff and R. Eccleshall, Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York:
Replication of dBrUMP-substituted mitochondria! DNA in yeast.
C. S. Newton and R. D. Ludescher, Department of Zoology, University of Iowa, Iowa City: Production of petites
by strains of yeast defective in DNA synthesis.
B. Y. Rubin and J. Blamire, Department of Biology, Brooklyn College, New York: Analysis of a mutant
conditionally deficient in mitochondrial DNA metabolism.
H. S. Cross and H. Ruis, Institut fdr Allgemeine Biochemie der Universitat Wien and Ludwig-Boltzmann-
Forschungsstelle fur Biochemie, Vienna, Austria: Catalase A deficiency of [rho]-, [mitt, and nuclear petite
mutants of S cerevisiae.
J. R. Mattoon, D. R. Malamud, A. Brunner, G. Braz, and A. Panek, Department of Physiological Chemistry, Johns
Hopkins University School of Medicine, Baltimore, Maryland, and Department of Biochemistry, Institute of
Chemistry, Federal University of Rio de Janeiro, Brazil: Chemical and genetic modification of delta-amino-
levulinic acid metabolism in yeast.
MONDAY MORNING, August 22
Session 10
Chairperson: R. R. Mortimer, University of California, Berkeley
S. Fogel, R. Mortimer, F. Tavares, and K. Lusnak, Departments of Genetics and Medical Physics, University of
California, Berkeley: Gene conversion in yeast-Updated.
D. Campbell and C. Methot, Department of Biology, Holy Cross College, Worcester, Massachusetts: Cold-
sensitive gene-conversion-deficient mutants of yeast.
J. F. Lemontt, Biology Division, Oak Ridge National Laboratory, Tennessee: Mutants of S. cerevisiae resistant to
ultraviolet forward mutation-Defective in fixation or expression of mutagenesis?
V. L. MacKay and J. F. Lemontt,* Waksman Institute of Microbiology, Rutgers University, Piscataway, New
Jersey; *Biology Division, Oak Ridge National Laboratory, Tennessee: Pleiotropic mutations which affect
mating and seemingly unrelated processes.
R. Rothstein and F. Sherman,* Department of Biochemistry, Cornell University, Ithaca, New York; *Department
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of Radiation Biology and Biophysics, University of Rochester School of Medicine, New York: Genetic studies
on mutations which affect iso-2-cytochrome c in yeast.
A. Toh-E and Y. Oshima, Department of Fermentation Technology, Faculty of Engineering, Osaka University,
Japan: Genetic control of acid phosphatase synthesis.
F. Messenguy and T. G. Cooper,* Institut de Recherches du CERIA, Brussels, Belgium; *Department of Life
Sciences, University of Pittsburgh, Pennsylvania: Evidence that the specific and general control of ornithine
carbamoyltransferase production occurs at the level of transcription in S. cerevisiae.
R. Bigelis, J. Keesey,* and G. R. Fink,* Cold Spring Harbor Laboratory, New York; *Section of Genetics,
Development, and Physiology, Cornell University, Ithaca, New York: The his4 multifunctional protein of
yeast.
T. Cooper, University of Pittsburgh, Pennsylvania: Pleiotropic mutants defective in production of the inducible
nitrogen catabolic enzymes.
E. W. Jones and P. G. Szauter, Department of Biological Sciences, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Biological properties of pep mutants.
M. J. Miller, J. Bossinger, C. Herring, N. H. Xuong, and E. P. Geiduschek, Departments of Biology, Physics, and
Chemistry, University of California, San Diego: Quantitation of yeast proteins separated by two-dimensional
gel electrophoresis.
B. Byers, K. Shriver, and G. Goetsch, Departments of Genetics and Biochemistry, University of Washington,
Seattle: Role of yeast spindle-pole bodies in the initiation of microtubule polymerization.
H. Greer and G. R. Fink, Department of Genetics, Development, and Physiology, Cornell University, Ithaca,
New York: Unstable genetic elements carrying the his4 region.
BACTERIOPHAGE
arranged by
AHMAD I. BUKHARI, Cold Spring H.4rbor Laboratory
THOMAS R. BROKER, Cold Spring Harbor Laboratory
246 participants
TUESDAY EVENING, August 23
Session 1: Lambda-Integrative recombination and replication
R. Hoess and A. Landy, Division of Biology and Medicine, Brown University, Providence, Rhode Island:
Nucleotide sequence of the attachment site in Xb2.
J. Engler and R.B. Inman, Department of Biochemistry and Biophysics Laboratory, University of Wisconsin,
Madison: An electron microscope study of site-specific recombination in phage X.
L. Enquist, R. Weisberg, and H. Nash, National Institutes of Health and NIMH, Bethesda, Maryland: Is a
cross-strand exchange an intermediate in coliphage Xint-promoted recombination?
L. Enquist and R. Weisberg, National Institutes of Health, Bethesda, Maryland: More int protein is required for
integrative than for excisive recombination of phage X.
Y. Kikuchi and H. Nash, NIMH, National Institutes of Health, Bethesda, Maryland: Some properties of purified
int protein.
A. Kikuchi and R. Weisberg, NICHHD, National Institutes of Health, Bethesda, Maryland: New mutants
affecting site-specific recombination.
H. Nash, A. Kikuchi,* R. Weisberg,* H. Miller,t D.I. Friedman,t NIMH and *NICHHD, National Institutes of
Health, Bethesda, Maryland; +University of Michigan, Ann Arbor: Biochemical studies of E. coli mutants
defective in X integration.
H.I. Miller and D.I. Friedman, Department of Microbiology, University of Michigan, Ann Arbor: Genetics of E.
coli phage integration host factors.
J.B. Hays and S. Balmer, Department of Chemistry, University of Maryland, Catonsville: Recombination of
bacteriophage X without phage gene expression.
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M.E. Furth, McArdle Laboratory, University of Wisconsin, Madison: Elements of the A replication system.
B.G. Williams, M.E. Furth,* K.E. Kruger, and F.R. Blattner, Department of Genetics and *McArdle Laboratory,
University of Wisconsin, Madison: Oops-A deletion of oop RNA which supports replication of phage X.
D.D. Moore, K. Denniston-Thompson, K.E. Kruger, M.E. Furth,* and F.R. Blattner, Department of Genetics and
*McArdle Laboratory, University of Wisconsin, Madison: DNA sequence of the amino terminus of the 0
gene of X.
K. Denniston-Thompson, D.D. Moore, K.E. Kruger, M.E. Furth,* and F.R. Blattner, Department of Genetics and
*McArdle Laboratory, University of Wisconsin, Madison: DNA sequence of the A origin.
D.L. Daniels and F.R. Blattner, Department of Genetics, University of Wisconsin, Madison: Construction of A
phage carrying a nonessential late promoter.
WEDNESDAY MORNING, August 24
Session 2A: Lambda--Regulatory systems
K. Ca lame and G. lh ler,* Department of Biochemistry, University of Pittsburgh School of Medicine, Pennsyl-
vania; *Department of Medical Biochemistry, College of Medicine, Texas A & M University,College Station:
Physical location of ribosome binding sites on A DNA.
M. Belfort and A. Oppenheim, Department of Microbiological Chemistry, Hebrew University-Hadassah Medi-
cal School, Jerusalem, Israel: Analysis of phage A functions in mutant E. coli hosts.
G.N. Gussin, T. Nelson, and D.L. Wulff,* Department of Zoology, University of Iowa, Iowa City; *Department of
Molecular Biology and Biochemistry, University of California, Irvine: Formation of stable lysogens by Aprm
116cinl phages.
G. Guarneros and T. Hernandez, Department of Genetics, Centro de Investigacion del IPN, Mexico: A new class
of phage A cll- pseudorevertants.
M.G. Beher and D.L. Wulff, Department of Molecular Biology and Biochemistry, University of California,
Irvine: Effects of the cin1 and cnc1 mutations on P gene expression in phage X.
K.Z. McCullough and G.R. Smith, Institute of Molecular Biology, University of Oregon, Eugene: Lambda
mutants affecting the control of repressor synthesis.
D.I. Friedman, P.K. Tomich, and P.R. Holton, Department of Microbiology, University of Michigan, Ann Arbor:
Molecular structure of A altA phage exhibiting alternating immunities.
E. Rosen, K.M. Yen, and G. Gussin, Department of Zoology, University of Iowa, Iowa City: Characterization of
prm- mutations in bacteriophage X.
A. Bailone and R. Devoret, Radiobiologie Cellulaire, Laboratoire d'Enzymologie, Centre National de la
Recherche Scientifique, Gif-sur-Yvette, France: Isolation of ultravirulent mutants of phage X.
N.E. Melechen, G. Go, and H.A. Lozeron, Departments of Microbiology and Biochemistry, St. Louis University
School of Medicine, Missouri: Thymineless and spontaneous induction of A lysogens are affected by the
levels of cl repressor.
M. Lieb, Department of Microbiology, University of Southern California School of Medicine, Los Angeles:
Heat-sensitive A repressor retains partial activity during induction.
J.W. Roberts, C.W. Roberts, and N.L. Craig, Department of Biochemistry, Cornell University, Ithaca, New York:
Biochemical mechanism of A induction.
A. Bailone, A. Levine, and R. Devoret, Radiobiologie Cellulaire, Laboratoire d'Enzymologie, Centre National de
la Recherche Scientifique, Gif-sur-Yvette, France: Inactivation of the A repressor in overproducing cells of E.
coli K12.
C.L. Smith and M. Oishi, Department of Genetics, Public Health Research Institute of the City of New York:
DNA degradation and temperate phage repressor inactivation.
M.G. Schechtman and J.W. Roberts, Department of Biochemistry, Molecular and Cell Biology, Cornell Univer-
sity, Ithaca, New York: Activity of late gene regulators of A and .1)82.
Y. Takeda and H. Echols, Department of Molecular Biology, University of California, Berkeley: In vitro studies of
the A cro gene product 1111.
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WEDNESDAY AFTERNOON, August 24
Session 2B: Lambda-N gene function
M.C. Gawron and J.R. Christensen, Department of Microbiology, University of Rochester, New York: "Early"
exclusion of T1 requires X N gene product and host factors involved in N gene expression.
D.A. Wilder and H.A. Lozeron, Department of Biochemistry, St Louis University School of Medicine, Missouri:
Processing and chemical decay of the N-dependent RNA transcript of bacteriophage X.
M. Gottesman, S. Adhya, A. Das, and D. Court, Laboratory of Molecular Biology, NCI, National Institutes of
Health, Bethesda, Maryland: Control of transcription termination in E. coli.
C. Dambly, M. Gottesman,* and S. Adhya,* Department de Biologie Moleculaire, University Libre de Bruxelles,
Rhode-St.-Genese, Belgium; *NCI, National Institutes of Health, Bethesda, Maryland: Control of gene
expression in the X (cro-c11-0-P-Q) operon.
D. Court, D. Wulff,* C. Brady, and M. Rosenberg, Laboratory of Molecular Biology, NCI, National Institutes of
Health, Bethesda, Maryland; *Department of Molecular Biology and Biochemistry, University of California,
Irvine: Transcription termination in phage X at tRl.
M. Rosenberg, D. Court, C. Brady, J.S. Salstrom,* and W. Szybalski,* Laboratory of Molecular Biology, NCI,
National Institutes of Health, Bethesda, Maryland; *McArdle Laboratory, University of Wisconsin, Madison:
The nucleotide sequence for the N recognition sites of col iphage X.
J. Shaw and M. Pearson, Department of Medical Genetics, University of Toronto, Ontario, Canada: The N
protein of bacteriophage X and its synthesis in host mutants defective in N-gene expression.
N.C. Franklin and G.N. Bennett, Department of Biological Sciences, Stanford University, California: DNA
sequencing of the N gene of bacteriophage X.
WEDNESDAY EVENING, August 24
Session 3: P1 and Mu
S. Austin, N. Sternberg, L. Rosner,* and M. Yarmolinsky, Basic Research Program, Frederick Cancer Research
Center, Frederick, Maryland; *NIAMDD, National Institutes of Health, Bethesda, Maryland: Miniplasmids of
bacteriophage P1.
N. Sternberg, M. Yarmolinsky, and S. Austin, Basic Research Program, Frederick Cancer Research Center,
Frederick, Maryland: The control of P1 -P7 immunity-A model for ant action.
N. Sternberg, Basic Research Program, Frederick Cancer Research Center, Frederick, Maryland: An initial
characterization of X-P1 hybrids.
J.R. Scott, R.H. Chesney, and D. Vapnek,* Department of Microbiology, Emory University, Atlanta, Georgia;
*Department of Microbiology, University of Georgia. Athens: Integrative suppression of E. coli dna Ats by
phages P1 and P7.
R.J. Mural and D. Vapnek, Program in Genetics and Departments of Zoology and Microbiology, University of
Georgia, Athens: Transcription of bacteriophage P1.
R. Kahmann and D. Kamp, Cold Spring Harbor Laboratory, New York: Characterization of the Mu modification
function (mom).
D. Kamp and R. Kahmann, Cold Spring Harbor Laboratory, New York: Inversion of the G segment of
bacteriophage Mu is a site-specific recombination event.
D. Kamp, J.M. Scott, R. Kahmann, and L.T. Chow, Cold Spring Harbor Laboratory, New York: Inversion of the G
segment of phage Mu by phage P1.
L.T. Chow, D. Kamp, and R. Kahmann, Cold Spring Harbor Laboratory, New York: Identificjon of two
insertion sequences in nondefective Mu substitution mutants.
K. O'Day, D. Schultz, and M. Howe, Department of Bacteriology, University of Wisconsin, Madison: A search
for integration-deficient mutants of bacteriophage Mu.
K. O'Day, D. Schultz, W. Ericsen, L. Rawluk, and M. Howe, Department of Bacteriology, University of
Wisconsin, Madison: Correction and refinement of the genetic map of bacteriophage Mu.
G.S. Gill, R.A. Hull, and R. Curtiss III, Department of Microbiology, University of Alabama, Birmingham:
Physical and genetic characterization of the DNA of a Mu-like phage D108.
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M. Magazin and B. Al let, Departement de Biologie Moleculaire, University de Geneve, Switzerland: In vitro
synthesis of Mu proteins.
H. Khatoon and A.I. Bukhari, Cold Spring Harbor Laboratory, New York: Turning on genes with Mu.
B.T. Waggoner and M.L. Pato, National Jewish Hospital and Research Center and University of Colorado
Medical Center, Denver: Early replication of Mu prophage DNA.
L. Ambrosio, A.I. Bukhari, F. de Bruijn, M.S. Du Bow, and E. Ljungquist, Cold Spring Harbor Laboratory, New
York: Studies on Mu DNA replication and integration.
THURSDAY MORNING, August 25
Session 4: Genetics/Transcription
P. Youderian and J. King, Massachusetts Institute of Technology, Cambridge: Isolation and characterization of
080 amber mutants.
B.M. Scher, M.F. Law, and A.J. Garro, Department of Microbiology, Mt. Sinai School of Medicine, New York:
Structural analysis of the Bacillus phage 0105 genome.
J.M. Cregg and C.R. Stewart, Department of Biology, Rice University, Houston, Texas: Terminal redundancy of
"high frequency of recombination" cistrons of B. subtilis phage SPO1.
G.M. Weinstock and D. Botstein, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Genetic and physical studies of bacteriophage P22 using translocatable drug-resistance elements.
S. Hilliker, M. Gottesman, and S. Adhya, Laboratory of Molecular Biology, NCI, National Institutes of Health,
Bethesda, Maryland: The role of Salmonella phage P22 gene-24 product in E. coli.
M.M. Susskind, Department of Microbiology, University of Massachusetts Medical School, Worcester: A new
regulatory gene of phage P22.
H.H. Prell, Department of Molecular Genetics, Gesellschaft fur Strahlem Forschung, Goettingen, West Ger-
many: The role of ant product of Salmonella phage P22 in transactivation of prophages PX1 and L.
L. Souza, J. Geisselsoder, A. Hopkins, and R. Calendar, Molecular Biology Department, University of California,
Berkeley: Physical mapping of the satellite phage P4 genome.
J.D. Harris and R. Calendar, Molecular Biology Department, University of California, Berkeley: Transcriptional
regulation of satellite phage P4 gene expression.
C. Talkington, G. Lee, N. Hannett, and J. Pero, The Biological Laboratories, Harvard University, Cambridge,
Massachusetts: Restriction-fragment analysis of the transcriptional specificity of phage SPO1- modified RNA
polymerase.
R. Zivin, S.C. Falco, K. Vanderlaan, J. Stambouly, and L.B. Rothman-Denes, Department of Biophysics and
Theoretical Biology, University of Chicago, Illinois. Analysis of bacteriophage N4 transcription.
B.A. Hesselbach and D. Nakada, Department of Biochemistry, University of Pittsburgh School of Medicine,
Pennsylvania: I protein-T7 phage gene-2-coded inhibitor of E. coli RNA polymerase.
I.I. Martinez, J.D. Harris, and R. Calendar, Molecular Biology Department, University of California, Berkeley:
The map location of an E. coli gene affecting the sigma subunit of DNA-dependent RNA polymerase.
Informal poster session
THURSDAY AFTERNOON, August 25
THURSDAY EVENING, August 25
Session 5: Morphogenesis: P22 and lambda
E. Jackson, C. Andres, and F. Laski, Department of Microbiology, University of Michigan, Ann Arbor:
Mutants which alter specificity of P22 DNA packaging.
A.R. Poteete and D. Botstein, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Purification of P22 gene-2 product.
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P.B. Berget and A.R. Poteete, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Purification and properties of Salmonella phage P22 baseplate protein.
S. Casjens, Microbiology Department, University of Utah Medical Center, Salt Lake City: Control of P22
gene-9 protein synthesis.
J.L. Bryant, Jr. and J. King, Department of Biology, Massachusetts Institute of Technology, Cambridge:
9-Aminoacridine-sensitized photoinactivation of bacteriophage P22.
T. Hohn and B. Hohn, Department of Microbiology, Biozentrum, University of Basel, Switzerland: A protease
specific for cutting bacteriophage A scaffold protein.
H. Murialdo, Department of Medical Genetics, University of Toronto, Ontario, Canada: Early intermediates
in A prohead assembly.
H. Murialdo and A. Becker, Department of Medical Genetics, University of Toronto, Ontario, Canada:
Genetic analysis of A prohead assembly in vitro.
S. Benchimol, H. Murialdo, M. Gold, and A. Becker, Department of Medical Genetics, University of Toronto,
Ontario, Canada: Studies of the A Fl gene product in DNA packaging and maturation in vitro.
J. Yochem, R. Fisher, M. Sunshine, and M. Feiss, Department of Microbiology, University of Iowa, Iowa City:
Analysis of the groP-C region of E. coli.
K. Krizsanovich-Williams, K. Chen, J. Donelson, and M. Feiss, Departments of Microbiology and Biochemis-
try, University of Iowa, Iowa City: cos- Lambda prophage-isolation and properties.
J.O. Thomas, N. Sternberg,* and R. Weisberg,* Department of Biochemistry, New York University Medical
School, New York; *NICHHD, National Institutes of Health, Bethesda, Maryland: Altered arrangement of
the DNA in injection-defective A.
P. Granboulan, Department of Microbiology, University of Basel, Switzerland, and Centre National de la
Recherche Scientifique, Gif-sur-Yvette, France: Light minor proteins of A.
FRIDAY MORNING, August 26
Session 6: Morphogenesis: P2, P4, and T phage
D.W. Bowden and R. Calendar, Department of Molecular Biology, University of California, Berkeley: Partial
purification and characterization of P2 "Ter" components.
D. Shore, C. Diana, and R. Goldstein, Department of Microbiology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts: Genetic and biochemical studies of a capsid-size determination mutant of
satellite phage P4.
C. Diana, D. Shore, and R. Goldstein, Department of Microbiology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts: Diploid and triploid progeny of the capsid-size direction mutant of satellite
phage P4-An analysis of the DNA packaging substrate and mature tandem DNA.
Y. Yamada, J. Silnutzer, and D. Nakada, Department of Biochemistry, University of Pittsburgh School of
Medicine, Pennsylvania: A host mutant which blocks T7 phage assembly.
B. Kemper, Institut kir Genetik der Universitat Köln, Weyertal, West Germany: Purification and preliminary
characterization of a gene-49-controlled nucleolytic activity of bacteriophage T4.
L.W. Black, Department of Biological Chemistry, University of Maryland Medical School, Baltimore: Studies on
the mechanism of DNA packaging into phage T4 heads.
C.L. Hsiao and L.W. Black, Department of Biochemistry, University of Maryland, Baltimore: The role of gene 40
in bacteriophage T4 head morphogenesis.
L. Onorato, B. Stirmer, and M. Showe, Department of Microbiology, Biozentrum, University of Basel, Switzer-
land: Expanded and unexpanded preheads produced by mutants in T4 head genes.
J. Tschopp and P.R. Smith, Departments of Biophysical Chemistry and Microbiology, Biozentrum, University of
Basel, Switzerland: Extra long T4 tails produced under in vitro conditions.
W. Earnshaw, J. King, S.J. Harrison,* and F.A. Eiserling,t Department of Biology, Massachusetts Institute of
Technology, Cambridge, *Department of Chemistry, Harvard University, Cambridge, Massachusetts;
tDepartment of Molecular Biology, University of California, Los Angeles: Orientation of DNA packing in
T4 giant phage.
P.B. Berget and J.A. King, Department of Biology, Massachusetts Institute of Technology, Cambridge: Charac-
terization of T4 baseplate precursors.
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S.C. (Cayman and J.A. King, Department of Biology, Massachusetts Institute of Technology, Cambridge:
Suppressors of temperature-sensitive gene-53 product in phage T4D.
A. Musafi, M. Baylor, and H. Fong, New York University Medical School, New York, and Biology Department,
State University of New York, Stony Brook: Conservation of some proteins of T-even phage.
FRIDAY AFTERNOON, August 26
Session 7: T phages-Nucleotide and nucleic acid metabolism
H.R. Warner, B.K. Duncan, T.J. Mozer, and R.B. Thompson, Department of Biochemistry, University of
Minnesota, St. Paul: Synthesis and properties of bacteriophage containing uracil in their DNA.
E. Kutter, B. Guttman, R. Schenck, B. Morton, R. Laiken, and E. Mosier, Evergreen State College, Washington:
Physiological effects of alc mutations.
C.G. Goff, Biology Department, Haverford College, Pennsylvania: Genetics of T4 proteins affecting E. coli RNA
polymerase after infection.
K. Sirotkin and L. Snyder, Department of Microbiology, Michigan State University, East Lansing: The biological
role of a T4-induced DNA phosphate shuttling enzyme.
D.H. Hall, K. Trofatter,* and D.L. Russel,* School of Biology, Georgia Institute of Technology, Atlanta;
*Department of Biochemistry, Duke University Medical Center, Durham, North Carolina: Suppressors of
mutations in gene 63 of bacteriophage T4.
T.J. Snopek, W.B. Wood,* and N.R. Cozzarelli, Department of Biochemistry, University of Chicago, Illinois;
*Division of Biology, California Institute of Technology, Pasadena: T4 RNA ligase is gene-63 product, the
protein that promotes tail-fiber attachment to the phage baseplate.
W.M. Huang, Department of Microbiology, University of Utah Medical Center, Salt Lake City: initiation
proteins of DNA replication in T -even bacteriophage-infected E. coli cells.
A.W. Kozinski, Department of Human Genetics, University of Pennsylvania, Philadelphia: The gene-32
protein-A factor protecting the integrity of the replicative fork and assuring unbiased replitation of both
parental DNA strands.
G. Mosig, S. Bock, W. Ream, and C. Hornaday, Department of Molecular Biology, Vanderbilt University,
Nashville, Tennessee: Multiple interactions of phage-T4 gene 32.
B.R. Baser and J.S. Wiberg, Department of Radiation Biology and Biophysics, University of Rochester School of
Medicine and Dentistry, New York: Separation of the two roles of protein 45 of bacteriophage T4D-
Temperature-insensitive DNA replication in vivo by a triple mutant of T4 synthesizing a temperature-
sensitive g45 protein.
P.D. Sadowski, L. Roberts, and R. Sheldon, Department of Medical Genetics, University of Toronto, Ontario,
Canada: Properties of the in vitro phage T7 recombination reaction.
J.J. Donegan and R. Sternglanz, Department of Biochemistry, State University of New York, Stony Brook:
Host- and phage-mediated resistance to nal id ixic acid (NAL) and novobiocin during col iphage T7 infection.
H.R. Revel and I. Lei lausis, Division of Biology, California Institute of Technology, Pasadena: Corrected location
of the rill gene on the genetic map of bacteriophage T4.
SATURDAY MORNING, August 27
Session 8: RNA phages, Transducing phages, and other phage systems
A.B. Jacobson, Department of Microbiology, State University of New York, Stony Brook: Electron microscopic
mapping of loops on single-stranded RNA from the bacteriophage MS2.
A. Rimon and R. Haselkorn, Department of Biophysics and Theoretical Biology, University of Chicago, Illnois:
RNA synthesis during bacteriophage 06 infection.
E. Goldman, W.M. Holmes, and G.W. Hatfield, Department of Medical Microbiology, University of California,
Irvine: RNA-phage-specific protein synthesis in vitro with tRNA'. isoaccepting species-Codon-anticodon
recognition.
A.R. Shaw and D.J. McCorquodale, Department of Biochemistry, Medical College of Ohio, Toledo: Mutants of
BF23 with deletions in their teminally redundant regions.
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J.N. Reeve and G. Mertens, Max-Planck-Institut fur Molekulare Genetik, Berlin, West Germany: Early develop-
ment of bacteriophages SPO1 and SP82G in minicells of B. subtilis.
J.A. Mayo and M. Ehrlich, Department of Microbiology, Louisiana State University Medical Center, and
Department of Biochemistry, Tulane Medical Center, New Orleans: Not all thymine-containing phage
DNAs can be labeled with radioactive thymidine.
F. Murillo, S. Martin, C. Manoi I, and D. Kaiser, Department of Biochemistry, Stanford University Medical School,
California: The use of bacteriophage to study cell-cell interactions in the development of myxobacteria.
C.K. Dasgupta and A. Guha, Department of Microbiology, Erindale College, University of Toronto, Ontario,
Canada: Isolation and characterization of the biotin genes of E. coli K12.
K.N. Kreuzer and N.R. Cozzarelli, Department of Biochemistry and the Committee on Genetics, University of
Chicago, Illinois: Isolation of X specialized transducing phages for the nalA region of E. coli.
A.M. Carothers, S. Palchaudhuri, T. Eckhardt, and E. McFall, Department of Microbiology, New York University
School of Medicine, New York: Isolation of a Xpdsd phage and its use for physical mapping of the o-serine
deaminase operon.
C.A. Irwin, G. Fletcher, J.M. Henson, and J.R. Walker, Department of Microbiology, University of Texas, Austin:
Characterization of X phages which carry the cell division-cell envelope genes near minute two on the E. coli
map.
L.D. Borchert and H. Drexler, Department of Microbiology and Immunology, Bowman Gray School of
Medicine. Wake Forest University, Winston-Salem, North Carolina: T1 genes which affect transduction.
J.A. Mayo, H.-W. Ackermann, and L. Berthiaume, Department of Microbiology, Louisiana State University
Medical Center, New Orleans; Faculty of Medicine, Laval University, Quebec, Canada; Institut Armand-
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SATURDAY EVENING, August 27
Session 1: In vitro replication
Chairperson: D.T. Denhardt, McGill University, Montreal, Quebec, Canada
S. Wickner, National Institutes of Health, Bethesda, Maryland: Conversion of single-stranded phage DNA to
double-stranded replicative forms in vitro.
S.L. Rowen, R. McMacken, and A. Kornberg, Department of Biochemistry, Stanford University School of
Medicine, California: Initiation of replication by dnaG primase.
L.J. Reha-Krantz and J. Hurwitz, Department of Developmental Biology and Cancer, Albert Einstein College of
Medicine, Bronx, New York: The dnaB-gene product of E. coli.
D. Capon and M. Gefter, Department of Biology, Massachusetts Institute of Technology, Cambridge: Initiation
of 95X174 replicative form synthesis in vitro.
S. Eisenberg, J.F. Scott, and A. Kornberg, Department of Biochemistry, Stanford University, California: An
enzyme system for replication of duplex circular OX174 RF and synthesis of circular single-stranded viral
DNA.
C. Sumida-Yasumoto, Department of Developmental Biology and Cancer, Albert Einstein College of Medicine,
Bronx, New York: OXREI DNA-dependent synthesis of OXRFI and 0174 viral DNA in vitro.
K. Geider, V. Berthold, M. Abdel-Monem, and H. Hoffman-Berling, Max-Planck-Institut fur Medizinische
Forschung, Heidelberg, West Germany: Functions of DNA-binding and unwinding proteins.
M.L. Bayne and L.B. Dumas, Department of Biochemistry and Molecular Biology, Northwestern University,
Evanston, Illinois: In vitro DNA synthesis on the isolated strands of phage fl RF DNA.
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SUNDAY MORNING, August 28
Session 2: In vivo replication I
Chairperson: I. Tessman, Purdue University, West Lafayette, Indiana
P.D. Baas, W.R. Teertstra, W. Keegstra, and H.S. Jansz, Institute of Molecular Biology and Laboratory for
Physiological Chemistry, State University, Utrecht, The Netherlands: Bacteriophage 0174 RF DNA replica-
tion in vivo.
K. Koths and D. Dressler, Harvard University, Cambridge, Massachusetts: An electron microscopic analysis of
the OX DNA replication cycle.
A. Sugino, C.L. Peebles, K.N. Kreuzer, and N.R. Cozzarelli, Departments of Biochemistry, Biophysics, and
Theoretical Biology, and Committee on Genetics, University of Chicago, Illinois: Mechanism of action of
nal id ixic acid and the interrelationship of the na/A-gene product, DNA gyrase, and a novel nicking-closing
enzyme.
K. Horiuchi, Rockefeller University, New York, New York: fl RFIV in vivo.
S. Dasgupta and S. Mitra, University of Tennessee Graduate School of Biomedical Science, Oak Ridge, and
Biology Division, Oak Ridge National Laboratory, Tennessee: Structure of nascent RF DNA of coliphage
M13.
B.E. Kessler-Liebscher, W.L. Staudenbauer, and P.H. Hofschneider, Max-Planck-Institut fur Biochemie,
Munich, West Germany: Replication of M13 duplex DNA in plasmolysed cells.
C. Hours and D. Denhardt, Department of Biochemistry, McGill University, Montreal, Quebec, Canada: 40(174
RF DNA as a probe of E. coli DNA metabolism.
A. Taketo and K. Kodaira, Department of Biochemistry, Kanazawa University School of Medicine, Ishikawa,
Japan: Properties of microvirid phages with special reference to their host-factor requirements.
T. Komano, H. Sakai, Y. Mano, K. Watabe, and Y. Takahashi, Department of Agricultural Chemistry, Kyoto
University, Japan: Requirement for dnaH, dnal, and dnaP functions in the growth of 4X174 and (0(174DNA
synthesis in vivo.
C.E. Dowell, Department of Microbiology, University of Massachusetts, Amherst: Change ina requirement for
DNA synthesis in host-range mutants of bacteriophages SO and 4A174.
SUNDAY EVENING, August 28
Session 3: In vivo replication II
Chairperson: D. Dressler, Harvard University, Cambridge, Massachusetts
F.C. Wheeler, E. Johnson, and R. Benzinger, Department of Biology, University of Virginia, Charlottesville:
Abnormal forms of fd phage and fd phage DNA.
M. Ohsumi, G.F. Vovis, and N.D. Zinder, Rockefeller University, New York, NewYork: Isolation and charac-
terization of f1 transducing particles.
J. Chen and D. Ray, Molecular Biology Institute, University of California, Los Angeles: Replication of bac-
teriophage M13 and its miniphage particles in E. coli polA ex1.
M. Farber and D.S. Ray, Molecular Biology Institute, University of California, Los Angeles: Clear mutants of
phage M13 affecting DNA replication.
V. Enea, J. Bergelson, and N.D. Zinder, Rockefeller University, New York, New York: Interference-resistant
mutants of fl.
A. Razin, A. Friedmann, and J. Friedman, Department of Cellular Biochemistry, Hebrew University-Hadassah
Medical School, Jerusalem, Israel: The role of DNA methylation in excision of one-genome-long 4X174
DNA.
T.J. Lerner and P. Model, Rockefeller University, New York, New York: RF synthesis late in ft infection.
R.K. Poddar, C.K. Dasgupta, U. Bandopadhyaya, and A.R. Thakur, Biophysics Section, Physics Department,
University College of Science, Calcutta, India: Repair of lesions on single-stranded DNA of phage OX174.
J. Das and J. Maniloff, Department of Microbiology, University of Rochester Medical Center, New York:
Replication of a single-stranded DNA mycoplasma virus-In vivo synthesis of virus-specific proteins.
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MONDAY MORNING, August 29
Session 4: DNA sequence studies
Chairperson: R.N.H. Konings, University of Nijmegen, The Netherlands
G.N. Godson and J.C. Fiddes, Medical Research Council Laboratory of Molecular Biology, Cambridge,
England: Sequencing G4 DNA.
D. Hourcade, J. Sims, and D. Dressler, Harvard University, Cambridge, Massachusetts: The site-specific
initiation of a DNA fragment.
A.D.M. van Mansfeld, S.A. Langeveld,* P.J. Weisbeek,* P.D. Baas,t H.S. Jansz,t and G.A. van Arkel,* Institute
of Molecular Biology, *Laboratory for Molecular Cell Biology, tLaboratory for Physiological Chemistry, State
University, Utrecht, The Netherlands: Nucleotide sequence at the replication origin of OX174 RF.
K. Sugimoto, H. Sugisaki, T. Takeya, T. Okamoto, and M. Takanami, Institute for Chemical Research, Kyoto
University, Japan: Sequence in a region covering genes X, V, VII, and VIII of bacteriophage fd.
J.V. Ravetch, K. Horiuchi, and N.D. Zinder, Rockefeller University, New York, New York: Nucleotide sequence
of a region related to the initiation of bacteriophage f1 DNA replication.
J.A. Lautenberger, C.A. Hutchison III, M.H. Edgell, S. Linn,* and D. Lackey,* Department of Bacteriology,
University of North Carolina, Chapel Hill; *Department of Biochemistry, University of California, Berkeley:
Localization of the nucleotide sequence recognized by the E. coli B modification enzyme on the replicative
form of OM 74sB-1.
J.H. Spencer, E. Rassart, F. Grosveld, and B. Goodchild, Department of Biochemistry, McGill University,
Montreal, Quebec, Canada: Location and sequence of the B-gene promoter in S13.
B.L. Smiley and R.C. Warner, Department of Molecular Biology and Biochemistry, University of California,
Irvine: Heteroduplex analysis and comparison of G4 and 0174 genomes.
J. French, I. Tessman, and E.S. Tessman, Department of Biological Sciences, Purdue University, West Lafayette,
Indiana: Genetics of G4.
C.A. Hutchison III, M.B. Edgell, M. Smith, S. Gil lam, P. Jahnke, and E. Trip, Department of Bacteriology and
Immunology, University of North Carolina, Chapel Hill, and Department of Biochemistry, University of
British Columbia, Vancouver: Techniques for specific alteration of the OX174 nucleotide sequence.
MONDAY AFTERNOON, August 29
Session 5: Transcription/Translation/Proteins
Chairperson: H.S. Jansz, State University, Utrecht, The Netherlands
T.J. Pollock and I. Tessman, Purdue University, West Lafayette, Indiana: Radiological mapping of functional
transcription units of bacteriophages 4X174 and S13.
T.J. Pollock, I. Tessman, and E.S. Tessman, Purdue University, West Lafayette, Indiana: Multiple products of
genes C, A, and G of phage 4X174 and read-through of the TGA codon.
T.J. Pollock and E.S. Tessman, Purdue University, West Lafayette, Indiana: Two sets of the four gene-G products
of 4iX174 and an assembly function of the gene-C product.
M.F. Shemyakin, E.A. Stukacheva, E.L. Kapitza, L.I. Patrushev, and M.M. Shemyakin, Institute of Bioorganic
Chemistry, Academy of Sciences of the USSR, Moscow: Studies on 4X174 genome expression in vitro.
P.D. Baas, W. Keegstra, W.R. Teertstra, and H.S. Jansz, Institute of Molecular Biology and Laboratory for
Physiological Chemistry, State University, Utrecht, The Netherlands: R loops in bacteriophage 0)(174 RF
DNA.
J.G.G. Schoenmakers, R.N.H. Konings, and L. Edens, Institute of Molecular Biology, University of Nijmegen,
The Netherlands: Mapping of promoters on the bacteriophage M13 genome.
M. La Farina and P. Model, Rockefeller University, New York, New York: Transcription in fl- infected E. coli.
P. Model, R.E. Webster, C. McGill, and M. Rementer, Duke University Medical Center, Durham, North
Carolina: Rockefeller University, New York, New York: Gene-V protein affects the synthesis of gene-II
protein.
P.J. Weisbeek, W.E. Borrias, and G.A. van Arkel, Laboratory for Molecular Cell Biology, State University,
Utrecht, The Netherlands: The gene A of 4iX174.
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L. Dubeau and D. Denhardt, Department of Biochemistry, McGill University, Montreal, Quebec, Canada:
Purification and properties of the 4X174 gene-A protein.
E.S. Tessman and P.K. Peterson, Department of Biological Sciences, Purdue University, West Lafayette, Indiana:
Genetic recombination of phage S13 in a host which overproduces the recA protein.
TUESDAY MORNING, August 30
Session 6: Structure and morphogenesis
Chairperson: D.S. Ray, University of California, Los Angeles
D.A. Marvin, European Molecular Biology Laboratory, Heidelberg, West Germany: Structure of the filamentous
phage virion.
L.A. Day, R.L. Wiseman, F.-C. Chen, and G. Koopmans, Public Health Research Institute, New York, New York:
DNA packing in three filamentous viruses, fd, Pf1, and Xf.
B. Chamberlain, R. Grant, J. Woolford, T. Yen, and R. Webster, Department of Biochemistry, Duke University
Medical Center, Durham, North Carolina: Interaction of the f1 and fd coat protein with membranes.
K. Hodgson, T. Lin, W. Konigsberg, and R. Webster, Department of Biochemistry, Duke University Medical
Center, Durham, North Carolina; Department of Molecular Biophysics and Biochemistry, Yale University,
New Haven, Connecticut: Isolation and characterization of a small protein from the fl filamentous bac-
teriophage.
N.L. Incardona, Microbiology Department, University of Tennessee Health Science Center, Memphis: Genetic
selection technique for eclipse mutants of 49X174.
H. Fujisawa and M. Hayashi, Department of Biology, University of California, San Diego: Assembly of
bacteriophage .0174-Identification of a virion capsid precursor and proposal of a model on the functions
of bacteriophage gene products during morphogenesis.
R. Mukai and M. Hayashi, Department of Biology, University of California, San Diego: Synthesis of infectious
0174 bacteriophage in vitro.
J. Messing, B. Gronenborn, B. Muller-Hill, and P.H. Hofschneider, Max-Planck-Institut fur Biochemie, Munich,
and Institut fiir Genetik, Universitat zu Köln, West Germany: The filamentous phage M13 as a receptor
molecule for in vitro recombined DNA.
SV40, POLYOMA, AND ADENOVIRUSES
arranged by
TERRI GRODZICKER, Cold Spring Harbor Laboratory
MICHAEL BOTCHAN, Cold Spring Harbor Laboratory
279 participants
WEDNESDAY EVENING, August 31
Session 1: SV40 and polyoma-Genetics
Chairperson: J. Mertz, University of Wisconsin, Madison
L. Crawford, C. Cole, and P. Tegtmeyer, Department of Biochemistry, Stanford University Medical Center,
California, and Department of Microbiology, State University of New York, Stony Brook: Proteins of the
SV40 early region.
N. Bouck, N. Beales, G. di Mayorca, T.E. Shenk,* C. Cole,t and P. Berg,t Department of Microbiology,
University of Illinois Medical Center, Chicago; *University of Connecticut Health Center, Farmington;
tDepartment of Biochemistry, Stanford University Medical School, California: Transformation-defective
viable deletion mutants of SV40.
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M.J. Sleigh, W.C. Topp, and J. Sambrook, Cold Spring Harbor Laboratory, New York: Viable deletion mutants of
SV40 restricted in their ability to induce transformation.
M. Fried, Y. Ito, and M. Griffiths, Imperial Cancer Research Fund Laboratories, London, England: Tantigens of
early-region deletion mutants of polyoma virus.
Y. Ito and J.R. Brocklehurst, Department of Cell Regulation, Imperial Cancer Research Fund Laboratories,
London, England: NG-18 fails to induce virus-specific proteins in the plasma membrane of infected 3T6
cells.
J.Y. Chou, Section on Developmental Enzymology, NICHHD, National Institutes of Health, Bethesda, Mary-
land: Human placental cells transformed by tsA mutants of SV40 and grown at a restrictive temperature
behave like normal placental cells.
M. Fluck and T. Benjamin, Pathology Department, Harvard Medical School, Boston, Massachusetts:
Properties of ts-a/A mutants of polyoma and SV40 in cell transformation.
B. Steinberg, R. Pollack, K. Nyman, A. Lo, W. Topp,* and M. Botchan,* Department of Microbiology, State
University of New York, Stony Brook; *Cold Spring Harbor Laboratory, New York: T-antigen-negative
revertants from transformed rat cells carrying one copy of SV40 DNA.
D. Zouzias and C. Basilico, Department of Pathology, New York University School of Medicine, New York:
Regulation of viral functions in SV40-transformed mouse cells.
THURSDAY MORNING, September 1
Session 2: SV40 and polyoma-Proteins
Chairperson: P. Tegtmeyer, State University of New York, Stony Brook
T.D. Kempe, W.G. Beattie, and W. Konigsberg, Department of Molecular Biophysics and Biochemistry, Yale
University School of Medicine, New Haven, Connecticut: Correlation of the nucleotide and protein
sequences for major structural protein of SV40 virus.
S.G. Siddell and A.E. Smith, Imperial Cancer Research Fund Laboratories, London, England: Polyoma virus has
three late mRNAs, one for each virion protein.
J. Silver, B. Schaffhausen, and T.L. Benjamin, Department of Pathology, Harvard Medical School, Boston,
Massachusetts: The size of T antigen in wild-type polyoma virus and an hr-t deletion mutant.
C.A.F. Edwards and R.G. Martin, Laboratory of Molecular Biology, NIAMDD, National Institutes of Health,
Bethesda, Maryland: Turnover of phosphorylated T antigen in SV40-transformed CHL cells.
C. Lawrence, K. Mann, T. Hunter, and G. Walter, Tumor Virology Laboratory, Salk Institute, San Diego,
California: Characterization of SV40-specific mRNA from He La cells infected with nondefective Ad2-SV40
hybrid viruses.
E. Paucha and A.E. Smith, Imperial Cancer Research Fund Laboratories, London, England: Cell-free synthesis of
94K and 17K T antigens.
C. Prives and Y. Beck, Department of Virology, Weizmann Institute of Science, Rehovot, Israel: Characterization
of SV40 T-antigen polypeptides.
D.M. Livingston, D.G. Tenen, A.P. Modest, A. Maxam, and W. Gilbert, Sidney Farber Cancer Institute, Harvard
Medical School, Boston, and The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Chemical and DNA binding properties of extensively purified SV40 T antigen.
R. Tjian, G. Fey, and A. Graessmann,* Cold Spring Harbor Laboratory, New York; *Freie Universitat, Berlin,
West Germany: SV40 T antigen and its related proteins from adenovirus-SV40 hybrids.
THURSDAY AFTERNOON, September 1
Session 3: Poster session on SV40 and polyoma
N.H. Acheson, Department of Virology, Swiss Institute for Experimental Cancer Research, Epalinges, Lausanne:
Extent of transcription of the E strand of polyoma DNA during the early phase of infection.
P. Beard, Department of Virology, Swiss Institute for Experimental Cancer Research, Epalinges, Lausanne:
Movement of histones on DNA.
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M. Bina-Stein, NCI, National Institutes of Health, Bethesda, Maryland: Folding of DNA by arginine-rich
histones.
S. Bratosin, 0. Laub, and Y. Aloni, Weizmann Institute of Science, Rehovot, Israel: Characterization of
transcriptional complexes of SV40 and determination of the initiation sites for transcription.
R.B. Carroll, D.S. Greenspan, S.M. Goldfine, and W.F. Mangel,* Department of Pathology, New York University
Medical Center, New York; *Department of Biochemistry, University of Illinois, Urbana: Immunogenicity
and multiple isoelectric focusing forms of SV40 T antigen and comparison of the tryptic fingerprints of T
antigens synthesized in vivo and in vitro.
C. Chang, S.W. Luborsky, and P.T. Mora, Macromolecular Biology Section, NCI, National Institutes of Health,
Bethesda, Maryland: Biological and biochemical properties of SV40-induced TSTA.
N. Chiu and N.P. Salzman, Laboratory of Biology of Viruses, NIAID, National Institutes of Health, Bethesda,
Maryland: The metabolism of SV40 RNA in cultured BSC-1 cells studied with a rapid uridine pulse-chase.
B. Cogen and W. Eckhart, Tumor Virology Laboratory, Salk Institute, San Diego, California: Virus-specific early
RNA in cells infected by temperature-sensitive mutants of polyoma virus.
H.J. Edenberg, S. Anderson, and M.L. DePamphilis, Department of Biological Chemistry, Harvard Medical
School, Boston, Massachusetts: Identification of the DNA polymerases involved in SV40 DNA replication.
G. Fey, A. Bothwell,* and A. Graessmann,t Cold Spring Harbor Laboratory, New York; *Massachusetts Institute
of Technology, Cambridge; tFreie Universitat, Berlin, West Germany: Helper function is provided by a small
carboxy-terminal domain of SV40 T antigen.
M. Fiori, M.M. Pater, and G. di Mayorca, Department of Microbiology, University of Illinois Medical Center,
Chicago: BK virus genome in transformed cells and in human tumors.
W.R. Folk and I.E. Bancuk, Department of Biological Chemistry, University of Michigan, Ann Arbor: Polyoma
DNA synthesis in ts-a-transformed BHK 21 cells.
A.H. Fried, Institute fur Virusforschung, Deutsches Krebsforschungszentrum, Heidelberg, West Germany:
Relative rates of synthesis of the mRNA and non-mRNA sequences from the L strand of SV40 DNA late after
infection.
M. Green, J.K. Mackey, and W.S.M. Wold, Institute for Molecular Virology, St. Louis University School of
Medicine, Missouri: Absence of BK virus DNA from DNA extracted from human tumors and malignant cell
lines.
P. Hale and J. Lebowitz, Department of Microbiology, University of Alabama Medical Center, Birmingham: In
vitro transcription of SV40 DNA by E. coli RNA polymerase-Effect of chemical modification of DNA on
binding of RNA polymerase.
J.R. Hartman, 0. Laub,* Y. Aloni,* and E. Winocour, Departments of Virology and *Genetics, Weizmann
Institute of Science, Rehovot, Israel: Transcription of the host DNA sequences in substituted SV40.
R. Kamen, J. Favaloro, and M. Fried, Imperial Cancer Research Fund Laboratories, London, England: In vivo
transcription of the defective polyoma virus D50.
G. Ketner and T.J. Kelly, Jr., Departments of Biology and Microbiology, Johns Hopkins University, Baltimore,
Maryland: The structure of integrated SV40 DNA in transformed cells.
M. Botchan, S. Weirich, and W. Topp, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York: The
integration of SV40 DNA and its rescue from rat chromosomal DNA.
H. Manor, Z. Lev, and R. Kamen,* Department of Biology, Technion, Haifa, Israel; *Department of Molecular
Virology, Imperial Cancer Research Fund Laboratories, London, England: Mapping of polyoma-specific
RNA sequences within poly(A)-containing giant RNA molecules isolated from polyoma-infected cells.
R.C. Moyer, M.P. Moyer, G. Lipotich, H. Hurtado, and D. Davis, Thorman Cancer Research Laboratory, Trinity
University, San Antonio, Texas: Maintenance of SV40 DNA fragments in permissive monkey cells.
L.W. Mozes and V. Defendi, Department of Pathology, New York University School of Medicine, NewYork:
The effect of interferon on SV40 T-antigen production.
B. Otto and E. Fanning, Fachbereich Biologie, University of Konstanz, West Germany: Replication enzymes in
SV40 nucleoprotein complexes.
C. Prives, Y. Gluzman, and E. Winocour, Weizmann Institute of Science, Rehovot, Israel:Cellular and cell-free
synthesis of T antigen in permissive and transformed cells.
S. Riva, M.A. Cline, and P.J. Laipis, Department of Biochemistry, University ofFlorida, Gainesville: Effect of
SV40 infection on DNA polymerase activity in monkey cells.
G. Sauer, K. Boss let, and W. Waldeck, Institut kir Virusforschung, Deutsches Krebsforschungszentrum, Heidel-
berg, West Germany: A new transforming papovavirus (HD virus).
113
A. Sen and G.J. Todaro, Laboratory of Viral Carcinogenesis, NCI, National Institutes of Health, Bethesda,
Maryland: DNA binding specificity of proteins purified from BALB/3T3 cells transformed by DNA tumor
viruses and by chemical carcinogens.
D.T. Simmons, K.K. Takemoto, and M.A. Martin, Laboratory of Biology of Viruses and Laboratory of Viral
Diseases, National Institutes of Health, Bethesda, Maryland: Relationships between papovavirus tumor
antigens.
T. Takano, Department of Microbiology, Keio University School of. Medicine, Tokyo, Japan: Expression of
baboon endogenous virus genome in human diploid cells transformed by SV40.
W.C. Topp, Cold Spring Harbor Laboratory, New York: Transformation of rat cells by restriction-
endonuclease-generated fragments of SV40.
H. -Rider and C. Salomon, Department of Molecular Biology, University of Geneva, Switzerland: Polyoma T
antigen.
R. Yang and R. Wu, Department of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca,
New York: BK virus DNA-Physical maps and sequences analysis.
THURSDAY EVENING, September 1
Session 4: Genome structure
Chairperson: M. Botchan, Cold Spring Harbor Laboratory, New York
B. Thimmappaya, V.B. Reddy, R. Dhar, K.N. Subramanian," B.S. Zain,t and S.M. Weissman, Department of
Human Genetics, Yale University School of Medicine, New Haven, Connecticut; *University of Chicago
Medical Center, Illinois; tCold Spring Harbor Laboratory, New York: Nucleotide sequence of the early
region of SV40 DNA.
V.B. Reddy, J. Pan, M. Celma, R. Dhar, K.N. Subramanian,* and S.M. Weissman, Department of Human
Genetics, Yale University School of Medicine, New Haven, Connecticut; *University of Chicago Medical
Center, Illinois: Nucleotide and mRNA sequences from the late region of SV40 DNA.
T. Friedmann, Medical Research Council Laboratory of Molecular Biology, Cambridge, England, and Depart-
ment of Pediatrics, University of California, San Diego: Nucleotide sequences around the origin of replica-
tion and start of mRNA transcription in polyoma DNA.
H. Rosenberg, M.F. Singer,* and M. Rosenberg, Laboratory of Molecular Biology and *Laboratory of Biochemis-
try, NCI, National Institutes of Health, Bethesda, Maryland: --3.5 x 108 Base pairs of the monkey genome-
Nucleotide sequence, characterization, and occurrence in defective SV40.
M.W. Gutai and D. Nathans,* Department of Medical Viral Oncology, Roswell Park Memorial Institute, Buffalo,
New York; *Department of Microbiology, Johns Hopkins University School of Medicine, Baltimore, Mary-
land: Nucleotide sequences at recombinant joints of SV40 variants.
F.J. O'Neill and D. Carroll, Veterans Administration Hospital, Research Service, and Department of Microbiol-
ogy, University of Utah, Salt Lake City: Characterization of defective SV40 DNA generated and amplified in
infected human glioblastoma cells, A172.
T. Shenk, Department of Microbiology, University of Connecticut Health Center, Farmington: Construction of a
viable variant of SV40 which contains two functional origins of DNA replication.
S. Goldberg and V. Defendi, Department of Pathology, New York University School of Medicine, New York:
Phenotypic and genotypic changes in doubly transformed cells.
A.J. van der Eb, Sylvius Laboratories, University of Leiden, The Netherlands: Recent studies on adenovirus and
SV40 transformation genes.
FRIDAY MORNING, September 2
Session 5: Adenoviruses: Transcription
Chairperson: M. Green, St. Louis University, Missouri
S.M. Berget, A.J. Berk, and P.A. Sharp, Center for Cancer Research. Massachusetts Institute of Technology,
Cambridge: Spliced segments at the 5' termini of Ad2 late mRNA.
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D.F. Klessig, Cold Spring Harbor Laboratory, New York: Two adenovirus mRNAs have a common 5'-terminal
leader sequence which is encoded at least 10 kilobases upstream from the main coding regions for these
messengers.
A.R. Dunn and J.A. Hassell, Cold Spring Harbor Laboratory, New York: Evidence for homology between
individual adenovirus mRNAs and multiple discrete areas of the viral genome.
L.T. Chow, R.E. Gelinas, T.R. Broker, and R.J. Roberts, Cold Spring Harbor Laboratory, New York: 5' Leader
sequences on late adenovirus mRNAs.
G. Kitchingman, S.-P. Lai, H.C. Meissner, and H. Westphal, NICHHD, National Institutes of Health, Bethesda,
Maryland: Nonadjacent sequences of virion DNA are linked in early cytoplasmic adenovirus transcripts.
A.J. Berk, S.M. Berget, and P.A. Sharp, Center for Cancer Research, Massachusetts Institute of Technology,
Cambridge: Biosynthesis of the Ad2 early mRNAs.
N.W. Fraser and E. Ziff, Department of Molecular Cell Biology, Rockefeller University, New York, New York:
Analysis of 3'-terminal regions of late Ad2 mRNAs.
R.M. Evans, N.W. Fraser, and E. Ziff, Department of Molecular Cell Biology, Rockefeller University, New York,
New York: Promotion of transcription of Ad2.
M. Mc Grogan and H.J. Raskas, Departments of Pathology and Microbiology, Washington University School of
Medicine, St. Louis, Missouri: Two regions of the Ad2 genome specify families of late mRNA containing
common sequences.
FRIDAY AFTERNOON, September 2
Session 6: Poster session adenoviruses
M. Arens and T. Yamashita, Institute for Molecular Virology, St. Louis University School of Medicine, Missouri:
In vitro termination of adenovirus DNA synthesis by a soluble replication complex.
J. Arrand, Division of Virology, National Institute of Medical Research, London, England: Analysis of adenovirus
mutants using DNA infection techniques.
S. Bachenheimer, Department of Bacteriology and Immunology, University of North Carolina, Chapel Hill: A
tentative intermediate in the processing of adenovirus nuclear precursor RNA into cytoplasmic mRNA.
D.H. Coombs and G.D. Pearson, Department of Biochemistry and Biophysics, Oregon State University,
Corvallis: Filter-binding assay for the adenovirus covalent DNA-protein complex.
F. Eggerding, D. Spector, M. Mc Grogan, and H.J. Raskas, Departments of Pathology and Microbiology,
Washington University School of Medicine, St. Louis, Missouri: Effect of protein-synthesis inhibitors on viral
mRNAs synthesized early in Ad2 infection.
M.S. Farber and S.G. Baum, Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York:
Transcription and translation of adenovirus mRNA in nonpermissive infection of monkey cells.
S.J. Flint and H. Weintraub, Princeton University, New Jersey: An altered subunit configuration associated with
actively transcribed DNA of the integrated adenovirus genome.
E. Fro lova, E. Zalmanzon, and E. Lukanidin, Institute of Molecular Biology, Academy of Sciences of the USSR,
Moscow: Transcription of fragments of viral DNA in Ad5-transformed cell lines.
K. Fujinaga, K. Sekikawa, and S. Ojima, Department of Molecular Biology, Cancer Research Institute, Sapporo
Medical College, Japan: Analysis of Ad7 genome by restriction endonuclese
K. Fujinaga, S. Yano, Y. Sawada, S. Ojima, K. Shiroki, and H. Shimojo, Department of Molecular Biology,
Cancer Research Institute, Sapporo Medical College, and Department of Tumor Virus Research, Institute of
Medical Science, University of Tokyo, Japan: Transforming DNA segments of Ad12.
D. Galloway, E. Lukanidin,* W. Topp, and J. Sambrook, Cold Spring Harbor Laboratory, New York; *Academy
of Sciences of the USSR, Moscow: Transformation of rat cells by the hybrid virus Ad2"HEY.
R.F. Geste land, N. Wills, J.B. Lewis, and T. Grodzicker, Cold Spring Harbor Laboratory, New York: Nonsense
mutants of Ad2"ND1.
M.L. Harter and J.B. Lewis, Cold Spring Harbor Laboratory, New York: Comparison of adenovirus-specific early
proteins synthesized in human cells and in vitro.
D. Kuhn and W. Doerfler, Institute of Genetics, University of Cologne, West Germany: Integration patterns of
Ad12 DNA in transformed hamster cells.
J.K. Mackey, M. Green, and W.S.M. Wold, Institute for Molecular Virology, St. Louis University School of
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Medicine, Missouri: Grouping of human adenovirus serotypes according to DNA and transforming DNA
fragment homology.
I. Mak, J. Smiley, S. Mak, and F. Graham, Biology Department and Pathology Department, McMaster University,
Hamilton, Ontario, Canada: Transformation of rat cells by DNA fragments of human Ad12 DNA.
J.L. Manley and R.F. Gesteland, Cold Spring Harbor Laboratory, New York: Characterization of ribosome-
protected regions of Ad2 late mRNAs.
M.B. Mathews and U. Pettersson,* Cold Spring Harbor Laboratory, New York; *Biomedical Center, Uppsala,
Sweden: The gene for polypeptide IX.
T. Mu Ilenbach, D. Groff, and E. Daniell, Department of Molecular Biology, University of California, Berkeley:
Adenovirus DNA replication-Generation of defective genomes of serotypes 2, 3, and 5 in permissive and
nonpermissive cells.
K. Nass and G.D. Frenkel, Department of Microbiology and Immunology, Albany Medical College, New York:
Adenovirus-induced inhibition of cellular DNase III.
B.M. Paterson, E.L. Kuff, B.E. Roberts,* and M.B. Matthews,t National Cancer Institute, Bethesda, Maryland;
*Brandeis University, Waltham, Massachusetts; tCold Spring Harbor Laboratory, New York: Mapping
messenger RNAs to adenovirus DNA by hybrid arrested cell-free translation.
U. Pettersson and M.B. Matthews,* Biomedical Center, Uppsala, Sweden; *Cold Spring Harbor Laboratory,
New York: Virus-associated RNAs-Enumeration and mapping of their genes.
E. Lukanidin,* T. Grodzicker, J. Lewis, D. Galloway, and J. Sambrook, *Institute of Molecular Biology, Academy
of Sciences of the USSR, Moscow; Cold Spring Harbor Laboratory, New York: Revertants of host-range
mutants of Ad2+ND1.
J. Schick, E. Fanning, and W. Doerfler, Institute of Genetics, University of Cologne, West Germany: Factors
affecting the amount of integrated viral DNA sequences in cells productively infected with Ad2.
A. Sergeant and H.J. Raskas, Departments of Pathology and Microbiology, Washington University School, of
Medicine, St. Louis, Missouri: Chromatinlike organization of the Ad2 genome early in the lytic cycle.
K. Shiroki, H. Handa, H. Shimojo, S. Yano, S. Ojima, and K. Fujinaga, Department of Tumor Virus Research,
Institute of Medical Science, University of Tokyo, and Department of Molecular Biology, Cancer Research
Institute, Sapporo, Japan: Establishment and characterization of rat cell lines transformed by restriction
endonuclease fragments of Ad12 DNA.
M.J. Sleigh and J. Sambrook, Cold Spring Harbor Laboratory, New York: Interserotypic recombination-A
mechanism for adenovirus evolution?
J. Weber and J. Hassell,* Departement de Microbiologie, Centre Hospital ier Universitaire, Sherbrooke, Quebec,
Canada; *Cold Spring Harbor Laboratory, New York: Mapping of Ad2 mutants and structural genes.
FRIDAY EVENING, September 2
Session 7: SV40 and polyoma-Transcription
Chairperson: L. Crawford, Imperial Cancer Research Fund Laboratories, London, England
Y. Aloni, R. Dhar, 0. Laub,* M. Hurowitz,* and G. Khoury, Laboratory of DNA Tumor Viruses, NCI, National
Institutes of Health, Bethesda, Maryland; *Weizmann Institute of Science, Rehovot, Israel: A novel mecha-
nism for RNA maturation-The leader sequences of SV40 mRNA are not transcribed adjacent to the coding
sequences.
S. Lavi and Y. Groner, Virology Department, Weizmann Institute of Science, Rehovot, Israel: The capped 5'
terminus of SV40 16S mRNA is coded by DNA sequences not adjacent to VP-1 coding region.
J.P. Ford and M.T. Hsu, Rockefeller University, New York, New York: Mapping the 5' ends of late SV40 mRNA
using a new technique.
J.E. Mertz, J.B. Gurdon,* and E.M. De Robertis,* McArdle Laboratory for Cancer Research, University of
Wisconsin, Madison; *Laboratory of Molecular Biology, Medical Research Council, Cambridge, England:
Characterization of the viral products synthesized in Xenopus oocytes injected with SV40 DNA.
T. White, L. Villarreal, C. Cole, and P. Berg, Department of Biochemistry, Stanford University Medical Center,
California: Molecular weights of SV40 RNAs and a specific map position for nuclear polyadenylation.
M. Grigoryan, P. Chumakov, E. Lukanidin, and G. Georgiev, Institute of Molecular Biology, Academy of
Sciences of the USSR, Moscow: SV40 gene expression in transformed cells.
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E. Birkenmeier, N. Chiu, M. Radonovich, and N.P. Salzman, Laboratory of Biology of Viruses, NIAID, National
Institutes of Health, Bethesda, Maryland: Control of early and late SV40 RNA synthesis without concurrent
viral DNA synthesis.
R. Condit, A. Cowie, R. Kamen, and M. Fried, Imperial Cancer Research Fund Laboratories, London, England:
Transcription of a defective polyoma virus genome.
C.-K.J. Shen and J.E. Hearst, Department of Chemistry, University of California, Berkeley: SV40 DNA-The
identification of symmetric sequences and the stabilization of transcription complexes by psoralen photo-
chemical crosslinking.
SATURDAY MORNING, September 3
Session 8: Adenoviruses-Genetics and proteins
Chairperson: J. Williams, Carnegie-Mellon University, Pittsburgh, Pennsylvania
N. Jones and T. Shenk, Department of Microbiology, University of Connecticut Health Center, Farmington:
Isolation of deletion and substitution mutants in Ad5.
E. Frost and J. Williams,* Institute of Virology, Glasgow, Scotland; *Department of Biological Sciences, Mellon
Institute, Carnegie-Mellon University, Pittsburgh, Pennsylvania: Mapping temperature-sensitive and host-
range mutations of Ad5 by marker rescue.
N.J. Lassam, F.L. Graham, and S.T. Bayley, Department of Biology, McMaster University, Hamilton, Ontario,
Canada: Production of virus-specific proteins by host-range mutants of Ad5.
W.S.M. Wold, Y.-H. Jeng, and M. Green, Institute for Molecular Virology, St. Louis University School of
Medicine, Missouri: Studies on Ad2-induced early and transformation proteins.
J.H. Lupker, A. Davis, H. Jochemsen, and A.J. van der Eb, Sylvius Laboratories, University of Leiden, The
Netherlands: Identification and partial characterization of "transforming" proteins of Ad5.
W.C. Russell, G.E. Blair, D.K. Rekosh, and C.H. Shaw, Division of Virology, National Institute for Medical
Research, London, England: Studies on regulatory mecnanisms in adenovirus infection.
H. Handa, K. Shiroki, and H. Shimojo, Department of Tumor Virus Research, Institute of Medical Science,
University of Tokyo, Japan: A helper factor(s) for growth of adeno-associated virus in cells transformed by
Ad 12.
A. Mirza and J. Weber, Departement de Microbiologie, Centre Hospital ier Universitaire, Sherbrooke, Quebec,
Canada: Core structure and decapsidation of a temperature-sensitive mutant of Ad2.
R.M.L. Buller and J.A. Rose, Laboratory of Biology of Viruses, NIAID, National Institutes of Health, Bethesda,
Maryland: Mechanism of host restriction of adeno-associated virus replication in African green monkey
kidney cells.
SATURDAY AFTERNOON, September 3
Session 9: Adenoviruses-Replication
Chairperson: T.J. Kelly, Jr., Johns Hopkins University, Baltimore, Maryland
J. Arrand and R.J. Roberts,* Imperial Cancer Research Fund Laboratories, London, England; *Cold Spring Harbor
Laboratory, New York: The nucleotide sequences of the termini of Ad2 DNA.
R. Lechner and T.J. Kelly, Jr., Johns Hopkins University School of Medicine, Baltimore, Maryland: Electron
microscopy of replicating Ad2 DNA molecules.
B. Weingartner, T. Reiter, and E.-L. Winnacker, Institute of Biochemistry, University of Munich, West Germany:
Two terminal initiation sites for Ad2 DNA replication.
J.S. Sussenbach, P. Steenbergh, and T. Kuijk, Laboratory for Physiological Chemistry, State University, Utrecht,
The Netherlands: Initiation of adenovirus DNA replication.
A.J. Robinson and G.D. Pearson, Department of Biochemistry and Biophysics, Oregon State University,
Corvallis: Replicating adenovirus molecules contain terminal protein.
L.M. Kaplan and M.S. Horwitz, Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New
York: Selective extraction of Ad2 DNA from infected nuclei-A soluble system for the replication of viral
DNA.
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C. Tibbetts, Department of Microbiology, University of Connecticut School of Medicine, Farmington: Expres-
sion of the Ad7 genome in cells infected by virions and incomplete particles.
E. Fanning and W. Doerfler, Institute of Genetics, University of Cologne, West Germany: Nature and occurrence
of high-molecular-weight DNA in productively infected cells.
J.L. Corden and G.D. Pearson, Department of Biochemistry and Biophysics, Oregon State University, Corvallis:
Adenovirus chromatin.
SUNDAY MORNING, September 4
Session 10: SV40 and polyoma-Replication
Chairperson: M. Fried, Imperial Cancer Research Fund Laboratories, London, England
M.T. Hsu and R. Fernandez-Munoz, Rockefeller University, New York, New York: Isolation and characteriza-
tion of SV40 nucleoprotein complexes isolated from SV40-infected CV-1 cells.
M.A. Waciar, M.J. Evans, D. Kowalski, Y. Tsubota, B.I. Milavetz, and J.A. Huberman, Department of Medical
Viral Oncology and Enzymology Laboratory, Roswell Park Memorial Institute, Buffalo, New York: Enzymes
associated with replicating SV40 chromosomes.
E. Shelton, K. Goh, J. Kang, P. Wassarman, and M. DePamphilis, Department of Biological Chemistry, Harvard
Medical School, Boston, Massachusetts: Structure and replication of SV40 chromatin.
J. Reiser, L.V. Crawford, and G.R. Stark, Department of Biochemistry, Stanford University Medical Center,
California: Association of SV40 T antigen with SV40 chromatin.
M.K. Hobish and V. Pigiet, Johns Hopkins University, Baltimore, Maryland: Polyoma chromatin replication in
vitro-Template specificity of Xenopus replication factors.
F. Birg, R. Kamen,* and M. Fried, INSERM, Marseille, France; *Imperial Cancer Research Fund Laboratories,
London, England: Characterization of the viral DNA in polyoma-virus-transformed rat cells.
S. Gattoni, D. Zouzias, and C. Basil ico, Department of Pathology, New York University School of Medicine,
New York: Nonintegrated viral DNA in rat cells transformed by polyoma virus.
P. Bourgaux, L. Delbecchi, K. Yu, and D. Bourgaux-Ramoisy, Departement de Microbiologie, Centre Hos-
polyoma
virus genome.
M.A. Israel, H. Chan, and M.A. Martin, Laboratory of Biology of Viruses, NIAID, National Institutes of Health,
Bethesda, Maryland: Biologic activity of polyoma DNA in animals.
DIFFERENTIATION OF NORMAL AND NEOPLASTIC
HEMATOPOIETIC CELLS
arranged by
BAYARD CLARKSON, Memorial Sloan-Kettering Cancer Center
PAUL A. MARKS, Columbia University
JAMES TILL, University of Toronto
129 participants
TUESDAY EVENING, September 6
Opening: J.D. Watson, Cold Spring Harbor Laboratory
Introductory remarks: J. Till, University of Toronto
Session 1: Ontogeny of hematopoietic development and stem cells I
Chairperson: J. Till, Ontario Cancer Institute, University of Toronto, Canada
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N. Le Douarin, Institut d'Embryologie du CNRS et du College de France, Nogent-sur-Marne,France: Ontogenyof hematopoietic organs studied in avian embryo interspecific chimeras.
I. Weissman, V. Papaioannou,* and R.Gardner,* Department of Pathology, Stanford University Medical Center,California; *Department of Zoology, Oxford University, England: Fetal hematopoietic origins of the adulthematolymphoid system.
G.R. Johnson and D. Metcalf, Cancer Research Unit, Walter and Eliza Hall Institute of Medical Research,Melbourne, Australia: In vitro clonal analysis of fetal hepatic hematopoiesis.
T.M. Dexter, Paterson Laboratories, Christie Hospital, and Holt Radium Institute, Withington, Manchester,England: In vitro analysis of self-renewal and commitment of hematopoietic stem cells.J.E. Till, S. Lan, R. Buick, J.E. Curtis, and E.A. McCullock, Ontario Cancer Institute, Toronto, Canada: Ap-proaches to the evaluation of human hematopoietic stem-cell function.
WEDNESDAY MORNING, September 7
Session 2: Stem cells // and committed erythroid precursor cells
Chairperson: P.A. Marks, Columbia University, New York, New York
R.A. Philips, Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, Canada:Stem-cell heterogeneity-Pluripotent and committed stem cells of the myeloid and lymphoid systems.J.W. Byron, Department of Pharmacology and Experimental Therapeutics, University of Maryland School ofMedicine, Baltimore: Histamine H2 receptor and the colony-forming unit-spleen.
A.A. Axelrad and D.L. McLeod, Division of Histology, Department of Anatomy, University of Toronto, Canada:Regulation of population size of erythropoietic progenitor cells.G. Van Zant and E. Goldwasser, Department of Biochemistry and Franklin McLean Memorial Research Institute,University of Chicago, Illinois: The competitive effects of erythropoietin and colony stimulation factor onhematopoietic cells.
N.N. Iscove and L.J. Guilbert,* Basel Institute for Immunology, Switzerland; *Friedrich Miescher-Institut, Basel,Switzerland: Regulation of proliferation and maturation at early and late stages of erythropoiesis.
C.J. Gregory and A.C. Eaves, British Columbia Cancer Foundation, Vancouver, Canada: In vitro studies of
erythropoietic progenitor cell differentiation.
D. Housman, R. Geller, R. Levenson, and J. Gusella, Center for Cancer Research, Massachusetts Institute of
Technology, Cambridge: Clonal analysis of in vitro differentiation of murine erythroleukemia cells.
R.A. Rifkind, E. Fibach, R.C. Reuben, H. Yamasaki, I.B. Weinstein, M. Terada, U. Nudel, Y. Gazitt, and P.A.
Marks, Department of Medicine and Human Genetics and Development, Columbia University, New York,New York: Erythroleukemia cells-Commitment to differentiate and the role of the cell surface.
WEDNESDAY EVENING, September 7
Session 3: Erythrocyte differentiation and regulation
Chairperson: V.M. Ingram, Massachusetts Institute of Technology, Cambridge
P.A. Marks, R.A. Rifkind, A. Bank, M. Terada, R. Reuben, R. Breslow, E. Fibach, U. Nudel, Y. Gazitt, and J.
Salmon, Cancer Research Center, Columbia University College of Physicians and Surgeons, New York, NewYork: Induction of murine erythroleukemia cells to differentiate-Cell-cycle-related events in expressionof erythroid differentiation.
I.W. Adamson, J.E. Brown, and W.J. Popovic, Hematology Research Laboratory, Veterans Administration
Hospital, and University of Washington, Seattle: Modulation of in vitro erythropoiesis.
A. Bernstein and D.L. Mager, Ontario Cancer Institute, Toronto, Canada: Early membrane events in Friend-cell
erythroid differentiation.
.R. Neumann, M.G. Riggs, H.K. Hagopian, L.A. Swartz, and V.M. Ingram, Department of Biology, Mas-
sachusetts Institute of Technology, Cambridge: Chromatin changes in Friend erythroleukemia and He La cellsduring treatment with DMSO and n-butyrate.
-I. Eisen, S. Sassa,* D. Granick,* and F. Keppel,t Institut Pasteur, Paris, France; *Rockefeller University, New
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York, New York; +University of Geneva, Switzerland: Two interdependent developmental programs ex-
pressed in inauced Friend cells.
A. Nienhuis, D. Axelrod, J. Barker, E. Benz, Jr., R. Croissant, D. Miller, and N. Young, Clinical Hematology
Branch, NHLBI, National Institutes of Health, Bethesda, Maryland: Regulation of the individual globin genes.
M. Obinata, R. Kameji, Y. Uchiyama, and Y. Ikawa, Laboratory of Viral Oncology, Cancer Institute, Tokyo,
Japan: Sequential gene expression during induced differentiation of cultured Friend erythroleukemia cells.
THURSDAY MORNING, September 8
Session 4: Granulocyte and monocyte differentiation and regulation
Chairperson: M. Moore, Memorial Sloan-Kettering Cancer Center, New York, New York
A.W. Burgess, D. Metcalf, and S. Russell, Cancer Research Unit, Walter and Eliza Hall Institute of Medical
Research, Parkville, Australia: Regulation of hematopoietic differentiation and proliferation by colony
stimulating factors.
M.J. Cline, T. Olofsson, M. Frolich, D.W. Golde, and S. Herman, Department of Medicine, University of
California School of Medicine, Los Angeles: Inhibitors of granulopoiesis.
G.B. Price and R.L. Krogsrud, Ontario Cancer Institute, Toronto, Canada: Use of molecular probes for detection
of human hematopoietic progenitors.
Z.A. Cohn, Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, New York:
The differentiation and activation of mononuclear phagocytes.
M.A.S. Moore, Memorial Sloan-Kettering Cancer Center, New York, New York: Regulatory interactions in
normal and leukemic myelopoiesis.
P.L. Greenberg and B. Mara, Department of Medicine, Stanford Medical Center, and Veterans Administration
Hospital, Palo Alto, California: Microenvironmental influences on granulopoiesis in acute myeloid leuke-
mia.
L. Sachs, Department of Genetics, Weizmann Institute of Science, Rehovot, Israel: Control of normal cell
differentiation and malignancy in myeloid leukemia.
THURSDAY EVENING, September 8
Session 5: Lymphocyte differentiation and regulation
Chairperson: H. Cantor, Harvard Medical School, Boston, Massachusetts
H. Cantor, Department of Medicine, Harvard Medical School, Boston, Massachusetts: Lymphocyte differentia-
tion and regulation of the immune system.
G. Sundharadas, C.E. Hayes, M.L. Sopori, P.R. Narayanan, B.J. Alter, M.L. Bach, and F.H. Bach, Immunobiology
Research Center, and Departments of Medical Microbiology, Pediatrics, Medical Genetics, and Surgery,
University of Wisconsin, Madison: Differentiation of precursor cytotoxic T lymphocytes following alloan-
tigenic stimulation.
G. Goldstein, Ortho Pharmaceutical Corporation, Raritan, New Jersey: Polypeptides regulating lymphocyte
differentiation.
A.E. Silverstone, N. Rosenberg, V.L. Sato,* M.P. Scheid,i- E.A. Boyse,t and D. Baltimore, Massachusetts Institute
of Technology, Cambridge; *The Biological Laboratories, Harvard University, Cambridge, Massachusetts;
t Memorial Sloan-Kettering Cancer Center, New York, New York: Tumor models for murine lymphoid
progenitor cells.
J.L. Strominger, Department of Biochemistry and Molecular Biology, The Biological Laboratories, Harvard
University, Cambridge, Massachusetts: Cell surface antigens of human lymphocytes.
F. Melchers, Basel Institute for Immunology, Switzerland: B- lymphocyte development and growth regulation.
J.W. Uhr, J. Cambier, J. Kettman, F. Ligler, S. Strober,* I. Zan-Bar,* and E. Vitetta, Southwestern Medical School,
Dallas, Texas; *Stanford University Medical School, Palo Alto, California: IgD and B-cell differentiation.
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FRIDAY MORNING, September 9
Session 6: Viruses, transformation, and differentiation
Chairperson: D. Baltimore, Massachusetts Institute of Technology, Cambridge
W.P. Rowe, Laboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland: The
virology of AKR lymphomagenesis.
E.M. Scolnick, D.H. Troxler, T.Y. Shih, H.A. Young, and D. Linemeyer, NCI, National Institutes of Health,
Bethesda, Maryland: A molecular model for the origin and nature of transforming genes of mammalian RNA
sarcoma and leukemia viruses.
R.A. Lerner, J.H. Elder, and F.C. Jensen, Scripps Clinic and Research Foundation, La Jolla, California: The
multigene family of endogenous proviruses encoding virion and differentiation antigens-Recombination
between family members during neoplasia.
J. Rommelaere and N. Hopkins, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge:
Recombinational origin of mink cell focus viruses as indicated by RNA fingerprinting and oligonucleotide
mapping.
I. Weissman and M. McGrath, Department of Pathology, Stanford University Medical Center, California: A
receptor-mediated model of viral leukemogenesis-Hypothesis and experiments.
R.A. Steeves and F. Lilly, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York: The
effect of FV-2r gene on spleen focus-forming virus and on embryonic development.
W.D. Hardy, Jr., E.E. Zuckerman, E.G. MacEwen, and M. Essex, Laboratory of Veterinary Oncology, Memorial
Sloan-Kettering Cancer Center, New York, New York, and Department of Microbiology, Harvard University,
Boston, Massachusetts: A feline leukemia and sarcoma-virus-induced tumor-specific antigen.
FRIDAY EVENING, September 9
Session 7: Viruses, transformation, and differentiation
Chairperson: E.M. Scolnick, NCI, National Institutes of Health, Bethesda, Maryland
T. Graf, H. Beug, W. Meyer-Glauner and B. Royer-Pokora, Max-Planck-Institut fiir Virusforschung,
Biologisch-Medizinische Abteilung, Tilbingen, West Germany: Transformation of chick bone marrow cells
by avian erythroblastosis virus-A new model system for normal and neoplastic erythroid differentiation.
S.D. Waksal, Department of Pathology and Cancer Research Center, Tufts School of Medicine, Boston,
Massachusetts: Differentiation and leukemic transformation of thymus-derived lymphocytes.
N.M. Teich and T.M. Dexter,* Imperial Cancer Research Fund, London; *Paterson Laboratory, Manchester,
England: The influence of murine leukemia virus infection upon hematopoietic differentiation of bone
marrow cultures.
R. Gallo, R. Ruscetti, and R. Gallagher, NCI, National Institutes of Health, Bethesda, Maryland: Human
leukocytes and type-C viral markers-Complex association signals the need for improved biological study
systems.
H.S. Kaplan, Cancer Biology Research Laboratory, Department of Radiology, Stanford University Medical
Center, California: Studies of an RNA virus isolated from a human histiocytic lymphoma cell line.
SATURDAY MORNING, September 10
Session 8A: Cytogenetics and expression of cell-surface antigens
Chairperson: J.D. Rowley, University of Chicago, Illinois
J.D. Rowley, Department of Medicine, University of Chicago, Illinois: Nonrandom involvement of
chromosomal segments in human hematologic malignancies.
A. Skoultchi, S. Benoff, S. Bruce, P. Lin, H. Lonial, and J. Pyati, Department of Cell Biology, Albert Einstein
College of Medicine, Bronx, New York: Genetic control of hemoglobin production by murine eryth-
roleukemic cells.
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I. Trowbridge, Salk Institute, San Diego, California: Genetic analysis of lymphocyte surface
ynthesis.
ior Roosevelt Institute for Cancer Research, Denver, Colorado: The role of cAMP and the cellular
system in cancer.
arrow architecture and microenvironment
.M. Fliedner, University of Ulm, West Germany
and W. Calvo, Department of Clinical Physiology, University of Ulm, West Germany:
etic stem-cell seeding of a cellular matrix-A principle of initiation and regeneration of
-son Laboratories, Christie Hospital, and Holt Radium Institute. Manchester, England: Cellular
ctural factors influencing the proliferation of hematopoietic stem cells.
NCI, National Institutes of Health, Bethesda, Maryland: Orderly cell proliferation and
on in relation to kinetic heterogeneity-Mouse bone marrow as an experimental model.
SATURDAY AFTERNOON, September 10
:linical-pathological relationships and differentiation of human hematopoietic tumors I
H.S. Kaplan, Stanford University School of Medicine, Palo Alto, California
/, R. Pahwa, B. Dupont, and R.A. Good, The Marrow Transplantation Unit, Memorial
tering Cancer Center, New York, New York: The use of fetal liver as a source of lymphoid stem
ransplantation and immunologic reconstitution of severe combined immunodeficiency.
/, Leukaemia Unit, Medical Research Council, Royal Postgraduate Medical School, London,
Cell characterization in leukemia by surface markers, cytochemistry, and ultrastructure.
es, G. Janossy, and J. Minowada, Department of MembraneImmunology, Imperial Cancer Research
boratories, London, England: Antigenic and enzymatic phenotypes of human leukemic cells and
hed leukemic cell lines.
r, R. Mertelsmann, and D. Filippa, Memorial Sloan-Kettering Cancer Center, New York, New York:
lymphoid neoplasias of T and null cell types.
nann, J.L. Preud'homme, and C.J. Brouet, Laboratory of Immunochemistry, Hopital Saint-Louis, Paris,
ce: Membrane markers in human lymphoid malignancies-Clinical-pathological correlations and
ght into the differentiation of normal and neoplastic cells.
appaport, G.A. Pangalis, and B.N. Nathwani, Department of Anatomic Pathology, City of Hope National
Medical Center, Duarte, California: The evolution of malignant lymphomas in morphologically non-
neoplastic immunoproliferative diseases.
SUNDAY MORNING, September 11
Session 10: Clinical-pathological relationships and differentiation of human hematopoietic tumors II
Chairperson: K. Lennert, University of Kiel, West Germany
K. Lennert, E. Kaiserling, and H.-K. Muller-Hermelink, Department of Pathology, University of Kiel, West
Germany: Malignant lymphomas-Models for differentiation and cooperation of lymphoreticular cells.
A.L. Epstein, S. Gartner, and H.S. Kaplan, Cancer Biology Research Laboratory, Department of Radiology,
Stanford University Medical Center, California: In vitro cultivation and characterization of human malignant
lymphomas.
R. Lukes, Department of Pathology, University of Southern California School of is,w.f icine, Los Angeles:
Immunological approach to malignant lymphomas.
P.J. Fialkow, Medical Service, Veterans Administration Hospital, and Departments of ) cine and Genetics,
University of Washington, Seattle: Stem-cell and clonal origin of human hematc; neoplasms studied
with G-6-PD markers.




JOSEPH KATES, State University of New York, Stony Brook
SAMUEL DALES, University of Western Ontario, Canada
54 participants
WEDNESDAY EVENING, October 12
Informal get-together and planning session
THURSDAY MORNING, October 13
Session 1: DNA Structure
C.V. Cabrera and M. Esteban, Department of Microbiology, Rutgers Medical School, Piscataway, New Jersey: A
procedure for purification of intact DNA from vaccinia virus.
L.G. Gafford, E. Bruce Mitchell, Jr., and C.C. Randall, University of Mississippi Medical Center, Jackson: A
comparison of sedimentation behavior of three poxvirus DNAs.
M. Soloski, E. Esteban, and J.A. Holowczak, Rutgers Medical School, Piscataway, New Jersey: Evidence for
proteins linked to the termini of vaccinia DNA molecules.
A. Weissbach, Roche Institute of Molecular Biology, Nutley, New Jersey: Analysis of vaccinia DNA by
reassociation kinetics.
G. Jaureguiberry, Institut de Recherche en Biologie Moleculaire du CNRS, Paris, France: Cleavage of vaccinia
virus DNA by restriction endonuclease isolation of the cross-links.
R.J. McCarron, C.V. Cabrera, M. Esteban, W.T. McAllister, and J.A. Holowczak, Rutgers Medical School,
Piscataway, New Jersey: Structure of vaccinia DNA-Analysis of the viral genome by restriction endonucle-
ases.
THURSDAY AFTERNOON, October 13
Session 2: Replication
M. Esteban, C. Cabrera, and J.A. Holowczak, Department of Microbiology, Rutgers Medical School, Piscata-
way, New Jersey: Proposed model for vaccinia DNA replication.
B.G. Pogo, Public Health Research Institute of the City of New York, New York: The mode of replication of
vaccinia virus DNA.
W.R. Bauer, E.G. Ressner, and J. Kates, Microbiology Department, State University of New York, Stony Brook:
Properties of a topoisomerase and a superhel ix-binding protein isolated from vaccinia virions.
A. Weissbach, Roche Institute of Molecular Biology, Nutley, New Jersey:The nature of the vaccinia-specific
DNA and RNA found in the nucleus and cytoplasm of vaccinia-infected HeLa cells.
R. Goorha, G. Murti, and A. Granoff, St. Jude Children's Hospital, Memphis, Tennessee: The nucleus is a site of
frog virus 3 DNA and RNA synthesis.
E. Katz, Chanock Centre for Virology, Hebrew University, Hadassah Medical School, Jerusalem, Israel:
Biochemical and maturational events during the growth of vaccinia virus in the presence of isatin
(3-thiosemicarbazone.
W.H.R. Langridge, Boyce Thompson Institute, Yonkers, New York: In vitro entomopoxvirus protein synthesis in
permissive cells.
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FRIDAY MORNING, October 14
Session 3: Transcription
D. Willis, R. Goorha, and A. Granoff, St. Jude Children's Hospital, Memphis, Tennessee: Transcriptional and
posttranscriptional regulation of gene expression by frog virus 3.
M. Nowakowski,* J. Kates,± and W. Bauer,t *Downstate Medical Center, State University of New York,
Brooklyn; tState University of New York, Stony Brook: Isolation of two DNA-binding proteins from the
intracellular replication complex of vaccinia virus.
W.K. Joklik and J.R. Nevins, Department of Microbiology and Immunology, Duke University Medical Center,
Durham, North Carolina: Isolation from infected cells and characterization of a DNA-dependent RNA
polymerase and a poly(A) polymerase specified by vaccinia virus.
E. Paoletti, Division of Laboratories and Research, New York State Department of Health, Albany, New York:
Under standard in vitro RNA polymerase reaction vaccinia virus rapidly depletes ATP.
M. Esteban, C.V. Cabrera, and J.A. Holowczak, Rutgers Medical School, Piscataway, New Jersey: Transcription
of vaccinia DNA by E. coli RNA polymerase-Visualization and physical location of RNA transcripts.
C.V. Cabrera, M. Esteban, R. McCarron, W.T. McAllister, and J.A. Holowczak, Rutgers Medical School,
Piscataway, New Jersey: Vaccinia virus transcription-Hybridization of mRNA to restriction fragments of
vaccinia DNA.
R.F. Boone and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Sequence complexity and
relative abundance of vaccinia virus mRNAs synthesized in vivo and in vitro.
FRIDAY AFTERNOON, October 14
Session 4: Transcription/Translation/Immunological taxonomy
A. Gershowitz and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Formation of high -
molecular- weight RNA by vaccinia virus cores in the presence of /3,y- analogs of ATP.
E. Barbosa and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Purification and characteri-
zation of an mRNA (nucleoside-2')-methyl transferase from vaccinia virions.
G. Monroy, E. Spencer, and J. Hurwitz, Department of Developmental Biology and Cancer, Albert Einstein
College of Medicine, Bronx, New York: Characteristics of the reaction catalyzed by GTP:RNA guanylyl
transferase isolated from vaccinia virus.
J.A. Cooper and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Translation of vaccinia virus
mRNA coupled to transcription in vitro.
I. Horak and M. Kaerlein, Institut fur Virologie and Immunbiologie der Universitat Wilirzburg, West Germany:
Vaccinia virus-induced modification of ribosomes in HeLa cells.
M. Schrom and R. Bablanian, Downstate Medical Center, State University of New York, Brooklyn: Inhibition of
protein synthesis by vaccinia virus.
J.J. Esposito, J.F. Obijeski, and J.H. Nakano, Center for Disease Control, Atlanta, Georgia: Differentiation of
variola, monkeypox, and vaccinia viruses by serological and biochemical assays.
SATURDAY MORNING, October 15
Session 5: Mutants, culture growth/Effects of virus on host function
S. Dales and G. McFadden, Department of Bacteriology and Immunology, University of Western Ontario,
Canada: Biogenesis of vaccinia -Isolation of conditional lethal mutants and electron microscopic charac-
terization of their phenotypically expressed defects.
R. Drillien, Laboratory of Virology, University of Strasbourg, France: Phenotypic characterization of two
vaccinia virus is mutants.
R. Raghow, St. Jude Children's Hospital, Memphis, Tennessee: Heat-inactivated frog virus 3.
R. Drillien, Laboratory of Virology, University of Strasbourg, France: Cell killing by frog virus 3.
A.-M. Aubertin, Laboratory of Virology, University of Strasbourg, France: Properties of proteins solubilized from
Fv-3 particles-Inhibition of cellular DNA synthesis.
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IN-HOUSE SEMINARS
Cold Spring Harbor in-house seminars were initiated to provide a
semiformal avenue for communication between the various research
groups at the laboratory. They are particularly useful for research
personnel who have joined the laboratory during the summer. The
seminars also afford a necessary opportunity for the graduate students
and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, semi-
nars were given by many others involved in research at this laboratory.
1976 -1977
October
22nd Dr. Ron Reeder, Carnegie Institution of Washington, Baltimore, Maryland: Studies on Xenopus 185 and 285 transcrip-
tion.
November
12th Dr. John Coffin, Tufts University, Boston, Massachusetts: Studies on RNA tumor viruses.
15th Drs. Z. Goldberg and G. Weber, Rockefeller University, New York, New York: Studies on adenovirus transcription.
23rd Dr. Nina Fedoroff, Carnegie Institution of Washington, Baltimore, Maryland: Sequence analysis of cloned 55 gene
sequences from Xenopus.
30th Dr. Ken Yamada, National Cancer Institute, Bethesda, Maryland: Studies on the LETS protein.
December
4th Special seminar on developmental genetics of Drosophila
and Dr. W. Gelbart, Harvard University, Cambridge, Massachusetts
5th Dr. Jerry Rubin, Stanford University, California
Dr. John Postlethwaite, University of Oregon, Eugene
Dr. Michael Ashburner, University of Cambridge, England
Dr. Walter Gehring, University of Basel, Switzerland
7th Dr. Harold Weintraub, Princeton University, New Jersey: Studies on chromatin.
14th Dr. Keith Bachman, Harvard University, Cambridge, Massachusetts: Studies on phage lambda genetics.
February
3rd Dr. Peter Rae, Yale University, New Haven, Connecticut: Studies on unusual bases in algae DNA.
March
10th Dr. Karl Illmense, The Jackson Laboratories, Bar Harbor, Maine: Drosophila and the problem of determination.
29th Dr. Larry Gold, University of Colorado, Boulder: The T4 gene-32 protein: A unique solution to a special problem.
April
7th Dr. George Kuo, Yale University: Maternal contributions to embryogenesis in Drosophila.
22nd Dr. David Livingston, Sidney Farber Cancer Center, Boston, Massachusetts: Recent studies on the 5V40 T antigen.
28th Dr. Clark Tibbetts, University of Connecticut, Farmington: Genome structure and transcription of the adenoviruses.
May





Another aspect of the summer program at the Laboratory is the participation of college undergraduate students in
active research projects under the supervision of full-time laboratory staff members. The program was initiated in
1959. Since that year, 184 students have completed the course, and many have gone on to creative careers in
biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental principles of biology,
(2) an increased awareness of major problem areas under investigation, (3) better understanding of the physical and
intellectual tools for modern research and the pertinence of this information to future training, and (4) a personal
acquaintance with research, research workers, and centers for study.
The following students, selected from a large number of applicants, took part in the program, which is now
mainly supported by Laboratory funds. They are listed below, with their laboratory sponsors and topics of research.
We gratefully acknowledge the generosity of Central General Hospital, Plainview, New York, which provided
additional support.
Vicki Lynn Brawley, University of
California, Berkeley
Supervisor: N. Harter




Mapping of a new gene controlling
the synthesis of an unusual
growth factor in E. coli
Jason S. Fisherman, Yale In situ assays for restriction
University endonucleases
Supervisor: R. Roberts
Robert Frank Hanich, Harvard Big T and little t in deletion
University mutants of SV40
Supervisor: R. Tjian
Cynthia L. Sammis, Wells
College
Supervisor: L.B. Chen







Studies on the synthesis of LETS
protein
Microinjection into X. leavis
oocytes






Iris Isabella Martinez, University
of California, Berkeley
Supervisor: D. Zipser
Two-dimensional separation of DNA
restriction fragments
The expression of cloned yeast




The Nature Study Program is designed for elementary and high school students who wish to achieve a greater
understanding of their environment. During the spring, summer, and fall, a total of 404 students participated in this
program. When weather permitted, most of the courses were held outdoors on Laboratory grounds or at Uplands
Farm Nature Preserve of the Nature Conservancy. The Laboratory has built and equipped classroom/laboratories at
Uplands Farm for the study of field specimens collected by the students.
This spring a Long Island Field Geology course was conducted, which included trips to such sites as the Montauk
Peninsula, North and South Shores of Long Island, and the State University of New York at Stony Brook. The
instructor was Steven Englebright, Curator of Geology, SUNY at Stony Brook.
In the fall, Observational Astronomy was offered as an introduction to all facets of celestial observation.
Photography as related to astronomy was emphasized, making use of our fully- equipped darkroom. Telescopes for
the observation sessions were provided by Toy Town/Sports Town of Huntington. Equipment and technical
assistance were provided by the Astronomical Society of Long Island and the Long Island Observers Association.
This summer a series of one-day Marine Biology Workshops was conducted on Long Island Sound aboard a
65-foot schooner, the RN Tradewind, chartered from Schooner, Inc., of New Haven, Connecticut. The vessel was
equipped with a variety of instrumentation and staffed by a captain, mate, and marine biologists. Students
participated in the biological studies and in the actual sailing of the Tradewind.
Program director: Sanford Kaufman, M.S., M.P.A., biology teacher, Hewlett
INSTRUCTORS
Linda Bovich, M.S., science teacher, Rocky Point High School
Donn Dunn, M.S., art and photography teacher, Hewlett High School
Steven Englebright, M.S., curator of geology, SUNY at Stony Brook
Fred Maasch, M.Ed., biology teacher, Islip High School
James Romansky, M.S., biology teacher, Bay Shore High School













Nature Photography I and II













































































































































ADMINISTRATIVE Sarah Jaime Chapin











































year ended October 31, 1977
with comparative figures for 1976
ASSETS
1977 1976
LIABILITIES AND FUND BALANCES
1977 1976
CURRENT FUNDS CURRENT FUNDS
Unrestricted Unrestricted
Cash $ 269,437 $ (68,573 ) Accounts payable $ 68,291 $ 49,097
Marketable securities - 85,903 Due to plant funds 417,178 293,468
Accounts receivable 89,366 66,739 Due to Banbury Educational Center 42,951
Inventory of books 121,937 212,839 Fund balance 199,544 178,695
Prepaid expenses 68,704 33,921
Due from restricted fund 135,569 233,382
Total unrestricted 685,013 564,211 Total unrestricted 685,013 564,211
Restricted Restricted
Grants receivable 2,396,218 728,974 Due to unrestricted funds 135,569 233,382
Fund balance 2,260,649 495,592
Total restricted 2,396,218 728,974 Total restricted 2,396,218 728,974
Total current funds 3,081,231 1,293,185 Total current funds 3,081,231 1,293,185
ENDOWMENT FUNDS ENDOWMENT FUNDS
Robertson Research Fund
Cash 96,492 82,144








(quoted market $20,951) 21,510
Total Olney Memorial Fund
Total endowment funds
22,060 18,728
Fund balance 7,978,156 7,650,2787,978,156 7,650,278
PLANT FUNDS PLANT FUNDS
Investment 84,508 85,037
Due from unrestricted fund 270,362 293,468
Land and improvements 719,545 595,954
Buildings 5,171,784 2,315,592
Furniture, fixtures, and equipment 792,690 614,980
Books and periodicals 365,630 365,630
Construction in progress 24,136 17,211
7,428,655 4,287,872
Less allowance for depreciation
and amortization 1,143,102 867,187
Total plant funds 6,285,553 3,420,685 Fund balance 6,285,553 3,420,685
BANBURY EDUCATIONAL CENTER BANBURY EDUCATIONAL CENTER
Cash 4,178 59,424




Due from unrestricted fund 42,951
Fund balance
1,537,907 1,606,979Total operating funds Operating 1,537,907 1,606,979
Land 772,500 772,500
Buildings 384,234 245,000
Furniture, fixtures, and equipment 147,887 113,343
Construction in progress - 3,954
1,304,621 1,134,797
Less allowance for depreciation 45,211 14,221
Total plant funds 1,259,410 1,120,576 Plant 1,259,410 1,120,576
Total Banbury Educational Center 2,797,317 2,727,555 Total Banbury Educational Center 2,797,317 2,727,555
Total-All funds $20,142,257 $15,091,703 Total-All funds $20,142,257 $15,091,703
CURRENT REVENUES, EXPENDITURES, AND TRANSFERS
year ended October 31, 1977









Grants $2,133,568 $1,918,414 Endowment income $ 107,291 $
Indirect cost allowance on grants 957,464 783,683 Contributions
Contributions (including land, buildings, and
Unrestricted 37,529 170,799 furnishings in 1976) 15,000 1,230,843
Restricted 25,000 - Rooms and apartments 12,750 11,646
Long Island Biological Association 194,000 - Appropriation from






19,754 Total revenues 196,084
1,242,489
Marina rental 38,000 35,430 EXPENDITURES
Investment income 10,430 10,363 Operation and maintenance of plant 56,665 65,361
Publications sales 383,196 289,698 General and administrative 12,545 13,301






11,762 Total expenditures 239,035 78,662
Total revenues 4,706,620 4,080,167 Excess (deficit) of revenues
EXPENDITURES
over expenditures ($42,951) $1,163,827
Research* 2,014,119 1,722,024
Summer programs* 342,544 371,888
Library 100,927 82,927
Operation and maintenance of plant 638,316 626,047
General and administrative 497,863 446,570
Publications sales* 303,829 225,863
Dining hall* 211,647 190,354
Total expenditures 4,109,245 3,665,673
TRANSFERS
Plant funds 515,483 403,464
Banbury Educational Center 61,043 -
Total transfers 576,526 403,464
Total expenditures and transfers 4,685,771 4,069,137
Excess of revenues
over expenditures and transters $ 20,849 $ 11, 030
*Reported exclusive of an allocation for operation and maintenance of plant,
general and administrative, and library.
NOTE: Copies of the complete financial statements, prepared by our independent auditors, Peat, Marwick, Mitchell & Co., are available upon
request from the Comptroller, Cold Spring Harbor Laboratory.
GRANTS
November 1, 1976 - December 31, 1977
NEW GRANTS
Grantor
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Helen Hay Whitney Foundation
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Principal investigator
and program Total award
Contract-advanced bacterial
genetics workshop $ 35,500 6/29/77- 6/30/78
Dr. Watson-Cancer Research
Center 13,185,000







training 48,600 5/16/77- 10/31/77

















































































Alfred P. Sloan Foundation
Volkswagen Foundation
Principal investigator Duration of
and program Total award grant
Dr. Watson-general research
support $ 46,495 4/1/76 3/31/77
Contract-advanced bacterial
genetics workshop 25,325 7/1/76 6/30/77
Dr. Watson-herpes virus workshop 22,000 6/30/76 6/29/77
Dr. Watson-conference on origins
of human cancer 60,000 6/30/76 6/29/77
Dr. Maniatis-research subcontract
from Harvard 26,850 7/1/76- 12/31/76
Dr. Bukhari-career development 150,000 5/1/75 4/30/80
Dr. Hassell-fellowship 26,000 10/1/75 9/30/77
Dr. Watson-Cancer Research
Center 7,789,000 1/1/72 12/31/76
Dr. Watson-Symposium support 96,000 4/1/74 3/31/79
Dr. Zipser-research 356,000 5/1/74 4/30/79
Dr. Gesteland-summer workshops 190,620 4/1/74 3/31/77











































The Cold Spring Harbor Laboratory is a publicly supported educational institution chartered by the University of
the State of New York and may receive contributions which are tax exempt under the provisions of the Internal
Revenue Code, particularly Section 501C. In addition, the Laboratory has been formally designated a "public
charity" by the Internal Revenue Service. Accordingly, it is an acceptable recipient of grants which would result
from the termination of "private" foundations.
The Laboratory depends upon the generous contributions of its sponsors, participating institutions, and friends
for central institutional needs and capital improvements. In addition, the development of any new programs, such
as year-round research in neurobiology and the marine sciences, can only be undertaken with substantial support
from private sources.
Methods of contributing to Cold Spring Harbor Laboratory
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
(1) Your broker or bank may sell the securities and remit the proceeds directly to the Laboratory.
(2) If you wish to send stock directly to the Laboratory, either (a) endorse the certificate(s) by signingyour name
on the back, leave the space for the transferee's name blank, have your signature guaranteed on the
certificate(s) by your bank or broker, and send the certificate(s) by registered mail to the Laboratory, or (b)
send unsigned certificate(s) with a covering letter and send under separate cover a stock power executed in
blank, with signature guarantee, for each certificate, and also a copy of the covering letter (use first-class
mail). Depreciated securities should be sold to establish a tax loss, then the contribution to the Laboratory
should be made by check.
Bequests
Probably most wills need to be updated. Designating Cold Spring Harbor Laboratory as a beneficiary ensures
that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program and can sell
others.
Life insurance and charitable remainder trusts can be structured to suit the donor's specific desires as to extent,
timing, and tax needs.
Conversion of private foundation to "public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the
private foundation could be accounted for as a separate fund and used for the purposes specified by the donor.
Alternatively, the private foundation can be established as a "supporting organization of Cold Spring Harbor
Laboratory."
For additional information, please contact the Administrative Director, Cold Spring Harbor Laboratory, P.O.
Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-692-6660.
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to Cold Spring Harbor Laboratory
Mr. W. French Anderson Pfizer, Inc.
Dr. & Mrs. Seymour Benzer Dr. Fred Rapp
Dr. Rolf Benzinger Mrs. Willis L. M. Reese
Dr. & Mrs. Paul Berg Dr. Werner E. Reichardt
Ms. Pamela Boffa Ms. Harriet L. Rice
Dr. Arik Brissenden Mr. Charles Robertson
Victor And Nancy Bruce Mrs. Donald W. Rose
Mr. & Mrs. John F. Carr Dr. Robert Schleif
Mr. Lon Chaikin Mrs. Franz Schneider
Ms. E. E. Clark Dr. & Mrs. W. Shropshire, Jr.
Chubb & Son, Inc. Dr. J. N. Spuhler
CIBA-GEIGY Corp. Dr. Gunther Stent
Mr. Roderick H. Cushman S. G. and D. L. Stephens
Mr. Lawrence L. Davis Dr. Takashi Sugimura
Dr. & Mrs. Lester Dubnick Dr. & Mrs. Samuel Teich
Mr. Walter N. Frank, Jr. Dr. Charles A. Thomas, Jr.
Mr. & Mrs. Frank Furth Felix & Hannah Wassermann
Dr. Martin Gellert Dr. James D. Watson
Mr. & Mrs. Folger P. Gifford Dr. Charles A. Werner
Dr. & Mrs. H. Bentley Glass Mrs. Alexander M. White
Mr. William R. Grant The Wohlers Family
Dr. & Mrs. Maurice Green Mr. William S. M. Wold
Dr. & Mrs. Alfred D. Hershey Woodhull School
Dr. Ira Herskowitz
Dr. Alexander Hollaender
Mr. & Mrs. David !graham
Dr. R. V. Lewis
Mrs. V. S. Littauer
Dr. Paul Margolin
Dr. & Mrs. Julius Marmur
Miss Leila L. McKnight
Mr. Calvin S. McLaughlin
Dr. & Mrs. Walter C. Meier
Dr. N. E. Melechen
Merck & Co.
Mrs. Agnes Meyer
Morgan Guaranty Trust Co.
Dr. Takeharu Nishimoto
Dr. Masayasu Nomura
Dr. Clarence P. Oliver
Mr. & Mrs. Walter H. Page




LIBA tour of laboratory grounds
The Laboratory was founded in 1890 by several local philanthropists and the Brooklyn Institute of Arts
and
Sciences. The first chairman of the Board of Managers of the Laboratory was
Eugene G. Blackford, who served from
1890 until his death in 1904. William J. Matheson succeeded him, serving until 1923.
In that year, when the Brooklyn Institute of Arts and Sciences withdrew from Cold Spring Harbor,
the local
supporters of the research formalized their efforts by incorporating as the Long Island Biological Association.
Colonel T.S. Williams became the first Chairman of the new group. Jointly with the Carnegie Institution
of
Washington, LIBA continued to support and direct the research at Cold Spring Harbor Laboratory.
In 1962 the Laboratory was reorganized as an operating organization
and LIBA relinquished its management
responsibilities. During the past 15 years, LIBA's chief function has been to widen the interest of the community
in








Mr. Walter H. Page
Mr. James A. Eisenman
Mrs. James J. Pirtle, Jr.
Mr. William R. Udry
DIRECTORS
Class of 1977 Class of 1978 Class of 1979
Class of 1980
Mr. Duncan Cox Mr. Ralph J. Maffei Mr. David C. Clark
Mrs. Charles 0. Ames
Mr. Arthur M. Crocker Mr. James A. McCurdy Mr. Roderick H. Cushman
Mr. Charles S. Gay
Mr. James A. Eisenman Mr. Walter H. Page Mr. Norris W. Darrell, Jr.
Mr. George J. Hossfeld, Jr.
Mr. Nevil Ford Mr. Gerard Piel
Mrs. William A. Flanigan, Jr. Mr. Samuel D. Parkinson
Mr. Angus P. McIntyre Mrs. Edward Everett Post Mr. Walter N. Frank, Jr.
Mr. William Parsons, Jr.
Mrs. Robert H. P. Olney Mrs. Richardson Pratt Mr. Clarence E. Galston
Mr. Edward Pulling
Mrs. James J. Pirtle, Jr. Mr. Richard J. Weghorn Mr. Theodore Wickersham
Dr. James D. Watson
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CONTRIBUTORS
to the Long Island Biological Association
Mr. & Mrs. Thomas Ackerman
Mr. & Mrs. Warren S. Adams II
Mr. & Mrs. Amyas Ames
Mrs. Charles E. Ames
Mr. & Mrs. Charles 0. Ames
Dr. & Mrs. Oakes Ames
Mr. & Mrs. Hoyt Ammidon
Mrs. Henry H. Anderson
Mr. & Mrs. J. S. Armentrout
Mr. & Mrs. Donald Arthur
Mr. & Mrs. Geoffrey Ashton
Dr. & Mrs. Joseph T. August
Dr. & Mrs. Alfred Azzoni
Mr. Henry D. Babcock, Jr.
Mr. & Mrs. Benjamin H. Balkind
Mrs. Gilbert Ball
Mr. & Mrs. George C. Barclay
Mr. & Mrs. Edmund Bartlett
Mrs. E. Farrar Bateson
Mr. & Mrs. E. Farrar Bateson, Jr.
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Mr. & Mrs. Nicholas Biddle, Jr.
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Mr. & Mrs. A. L. Boorstein
Dr. & Mrs. George Bowen
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Mr. & Mrs. Rolla Campbell
Mr. & Mrs. Ward C. Campbell
Mr. & Mrs. William Carl
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Miss Joan Chodkowski
Mr. & Mrs. Charles M. Clark
Mr. & Mrs. David C. Clark
Dr. & Mrs. Bayard Clarkson
Mr. & Mrs. John H. Coleman
Mr. Bradley Collins
Mr. & Mrs. Michael Collins
Mr. & Mrs. Patrick Collins
Mrs. Ralph C. Colyer
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Mr. & Mrs. Howard Corning, Jr.
Mr. & Mrs. Duncan B. Cox
Mr. E. V. Cox, Jr.
Mr. & Mrs. Charles L. Craig
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Mr. & Mrs. Arthur M. Crocker
Mr. Robert L. Cummings
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